a:1499:{i:80965;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:203:"A non-NHP because listed in Schedule IV of the Controlled Drugs and Substances Act as follows: 23. Anabolic steroids and their derivatives including: (36) Prasterone (3ß--hydroxyandrost--5--en--17--one)";s:25:"field_non_nhp_rationale_f";s:211:"Un non PSN à cause de sa présence à l'Annexe IV de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants:  (36) prastérone (hydroxy–3ß androstène–5 one–17)";s:19:"field_old_rationale";s:688:"DHEA is a natural substance produced in the adrenal glands, gonads and brain; and is metabolized to other steroid hormones. Meanwhile DHEA is a natural steroid hormone produced from cholesterol by the adrenal glands and it is the most abundant hormone precursor in the human blood. DHEA is chemically similar to testosterone and estrogen and is easily converted into those hormones. It cannot be obtained from the barbasco root or wild yam in the Mexican forest as some authorities thinks.  DHEA is excluded from the Schedule F sex hormones and covered under the anabolic steroids and their derivatives, under Schedule IV of the CDSA and therefore, it will be considered as such, not NHP.";s:16:"field_legacy_nid";s:5:"76273";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Prasterone";s:5:"title";s:10:"Prasterone";s:3:"nid";s:5:"80965";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80966;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:265:"A non-NHP because listed in Schedule I of the Controlled Drugs and Substances Act as follows: Opium Poppy (Papaver somniferum), its preparations, derivatives, alkaloids and salts, including: (3) Morphine (7,8--didehydro--4,5--epoxy--17 --methylmorphinan--3,6--diol)";s:25:"field_non_nhp_rationale_f";s:341:"Un non PSN à cause de sa présence à l'Annexe I de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants:  Pavot à opium (Papaver somniferum), ainsi que ses préparations, dérivés, alcaloïdes et sels, notamment : (3) morphine (didéhydro–7,8 époxy–4,5 méthyl–17 morphinanediol–3,6)";s:16:"field_legacy_nid";s:5:"76274";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Morphine";s:5:"title";s:8:"Morphine";s:3:"nid";s:5:"80966";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80967;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:205:"A non-NHP because listed in Schedule IV of the Controlled Drugs and Substances Act as follows: 23. Anabolic steroids and their derivatives including: (40) Testosterone (17ß--hydroxyandrost--4--en--3--one)";s:25:"field_non_nhp_rationale_f";s:213:"Un non PSN à cause de sa présence à l'Annexe IV de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants:  (40) testostérone (hydroxy–17ß androstène–4 one–3)";s:16:"field_legacy_nid";s:5:"76275";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Testosterone";s:5:"title";s:12:"Testosterone";s:3:"nid";s:5:"80967";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80968;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:261:"A non-NHP because listed in Schedule III of the Controlled Drugs and Substances Act as follows: Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including: (1) amphetamine (?--methylbenzeneethanamine)";s:25:"field_non_nhp_rationale_f";s:345:"Un non PSN à cause de sa présence à l'Annexe II de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants:  Les amphétamines, leurs sels, dérivés, isomères et analogues, ainsi que les sels de leurs dérivés, isomères et analogues, notamment :  (1) amphétamine (a–méthylbenzèneéthanamine)";s:16:"field_legacy_nid";s:5:"76276";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Amphetamine";s:5:"title";s:11:"Amphetamine";s:3:"nid";s:5:"80968";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80969;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:213:"A non-NHP because listed in Schedule I of the Controlled Drugs and Substances Act as follows: Coca (Erythroxylon), its preparations, derivatives, alkaloids and salts, including: (2) Cocaine (benzoylmethylecgonine)";s:25:"field_non_nhp_rationale_f";s:303:"Un non PSN à cause de sa présence à l'Annexe I de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants:  Coca (érythroxylone), ainsi que ses préparations, dérivés, alcaloïdes et sels, notamment : (2) cocaïne (ester méthylique de la benzoylecgonine)";s:16:"field_legacy_nid";s:5:"76277";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Cocaine";s:5:"title";s:7:"Cocaine";s:3:"nid";s:5:"80969";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80970;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:219:"A non-NHP because listed in Schedule I of the Controlled Drugs and Substances Act as follows: Opium Poppy (Papaver somniferum), its preparations, derivatives, alkaloids and salts, including: (2) Codeine (methylmorphine)";s:25:"field_non_nhp_rationale_f";s:293:"Un non PSN à cause de sa présence à l'Annexe I de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants:  Pavot à opium (Papaver somniferum), ainsi que ses préparations, dérivés, alcaloïdes et sels, notamment : (2) codéine (méthylmorphine)";s:16:"field_legacy_nid";s:5:"76278";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Codeine";s:5:"title";s:7:"Codeine";s:3:"nid";s:5:"80970";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80971;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:187:"A non-NHP because it is a derivative of the anabolic steroid Prasterone, where anabolic steroids and their derivatives are listed in Schedule IV of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:251:"Un non PSN parce qu'un dérivé du stéroide anabolisant Prastérone, et les stéroides anabolisants et leurs dérivés sont présents à l'Annexe IV de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants.";s:19:"field_old_rationale";s:895:"7-Keto-DHEA is a naturally occurring metabolite of the androgenic steroid hormone DHEA, which is listed in Schedule IV of the Controlled Drugs and Substances Act under the name Prasterone.  Unlike DHEA, 7-keto-DHEA (or its acetylated form) is not converted to androgens and estrogens and when administered orally or topically, some studies have suggested that 7-Keto-DHEA (usually administered as 3-Acetyl-7-keto-DHEA) does not affect plasma levels of steroid hormones.  7-Keto-DHEA have demonstrated some efficacy to promote weight loss by increasing metabolism and thermogenesis.  However, because 7-Keto-DHEA (or its acetylated form) is a structurally related derivative of DHEA (being one of its metabolites) and that all anabolic steroids and their derivatives are listed in Schedule IV of the Controlled Drugs and Substances, 7-Keto-DHEA will be considered as a controlled drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76279";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"7-Oxodehydroepiandrosterone";s:5:"title";s:27:"7-Oxodehydroepiandrosterone";s:3:"nid";s:5:"80971";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80972;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:214:"A non-NHP because alkaloid occurring in Opium poppy;  where all preparations, derivatives, alkaloids and salts of Opium Poppy (Papaver somniferum) are listed in Schedule I of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:302:"Un non PSN parce que alcaloides qui sont présents dans Pavot à opium; et Pavot à opium (Papaver somniferum), ainsi que ses préparations, dérivés, alcaloïdes et sels sont présents à l'Annexe I de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants.";s:19:"field_old_rationale";s:395:"Narceine (known as Narceinum in homeopathic medicines) is an alkaloid occurring in small amount in opium (0.1-0.5%), which is obtained from the plant called Opium poppy (Papaver somniferum L.).  Since all preparations, derivatives, alkaloids and salts of this plant are listed in Schedule I of the Controlled Drugs and Substances Act, Narceine will be considered as a non-NHP, a controlled drug.";s:16:"field_legacy_nid";s:5:"76280";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Narceine";s:5:"title";s:8:"Narceine";s:3:"nid";s:5:"80972";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80973;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:145:"A non-NHP because listed in Schedule III of the Controlled Drugs and Substances Act as follows: 4-hydroxybutanoic acid (GHB) and any salt thereof";s:25:"field_non_nhp_rationale_f";s:336:"Un non PSN à cause de sa présence à l'Annexe II de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants:  Les amphétamines, leurs sels, dérivés, isomères et analogues, ainsi que les sels de leurs dérivés, isomères et analogues, notamment : Acide hydroxy–4 butanoïque et ses sels";s:16:"field_legacy_nid";s:5:"76281";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"gamma-Hydroxybutyrate";s:5:"title";s:21:"gamma-Hydroxybutyrate";s:3:"nid";s:5:"80973";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80974;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:159:"A non-NHP because it is an anabolic steroid, where anabolic steroids and their derivatives are listed in Schedule IV of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:225:"Un non PSN parce que stéroide anabolisant, et les stéroides anabolisants et leurs dérivés sont présents à l'Annexe IV de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants.";s:19:"field_old_rationale";s:127:"Methasterone (Superdrol) is a synthetic drug (anabolic) recently banned by FDA. It will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76282";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Methasterone";s:5:"title";s:12:"Methasterone";s:3:"nid";s:5:"80974";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80975;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:259:"A non-NHP because listed in Schedule I of the Controlled Drugs and Substances Act as follows: Amidones, their intermediates, salts, derivatives and salts of intermediates and derivatives including: (4) Methadone (6--dimethylamino--4,4--diphenyl--3--heptanone)";s:25:"field_non_nhp_rationale_f";s:340:"Un non PSN à cause de sa présence à l'Annexe I de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants:  Amidones, leurs sels, intermédiaires et dérivés, ainsi que les sels de leurs intermédiaires et dérivés, notamment : (4) méthadone (diméthylamino–6 diphényl–4,4 heptanone–3)";s:16:"field_legacy_nid";s:5:"76283";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Methadone";s:5:"title";s:9:"Methadone";s:3:"nid";s:5:"80975";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80976;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:189:"A non-NHP because it is a derivative of the anabolic steroid Testosterone, where anabolic steroids and their derivatives are listed in Schedule IV of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:253:"Un non PSN parce qu'un dérivé du stéroide anabolisant Testostérone, et les stéroides anabolisants et leurs dérivés sont présents à l'Annexe IV de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants.";s:16:"field_legacy_nid";s:5:"76284";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Methyltestosterone";s:5:"title";s:18:"Methyltestosterone";s:3:"nid";s:5:"80976";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80977;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:159:"A non-NHP because it is an anabolic steroid, where anabolic steroids and their derivatives are listed in Schedule IV of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:225:"Un non PSN parce que stéroide anabolisant, et les stéroides anabolisants et leurs dérivés sont présents à l'Annexe IV de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants.";s:19:"field_old_rationale";s:357:"Methyldienolone is an anabolic Steroid. It is in the prohibited list of the World Anti-Doping Agency (WADA). Anabolic steroids and their derivatives are in Schedule IV of the Controlled Drugs and Substances Act. There is very limited information regarding its chemistry (such as structure and synthesis), biochemistry (such as action), and safety and so on.";s:16:"field_legacy_nid";s:5:"76285";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Methyldienolone";s:5:"title";s:15:"Methyldienolone";s:3:"nid";s:5:"80977";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80978;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:159:"A non-NHP because it is an anabolic steroid, where anabolic steroids and their derivatives are listed in Schedule IV of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:225:"Un non PSN parce que stéroide anabolisant, et les stéroides anabolisants et leurs dérivés sont présents à l'Annexe IV de la Loi réglementant certaines drogues de autres substances et au Règlement sur les stupéfiants.";s:19:"field_old_rationale";s:1739:"Androstenedione is a 19-carbon steroid hormone produced in the adrenal glands and the gonads as an intermediate step in the biochemical pathway. Androstenedione is the common precursor of male and female sex hormones. Some androstenedione is also secreted into the plasma, and may be converted in peripheral tissues to testosterone and estrogens. Androstenedione originates either from the conversion of dehydroepiandrosterone or from 17-hydroxyprogesterone. It is further converted to either testosterone or estrone. In April 2004, the FDA banned the sale of Androsterenedione, citing that the drug poses significant health risks commonly associated with steroids. Because androstenedione is converted in part to estrogens, persons taking this supplement may have estrogenic side-effects. A visible problem could be gynecomastia (formation of breast tissue) in males. Androstenedione is prohibited as an anabolic agent under the World Anti-Doping Code 2007 Prohibited List (in effect 1/1/07) because of its anabolic properties. Anabolic steroids and their derivatives are under Schedule IV of CDSA listing. Androstenedione will not be a NHP,but a CDSA substance.                                                                                                             References:                                                                                                                                                                                              [1] www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/and_0022.shtml
[2] www.cfsan.fda.gov/~dms/androqa.html
[3] Dictionary of Natural Products
[4] The Merck Index
[5] www.asada.gov.au/substances/facts/androstenedione.htm
[6] The World Anti-Doping Agency (WADA)";s:16:"field_legacy_nid";s:5:"76286";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Androstenedione";s:5:"title";s:15:"Androstenedione";s:3:"nid";s:5:"80978";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80979;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:423:"The rationale for bismuth citrate for being classified as a drug would be the same rationale as for bismuth subsalicylate. Bismuth citrate initially hydrolysis in the digestive system into bismuth hydroxide which is then react with the gastric acid to produce bismuth oxychloride. Since bismuth oxychloride is a synthetic drug that is not found in nature, therefore bismuth citrate will be considered as a drug, not an NHP.";s:16:"field_legacy_nid";s:5:"76287";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Bismuth subsalicylate";s:5:"title";s:21:"Bismuth subsalicylate";s:3:"nid";s:5:"80979";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80980;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76288";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ensulizole";s:5:"title";s:10:"Ensulizole";s:3:"nid";s:5:"80980";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80981;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:422:"Diphenylpyraline (hydrochloride) is a synthetic compound used as a drug in allergic rhinitis. It is not found in nature despite its existence in blood and urine of patients whose have consumed it. Diphenylpyran and its salts are in the list of "Prohibited and Restricted Cosmetic  Ingredients (The Cosmetic Ingredient Hotlist)" of Health Canada dated May 2005. Diphenylpyraline will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76289";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Diphenylpyraline";s:5:"title";s:16:"Diphenylpyraline";s:3:"nid";s:5:"80981";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80982;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76290";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Famotidine";s:5:"title";s:10:"Famotidine";s:3:"nid";s:5:"80982";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80983;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:124:"Piroctone olamine is a synthetic product that is not found in nature; therefore, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76291";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Piroctone olamine";s:5:"title";s:17:"Piroctone olamine";s:3:"nid";s:5:"80983";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80984;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76292";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Padimate O";s:5:"title";s:10:"Padimate O";s:3:"nid";s:5:"80984";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80985;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:563:"Sodium cyclamate and Calcium cyclamate are the sodium and calcium salts of Cyclamic acid respectively, known as non-nutritive and artificial sweeteners.  The sweetness of these compounds was discovered by accident by Micheal Sveda in 1937, and it is known to be 30 to 50 times sweeter than sugar, which is also why these are listed in the NHPD acceptable NMIs list.  Since Cyclamic acid and its salts are not found in nature, not used as calcium or sodium sources, and are synthetically prepared, Cyclamic acid and its salts will be considered as drugs, not NHPs.";s:16:"field_legacy_nid";s:5:"76293";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Cyclamic acid";s:5:"title";s:13:"Cyclamic acid";s:3:"nid";s:5:"80985";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80986;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76294";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Quaternium-16";s:5:"title";s:13:"Quaternium-16";s:3:"nid";s:5:"80986";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80987;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76295";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"m-Chlorophenol";s:5:"title";s:14:"m-Chlorophenol";s:3:"nid";s:5:"80987";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80988;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76296";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Aspirin";s:5:"title";s:7:"Aspirin";s:3:"nid";s:5:"80988";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80989;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76297";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Avobenzone";s:5:"title";s:10:"Avobenzone";s:3:"nid";s:5:"80989";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80990;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76298";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Cyproheptadine";s:5:"title";s:14:"Cyproheptadine";s:3:"nid";s:5:"80990";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80991;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76299";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Dibucaine hydrochloride";s:5:"title";s:23:"Dibucaine hydrochloride";s:3:"nid";s:5:"80991";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80992;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:400:"Iron pentacarbonyl is a toxic and highly flammable iron compound with chemical formula Fe(CO)5. It may be formed by the reaction of fine iron particles with carbon monoxide; if heated to decomposition, it produces carbon monoxide and iron oxides. Being a strong reducing agent, it reacts violently with oxidants. It is not recommended for consumption. It is not found in nature so it cannot be a NHP.";s:16:"field_legacy_nid";s:5:"76300";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Iron pentacarbonyl";s:5:"title";s:18:"Iron pentacarbonyl";s:3:"nid";s:5:"80992";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80993;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76301";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Dimenhydrinate";s:5:"title";s:14:"Dimenhydrinate";s:3:"nid";s:5:"80993";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80994;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:560:"Sodium chlorite (NaClO2) is derived indirectly from sodium chlorate, NaClO3. Because it is a chemical precursor of chlorine dioxide, sodium chlorite is also called "stabilized chlorine dioxide". The main application of sodium chlorite is the generation of chlorine dioxide for bleaching and stripping of textiles, pulp, and paper. It is also used for disinfection in a few municipal water treatment plants after conversion to chlorine dioxide. Since sodium chlorite is a synthetic compound (not found in nature), it will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76302";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Sodium chlorite";s:5:"title";s:15:"Sodium chlorite";s:3:"nid";s:5:"80994";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80995;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76303";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:55:"Polyethoxypolypropoxypolyethoxyethanol - iodine complex";s:5:"title";s:55:"Polyethoxypolypropoxypolyethoxyethanol - iodine complex";s:3:"nid";s:5:"80995";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80996;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:528:"Polyvinyl alcohol (or PVA) is a synthetically prepared polymer synthesized not by polymerization of the corresponding monomer (its monomer exist only as the tautomeric form, acetaldehyde), but by partial or total hydrolysis of polyvinyl acetate.  This polymer is widely used in industry because of its changing properties depending on the length of the carbon chain, which is also why it is listed in the NHPD acceptable NMIs list.  Since Polyvinyl alcohol is not found in nature, it will be considered as a non-NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76304";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Polyvinyl alcohol";s:5:"title";s:17:"Polyvinyl alcohol";s:3:"nid";s:5:"80996";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80997;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:213:"Mexoryl or 3,3'-terephthalydene 10,10'-dicamphorsulfonic acid is used to formulate sunscreens and moisturizers. Since Mexoryl is a synthetic product that is not found in nature, it will not be considered as a NHP.";s:16:"field_legacy_nid";s:5:"76305";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Ecamsule";s:5:"title";s:8:"Ecamsule";s:3:"nid";s:5:"80997";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80998;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:660:"Ammoniated mercury (Mercuric Chloride Ammoniated, Hg(NH2)Cl) is a synthetic drug derived from mercuric salts and ammonia. This drug is available over the counter without a prescription and is used to treat impetigo, psoriasis, minor skin infections, and other skin disorders but the use of such mercurial preparations is generally deprecated. Frequent or prolonged application to large areas or to broken skin or mucous membranes can cause mercury poisoning. Ammoniated mercury is also a potent sensitizer and can produce allergic reactions.  Since ammoniated mercury is a synthetic drug that is not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76306";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Mercuric chloride, ammoniated";s:5:"title";s:29:"Mercuric chloride, ammoniated";s:3:"nid";s:5:"80998";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:80999;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:6388:"Ipriflavone is a semisynthetic isoflavone prepared synthetically from the soy isoflavone Daidzein [1,2,3]. It is also the isopropyl ether derivative of another naturally occurring isoflavone called 7-Hydroxyisoflavone, a constituent of the flowers of Thespesia populnea [4].  Ipriflavone is used orally in Europe and Japan for the prevention and treatment of osteoporosis, mainly in postmenopausal women [5].  This usage has been supported by many in vivo and in vitro studies (mainly before 2000), both in animal and human models, demonstrating several possible mechanisms of action [6].  For example,  some studies suggested that Ipriflavone inhibits bone resorption and stimulates osteoblast activity in vitro in cell cultures [7,8] and in vivo in experimental models of osteoporosis, such as showing inhibition of bone loss in osteoporotic rats [9].  One of the advantages for using Ipriflavone in the treatment of osteoporosis is its lack of direct estrogenic effect demonstrated by the in vitro investigation of the interaction between Ipriflavone and preosteoclastic cell lines, which showed that it was not mediated by direct interaction with estrogen receptors, but with the interaction of novel receptors coupled to calcium influx [10, 11].  In comparison, naturally occurring isoflavones (e.g. daidzein and genistein) are known to bind to estrogen receptors leading to weak estrogenic and antiestrogenic activities [12].  Ipriflavone is known to be metabolized to 7 metabolites (M1 to M7) mainly in the liver, by oxidation of the isopropyl group and/or hydroxylation of the beta-ring followed by phase II glucuronidation or sulfation (Fig. 1).  Since M1 (7-Hydroxyisoflavone), M2 (Daidzein), M3, and M5 have shown some pharmacological activity related to bone formation and bone resorption [13], the overall pharmacological activity of Ipriflavone is not only the result of Ipriflavone and its naturally occurring metabolites M1 and M2, but also the result of its non-natural metabolites M3 and M5.  For example, an in vitro examination of the osteoblastic effect of ipriflavone and its metabolites showed that Ipriflavone and one of its metabolites stimulated cell proliferation of an osteoblast-cell line, whereas ipriflavone and another metabolite increased alkaline phosphatase activity, while another metabolite enhanced collagen formation [10, 14].  In another study, the plasma concentrations of Ipriflavone and two of its metabolites showed that the concentration of Ipriflavone in plasma (subject receiving 3 x 200 mg daily doses for 48 weeks) was a minor component (in the range of 0.33 uM), that the major metabolite was 7-(1-Carboxy-ethoxy)-isoflavone (M5; 3.46 uM), whereas the dealkylated metabolite (M1; 7-Hydroxyisoflavone) was in the range of 1.44 uM [15]. These results led to a number of conflicting clinical trials testing the efficacy on bone mass and safety of Ipriflavone in various populations; where most studies have shown that Ipriflavone is able to prevent bone loss and increase bone mass in postmenopausal women [6,10].  However, in 2001, a randomized, double-blind, placebo-controlled, 4-year clinical trial designed to investigate the efficacy and safety of Ipriflavone on bone density, biochemical markers of bone turnover, and fracture rate in postmenopausal women with osteoporosis concluded that Ipriflavone does not prevent bone loss or affect biochemical markers of bone metabolism.  Additionnaly, this study found that Ipriflavone induces lymphocytopenia in a significant number of women [16].  These results led to another study on soy protein supplementation, where the results showed that overall consumption of 25g soy protein containing 60mg isoflavones daily for one year does not cause lymphocytopenia [17]. Despite the fact that the safety & efficacy of Ipriflavone is not fully understood, these findings demonstrated that 1) Ipriflavone is not a naturally occurring substance, and 2) Ipriflavone shows a different ADMET (Administration, Distribution, Metabolism, Excretion, and Toxicity) profile than the natrurally occurring substances Daidzein and 7-Hydroxyisoflavone.  Therefore, Ipriflavone will not be considered as an NHP, neither a source of an NHP, but a drug.
References: 
[1] http://en.wikipedia.org/wiki/Ipriflavone
[2] ChemIDplus Advanced online
[3] The Merck Index on CD-ROM, version 12:3
[4] Natural Medicines Comprehensive Database online (http://www.naturaldatabase.com/(S(34jd3b45lu41u3bdbxb3vjih))/nd/Search.aspx?cs=&s=ND&pt=100&id=310&fs=ND&searchid=7233902&name=IPRIFLAVONE)
[5] Chung, H. J. et al., Effects of water deprivation for 72h on the pharmacokinetics of ipriflavone in rats, Res. Vet. Sci. 2007), doi:10.1016/j.rvsc.2007.08.010
[6] Head, K. A., Ipriflavone: An important bone-builiding Isoflavone, Alternative Medicine Review, Volume 4, Number 1, 1999
[7] Tsuda M. et al., The effect of ipriflavone (TC-80) on bone resorption in tissue culture, J. Bone Miner. Res. 1986; 1:206-211
[8] Notoya K. et al., Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells, Calcif. Tissue Int. 1992; 51 (suppl 1): S1-S6
[9] Yamazaki I. et al., Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats, Life Sci. 1986; 38:951-958
[10] Ipriflavone, Alternative Medicine Review, Volume 5, Number 3, 2000
[11] Miyauchi A. et al., Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function, Endocrinology, 1996; 137:3544-3550
[12] Somekawa Y. et al. Efficacy of ipriflavone in preventing adverse effects of leuprolide, The Journal of Clinical endocrinology & metabolism, (2001) Vol. 86, No. 7, 3202-3206
[13] Moon Y. et al., Characterization of cytochrome P450s mediating ipriflavone metabolism in human liver microsomes, Xenobiotica, 2007 Mar; 37(3):246-9.
[14] Benvenuti S. et al., Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line, J. Bone Miner. Res. 1991; 6:987-996.
[15] Monostory K. et al., Ipriflavone as an inhibitor of human cytochrome P450 enzymes, British Journal of Pharmacology (1998) 123, 605-610.
[16] Alexandersen P. et al. Ipriflavone in the treatment of postmenopausal osteoporosis, a randomized controlled trial, JAMA, Vol. 285, No. 11, March 21, 2001
[17] Soung D. Y. et al., Soy supplementation does not cause lymphocytopenia in postmenaopausal women, Nutrition Journal 2006, 5: 12.";s:16:"field_legacy_nid";s:5:"76307";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ipriflavone";s:5:"title";s:11:"Ipriflavone";s:3:"nid";s:5:"80999";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81000;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:313:"Meso-2,3-dimercaptosuccinic acid (DMSA) is a sulfhydryl-containing, water-soluble, non-toxic, orally-administered metal chelater which has been in use as an antidote to heavy metal toxicity since the 1950s. Since DMSA is a synthetic product that is not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76308";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Succimer";s:5:"title";s:8:"Succimer";s:3:"nid";s:5:"81000";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81001;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1064:"We spent sometimes looking for any isohumulones natural sources and it seems that there isn't any. The only way to produce this product is through wort boiling transformations of the humulones which have been studied in great detail. By far the most important chemical conversion overall during the brewing of beer is the thermal isomerization of the alpha-acids or humulones to the iso-alpha-acids or isohumulones via an acyloin-type ring contraction. Each humulone gives rise to two epimeric isohumulones, which are distinguished as cis-isohumulones and trans-isohumulones, depending on the spatial arrangement of the tertiary alcohol function at C(4) and the prenyl side chain at C(5). The terms trans and cis indicate that these groups point to opposite faces and to the same face of the five-membered ring, respectively. Since cis- and trans-isohumulones are neither found naturally nor produced by a normal fermentation process and they are only produced via wort boiling transformation of the humulones, these products will be considered as drugs, not NHPs.";s:16:"field_legacy_nid";s:5:"76309";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Isohumulone";s:5:"title";s:11:"Isohumulone";s:3:"nid";s:5:"81001";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81002;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:7:"67;2977";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:320:"BHT is a phenolic compound often added to foods to preserve fats or act as an antioxidant. It reacts with oxygen free radicals. It can thus slow down the autoxidation rate of ingredients in a product that can cause changes in the taste or color. Synthetic drug for a therapeutic activity; otherwise, acceptable as a NMI.";s:16:"field_legacy_nid";s:5:"76310";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Butylated hydroxytoluene";s:5:"title";s:24:"Butylated hydroxytoluene";s:3:"nid";s:5:"81002";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81003;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76311";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Docusate sodium";s:5:"title";s:15:"Docusate sodium";s:3:"nid";s:5:"81003";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81004;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76312";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Sulisobenzone";s:5:"title";s:13:"Sulisobenzone";s:3:"nid";s:5:"81004";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81005;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76313";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Cetalkonium chloride";s:5:"title";s:20:"Cetalkonium chloride";s:3:"nid";s:5:"81005";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81006;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76314";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Dequalinium chloride";s:5:"title";s:20:"Dequalinium chloride";s:3:"nid";s:5:"81006";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81007;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:202:"It is prepared from glycerol. Propylene glycol is prepared from hydroxyacetone by yeast reduction. It cannot be found in nature so it is not a NHP. However, it is an acceptable non-medicinal ingredient.";s:16:"field_legacy_nid";s:5:"76315";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Propylene glycol";s:5:"title";s:16:"Propylene glycol";s:3:"nid";s:5:"81007";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81008;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76316";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Edetic acid";s:5:"title";s:11:"Edetic acid";s:3:"nid";s:5:"81008";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81009;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:83:"Synthetic drugs when they have a therapeutic activity, otherwise, they are NMI’s.";s:16:"field_legacy_nid";s:5:"76317";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Carboxymethylcellulose sodium";s:5:"title";s:29:"Carboxymethylcellulose sodium";s:3:"nid";s:5:"81009";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81010;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76318";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ibuprofen";s:5:"title";s:9:"Ibuprofen";s:3:"nid";s:5:"81010";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81011;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76319";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Quaternium-24";s:5:"title";s:13:"Quaternium-24";s:3:"nid";s:5:"81011";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81012;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76320";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Pyrvinium pamoate";s:5:"title";s:17:"Pyrvinium pamoate";s:3:"nid";s:5:"81012";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81013;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76321";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Homosalate";s:5:"title";s:10:"Homosalate";s:3:"nid";s:5:"81013";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81014;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:186:"Since Mesna is a synthetic drug, which is delivered by injection, used in cancer chemotherapy as a detoxifying agent, not found in nature; it will be considered as a non-NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76322";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:5:"Mesna";s:5:"title";s:5:"Mesna";s:3:"nid";s:5:"81014";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81015;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:260:"Tergitol NP-9 (Nonoxynol-9) is a synthetic non-ionic surfactant that is found in condoms as a spermicide. It is prepared by the reaction of nonylphenol with ethylene oxide and is not found in nature. Therefore, Tergitol NP-9 is considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76323";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Nonoxynol";s:5:"title";s:9:"Nonoxynol";s:3:"nid";s:5:"81015";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81016;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because it is an antibiotic substance included in Schedule 2 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN car une substance antibiotique comprise dans l'Annexe 2 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76324";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Bacitracin";s:5:"title";s:10:"Bacitracin";s:3:"nid";s:5:"81016";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81017;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:123:"Cetylpyridinium chloride is a synthetic drug that is not found in nature; therefore, it is considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76326";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Cetylpyridinium chloride";s:5:"title";s:24:"Cetylpyridinium chloride";s:3:"nid";s:5:"81017";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81018;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:211:"1,3-Butylene glycol is a synthetic product that is not found in nature; therefore, it will be considered as a drug. However, this product can also be used as solvent for flavouring agents up to 4 mg/kg b.w./day.";s:16:"field_legacy_nid";s:5:"76327";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"1,3-Butylene glycol";s:5:"title";s:19:"1,3-Butylene glycol";s:3:"nid";s:5:"81018";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81019;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76328";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Tripelennamine";s:5:"title";s:14:"Tripelennamine";s:3:"nid";s:5:"81019";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81020;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76329";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Dyclonine";s:5:"title";s:9:"Dyclonine";s:3:"nid";s:5:"81020";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81021;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76330";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Roxadimate";s:5:"title";s:10:"Roxadimate";s:3:"nid";s:5:"81021";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81022;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:182:"A non-NHP because the intent of the Natural Health Products Regulations is to regulate over-the-counter products, a regulatory framework not suited to the regulation of medical gases";s:25:"field_non_nhp_rationale_f";s:191:"Un non PSN car c'est le but du Règlement sur les produits de santé naturels est la réglementation des produits en vente libre, une structure réglementaire non applicable aux gaz médicaux";s:19:"field_old_rationale";s:417:"Nitrogen dioxide (NO2) or Nitrogen(IV) oxide, is a brown, acidic, pungent gas that is harmful if inhaled and contributes to the formation of acid rain, as it dissolves in water to form nitric acid. If liquefied, it gives a colourless solution (N2O4), it has been used in rocket fuels. Nitric oxide (NO) and nitrogen oxide (NO2) belongs to the same family, both are classified as medical gases and considered as drugs.";s:16:"field_legacy_nid";s:5:"76331";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Nitrogen dioxide";s:5:"title";s:16:"Nitrogen dioxide";s:3:"nid";s:5:"81022";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81023;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76332";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tetracaine";s:5:"title";s:10:"Tetracaine";s:3:"nid";s:5:"81023";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81024;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"103";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76333";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Chlorpheniramine";s:5:"title";s:16:"Chlorpheniramine";s:3:"nid";s:5:"81024";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81025;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76334";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"p-Phenylphenol";s:5:"title";s:14:"p-Phenylphenol";s:3:"nid";s:5:"81025";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81026;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:292:"2,4-Dichlorobenzyl alcohol (or Dybenal) is a synthetic compound, not found in nature, that is used as an antiseptic agent in a product that was developed by the Boots company back in 1958, called Strepsils.  For this reason, 2,4-Dichlorobenzyl alcohol will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76335";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"2,4-Dichlorobenzyl alcohol";s:5:"title";s:26:"2,4-Dichlorobenzyl alcohol";s:3:"nid";s:5:"81026";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81027;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1173";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:213:"Since Carbopol is a synthetic high molecular weight polymer of acrylic acid cross linked with allylsucrose or allylpentaerythritol that is not found naturally, this product will be classified as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76336";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Carboxypolymethylene";s:5:"title";s:20:"Carboxypolymethylene";s:3:"nid";s:5:"81027";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81028;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:440:"Oxetacaine is an amide anaesthetic that is stated to have a prolonged action. It is administered by mouth in conjunction with antacids for the symptomatic relief of gastro-oesophageal reflux disease.  It has also been used as the hydrochloride in ointments and suppositories for the relief of pain associated with haemorrhoids. Since Oxetacaine is a synthetic product that is not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76337";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Oxethazaine";s:5:"title";s:11:"Oxethazaine";s:3:"nid";s:5:"81028";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81029;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:423:"The rationale for bismuth citrate for being classified as a drug would be the same rationale as for bismuth subsalicylate. Bismuth citrate initially hydrolysis in the digestive system into bismuth hydroxide which is then react with the gastric acid to produce bismuth oxychloride. Since bismuth oxychloride is a synthetic drug that is not found in nature, therefore bismuth citrate will be considered as a drug, not an NHP.";s:16:"field_legacy_nid";s:5:"76338";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Bismuth citrate";s:5:"title";s:15:"Bismuth citrate";s:3:"nid";s:5:"81029";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81030;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:221:"Since Iodoform (or triiodomethane) is a synthetically prepared volatile compound, not found in nature, which has been used as an anti-infective, antiseptic and disinfectant, it will be considered as a non-NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76339";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Iodoform";s:5:"title";s:8:"Iodoform";s:3:"nid";s:5:"81030";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81031;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76340";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:46:"Nonylphenoxypolyethoxyethanol - iodine complex";s:5:"title";s:46:"Nonylphenoxypolyethoxyethanol - iodine complex";s:3:"nid";s:5:"81031";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81032;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76341";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Enzacamene";s:5:"title";s:10:"Enzacamene";s:3:"nid";s:5:"81032";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81033;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:422:"Lindane is commonly used as an insecticide, but also as a pediculicide and scabicide. Since Lindane is a synthetic product that is not found in nature, therefore it will be classified as a drug. Lindane and other hexachlorocyclohexane isomers are reasonably anticipated to be human carcinogens, and are associated with various side-effects. We may consider these safety issues when classifying such products for human use.";s:16:"field_legacy_nid";s:5:"76342";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Lindane";s:5:"title";s:7:"Lindane";s:3:"nid";s:5:"81033";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81034;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76343";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Octocrylene";s:5:"title";s:11:"Octocrylene";s:3:"nid";s:5:"81034";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81035;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76345";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Triclosan";s:5:"title";s:9:"Triclosan";s:3:"nid";s:5:"81035";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81036;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:182:"A non-NHP because the intent of the Natural Health Products Regulations is to regulate over-the-counter products, a regulatory framework not suited to the regulation of medical gases";s:25:"field_non_nhp_rationale_f";s:191:"Un non PSN car c'est le but du Règlement sur les produits de santé naturels est la réglementation des produits en vente libre, une structure réglementaire non applicable aux gaz médicaux";s:19:"field_old_rationale";s:1255:"Nitric oxide (NO) is a gas. It is highly reactive; that is, it participates in many chemical reactions. NO is synthesized within cells by an enzyme NO synthase (NOS) and the human (and mouse) genome contains 3 different genes encoding NO synthases. All types of NOS produce NO from arginine with the aid of molecular oxygen and NADPH. Nitroglycerine, which is often prescribed to reduce the pain of angina, does so by generating nitric oxide, which relaxes the walls of the coronary arteries and arterioles. NO has been implicated in many plant activities and considered as a weapon against invading pathogens in plants. The popular prescription drug sildenafil citrate (Viagra®) enhance the effects of NO by inhibiting the enzyme that normally breaks down cGMP. Nitrogen monoxide (NO), or Nitric oxide, is a colourless gas discovered during the 1980s to act as a chemical messenger in small quantities within the human body, despite being toxic at higher concentrations and its rapid reaction with oxygen. The medical condition of septic shock is linked to overproduction by the body of nitrogen monoxide. In conclusion, nitric oxide (NO) and nitrogen oxide (NO2) belongs to the same family, both are classified as medical gases and considered as drugs.";s:16:"field_legacy_nid";s:5:"76346";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Nitric oxide";s:5:"title";s:12:"Nitric oxide";s:3:"nid";s:5:"81036";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81037;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76347";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Cinoxate";s:5:"title";s:8:"Cinoxate";s:3:"nid";s:5:"81037";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81038;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:608:"Phenylephrine is an alpha-adrenergic receptor agonist, mainly used as a decongestant, mydriatic agent (to dilate the pupil) and as a vasopressor (to increase blood pressure).  This chemical is synthetically prepared from m-Hydroxy-omega-chloroacetophenone and Methylamine or directly starting with m-Benzyloxybenzaldehyde.  Phenylephrine and its salts are listed in Schedule F to the Food and Drug Regulations in preparations for ophthalmic or parenteral use in concentrations greater than 2.5%.  Since Phenylephrine is a synthetically prepared compound; not found in nature, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76348";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Phenylephrine hydrochloride";s:5:"title";s:27:"Phenylephrine hydrochloride";s:3:"nid";s:5:"81038";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81039;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:425:"Benzylpiperazine is a recreational drug with euphoric, stimulant effects. It is banned in many countries, including the United States and in parts of Australia and Europe. Producers frequently claim that BZP is a "natural" product, describing it as a "pepper extract" or "herbal high". In fact, the drug is entirely synthetic, not occurring naturally in any plant. Benzylpiperazine will not be considered as a NHP but a drug.";s:16:"field_legacy_nid";s:5:"76350";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Benzylpiperazine";s:5:"title";s:16:"Benzylpiperazine";s:3:"nid";s:5:"81039";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81040;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76351";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Methylcellulose";s:5:"title";s:15:"Methylcellulose";s:3:"nid";s:5:"81040";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81041;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76352";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Polidronium chloride";s:5:"title";s:20:"Polidronium chloride";s:3:"nid";s:5:"81041";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81042;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:266:"Benzethonium chloride is a quaternary ammonium salt which is used primarily in cosmetics for its preservative, antimicrobial and cationic surfactant properties.  Since it is not found in nature, but synthetically prepared, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76355";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Benzethonium chloride";s:5:"title";s:21:"Benzethonium chloride";s:3:"nid";s:5:"81042";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81043;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76356";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Chloroxylenol";s:5:"title";s:13:"Chloroxylenol";s:3:"nid";s:5:"81043";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81044;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76357";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Dimethisoquin";s:5:"title";s:13:"Dimethisoquin";s:3:"nid";s:5:"81044";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81045;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76358";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Octisalate";s:5:"title";s:10:"Octisalate";s:3:"nid";s:5:"81045";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81046;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76359";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Chlorphenesin";s:5:"title";s:13:"Chlorphenesin";s:3:"nid";s:5:"81046";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81047;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:515:"Benadryl hydrochloride or Diphenhydramine hydrochloride (trade name Benadryl®, or Dimedrol outside the US) is an antihistamine and sedative having the chemical name 2-(Diphenylmethoxy)-N, N-dimethylethylamine hydrochloride. It is also given in conjunction with typical antipsychotics to prevent tardive dyskinesia. It is a member of the ethanolamine class of antihistaminergic agents.  Since Diphenhydramine hydrochloride is a synthetic drug that is not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76360";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Diphenhydramine";s:5:"title";s:15:"Diphenhydramine";s:3:"nid";s:5:"81047";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81048;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:433:"Piperazine is a synthetic organic compound that consists of a six-membered ring containing two opposing nitrogen atoms. Piperazines were originally named because of their chemical similarity with piperidine, the main active chemical agent in black pepper and relatives (Piper sp.) and also is present in numerous natural alkaloids such as piperine and quinine.  Piperazine does not occur in nature so it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76361";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Piperazine";s:5:"title";s:10:"Piperazine";s:3:"nid";s:5:"81048";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81049;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:182:"A non-NHP because the intent of the Natural Health Products Regulations is to regulate over-the-counter products, a regulatory framework not suited to the regulation of medical gases";s:25:"field_non_nhp_rationale_f";s:191:"Un non PSN car c'est le but du Règlement sur les produits de santé naturels est la réglementation des produits en vente libre, une structure réglementaire non applicable aux gaz médicaux";s:19:"field_old_rationale";s:832:"Carbon dioxide results from the combustion of organic matter if sufficient amounts of oxygen are present. It is also produced by various microorganisms from fermentation and cellular respiration and therefore carbon dioxide is considered as a natural substance. However, NHP Regulations did not intend to capture and regulate medicinal gases such as oxygen and carbon dioxide and therefore these gases will be added to the Schedule 2 of the NHP Regulations to exclude them.  In addition, Carbon dioxide is also used commercially in several cases, such as giving the sparkle in carbonated softdrinks, as well as being used as a preservative, freezing agent, solvent, etc.  For these reasons, Carbon dioxide is currently listed in the NHPD acceptable NMIs list, which means that Carbon dioxide is an acceptable NMI to be used in NHPs.";s:16:"field_legacy_nid";s:5:"76362";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Carbon dioxide";s:5:"title";s:14:"Carbon dioxide";s:3:"nid";s:5:"81049";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81050;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76363";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Coal tar";s:5:"title";s:8:"Coal tar";s:3:"nid";s:5:"81050";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81051;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:6:"103;67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76364";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Benzalkonium chloride";s:5:"title";s:21:"Benzalkonium chloride";s:3:"nid";s:5:"81051";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81052;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:867:"Lactulose is a synthetic disaccharide molecule composed of two smaller sugar molecules fructose and galactose. Mammals and birds are not able to digest Lactulose so it passes unabsorbed from mouth all the way down to the large intestine, which indicates that it is resistant to hydrolysis by human digestive enzymes. However,  Lactulose is fermented by bifidobacteria, lactobacilli and some other bacteria in the colon to produce mainly organic acids, such as lactic acid and small-chain fatty acids such as lactic, acetic and formic acid, which, by exerting a local osmotic effect in the colon, result in increased fecal bulk and stimulation of peristals. Although the metabolites are naturally occurring carboxylic acids (lactic, acetic and formic), Lactulose is a synthetic drug that is not found in nature and therefore it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76365";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Lactulose";s:5:"title";s:9:"Lactulose";s:3:"nid";s:5:"81052";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81053;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76366";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Docusate calcium";s:5:"title";s:16:"Docusate calcium";s:3:"nid";s:5:"81053";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81054;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:212:"Phenoxyethanol is a synthetic product that is not found in nature, it is produced by treatment of phenol with ethylene oxide in basic conditions. Therefore, Phenoxyethanol will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76367";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Phenoxyethanol";s:5:"title";s:14:"Phenoxyethanol";s:3:"nid";s:5:"81054";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81055;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76368";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:32:"Dimethyldioctylammonium chloride";s:5:"title";s:32:"Dimethyldioctylammonium chloride";s:3:"nid";s:5:"81055";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81056;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76369";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"o-Phenylphenol";s:5:"title";s:14:"o-Phenylphenol";s:3:"nid";s:5:"81056";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81057;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1640:"Isomalt is a disaccharide alcohol belonging to the group of sugar alcohols or polyols. Isomalt is derived from sucrose in a two-stage chemical process. First, the sucrose is converted to the disaccharide 6-0-alpha-D-glucopyranosyl fructose (isomaltulose)  -  a significantly more stable reducing compound.  The isomaltulose is then enriched with hydrogen under high pressure with the aid of a Raney-Nickel catalyst. Despite the fact that Isomalt can also be made in two-step process including enzyme rearrangement followed by addition of two hydrogens, there is no reference to confirm that Isomalt is produced naturally. NHPD agrees that most polyols are present in nature and for example sugar and xylose derived from corn cobs, almond shells and birch bark have become a source for production of isomalt and xylitol respectively. However, these source materials undergo further chemical changes after isolation from their natural sources: the starch from the cereal undergoes an enzymatic conversion to the proper disaccharides followed by hydrogenation in the presence of Raney-Nickel catalysts to convert the aldehyde and ketone groups into alcohol functions.  As a consequence, the chemical structure is made linear and the chemical stability is improved. It also modifies several physicochemical properties such as solubility, viscosity, hygroscopicity and boiling temperature which all contributes to the differences in behaviour between polyols. Since the chemical and physical properties of the natural sugar is changed completely to produce different product (isomalt), therefore, isomalt will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76370";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Palatinit";s:5:"title";s:9:"Palatinit";s:3:"nid";s:5:"81057";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81058;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:385:"Clotrimazole and its salts (except in preparations for topical and vaginal use) are listed under Schedule F ingredients and therefore they are drugs. Since Clotrimazole is a synthetic drug that is not found in nature, Clotrimazole will also be considered as a drug when it is used for topical and vaginal use. Therefore, Clotrimazole and its salts are classified as drugs for all uses.";s:16:"field_legacy_nid";s:5:"76371";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Clotrimazole";s:5:"title";s:12:"Clotrimazole";s:3:"nid";s:5:"81058";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81059;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76372";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Dehydrocholic acid";s:5:"title";s:18:"Dehydrocholic acid";s:3:"nid";s:5:"81059";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81060;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76373";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Pyrantel pamoate";s:5:"title";s:16:"Pyrantel pamoate";s:3:"nid";s:5:"81060";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81061;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76374";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Meradimate";s:5:"title";s:10:"Meradimate";s:3:"nid";s:5:"81061";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81062;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:213:"Gentian violet is a synthetically prepared compound, not found in nature, which is used as an antifungal agent and as a commercial dye.  For this reason, Gentian violet will be considered as a non-NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76375";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Gentian violet";s:5:"title";s:14:"Gentian violet";s:3:"nid";s:5:"81062";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81063;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:464:"Quaternium-15 is widely used as a preservative in cosmetics and industrial substances, since it is a formaldehyde releasing preservative, where formaldehyde is well-known for its antibacterial activity.  It can be found in many products, such as mascara, shampoo, ointments, paints, etc.  Since this product is not found in nature, synthetically prepared, not used in humans, it will be considered as a drug, not a NHP.  However, this product is an acceptable NMI.";s:16:"field_legacy_nid";s:5:"76376";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Quaternium-15";s:5:"title";s:13:"Quaternium-15";s:3:"nid";s:5:"81063";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81064;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:337:"Sodium bisulfite (NaHSO3) is widely used in various areas, such as in making paper, leather and food products and this, as a disinfectant, preservative, antiseptic, antioxidant, etc. It is also listed under the NHPD acceptable NMIs list.  However, because this chemical is not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76377";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Sodium bisulfite";s:5:"title";s:16:"Sodium bisulfite";s:3:"nid";s:5:"81064";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81065;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1473:"Benzoyl peroxide preparations have proven to be effective agents in the treatment of acne. It was found that benzoyl peroxide penetrates the stratum corneum very quickly where it is rapidly degraded to benzoic acid. The mechanism of action of Benzoyl peroxide is not totally understood but its antibacterial activity is presumed that benzoyl peroxide is easily absorbed into pores where it works by interfering with acne bacterial metabolism through oxidation. Little is known about the percutaneous penetration, metabolism, and excretion of Benzoyl peroxide, although it has been shown that Benzoyl peroxide absorbed by the skin is metabolized to benzoic acid and then excreted as benzoate in the urine. Unlike hydrogen peroxide, the first reaction/decomposition that will occur in the utilization of Benzoyl peroxide is the cleavage of the peroxide linkage to produce the stabilized benzyl radical species. This active radical species will act in turn as a strong oxidizing agent in the surrounding media and producing benzoic acid as a side product. Despite the fact that Benzoyl peroxide is a derivative of hydrogen peroxide, it is neither acting in a similar way to hydrogen peroxide nor considered as a source material for hydrogen peroxide. Furthermore, Benzoyl peroxide and benzoyl radical intermediate having different chemical and physical properties than the natural benzoic acid and its salt. Therefore, Benzoyl peroxide will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76378";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Benzoyl peroxide";s:5:"title";s:16:"Benzoyl peroxide";s:3:"nid";s:5:"81065";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81066;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76380";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Riseptin";s:5:"title";s:8:"Riseptin";s:3:"nid";s:5:"81066";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81067;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:980:"Trichloroacetic acid is an analog of acetic acid which can be prepared by oxidation of chloral hydrate with nitric acid or by chlorination of acetic acid. It is widely used in biochemistry for the precipitation of macromolecules such as proteins, DNA and RNA and as a selective herbicide. It also finds use in the metal, plastics and textile industries and as an analytical reagent. Interestingly, Trichloroacetic acid is a urinary metabolite of trichloroethylene and perchloroethylene. Although available data for trichloroacetic acid are sufficient to demonstrate that food and air are relevant exposure sources in addition to drinking-water, the data are not adequate to quantify the contributions of each source for an overall assessment of exposure. Wider exposure to trichloroacetic acid occurs at microgram-per-litre levels in drinking-water and swimming pools as a result of chlorination or chloramination. Trichloroacetic acid will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76381";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Trichloroacetic acid";s:5:"title";s:20:"Trichloroacetic acid";s:3:"nid";s:5:"81067";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81068;a:12:{s:4:"body";s:0:"";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76382";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Stearalkonium chloride";s:5:"title";s:22:"Stearalkonium chloride";s:3:"nid";s:5:"81068";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81069;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76383";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Quaternium-12";s:5:"title";s:13:"Quaternium-12";s:3:"nid";s:5:"81069";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81070;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:303:"Benzoin is a synthetic organic compound that is not found in nature. Benzoin is synthesized from benzaldehyde in the benzoin condensation. Benzoin is not a constituent of benzoin resin obtained from the benzoin tree (Styrax) or tincture of benzoin. Therefore, benzoin is classified as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76384";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Benzoin";s:5:"title";s:7:"Benzoin";s:3:"nid";s:5:"81070";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81071;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76385";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Haloprogin";s:5:"title";s:10:"Haloprogin";s:3:"nid";s:5:"81071";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81072;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76386";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Mupirocin";s:5:"title";s:9:"Mupirocin";s:3:"nid";s:5:"81072";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81073;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76387";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Triclocarban";s:5:"title";s:12:"Triclocarban";s:3:"nid";s:5:"81073";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81074;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76388";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Pramoxine hydrochloride";s:5:"title";s:23:"Pramoxine hydrochloride";s:3:"nid";s:5:"81074";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81075;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:448:"Glycol salicylate, or 2-hydroxyethyl salicylate, is a salicylic acid derivative used in topical rubefacient preparations for the relief of muscular and rheumatic pain.  Even if salicylic acid esters are found in several plants (usually as the methyl salicylate), glycol salicylate itself is synthetically prepared, from salicylic acid and ethylene glycol, and not known to occur in nature. Glycol salicylate will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76389";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Glycol salicylate";s:5:"title";s:17:"Glycol salicylate";s:3:"nid";s:5:"81075";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81076;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76390";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"p-Chloro-o-phenylphenol";s:5:"title";s:23:"p-Chloro-o-phenylphenol";s:3:"nid";s:5:"81076";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81077;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76391";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Naftifine";s:5:"title";s:9:"Naftifine";s:3:"nid";s:5:"81077";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81078;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76392";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Butamben picrate";s:5:"title";s:16:"Butamben picrate";s:3:"nid";s:5:"81078";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81079;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76393";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Trolamine salicylate";s:5:"title";s:20:"Trolamine salicylate";s:3:"nid";s:5:"81079";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81080;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76394";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Calcium polycarbophil";s:5:"title";s:21:"Calcium polycarbophil";s:3:"nid";s:5:"81080";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81081;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:341:"Naphazoline (decongestant) is used in a combination with Pheniramine (antihistamine) to relieve redness due to minor eye irritations, such as those caused by colds, dust, wind, smog, pollen, swimming, or wearing contact lenses. Since Naphazoline is a synthetic product that is not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76395";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Naphazoline";s:5:"title";s:11:"Naphazoline";s:3:"nid";s:5:"81081";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81082;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:157:"Octyl methoxycinnamate is used in many sunscreens. It is a synthetic product that is not found in nature and therefore it is considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76396";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Octinoxate";s:5:"title";s:10:"Octinoxate";s:3:"nid";s:5:"81082";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81083;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76397";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Quaternium-11";s:5:"title";s:13:"Quaternium-11";s:3:"nid";s:5:"81083";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81084;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76398";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Lidocaine";s:5:"title";s:9:"Lidocaine";s:3:"nid";s:5:"81084";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81085;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:743:"Permethrin is an insecticide widely used for lice infestations and scabies, as well as in insect repellents.  It is known to function as a neurotoxin, affecting neurons cells of insects.  Permethrin is a member of the synthetic chemicals called pyrethroids, which are similar to the naturally occurring Pyrethrins [Pyrethrin I and Pyrethrin II], produced by Chrysanthemum cinerariaefolium and Chrysanthemum coccineum .  However, Permethrin is a synthetically prepared compound, more stable to light, as active as the natural Pyrethrins and with lower mammalian toxicity, where the (1R,trans) and the (1R,cis) isomers are primarily responsible for the insecticidal activity.  For these reasons, Permethrin will be considered as a drug, not NHP.";s:16:"field_legacy_nid";s:5:"76399";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Permethrin";s:5:"title";s:10:"Permethrin";s:3:"nid";s:5:"81085";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81086;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:354:"Since Sodium dodecyl sulfate is a synthetically prepared compound, by sulfation of 1-Dodecanol followed by neutralization with Sodium carbonate, which is used in the preparation of electrophoresis gels, toothpastes, shampoos, shaving foams and bubble baths for its thickening effect and amphiphilic properties, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76400";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Sodium lauryl sulfate";s:5:"title";s:21:"Sodium lauryl sulfate";s:3:"nid";s:5:"81086";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81087;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:231:"Activated charcoal, because it is processed to change the pharmacology of natural charcoal and does not fit into any category on Schedule 1 of the NHP Regulations, has been classified as a pharmaceutical requiring a DIN, not a NPN.";s:16:"field_legacy_nid";s:5:"76401";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Charcoal - activated";s:5:"title";s:20:"Charcoal - activated";s:3:"nid";s:5:"81087";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81088;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76402";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cetirizine";s:5:"title";s:10:"Cetirizine";s:3:"nid";s:5:"81088";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81089;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76403";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Docusate potassium";s:5:"title";s:18:"Docusate potassium";s:3:"nid";s:5:"81089";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81090;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76404";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Dioxybenzone";s:5:"title";s:12:"Dioxybenzone";s:3:"nid";s:5:"81090";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81091;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76405";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Loratadine";s:5:"title";s:10:"Loratadine";s:3:"nid";s:5:"81091";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81092;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76406";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"p-tert-Amylphenol";s:5:"title";s:17:"p-tert-Amylphenol";s:3:"nid";s:5:"81092";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81093;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:248:"Idebenone is a synthetically prepared quinone compound, related to coenzyme Q10, which is used in different degenerative diseases for its antioxidant activity.  Since Idebenone is not found in nature, it will be considered as a non-NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76407";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Idebenone";s:5:"title";s:9:"Idebenone";s:3:"nid";s:5:"81093";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81094;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76408";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Alcloxa";s:5:"title";s:7:"Alcloxa";s:3:"nid";s:5:"81094";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81095;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76409";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Hexylresorcinol";s:5:"title";s:15:"Hexylresorcinol";s:3:"nid";s:5:"81095";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81096;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:182:"A non-NHP because the intent of the Natural Health Products Regulations is to regulate over-the-counter products, a regulatory framework not suited to the regulation of medical gases";s:25:"field_non_nhp_rationale_f";s:191:"Un non PSN car c'est le but du Règlement sur les produits de santé naturels est la réglementation des produits en vente libre, une structure réglementaire non applicable aux gaz médicaux";s:19:"field_old_rationale";s:862:"The draft document describing what was agreed upon by TPD and NHPD is attached below. TPD has not yet had a chance to comment on this revision to the document that was presented to them last week, but hopefully it captures the essence of what we decided. The document identifies those gases that could be interpreted as NHPs, the interim approach, and the rationale for the RIAS to the amendment to Schedule 2 excluding gases from NHPs. Any submissions for medical gases should be transferred to SIPD for assessment by TPD staff according to the requirements of the Food and Drugs Act and Food and Drug Regulations. As soon as NHPD has the amendment to Schedule 2 in place (to be prepared on an urgent basis), TPD will then have the jurisdiction to authorize the licences. By reviewing the applications now, it will minimize any further delay for the applicants.";s:16:"field_legacy_nid";s:5:"76410";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Oxygen";s:5:"title";s:6:"Oxygen";s:3:"nid";s:5:"81096";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81097;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76411";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Clorophene";s:5:"title";s:10:"Clorophene";s:3:"nid";s:5:"81097";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81098;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76412";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Isopropyl myristate";s:5:"title";s:19:"Isopropyl myristate";s:3:"nid";s:5:"81098";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81099;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76413";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Ethylene oxide";s:5:"title";s:14:"Ethylene oxide";s:3:"nid";s:5:"81099";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81100;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76414";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:31:"Diethanolamine methoxycinnamate";s:5:"title";s:31:"Diethanolamine methoxycinnamate";s:3:"nid";s:5:"81100";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81101;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"5742";s:25:"field_non_nhp_rationale_e";s:211:"At any concentration where Simethicone is associated with a health claim (e.g. as an antiflatulent), Simethicone is classified as a drug medicinal ingredient subject to the Food and Drug Regulations, not an NHP.";s:25:"field_non_nhp_rationale_f";s:255:"À Toute concentration où Siméthicone est associé à une allégation de santé (p. ex. comme antiflatulent), Siméthicone est classifié comme ingrédient médicinal pour drogue assujetti au Règlement sur les aliments et drogues, et non pas comme PSN.";s:19:"field_old_rationale";s:393:"Simethicone is basically a detergent substance acting as an anti-gas (anti-flatulence) medication. It acts in the stomach and intestines to change the surface tension of gas bubbles, enabling smaller bubbles to join together into bigger bubbles. In this way it is believed that gas can be eliminated more easily by belching or passing flatus. Simethicone is classified as a drug, not as a NHP.";s:16:"field_legacy_nid";s:5:"76415";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Simethicone";s:5:"title";s:11:"Simethicone";s:3:"nid";s:5:"81101";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81102;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76416";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Methylbenzethonium chloride";s:5:"title";s:27:"Methylbenzethonium chloride";s:3:"nid";s:5:"81102";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81103;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:153:"Crotamiton belongs to the group of medicines known as antipruritics. This synthetic drug is not found in nature and therefore it is considered as a drug.";s:16:"field_legacy_nid";s:5:"76417";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Crotamiton";s:5:"title";s:10:"Crotamiton";s:3:"nid";s:5:"81103";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81104;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76418";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Polyethylene glycol";s:5:"title";s:19:"Polyethylene glycol";s:3:"nid";s:5:"81104";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81105;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76419";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Oxybenzone";s:5:"title";s:10:"Oxybenzone";s:3:"nid";s:5:"81105";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81106;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76420";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tolnaftate";s:5:"title";s:10:"Tolnaftate";s:3:"nid";s:5:"81106";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81107;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76421";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Domiphen bromide";s:5:"title";s:16:"Domiphen bromide";s:3:"nid";s:5:"81107";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81108;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76422";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Lisadimate";s:5:"title";s:10:"Lisadimate";s:3:"nid";s:5:"81108";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81109;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76423";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Acetaminophen";s:5:"title";s:13:"Acetaminophen";s:3:"nid";s:5:"81109";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81110;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76424";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Bisacodyl";s:5:"title";s:9:"Bisacodyl";s:3:"nid";s:5:"81110";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81111;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because it is an antibiotic substance included in Schedule 2 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN car une substance antibiotique comprise dans l'Annexe 2 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76425";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Gramicidin";s:5:"title";s:10:"Gramicidin";s:3:"nid";s:5:"81111";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81112;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:173:"Timonacic is prepared from DL- or L-Cysteine and formaldehyde. It is a synthetic material which is not found in nature. Timonacic will not be considered as a NHP but a drug.";s:16:"field_legacy_nid";s:5:"76426";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Timonacic";s:5:"title";s:9:"Timonacic";s:3:"nid";s:5:"81112";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81113;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76427";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Pyrithione zinc";s:5:"title";s:15:"Pyrithione zinc";s:3:"nid";s:5:"81113";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81114;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:325:"Tetrahydrozoline is a derivative of Imidazoline which is found in over-the-counter eye drops and nasal sprays. It is a synthetic material and not found in nature. Tetrahydrozoline is listed in the "List of prohibited and restricted cosmetic ingredients [Hot list (May, 2005)]". It will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76428";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Tetrahydrozoline";s:5:"title";s:16:"Tetrahydrozoline";s:3:"nid";s:5:"81114";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81115;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:405:"Zinc phenolsulfonate is found in Antiperspirant/Deodorant, Foot Treatment (as drug). It has a stringent and antimicrobial properties. It has also been used in antidiarrheal, antiemetic medication. Zinc phenolsulfonate is a synthetic compound that is not found in nature and it is not considered as an acceptable source for zinc. Therefore, Zinc phenolsulfonate will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76429";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Zinc phenolsulfonate";s:5:"title";s:20:"Zinc phenolsulfonate";s:3:"nid";s:5:"81115";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81116;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:790:"Hydroxypropyl guar is a synthetically prepared derivative of natural guar.  Guar galactomannan (or natural guar) is a water-soluble polysaccharide extracted from the seeds of Cyamopsi tetragonoloba, which consists of a linear backbone of beta-1,4 linked mannose units solubilized by alpha-1,6 galactose units side chains.  Because natural guars are known to contained as much as 10-14% insoluble residues, more soluble derivatives, such as hydroxypropyl guar, are used in various commercial applications.  Hydroxypropyl guar is made by treating natural guar with propylene oxide in an alkaline medium, which makes it more soluble in water with less insoluble residues.  Since hydroxypropyl guar is a synthetic product that is not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76430";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Hydroxypropyl guar";s:5:"title";s:18:"Hydroxypropyl guar";s:3:"nid";s:5:"81116";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81117;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:485:"Ciclesonide is a novel nonhalogenated inhalative glucocorticoid.  Since this chemical is a prodrug, it is converted in the lung to a potent metabolite, which have an affinity for the glucocorticoid receptor 100 times higher than the parent molecule.  Ciclesonide was found to be clinically effective essentially against bronchial asthma.  Since Ciclesonide is synthetically prepared by Altana Pharma Incorporated that is not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76431";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ciclesonide";s:5:"title";s:11:"Ciclesonide";s:3:"nid";s:5:"81117";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81118;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1068:"Bismuth Trinitrate Pentahydrate, Bi (NO3)3. 5H2O. Colorless, columnal crystals. Prepared by dissolving bismuth metal, Bi2O3, or (BiO)2CO3 in nitric acid. The nitrate is soluble in strong inorganic acids, glacial acetic acid, and glycerol. It is the starting material for basic bismuth nitrates of composition x Bi2O3 · yN2O5 · z H2O. Bismutum subnitricum, approximate composition 6Bi 2O3· 5N2O5 · 9H2O, was commonly used for medical purposes. Bismuth nitrate (or Bismuth trinitrate, CAS: [10361-44-1]) is a strong oxidizer and can be used as radiogenic agent. Bismuth nitrate is synthetic and not found in nature and will be considered as a drug, not NHP.                                                                                 Ref.:
[1] G. Gattow, G. Kiel, Z. Anorg. Allg. Chem. 335 (1965) 61.
[2] Bismuth, Bismuth Alloys, and Bismuth Compounds; Ullmann's Encyclopedia of Industerial Chemistry (2005)
[3] O. Kagimoto et al. Effect of the administration of Bismuth nitrate on radiogenic thymoma induction in mice, J. Radiat. res. (Tokyo). 32(4) (1991) 417.";s:16:"field_legacy_nid";s:5:"76432";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Bismuth nitrate";s:5:"title";s:15:"Bismuth nitrate";s:3:"nid";s:5:"81118";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81119;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:565:"Methylene blue is a heterocyclic aromatic compound used in various applications, such as in biology (used as a dye in different staining procedures), in chemistry (as a redox indicator in analytical chemistry, since this chemical is blue in an oxidizing environment and colourless when in contact with a reducing agent) and in medicine (as a cyanide antidote or as an antimethemoglobinemic).  Despite the fact that Methylene blue is acceptable as a NMI, it is a synthetic product that is not found in nature and therefore it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76433";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Methylene blue";s:5:"title";s:14:"Methylene blue";s:3:"nid";s:5:"81119";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81120;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:579:"Prednisolone is used as eyedrops or ointments in the reduction of irritation, redness, burning, and swelling of eye inflammation caused by chemicals, heat, radiation, infection, allergy, or other foreign bodies in the eye.  It is also used after eye surgery.  It is known to be the active compound of the oral prodrug Prednisone, converted to Prednisolone in the liver, which is why Prednisolone is considered to be metabolically interconvertible with Prednisone.  Since this product is a synthetic corticosteroid, not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76434";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Prednisolone";s:5:"title";s:12:"Prednisolone";s:3:"nid";s:5:"81120";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81121;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:620:"Ammonium laureth sulfate (or Ammonium lauryl ether sulfate) is a chemical compound used mainly in the cosmetics/personal care industry, as a detergent and surfactant, which is why this compound is listed in the NHPD acceptable NMIs list.  This chemical have similar properties than ammonium lauryl sulfate or sodium lauryl sultate (already classified in the database as a drug), except that Ammonium laureth sulfate, being a slightly larger molecule, do not penetrate the skin and hair as easily.  Since Ammonium laureth sulfate is synthetically prepared, not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76435";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Ammonium laureth sulfate";s:5:"title";s:24:"Ammonium laureth sulfate";s:3:"nid";s:5:"81121";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81122;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:746:"Tetradecylthioacetic acid (TTA) is a novel sulfur-substituted fatty acid analog, which has been studied in animal models for the treatment of glioma cancers.  TTA has chemical and physical properties almost identical to normal and natural saturated fatty acids, but TTA cannot undergo ß-oxidation, which is the reason why TTA is believed to reduce proliferation of both rat and human glioma cells.  For example, Gerge et al. have demonstrated that the presence of 100 µm TTA reduced the accumulation of DNA by ~45% in rat BT4Cn glioma cells after 8 days of treatment, whereas the control (palmitic acid) had no effect on DNA accumulation.  Since TTA is synthetically prepared and not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76436";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Tetradecylthioacetic acid";s:5:"title";s:25:"Tetradecylthioacetic acid";s:3:"nid";s:5:"81122";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81123;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:670:"Phenyltrimethicone is an inorganic-organic polymer part of the silicones family, which are polymers consisting of inorganic silicon-oxygen backbone (-Si-O-Si-O-) and an organic side groups, such as methyl, ethyl and phenyl groups.  Since these polymers can be syntesized with different  chain lenghts, side groups and may be crosslinked, they can have different physical properties, which is why silicones can be liquids, gels, rubbers, hard plastics, etc.  Phenyltrimethicone is used principally in the cosmetic industry as an emollient, lubricant agent.  Since Phenyltrimethicone is a synthetic polymer, not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76437";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Phenyl trimethicone";s:5:"title";s:19:"Phenyl trimethicone";s:3:"nid";s:5:"81123";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81124;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:369:"4-Hydroxy-3,5-diiodophenylacetic acid is a synthetically prepared derivative of the naturally occurring compound 4-Hydroxyphenylacetic acid, which is found in many biological sources such as sweet clover (Melilotus officinalis) and in the seeds of Taraxacum officinale. For this reason, 4-Hydroxy-3,5-diiodophenylacetic acid will be considered as a non-NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76438";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:37:"4-Hydroxy-3,5-diiodophenylacetic acid";s:5:"title";s:37:"4-Hydroxy-3,5-diiodophenylacetic acid";s:3:"nid";s:5:"81124";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81125;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:402:"Telmesteine is a muco-active drug with anti-protease activity used in the management of both acute and chronic bronchitis and in the obstructive airways disease.  This drug is a derivative of Timonacic (Thiazolidine-4-carboxylic acid), which is a sulfur-containing analogue of proline, synthesized from DL or L-Cysteine and formaldehyde.  Therefore, Telmesteine will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76439";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Telmesteine";s:5:"title";s:11:"Telmesteine";s:3:"nid";s:5:"81125";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81126;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:376:"Polyglucitol (more commonly known as polyglycitol syrup) is a hydrogenated starch hydrolysate used mainly as non-medicinal ingredient; as a sweetening agent, humectant, texturizer, stabilizer and bulking agent. Polyglycitol is considered as an acceptable NMI. Since Polyglycitol is a synthetic product that is not found in nature, therefore it will not be considered as a NHP.";s:16:"field_legacy_nid";s:5:"76440";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Polyglycitol syrup";s:5:"title";s:18:"Polyglycitol syrup";s:3:"nid";s:5:"81126";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81127;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:453:"The methyl ether derivative of Hydroxyquinone, namely 2-Methoxy-1,4-benzoquinone, has been isolated from the fruits of Diospyros kaki (Japanese persimmon) and therefore it is a NHP.  However, Hydroxyquinone is not found in any natural sources but it was proposed as a degradation intermediate product of 1,4-dinitrotoluene and 2,7-dichlorodibenzo-p-dioxin by the fungus Phanerochaete chrysosporiu. Therefore, Hydroxyquinone will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76441";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Hydroxyquinone";s:5:"title";s:14:"Hydroxyquinone";s:3:"nid";s:5:"81127";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81128;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:241:"Fenofibrate is a synthetically prepared drug, sold by Abbott Laboratories under the trade name TriCor, which is used to reduce cholesterol levels in cardiovascular disease risky patients.  Therefore, Fenofibrate will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76442";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Fenofibrate";s:5:"title";s:11:"Fenofibrate";s:3:"nid";s:5:"81128";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81129;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:404:"Moroxydine is a synthetically prepared compound, patented back in 1957. This drug was initially proposed in 1960 to be an influenza suppressant; however, it has been mostly used as an antiviral drug, since it has demonstrated clinically to possess activity against a wide range of DNA and RNA viruses.  Since Moroxydine (or its hydrochloride salt) is not found in nature, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76443";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Moroxydine";s:5:"title";s:10:"Moroxydine";s:3:"nid";s:5:"81129";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81130;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:121:"6-Methyluracil is a synthetically prepared derivative of uracil and therefore it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76445";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"6-Methyluracil";s:5:"title";s:14:"6-Methyluracil";s:3:"nid";s:5:"81130";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81131;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:697:"Neohesperidin dihydrochalcone (NHDC) is an artificial sweetener, synthetically prepared by the alkaline hydrogenation of the naturally occurring Neohesperidin.  This chemical is used as a sweetening agent especially in chewing gum and dentifrices, and it is known to be 1000 to 1500 times sweeter than sucrose and 20 times sweeter than saccharin.  Industrially, NHDC is produced by the extraction of Neohesperidin from bitter orange (Citrus aurantium) followed by hydrogenation.  Because of the synthetic modifications made on the naturally occurring starting material, NHDC is not considered as a source and/or derivative of Neohesperidin; therefore, NHDC will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76446";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Neohesperidin dihydrochalcone";s:5:"title";s:29:"Neohesperidin dihydrochalcone";s:3:"nid";s:5:"81131";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81132;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:266:"TFMPP is a piperazine-based drug, working as a serotonin receptor agonist, which have a similar mode of action than ecstasy on the serotonin system.  This chemical is synthetically prepared, not found in nature; therefore, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76447";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:37:"1-(3-Trifluoromethylphenyl)piperazine";s:5:"title";s:37:"1-(3-Trifluoromethylphenyl)piperazine";s:3:"nid";s:5:"81132";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81133;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:261:"Triethanolamine is a  synthetic organic compound.  It is used mostly as a pH balancer in cosmetic preparations, as well as having analgesic properties. Triethanolamine is not a naturally occurring compound; therefore, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76448";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Triethanolamine";s:5:"title";s:15:"Triethanolamine";s:3:"nid";s:5:"81133";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81134;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:426:"Varenicline is a synthetically prepared drug, sold under the trade name Chantix by Pfizer, used to treat smoking addiction. It is a partial agonist of alpha4, beta2- subtype of the nicotinic acetylcholine receptor. Varenicline is a structurally related to the naturally occurring compound Cytisine, but not considered as a derivative or source material for it and therefore Varenicline will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76449";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Varenicline";s:5:"title";s:11:"Varenicline";s:3:"nid";s:5:"81134";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81135;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:386:"Erlotinib, a drug sold under the trade name Tarceva, is a drug used to treat non-small cell lung cancer, pancreatic cancer and other types of cancer, and this, as an inhibitor of the epidermal growth factor receptor tyrosine kynase, which is highly expressed in those cancers.  Erlotinib is a synthetically prepared drug, not found in nature; therefore, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76450";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Erlotinib";s:5:"title";s:9:"Erlotinib";s:3:"nid";s:5:"81135";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81136;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:209:"Resocortol butyrate is a novel glucocorticoid drug developed especially for the topical treatment of pyotraumatic dermatitis in dogs.  It is not naturally occurring; therefore, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76451";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Resocortol butyrate";s:5:"title";s:19:"Resocortol butyrate";s:3:"nid";s:5:"81136";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81137;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:228:"Deracoxib is a non-steroidal anti-inflammatory drug member of the coxib family of drugs, such as Vioxx.  These drugs are known to be synthetically prepared, not found in nature; therefore, Deracoxib will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76452";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Deracoxib";s:5:"title";s:9:"Deracoxib";s:3:"nid";s:5:"81137";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81138;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:256:"Trospium chloride is a tropine derivative with anticholinergic activity, used as a antispasmodic drug in the treatment of urinary incontinence.  Since Trospium chloride is a synthetically prepared drug, not found in nature, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76453";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Trospium chloride";s:5:"title";s:17:"Trospium chloride";s:3:"nid";s:5:"81138";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81139;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:426:"Histrelin acetate is a synthetic nonapeptide agonist analog of the luteinizing hormone-releasing hormone, which is used to stop the production of sex hormones, used in the treatment of hormone-sensitive cancers and in the treatment of systemic precocious puberty.  It is sold under the tradename Supprelin and administered as a daily intramuscular injection.  For these reasons, Histrelin acetate will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76454";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Histrelin acetate";s:5:"title";s:17:"Histrelin acetate";s:3:"nid";s:5:"81139";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81140;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:285:"Solifenacin, sold as Solifenacin succinate under the tradename Vesicare, is a synthetically prepared muscarinic receptor antagonist used in the treatment of overactive bladder with urge incontinence.  Since Solifenacin succinate is not found in nature, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76455";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Solifenacin succinate";s:5:"title";s:21:"Solifenacin succinate";s:3:"nid";s:5:"81140";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81141;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:359:"Pregabalin is an anticonvulsant drug used for neuropathic pain, as an adjunct therapy for partial seizures and in generalized anxiety disorder; having analgesic, anticonvulsant and anxiolytic activity.  Even if it is an analog of the neurotransmitter GABA, it is not found in nature, synthetically prepared; therefore, Pregabalin will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76456";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pregabalin";s:5:"title";s:10:"Pregabalin";s:3:"nid";s:5:"81141";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81142;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:273:"Sunitinib is a synthetically prepared drug, approved by the FDA in January 2006, used in the treatment of gastrointestinal stromal tumor and renal cell carcinoma; being a receptor tyrosine kinase inhibitor.  Since it is not found in nature, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76457";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Sunitinib";s:5:"title";s:9:"Sunitinib";s:3:"nid";s:5:"81142";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81143;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:239:"Entecavir is a synthetically prepared drug, analogous to guanosine, which is used as an antiviral drug in the treatment of hepatitis B infection.  Since it is not found in nature; nor a source of guanosine, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76458";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Entecavir";s:5:"title";s:9:"Entecavir";s:3:"nid";s:5:"81143";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81144;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:239:"Darunavir that is sold under the tradename Presista and approved by the FDA in June 2006, is a protease inhibitor used to treat HIV.  This compound is synthetically prepared, not found in nature; therefore, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76459";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Darunavir";s:5:"title";s:9:"Darunavir";s:3:"nid";s:5:"81144";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81145;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:215:"Rasagiline is a selective irreversible inhibitor of monoamine oxidase B, developed by Teva Neuroscience.  It is a synthetically prepared drug; not found in nature; therefore, Rasagiline will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76460";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Rasagiline";s:5:"title";s:10:"Rasagiline";s:3:"nid";s:5:"81145";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81146;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:348:"Sorafenib is a novel, potent, orally available bi-aryl urea compound used in the treatment of advanced renal cell cancer, beign a tumor cell proliferation inhibitor.  This drug is sold under the tradename Nexavar by the company Bayer.  Sorafenib is a synthetically prepared molecule, not found in nature; therefore, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76461";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Sorafenib";s:5:"title";s:9:"Sorafenib";s:3:"nid";s:5:"81146";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81147;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:476:"Tigecycline is a glycylcycline antibiotic developed and marketed by the company Wyeth under the brandname Tygacil.  This antibiotic, developed in response to the growing prevalence of antibiotic resistance in bacteria, have shown good activity against a broad range of gram-positive and gram-negative bacteria.  Since antibiotics are excluded from the NHP Regulations by being listed in Schedule 2, and that Tigecycline is not found in nature, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76462";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Tigecycline";s:5:"title";s:11:"Tigecycline";s:3:"nid";s:5:"81147";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81148;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because it is an antibiotic substance included in Schedule 2 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN car une substance antibiotique comprise dans l'Annexe 2 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:334:"Pirlimycin is a semi-synthetic antibiotic; known to be structurally related to Clindamycin.  This antibiotic is mostly used as an antibacterial agent by veterinarian.  Since antibiotics are excluded from the NHP Regulations by being listed in Schedule 2; and because Pirlimycin is not found in nature, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76463";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pirlimycin";s:5:"title";s:10:"Pirlimycin";s:3:"nid";s:5:"81148";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81149;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:219:"Pimobendan is an inotropic drug with vasodilating action, used clinically in the treatment of heart failure.  It is a synthetically prepared drug, not found in nature; therefore, Pimobendan will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76464";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pimobendan";s:5:"title";s:10:"Pimobendan";s:3:"nid";s:5:"81149";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81150;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:258:"Lumiracoxib is a synthetically prepared NSAID drug. It has different structure from the standard COX-2 inhibitor, making this compound part of the arylalkonoic acid family of NSAIDs.  Since it is not found in nature, Lumiracoxib will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76465";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Lumiracoxib";s:5:"title";s:11:"Lumiracoxib";s:3:"nid";s:5:"81150";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81151;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:261:"Telbivudine is the L-form of the naturally occurring nucleoside Thymidine.  It is used as an ativiral agent in the treatment of hepatitis B virus.  However, L-forms of nucleosides are not naturally occurring; therefore, Telbivudine will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76466";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Telbivudine";s:5:"title";s:11:"Telbivudine";s:3:"nid";s:5:"81151";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81152;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:368:"Posaconazole is a triazole antifungal drug, orally available, well tolerated and effective against several mycoses including aspergillosis, zygomycosis, coccidioidomycosis, and fusariosis.  This drug, marketed in the U.S. by Schering-Plough under the tradename Noxafil, is a synthetically prepared drug, not found in nature; therefore, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76467";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Posaconazole";s:5:"title";s:12:"Posaconazole";s:3:"nid";s:5:"81152";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81153;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:464:"Acamprosate calcium (manufactured and marketed by Merck KGaA under the brand name Campral), is a drug used in the treatment of alcoholism.  It is functioning by blocking glutaminergic N-methyl-D-aspartate receptors, while activating gamma-Aminobutyric acid type A receptors.  Acamprosate calcium is a synthetically prepared drug, not found in nature, nor used as a source of calcium or any naturally occurring compounds; therefore, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76468";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Acamprosate calcium";s:5:"title";s:19:"Acamprosate calcium";s:3:"nid";s:5:"81153";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81154;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:432:"Oxaliplatin (marketed by Sanofi-Aventis under the trademark Eloxatin) is an antineoplastic drug; used mostly in combination with fluorouracil and leucovorin in the treatment of colorectal cancer.  Oxaliplatin has shown anti-tumor activity against colon carcinoma through its non-targeted cytotoxicity.  Since this drug is synthetically prepared, not found in nature nor used as a source of platinum, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76469";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Oxaliplatin";s:5:"title";s:11:"Oxaliplatin";s:3:"nid";s:5:"81154";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81155;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:191:"Sodium picosulfate is a synthetic laxative and cathartic. It is not found in nature and is not an acceptable source for Sodium. Sodium picosulfate will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76470";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Sodium picosulfate";s:5:"title";s:18:"Sodium picosulfate";s:3:"nid";s:5:"81155";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81156;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:628:"Sodium metabisulfite is an inorganic compoud which is mostly used as a food additive or pharmaceutic aid, sterilization or cleaning agent in homebrewing preparations, generally for its preservative/antioxidant properties.  When tis inorganic salt is mixed with water, it releases sulfur dioxide gas (a pungent unpleasant smelling gas which may cause breathing difficulties), which is why it is now not commonly used, but replaced by other compounds such as hydrogen peroxide.  Since Sodium metabisulite is a synthetically prepared inorganic salt, not used as a source of either sodium or sulfur, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76471";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Sodium metabisulfite";s:5:"title";s:20:"Sodium metabisulfite";s:3:"nid";s:5:"81156";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81157;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:906:"Glutaraldehyde is a dialdehyde liquid molecule having a pungent odour, mostly used as a disinfectant in the sterilization of endoscopic instruments, as well as a tanning agent for leather and as a fixative in electron microscopy.  Additionally, Glutaraldehyde is currently listed in the NHPD acceptable NMIs list for its use as a fixing agent in the immobilization of enzyme preparations, as a cross-linking agent for microencapsulation of flavouring substances and as an antimicrobial for sugar milling.  Medicinally, it has also been used in keratolytic therapy, which is a treatment to remove warts or other lesions in which the epidermis produces excess skin.  However, Glutaraldehyde is known to be relatively toxic, causing for example, severe eye, nose, throat and lung irritation.  This chemical is a synthetically prepared compound, not found in nature; therefore, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76472";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Glutaraldehyde";s:5:"title";s:14:"Glutaraldehyde";s:3:"nid";s:5:"81157";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81158;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:486:"Bismuth subgallate is a synthetically prepared bismuth compound, which is mostly used as an internal deodorant to treat malodor by deodorizing flatulence and stool.  It has also been used to treat Helicobacter pilori infection and in wound therapy.  It is prepared from bismuth nitrate and gallic acid in an acetic acid medium.  Since bismuth subgallate is not used for bismuth deficiency nor as a source of the naturally occurring compound gallic acid, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76473";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Bismuth subgallate";s:5:"title";s:18:"Bismuth subgallate";s:3:"nid";s:5:"81158";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81159;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:392:"Diethylamine salicylate is a salicylic acid derivative used in topical rubefacient preparations to relieve the muscle and joint pain.  Even if salicylic acid esters are found in several plants, Diethylamine salicylate itself is synthetically prepared, from salicylic acid and Diethylamine, and not known to occur in nature. Diethylamine salicylate will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76474";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Diethylammonium salicylate";s:5:"title";s:26:"Diethylammonium salicylate";s:3:"nid";s:5:"81159";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81160;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because it is an antibiotic substance included in Schedule 2 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN car une substance antibiotique comprise dans l'Annexe 2 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:853:"Temsirolimus is a derivative of Rapamycin (Sirolimus), where Rapamycin is a natural compound produced by bacteria (Streptomyces hygroscopicus). This macrolide antibiotic has shown some immunosuppressive and anticancer properties attributed to the inhibition of the mTOR signaling pathway, which controls mRNA translation and cell proliferation.  The poor solubility that compromised Rapamycin as an intravenous agent led to the development of a more soluble ester analog, Temsirolimus. This semi-synthetic analog of Rapamycin has been developed for intravenous use in cancer chemotherapy.  Despite the fact that Temsirolimus can be considered as a source for the naturally occurring compound Rapamycin (being its ester derivative),  it doesn't meet the definition of a NHP, since it is an antibiotic administered intravenously, by puncturing the dermis.";s:16:"field_legacy_nid";s:5:"76475";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Temsirolimus";s:5:"title";s:12:"Temsirolimus";s:3:"nid";s:5:"81160";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81161;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:318:"Sitaxsentan is an organic  molecule, synthetically prepared and marketed by Incysive Pharmaceuticals under the name Thelin, that antagonizes the action of endothelin, a mediator of blood vessel constriction and growth of smooth muscle in vascular walls.  Therefore, Sitaxsentan will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76476";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Sitaxsentan";s:5:"title";s:11:"Sitaxsentan";s:3:"nid";s:5:"81161";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81162;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76477";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"p-Chlorophenol";s:5:"title";s:14:"p-Chlorophenol";s:3:"nid";s:5:"81162";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81163;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76478";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"o-Chlorophenol";s:5:"title";s:14:"o-Chlorophenol";s:3:"nid";s:5:"81163";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81164;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:626:"Sodium cocoyl glutamate is a synthetically prepared washing substance (used in foaming bath preparations, shower gels, face cleansers, etc...) derived from a combination of glutamic acid and natural coconut fatty acids.  Since this chemical is not naturally occurring, nor used as a source of glutamic acid and/or coconut oil, it will be considered as a drug; not a NHP.  However, since foaming agent/surfactant/cleansing agent are considered acceptable NMI purposes, Sodium cocoyl glutamate will be considered as an acceptable NMI, provided the necessary evidence, since not currently listed in the NHPD acceptable NMIs list.";s:16:"field_legacy_nid";s:5:"76479";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Sodium cocoyl glutamate";s:5:"title";s:23:"Sodium cocoyl glutamate";s:3:"nid";s:5:"81164";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81165;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:321:"Dasatinib is a novel, orally available, small-molecule multitargeted kinase inhibitor produced by Bristol-Myers Squibb (sold under the trade name Sprycel) targeted to treat patients with chronic myelogenous leukemia.  Since this chemical is synthetically prepared and not found in nature, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76480";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Dasatinib";s:5:"title";s:9:"Dasatinib";s:3:"nid";s:5:"81165";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81166;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:305:"Deferasirox (sold under the tradename Exjade) is an oral iron chelator, approved in 2005 to be used to reduce the chronic iron overload in patients receiving long-term blood transfusions.  This chemical is a synthetically prepared compound, not found in nature; therefore, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76481";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Deferasirox";s:5:"title";s:11:"Deferasirox";s:3:"nid";s:5:"81166";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81167;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:702:"Methylhexaneamine (or 1,3-Dimethylamylamine) is an amine compound structurally related to amphetamine.  It has been patented in 1944 and considered for use as a local vasoconstrictor of nasal mucosa in the treatment of nasal congestion by Eli Lily and company.  This compound has been associated with the marketing of a dietary supplement containing an amphetamine-like substance that would be undetectable in current sports drug tests, prepared by an Illinois chemist involved in a steroid scandal in the United States.  It was reported to be a naturally occurring substance in a Chinese researchpaper;  however,  no such information could be verified.  Methylhexaneamine will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76482";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Methylhexaneamine";s:5:"title";s:17:"Methylhexaneamine";s:3:"nid";s:5:"81167";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81168;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:608:"Lenalidomide is an immunomodulatory and anti-neoplastic drug, approved in 2005 by the USFDA for patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities; sufficient to say that it is an anti-cancer drug.  Lenalidomide is a synthetically prepared drug (derivative of Thalidomide, a Schedule F drug), sold under the tradename Revlimid by Celgene; therefore, it is not a naturally occurring substance and consequently, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"76483";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Lenalidomide";s:5:"title";s:12:"Lenalidomide";s:3:"nid";s:5:"81168";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81169;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:969:"Ichthammol is obtained by sulfation and ammoniation of a distillate from mineral deposits (bituminous schists) originally found near Seefeld, Austria. It contains saturated and unsaturated hydrocarbons, nitrogenous bases, acids, and several thiophene derivs. Analysis shows at least 2.5% NH 3 and at least 10% S. It also contains traces of some 20 miner als and "zoomelanoidic" acids . Chemically, it is a sulfonated shale oil. It can be presented in two forms: pale sulfonated shale oil (PSSO), and dark sulfonated shale oil (DSSO). The last form is a thick reddish brown liquid, possessing a bituminous odor and taste. Pharmacologically, PSSO and DSSO have anti-inflammatory, bactericidal and fungicidal properties. Although the starting material for preparing this chemical is natural, Ichthammol itself is not natural (it is prepared synthetically). Furthermore, it is not a source for the natural parent(s). Ichthammol will not be considered as an NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76484";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ichthammol";s:5:"title";s:10:"Ichthammol";s:3:"nid";s:5:"81169";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81170;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:327:"Maraviroc is an chemokine receptor antagonist drug developed by the drug company Pfizer that is designed to act against HIV by interfering with the interaction between HIV and CCR5. Maraviroc is a synthetically prepared drug; it is not a naturally occurring substance and consequently, it will be considered as a drug, not NHP.";s:16:"field_legacy_nid";s:5:"76485";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Maraviroc";s:5:"title";s:9:"Maraviroc";s:3:"nid";s:5:"81170";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81171;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:483:"Ziprasidone (marketed as Geodon, Zeldox) is used to treat the symptoms of schizophrenia. It is also used to treat episodes of mania or mixed episodes in patients with bipolar disorder. Ziprasidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain. Ziprasidone is a synthetically prepared drug; it is not a naturally occurring substance and consequently, it will be considered as a drug, not NHP.";s:16:"field_legacy_nid";s:5:"76486";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ziprasidone";s:5:"title";s:11:"Ziprasidone";s:3:"nid";s:5:"81171";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81172;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1037:"Raltegravir (MK-0518, brand name Isentress) is an experimental antiretroviral drug from Merck. It is the first to enter Phase III clinical trials in the integrase inhibitor class. It targets integrase, an enzyme that HIV uses to integrate its genetic material into human cells. Raltegravir, and other integrase inhibitors, are often termed strand transfer inhibitors. This refers to the process of DNA strand transfer from the viral genome to the host genome. During 2006, the drug entered Phase III clinical trials, and it is available to certain patients with advanced HIV disease through an expanded access program. Raltegravir is a synthetic drug, not a NHP.                                                                                                         References:
[1] http://www.benchmrk.com/secure/earmrk/earmrk.html
[2] http://en.wikipedia.org/wiki/Raltegravir
[3] Savarino A. ‘A historical sketch of the discovery and development of HIV-1 integrase inhibitors’ Expert Opin. Investig. Drugs. 2006 Dec;15(12):1507-22.";s:16:"field_legacy_nid";s:5:"76487";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Raltegravir";s:5:"title";s:11:"Raltegravir";s:3:"nid";s:5:"81172";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81173;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1475:"Anidulafungin is an anti-fungal drug manufactured by Pfizer that gained approval by FDA in 2006 [1]. There is preliminary evidence that it has a similar safety profile to caspofungin. It has proven efficacy against oesophageal candidiasis, but its main utility will probably be in invasive Candida infection; it will probably also have application in treating invasive Aspergillus infection. It is a member of the class of anti-fungal drugs known as the echinocandins. Anidulafungin is a synthetic material (not natural) and will not be considered as a NHP, but a drug.                             References:
[1] www.fda.gov/bbs/topics/news/2006/NEW01321.html
[2] Krause DS, Reinhardt J, Vazquez JA, Reboli A, Goldstein BP, Wible M, Henkel T (2004). "Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia". Antimicrob Agents Chemother 48 (6): 2021–4.  
[3] Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ (2005). "In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of Candida spp., Including 315 Isolates Resistant to Fluconazole". J Clin Microbiol 43 (11): 5425–7.  
[4] Pfaller MA, Diekema DJ, Boyken L, Messer SA, Tendolkar S, Hollis RJ, Goldstein BP (2005). "Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis". Antimicrob Agents Chemother 49 (11): 4795–7. 
[5] http://en.wikipedia.org/wiki/Anidulafungin";s:16:"field_legacy_nid";s:5:"76488";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Anidulafungin";s:5:"title";s:13:"Anidulafungin";s:3:"nid";s:5:"81173";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81174;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:764:"Lanreotide is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin (a naturally-occurring inhibitory hormone), like octreotide. Lanreotide (as lanreotide acetate) is manufactured by Ipsen. It was approved for sale in the US by FDA [1]. SOMATULINE® AUTOGEL® is a solution of Lanreotide for ingection. Lanreotide is a synthetic material (not natural) and will be considered as a drug, not NHP.                                                                      References:
[1] www.fda.gov/bbs/topics/NEWS/2007/NEW01692.html 
[2] www.sigmaaldrich.com/catalog/search/ProductDetail/SIGMA/N9642
[3] http://en.wikipedia.org/wiki/Lanreotide#_ref-0";s:16:"field_legacy_nid";s:5:"76489";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Lanreotide";s:5:"title";s:10:"Lanreotide";s:3:"nid";s:5:"81174";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81175;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:891:"Duloxetine (Cymbalta, LY248686) is a drug which primarily targets major depressive disorder (MDD), generalized anxiety disorder (GAD), pain related to diabetic peripheral neuropathy and in some countries stress urinary incontinence (SUI). It is manufactured and marketed by Eli Lilly and Company. Eli Lilly and Company had the formula for duloxetine hydrochloride patented in 1991. Duloxetine (as Cymbalta) was approved by the FDA for MDD, and for diabetic neuropathy in 2004 [1]. Since Duloxetine is a synthetically prepared material (not natural), it will be considered as a drug, not NHP.                                                                                                                                                                                   References:
[1] http://www.fda.gov/cder/drug/infopage/duloxetine/historical.htm
[2] http://en.wikipedia.org/wiki/Cymbalta";s:16:"field_legacy_nid";s:5:"76490";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Duloxetine";s:5:"title";s:10:"Duloxetine";s:3:"nid";s:5:"81175";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81176;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:886:"Rotigotine is a non-ergot (or non-ergotamine) dopamine agonist drug and is indicated for the treatment of Parkinson's disease. It has been developed by the German pharmaceutical company Schwarz Pharma. Rotigotine is intended to be delivered through transdermal patches, so as to ensure a slow and constant dosage in a 24-hour period. The drug has been approved by the EMEA for use in the EU in 2006 and is today being sold in several European countries. In 2007, the Neupro patch has been approved by the FDA as the first transdermal treatment of Parkinson's disease in the United States. Rotigotine is a synthetic material (not natural) and will not be considered as a NHP, but a drug.                                                                               References:
[1] ChemID
[2] www.reuters.com/article/idUSN0932380520070509
[3]http://news.bbc.co.uk/2/hi/health/4880762.stm";s:16:"field_legacy_nid";s:5:"76491";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Rotigotine";s:5:"title";s:10:"Rotigotine";s:3:"nid";s:5:"81176";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81177;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:962:"Piracetam is a cerebral function regulating drug which, it is claimed, is able to enhance cognition and memory, slow down brain aging, increase blood flow and oxygen to the brain, aid stroke recovery, and improve Alzheimer's, Down's Syndrome, dementia, and dyslexia, among others. Piracetam shares the same 2-oxo-pyrrolidone base structure with 2-oxo-pyrrolidine carboxylic acid (pyroglutamate). Piracetam is a cyclic derivative of GABA and one of the racetams. Piracetam was first synthesized in 1964 by scientists at the Belgian pharmaceutical company UCB. The drug was the first of the so-called nootropics ("smart drugs" or "cognitive enhancers"), that is, substances which purportedly enhance mental performance. Piracetam is a synthetic material (not natural) and will not be considered as a NHP, but a drug.                                              References:
[1] ChemID
[2] The Merck Index
[3] Sigma-Aldrich
[4] www.smart-drugs.com/ias-piracetam.htm";s:16:"field_legacy_nid";s:5:"76492";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Piracetam";s:5:"title";s:9:"Piracetam";s:3:"nid";s:5:"81177";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81178;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:600:"Ibafloxacin (a fluorinated 4-quinolone) is a broad spectrum antibiotic with bactericidal action against Gram-positive and Gram-negative bacteria. The antimicrobial activity of the Ibafloxacin (racemate) originates mainly from the S-enantiomer. Ibafloxacin is a synthetic material (not natural) and will not be considered as a NHP, but a drug.                                                                                                                                                                                Ref.: 
The Merck Index
www.pubmedcentral.nih.gov/articlerender.fcgi?&artid=1635999";s:16:"field_legacy_nid";s:5:"76493";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ibafloxacin";s:5:"title";s:11:"Ibafloxacin";s:3:"nid";s:5:"81178";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81179;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:609:"Minoxidil is a potent direct-acting peripheral vasodilator that reduces peripheral resistance and produces a fall in blood pressure. It is given by mouth in the treatment of severe hypertension unresponsive to other therapy. It is also used topically in the treatment of male-pattern baldness. Minoxidil is a synthetic material (not natural) and will not be considered as a NHP, but a drug.                                                                                                                                        References: 
[1] ChemID
[2] The Merck Index
[3] Martindale, The Extra Pharmacopoeia";s:16:"field_legacy_nid";s:5:"76494";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Minoxidil";s:5:"title";s:9:"Minoxidil";s:3:"nid";s:5:"81179";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81180;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:552:"Neutral red is a vital dye used as an indicator and biological stain (it is an eurhodin dye used for staining in histology). It is a synthetic material prepared from N,N- dimethyl- p- nitrosoaniline hydrochloride and  toluene-2,4-diamine. Neutral red is not natural and will not be considered as a NHP.                                                                                                                                                                                                                References:
[1] The Merck Index
[2] ChemID";s:16:"field_legacy_nid";s:5:"76495";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Neutral red";s:5:"title";s:11:"Neutral red";s:3:"nid";s:5:"81180";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81181;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because it is an antibiotic substance included in Schedule 2 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN car une substance antibiotique comprise dans l'Annexe 2 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1267:"Daptomycin is a lipopeptide antibiotic used in the treatment of certain infections caused by Gram-positive organisms. It is a naturally-occurring compound found in the soil saprotroph Streptomyces roseosporus. The compound was originally discovered by researchers at Eli Lilly and Company in the 1980s. Daptomycin has been approved for the treatment of complicated skin and soft tissue infections. CUBICIN® (Daptomycin for Injection) is automathically excluded from NHPD because of the route of administration, i.e. injection. Furthermore, Cubicin is listed in 'Health Canada' as 'PRESCRIPTION PRODUCTS FOR HUMAN USE' in September 2007.  Due to its antibacteral activity (as antibiotic-antibiotics are excluded from the NHP Regulations by being listed in Schedule 2), despite its natural source, Daptomycin will not be considered as a NHP, but a drug.                                                                                                                                                                                                                   References:
[1] ChemID
[2] Dictionary of Natural Products
[3] www.ucsf.edu/idmp/whatsnew/dapto_monograph.htm 
[4] www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/noc-lac/archive_e/2007-10-12/pre2007etw.txt";s:16:"field_legacy_nid";s:5:"76496";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Daptomycin";s:5:"title";s:10:"Daptomycin";s:3:"nid";s:5:"81181";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81182;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:718:"Naproxen is an anti-inflammatory (non-steroidal) agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.  Naproxen and its salts are listed under Schedule F ingredients. The FDA approved the use of Naproxen sodium as an over-the-counter (OTC) drug in 1994. However, Naproxen is a synthetic material (not natural) and is not considered as a NHP, but a drug.                                                                                              References:
[1] The Merck Index
[2] ChemID
[3] www.fda.gov/bbs/topics/news/2004/NEW01148.html
[4] Sigma-Aldrich";s:16:"field_legacy_nid";s:5:"76497";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Naproxen";s:5:"title";s:8:"Naproxen";s:3:"nid";s:5:"81182";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81183;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:930:"Methyl hesperidin is the methylated form of Hesperidin. It has been used as a food additive.  In one study, in order to clarify the components of the commercial food additives, four main compounds from methylated hesperidin were isolated and identified as 3'-monomethylhesperidin, 3',5-dimethylhesperidin, 2',3,6'-trimethylhesperidin chalcone and 2',3,6'-trimethyl-4'-(rhamnosy1-2-O-methylglucosy1)-hesperetin chalcone, by spectroscopic analyses. These forms of methylated hesperidin are not naturally occurring substances and are not sources for Hesperidin.  Therefore, Methyl hesperidin will be considered as a drug, not NHP.                                                                                                                           References:
[1] ChemID
[2] Tanaka, R. et al. 'Component determination and specification of a food additive, Methyl Hesperidin'  Japanese Journal of Food Chemistry, Vol. 12(2), 2005";s:16:"field_legacy_nid";s:5:"76498";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Methyl hesperidin";s:5:"title";s:17:"Methyl hesperidin";s:3:"nid";s:5:"81183";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81184;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:182:"A non-NHP because it is a drug obtained via recombinant DNA procedure, which falls under "Drugs Obtained By Recombinant DNA Procedures" listed in Schedule D of the Food and Drugs Act";s:25:"field_non_nhp_rationale_f";s:227:"Un non PSN parce qu'une drogue obtenue par procédure de recombinaison de l' ADN, de qui correspond à "Drogues obtenues par des procédures de recombinaison de l’ADN" dans l'Annexe D de la Loi sur les aliments et les drogues";s:19:"field_old_rationale";s:1068:"Nesiritide is an exogenous form of human b (brain)-type natriuretic peptide (hBNP), a 32 amino acid peptide manufactured from E.coli using recombinant DNA technology (Recombinant DNA is a form of artificial DNA which is engineered through the combination or insertion of one or more DNA strands, thereby combining DNA sequences which would not normally occur together, i.e. naturally). NATRECOR® (Nesiritide) is a prescribed drug across the U.S. for the treatment of acutely decompensated congestive heart failure patients with dyspnea (shortness of breath) at rest or with minimal activity (such as talking, eating or bathing). Since drugs obtained by recombinant DNA procedures are listed under Schedule D to the Food and Drugs Act, Nesiritide will not be considered as a NHP, but a drug.                                                                                    References:
[1] Weibel, K. Journal of the Pharmacy Society of Wisconsin, 2002, 28-31
[2] ChemID
[3] www.natrecor.com
[4] http://lois.justice.gc.ca/en/ShowDoc/cs/F-27///en?page=1&isprinting=true";s:16:"field_legacy_nid";s:5:"76499";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nesiritide";s:5:"title";s:10:"Nesiritide";s:3:"nid";s:5:"81184";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81185;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1039:"Sodium polystyrene sulfonate is a type of polymer and ionomer based on polystyrene. The polyanion is readily soluble in water, and insoluble in lower alcohols. It may be prepared by polymerization or copolymerization of sodium styrene sulfonate or by sulfonation of polystyrene. It is used as a superplastifier in cement, crosslinked polystyrenes that are then sulfonated have found widespread use in ion-exchange applications, it is used as a dye improving agent for cotton and as proton exchange membranes in fuel cell applications. It is also a medication used to treat abnormally high potassium levels. Sodium polystyrene sulfonate is a synthetic material (not natural) and will not be considered as a NHP, but a drug.                                                                                                                                                                                                               References:
[1] Merck Index
[2] ChemID
[3] www.medicinenet.com/sodium_polystyrene_sulfonate-powder/article.htm";s:16:"field_legacy_nid";s:5:"76501";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Sodium polystyrene sulfonate";s:5:"title";s:28:"Sodium polystyrene sulfonate";s:3:"nid";s:5:"81185";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81186;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:686:"Sitaliptin (Sitagliptin phosphate) is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Sitagliptin was approved by the FDA as a treatment for diabetes on October 2006 and is marketed in the US as Januvia by Merck & Co. Sitagliptin is a synthetic material (not natural) and will not be considered as a NHP, but a drug.                                                                                                        References:
[1] ChemID
[2] www.fda.gov/bbs/topics/NEWS/2006/NEW01492.html
[3] Choy M. and Lam S.'Sitagliptin: a novel drug for the treatment of type 2 diabetes', Cardiol Rev. 2007 Sep-Oct;15(5):264-71.";s:16:"field_legacy_nid";s:5:"76502";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Sitagliptin phosphate";s:5:"title";s:21:"Sitagliptin phosphate";s:3:"nid";s:5:"81186";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81187;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:729:"Isosorbide mononitrate is the mononitrate compound of Isosorbide (a synthetic material; chemically inert osmotic diuretic used mainly to treat hydrocephalus and glaucoma). Isosorbide mononitrate is a drug (made by AstraZeneca as 'Imdur') used principally in the treatment of angina pectoris and acts by dilating the blood vessels for reducing the blood pressure. Isosorbide mononitrate is a synthetic material (not natural) and will not be considered as a NHP, but a drug.                                                                                                                                                             References:
[1] ChemID
[2] www.astrazenecacardiovascular.com/article/503963.aspx
[3] The Merck Index";s:16:"field_legacy_nid";s:5:"76503";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Isosorbide mononitrate";s:5:"title";s:22:"Isosorbide mononitrate";s:3:"nid";s:5:"81187";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81188;a:11:{s:4:"body";s:0:"";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:846:"Teprenone is an acyclic polyisoprenoid 2:3 mixture of (5Z,9E,13E) and all trans (5E,9E,13E) isomers. It is an anti-ulcer agent (in treatment of gastric ulcera). It is a synthetic material prepared from geranylgeranyl bromide. When administrated orally to rats, intact GGA and its hydroxylated form (GGA-OH) were found in the gastric mucosa. Teprenone is not considered as a source for any natural product. It will not be considered as a NHP, but a drug.                                                                                                                                                                   References:
[1] The Merck Index
[2] ChemID
[3] L. Ruzicka, and L. Castro 'Synthese des Geranyl-nerolidols', Helv. Chim. Acta 28, 590 (1945)- Article in German
[4] Y. Nishizawa et al., Biochem. Biophys. Res. Commun. 103, 706 (1981)";s:16:"field_legacy_nid";s:5:"76504";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Teprenone";s:5:"title";s:9:"Teprenone";s:3:"nid";s:5:"81188";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81189;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1233:"Eosin is a red fluorescent dye. There are two very closely related compounds commonly referred to as eosin; Eosin Y and Eosin B. All eosins are bromine derivatives of fluorescein, used in dyeing textiles, ink manufacturing, in coloring cosmetics, in coloring gasoline and as a toner. The sodium or potassium salt of eosin, red to rose-colored crystalline powder, is used in biology to stain cells. Eosin is strongly absorbed by red blood cells, colouring them bright red. Eosin imparts reddish colour to cytoplasmic materials and connective tissues (cell membranes, extracellular structures) as a counterstain to haematoxylin and some Gram staining. Eosin B is water-soluble (distinctly bluish shade) and a cytoplasmic counterstain for hematoxylin. Eosins are prepared by bromination of Fluorescein (also a synthetic material). Eosins including Eosin B will not be considered as NHPs, but drugs.                                                                                                                                                                      References:
[1] www.chemicalland21.com/specialtychem/finechem/EOSIN%20B.htm
[2] Sigma-Aldrich at www.sigmaaldrich.com/catalog/search/ProductDetail/SIAL/861006
[3] ChemID";s:16:"field_legacy_nid";s:5:"76505";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Eosin B";s:5:"title";s:7:"Eosin B";s:3:"nid";s:5:"81189";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81190;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:849:"Thiocolchicoside (TCC) is a synthetic derivative of colchicoside [a naturally occurring Alkaloid from seeds of Colchicum autumnale and Gloriosa superba (Liliaceae)] derived by substitution of a methoxy group with a thiomethyl group. 3-O-glucuronidated aglycone is the major metabolite of TCC and is responsible for the muscle relaxant activity of the parent compound [1]. Neither Thiocolchicoside nor its metabolite are naturally occuring. Thiocolchicoside will not be considered as a NHP but a drug.                                                                                                                       References:
[1] Trellu M. et al.‘New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans’ Fundam. Clin. Pharmacol. 2004 Aug;18(4):493-501
[2] ChemID
[3] The Merck Index";s:16:"field_legacy_nid";s:5:"76506";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Thiocolchicoside";s:5:"title";s:16:"Thiocolchicoside";s:3:"nid";s:5:"81190";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81191;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:11:"67;956;3685";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:645:"Hypromellose is a partly O-methylated and O-(2-hydroxypropylated) cellulose. For its synthesis, the alkali cellulose (cellulose reacted with sodium hydroxide) is treated with chloromethane and propylene oxide.  Hypromellose is widely used as an excipient in oral and topical pharmaceutical formulations. However, it is not naturally found; therefore, Hypromellose will not be considered as a NHP, but a drug.                                                                          References:
[1] The Merck Index
[2] Dictionary of Natural Products
[3] ChemID
[4] Handbook of Pharmaceutical Excipients, 5th Edition, By Raymond C Rowe et al. 2006";s:16:"field_legacy_nid";s:5:"76507";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Hypromellose";s:5:"title";s:12:"Hypromellose";s:3:"nid";s:5:"81191";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81192;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1750:"Carglumic acid is a structural analogue of N-Acetylglutamate [1,2], which is the naturally occurring activator of carbamoyl phosphate synthetase (CPS).  It is a N-carbamoyl derivative of Glutamic acid, recognized as an 'Orphan Drug' (a drug for rare diseases) in Europe [3].  Carglumic acid is used in the prevention and treatment of hyperammonemia encountered in liver diseases [4].  Unlike N-Acetylglutamate, Carglumic acid can enter the mitochondria [5].  Carglumic acid was shown to be weaker activator of CPS than N-Acetylglutamate, but in vivo it was more efficient [6].  A recent study shows oral Carglumic acid supplementation increases plasma arginine and somatotropin levels, leading to an increase in growth rate and muscle protein synthesis in nursing piglets [7].  These examples and many others show that the pharmacological properties (distribution, metabolism, excretion, mechanism of action, etc.) of Carglumic acid are different than N-Acetylglutamate and Glutamic acid.  Moreover, Carglumic acid is a synthetic material (not natural) and is not considered as a source for either Glutamic acid or N-Acetylglutamate.  Carglumic acid will not be considered as a NHP, but a drug.                                                                                                                                           References: 
[1] Dictionary of Natural Products
[2] ChemIDAdvanced
[3] http://ec.europa.eu/enterprise/pharmaceuticals/register/orphreg.htm
[4] Lee, J.-H. et al., Biochem. Biophys. Res. Commun., 1998, 248, 391-394
[5] O'Connor, J.E. et al., Eur. J. Pediatr., 1985, 143, 196-197
[6] Rubio V and Grisolia S (1981) Human carbamylphosphate synthetase I. Enzyme, 26: 233-9
[7] Frank JW. Et al. J Nutr. 2007 Feb;137(2):315-9";s:16:"field_legacy_nid";s:5:"76508";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Carglumic acid";s:5:"title";s:14:"Carglumic acid";s:3:"nid";s:5:"81192";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81193;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:459:"Sodium lauryl sulfoacetate is a synthetic surfactant [1].  It has been used in laxative formulations [2].  Sodium lauryl sulfoacetate is not used as a source for sodium and/or lauric acid.  It will not be considered as a NHP, but a drug.                                                                                                              References:
[1] ChemID
[2] www.hc-sc.gc.ca/fnih-spni/nihb-ssna/provide-fournir/pharma-prod/med-list/56-00_e.html";s:16:"field_legacy_nid";s:5:"76509";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Sodium lauryl sulfoacetate";s:5:"title";s:26:"Sodium lauryl sulfoacetate";s:3:"nid";s:5:"81193";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81194;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:422:"Etravirine is a drug approved in the United States (Jan., 2008) for the treatment of HIV [1]. It has also antiviral activity [2]. Etravine is a synthetic material (not found in nature). It will not be considered as a NHP, but a drug.                                                                                                                    References:
[1] www.fda.gov/bbs/topics/NEWS/2008/NEW01783.html
[2] ChemID";s:16:"field_legacy_nid";s:5:"76510";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Etravirine";s:5:"title";s:10:"Etravirine";s:3:"nid";s:5:"81194";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81195;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:403:"Ambrisentan is a drug being researched for use in the treatment of pulmonary hypertension and approved by FDA in June 2007 [1].  Ambrisentan is a synthetic material (not found in nature).  It will not be considered as a NHP, but a drug.                                                                                              References:
[1] www.fda.gov/bbs/topics/NEWS/2007/NEW01653.html
[2] ChemID";s:16:"field_legacy_nid";s:5:"76511";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ambrisentan";s:5:"title";s:11:"Ambrisentan";s:3:"nid";s:5:"81195";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81196;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:729:"Maropitant is a novel neurokinin-1 receptor antagonist formulated for the treatment and prevention of acute vomiting in dogs.  Since this durg is synthetically prepared and recommended for dogs, not humans, it will be considered as a drug, not NHP.                                                                  References:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17199418&query_hl=5&itool=pubmed_docsum
http://chem.sis.nlm.nih.gov/chemidplus/ProxyServlet?objectHandle=Search&actionHandle=getAll3DMViewFiles&nextPage=jsp%2Fcommon%2FChemFull.jsp%3FcalledFrom%3D&chemid=147116674&formatType=_3D
http://www.ingentaconnect.com/content/bsc/vco/2007/00000005/00000001/art00004";s:16:"field_legacy_nid";s:5:"76512";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Maropitant";s:5:"title";s:10:"Maropitant";s:3:"nid";s:5:"81196";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81197;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1155:"p-Hydroxyephedrine (Methylsynephrine) has a similar structure to both Ephedrine and Synephrine (both are natural products); a hydroxyl group in para position on phenyl ring of Ephedrine and a methyl group in alpha position of Synephrine [1].  However, these groups (hydroxyl and methyl) can not be removed from the molecule by administration.  Therefore, it is not a source for Ephedrine and/or Synephrine.  p-Hydroxyephedrine has been used as an adrenergic [2].  As a stimulant, it is included in the world anti-doping prohibited list [3].  Synephrine is not included in this prohibited list.  Ephedrine (as stimulant) is included only if certain amount of it can be detected in urine sample.  Based on this information, Methylsynephrine should be considered different than Ephedrine and Synephrine.  As p-Hydroxyephedrine is not naturally occurring, it will not be considered as a NHP, but a drug.                                                                                                                                                                           References:
[1] ChemID
[2] The Merck Index
[3] www.wada-ama.org/en/prohibitedlist.ch2";s:16:"field_legacy_nid";s:5:"76513";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Oxilofrine";s:5:"title";s:10:"Oxilofrine";s:3:"nid";s:5:"81197";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81198;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:379:"Sevoflurane is a fluorinated methyl/isopropyl ether used as an anesthetic (inhalation) [1-2]. It is a synthetic material (not found in nature) and is not a source for any natural product. Sevoflurane will not be considered as a NHP, but a drug.                                                                                             References:
[1] The Merck Index
[2] ChemID";s:16:"field_legacy_nid";s:5:"76514";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Sevoflurane";s:5:"title";s:11:"Sevoflurane";s:3:"nid";s:5:"81198";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81199;a:11:{s:4:"body";s:0:"";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:972:"Dirlotapide[1] is a drug used to treat obesity in dogs, and approved by the FDA (see figure below)[2]. It is prepared by Pfizer under the brand name Sentrol.The preparation of Dirlotapide is achieved via a three-step linear synthesis [3]. When ingested by dogs, Dilotapide is metabolized to more than 20 metabolites[4]. Based on the complex synthetic pathway of this chemical, it’s metabolic pathway in vivo and the fact that there are only a few naturally occurring products that contain a C-F bond [5], this product is classified as a drug, not an NHP.                                                              References:
[1] http://chem.sis.nlm.nih.gov/chemidplus/
[2] http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=17567513&cmd=showdetailview&indexed=google
[3] Bioinorganic and Medicinal Chemistry letters, Volume 17, Issue 7, 1996-1999
[4] Jounal of Fluorine chemistry, Volume 126, Issue 2, 157-163
[5] J. vet. Pharmacol. Therap. 30 (Suppl. 1), 17–23";s:16:"field_legacy_nid";s:5:"76515";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Dirlotapide";s:5:"title";s:11:"Dirlotapide";s:3:"nid";s:5:"81199";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81200;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:768:"Paliperidone is a new atypical anti-psychotic drug developed by the Janssen Pharmaceutica company.  This second generation anti-psychotic, approved by the FDA in December 2006 for the treatment of schizophrenia and bipolar mania, is the 9-hydroxy derivative and primary metabolite of the drug Risperidone.  Since Paliperidone is a synthetically prepared substance not occurring naturally, it will be considered as a drug.                                                       References:
http://chem.sis.nlm.nih.gov/chemidplus/ProxyServlet?objectHandle=Search&actionHandle=getAll3DMViewFiles&nextPage=jsp%2Fcommon%2FChemFull.jsp%3FcalledFrom%3D&chemid=144598754&formatType=_3D
http://www.fda.gov/fdac/departs/2007/207_upd.html
http://en.wikipedia.org/wiki/Paliperidone";s:16:"field_legacy_nid";s:5:"76516";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Paliperidone";s:5:"title";s:12:"Paliperidone";s:3:"nid";s:5:"81200";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81201;a:11:{s:4:"body";s:0:"";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because it is an antibiotic substance included in Schedule 2 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN car une substance antibiotique comprise dans l'Annexe 2 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1102:"Doxycycline [1] is a member of tetracycline antibiotics. It is synthesized from oxytetracycline or methacycline [2].  Oxytetracycline can be naturally occurring and was first found in the actinomycete (a group of gram-postive bacteria), Streptomyces rimosus, by Finlay [3].  Since Doxycycline is synthesized from oxytetracycline, is sometimes considered semi-synthetic in nature.  Doxycyline is found on Schedule F to the Food and Drugs Regulations when sold for intramuscular administration in caged birds.  And because it falls under Item 6 of Schedule 2 of the Natural Health Products Regulations (‘an antibiobiotic prepared from an alga, a bacterium, a fungus or a synthetic duplicate of that antibiotic’), it is considered as a non-NHP.                                                                                                                                                                                         References:
[1] http://chem.sis.nlm.nih.gov/chemidplus/ProxyServlet?chemidheavy
[2] Pharmacological Research, Volume 49, Issue 5, 487-491
[3] Science, Jan 27, 1950, Vol III";s:16:"field_legacy_nid";s:5:"76517";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Doxycycline";s:5:"title";s:11:"Doxycycline";s:3:"nid";s:5:"81201";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81202;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76518";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Chlophedianol";s:5:"title";s:13:"Chlophedianol";s:3:"nid";s:5:"81202";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81203;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76519";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Dextromethorphan";s:5:"title";s:16:"Dextromethorphan";s:3:"nid";s:5:"81203";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81204;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76520";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Xylometazoline";s:5:"title";s:14:"Xylometazoline";s:3:"nid";s:5:"81204";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81205;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76521";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Etafedrine";s:5:"title";s:10:"Etafedrine";s:3:"nid";s:5:"81205";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81206;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76522";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Sodium dibunate";s:5:"title";s:15:"Sodium dibunate";s:3:"nid";s:5:"81206";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81207;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76523";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Phenyltoloxamine citrate";s:5:"title";s:24:"Phenyltoloxamine citrate";s:3:"nid";s:5:"81207";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81208;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because it is an antibiotic substance included in Schedule 2 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN car une substance antibiotique comprise dans l'Annexe 2 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1041:"Retapamulin (Fig.1) [1] is a topical antibiotic.  It is a semisynthetic pleuromutilin compound (via a 5-step synthetic process) [2][4] with in vitroactivity against gram-positive bacteria.  Pleuromutilin (Fig. 2) is a tricyclic, diterpene natural product first identified from the basidiomycete bacterial species Pleurotus mutilus (now referred to as Clitopilus scyphoides) [3] that possesses modest antibacterial activity against primarily gram-positive bacterial organisms.  Retapamulin falls under Item 6 of Schedule 2 of the Natural Health Products Regulations (an antibiotic prepared from an alga, a bacterium, a fungus or a synthetic duplicate of that antibiotic), it is considered as a non-NHP.                                                                                          References:
[1] http://chem.sis.nlm.nih.gov/chemidplus
[2] Future Microbilogy, 2007 Dec;2:591-600
[3] Antimicrobial Agents and Chemotherapy, November 2006, p. 3875-3881, Vol. 50, No. 11
[4] www.emea.europa.eu/humandocs/PDFs/EPAR/altargo/H-757-en6.pdf";s:16:"field_legacy_nid";s:5:"76524";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Retapamulin";s:5:"title";s:11:"Retapamulin";s:3:"nid";s:5:"81208";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81209;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1062:"Nilotinib (Fig. 1) [1] is a synthetic aminopyrimidine, containing a CF3 bond.  It is synthesized from 3-bromo-5(trifluoromethyl)aniline (Fig. 2) through a 4-step process [2].  In vivo studies have shown that once ingested, biotransformations happens in the human body, which resulted in the detection of twenty distinct human metabolites [3].  Since this compound is synthetic, and contains a CF3 bond (which makes it unlikely that it can be naturally occuring) [4], and given the fact that it gets metabolized to more than 20 metabolites in the human body, it is considered a drug, not an NHP.                                                                                                                                                                                                                  References:
[1] http://chem.sis.nlm.nih.gov/chemidplus/
[2] Journal of Synthetic Organic Chemistry, 2007, No. 14, Pages 2121-2125
[3] www.emea.europa.eu/humandocs/PDFs/EPAR/tasigna/H-798-en6.pdf
[4]  Jounal of Fluorine chemistry, Volume 126, Issue 2, 157-163";s:16:"field_legacy_nid";s:5:"76525";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Nilotinib";s:5:"title";s:9:"Nilotinib";s:3:"nid";s:5:"81209";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81210;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:129:"A non-NHP because Uranium is slightly radioactive; where radiopharmaceuticals are listed in Schedule C of the Food and Drugs Act.";s:25:"field_non_nhp_rationale_f";s:176:"Un non PSN parce que l'uranium est légèrement radioactif; ce qui correspond aux produits pharmaceutiques radioactifs dans l'Annexe C de la Loi sur les aliments et les drogues";s:19:"field_old_rationale";s:810:"Uranium nitrate is the uranium salt of nitric acid. Uranium nitrate, as Uranium nitricum, is one of the homeopathic medicines derived from Substances in Schedule C of the Food and Drugs Act (Radiopharmaceuticals); these substances are found in accepted pharmacopoeia (e.g. in this case in HPUS) but are not regulated under the regulations and therefore do not qualify for a DIN-HM. Uranium nitrate will not be considered as a NHP, but a schedule C substance.                                                                                                                                             References:
[1] ChemID
[2] Evidence for Homeopathic Medicines Guidance Document at http://hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/ehmg-nprh_e.html
[3] Homeopathic Pharmacopoeia of the United States (HPUS)";s:16:"field_legacy_nid";s:5:"76526";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Uranium nitrate";s:5:"title";s:15:"Uranium nitrate";s:3:"nid";s:5:"81210";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81211;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in Schedule D of the Food and Drugs Act as follows: Cholecystokinin";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues : Cholécystokinine";s:16:"field_legacy_nid";s:5:"76527";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Cholecystokinin";s:5:"title";s:15:"Cholecystokinin";s:3:"nid";s:5:"81211";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81212;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:138:"A non-NHP because it is a pituitary hormone which falls under "Anterior Pituitary Extracts" listed in Schedule D of the Food and Drugs Act";s:25:"field_non_nhp_rationale_f";s:152:"Un non PSN car hormone pituitaire qui correspond à "Extraits hypophysaires (lobe antérieur)" dans l'Annexe D de la Loi sur les aliments et les drogues";s:19:"field_old_rationale";s:495:"Adrenocorticotropic hormone (ACTH or corticotrophin), a single chain polypeptide pituitary hormone containing 39 amino acids, is responsible for the secretion of adrenal cortical steroids and growth induction of the adrenal cortex.  Since this hormone is isolated by the extraction of the pituitaries of different animals, and that all pituitary extracts are listed in Schedule D to the Food and Drugs Act, Adrenocorticotropic hormone will be considered as a non-NHP, but a Schedule D substance.";s:16:"field_legacy_nid";s:5:"76528";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Corticotropin";s:5:"title";s:13:"Corticotropin";s:3:"nid";s:5:"81212";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81213;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:85:"A non-NHP because listed in Schedule D of the Food and Drugs Act as follows: Secretin";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues :  Sécrétine";s:16:"field_legacy_nid";s:5:"76529";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Secretin";s:5:"title";s:8:"Secretin";s:3:"nid";s:5:"81213";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81214;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:138:"A non-NHP because it is a pituitary hormone which falls under "Anterior Pituitary Extracts" listed in Schedule D of the Food and Drugs Act";s:25:"field_non_nhp_rationale_f";s:152:"Un non PSN car hormone pituitaire qui correspond à "Extraits hypophysaires (lobe antérieur)" dans l'Annexe D de la Loi sur les aliments et les drogues";s:19:"field_old_rationale";s:364:"Tyrotrophin (or thyrotropin) is a thyroid-stimulating hormone (TSH) produced by the anterior lobe of the pituitary gland, which appears to be essential for the correct functioning of the thyroid gland.  Because all anterior pituitary extracts are listed in Schedule D, Tyrotrophin will be considered as a Schedule D substance under the Food and Drugs Act, not NHP.";s:16:"field_legacy_nid";s:5:"76530";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Thyrotropin";s:5:"title";s:11:"Thyrotropin";s:3:"nid";s:5:"81214";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81215;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in Schedule D of the Food and Drugs Act as follows: Interferon";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues :  Interferon";s:16:"field_legacy_nid";s:5:"76531";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Interferon";s:5:"title";s:10:"Interferon";s:3:"nid";s:5:"81215";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81216;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:85:"A non-NHP because listed in Schedule D of the Food and Drugs Act as follows: Glucagon";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues :  Glucagon";s:16:"field_legacy_nid";s:5:"76532";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Glucagon";s:5:"title";s:8:"Glucagon";s:3:"nid";s:5:"81216";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81217;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:86:"A non-NHP because listed in Schedule D of the Food and Drugs Act as follows: Aprotinin";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues :  Aprotinine";s:16:"field_legacy_nid";s:5:"76533";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Aprotinin";s:5:"title";s:9:"Aprotinin";s:3:"nid";s:5:"81217";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81218;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:84:"A non-NHP because listed in Schedule D of the Food and Drugs Act as follows: Insulin";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues :  Insuline";s:16:"field_legacy_nid";s:5:"76534";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Insulin";s:5:"title";s:7:"Insulin";s:3:"nid";s:5:"81218";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81219;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:86:"A non-NHP because listed in Schedule D of the Food and Drugs Act as follows: Urokinase";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues :  Urokinase";s:16:"field_legacy_nid";s:5:"76535";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Urokinase";s:5:"title";s:9:"Urokinase";s:3:"nid";s:5:"81219";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81220;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:138:"A non-NHP because it is a pituitary hormone which falls under "Anterior Pituitary Extracts" listed in Schedule D of the Food and Drugs Act";s:25:"field_non_nhp_rationale_f";s:152:"Un non PSN car hormone pituitaire qui correspond à "Extraits hypophysaires (lobe antérieur)" dans l'Annexe D de la Loi sur les aliments et les drogues";s:19:"field_old_rationale";s:538:"Prolactin is a polypeptide hormone present in the adenohypophyseal tissue or the whole pituitary gland and can be used therapeutically as a lactation stimulating hormone, since this hormone is essential for the induction of lactation in mammals at parturition.  Also, its synergic action with estrogen promotes mammary gland proliferation and brings about the release of progesterone. Since anterior pituitary extracts are listed in Schedule D, Prolactin will be regulated as a Schedule D substance under the Food and Drugs Act., not NHP.";s:16:"field_legacy_nid";s:5:"76536";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Prolactin";s:5:"title";s:9:"Prolactin";s:3:"nid";s:5:"81220";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81221;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:138:"A non-NHP because it is a pituitary hormone which falls under "Anterior Pituitary Extracts" listed in Schedule D of the Food and Drugs Act";s:25:"field_non_nhp_rationale_f";s:152:"Un non PSN car hormone pituitaire qui correspond à "Extraits hypophysaires (lobe antérieur)" dans l'Annexe D de la Loi sur les aliments et les drogues";s:19:"field_old_rationale";s:427:"Somatotropin (Growth hormone)  is an anabolic protein (hormone) secreted by the anterior pituitary gland, which is known to stimulate protein synthesis, regulate carbohydrate and lipid metabolism and promote somatic growth.  Since this hormone is extracted from the anterior pituitary gland and that all anterior pituitary extracts are listed in Schedule D, Somatotropin will be considered as a Schedule D substance, not a NHP.";s:16:"field_legacy_nid";s:5:"76538";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Somatotropin";s:5:"title";s:12:"Somatotropin";s:3:"nid";s:5:"81221";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81222;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:185:"A non-NHP because it is a hormone obtained via recombinant DNA procedure, which falls under "Drugs Obtained By Recombinant DNA Procedures" listed in Schedule D of the Food and Drugs Act";s:25:"field_non_nhp_rationale_f";s:228:"Un non PSN parce qu'une hormone obtenue par procédure de recombinaison de l' ADN, de qui correspond à "Drogues obtenues par des procédures de recombinaison de l’ADN" dans l'Annexe D de la Loi sur les aliments et les drogues";s:19:"field_old_rationale";s:459:"Lutropin alfa is the recombinant human luteinising hormone, which is known to stimulate the follicle maturation and administered parenterally for the  treatment of infertility. Since drugs obtained by recombinant DNA procedures are listed in Schedule D to the Food and Drugs Act; and that drugs administered by puncturing the dermis are excluded from NHP Regulations by being captured in Schedule 2, Lutropin alfa will be considered as a Schedule D substance.";s:16:"field_legacy_nid";s:5:"76539";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Lutropin alfa";s:5:"title";s:13:"Lutropin alfa";s:3:"nid";s:5:"81222";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81223;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:193:"A non-NHP because it is a monoclonal antibody, where monoclonal antibodies are listed in Schedule D of the Food and Drugs Act as follows: Monoclonal antibodies, their conjugates and derivatives";s:25:"field_non_nhp_rationale_f";s:178:"Un non PSN parce qu'anticorps monoclinal, ce qui correspond aux "Anticorps monoclonaux et leurs dérivés et conjugués" dans l'Annexe D de la Loi sur les aliments et les drogues";s:19:"field_old_rationale";s:297:"Natalizumab is a monoclonal antibody used in the treatment of two serious autoimmune disorders, namely multiple sclerosis and Crohn's disease.  Since monoclonal antibodies are currently listed in Schedule D to the Food and Drugs Act, Natalizumab will be considered as such, a Schedule D substance.";s:16:"field_legacy_nid";s:5:"76542";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Natalizumab";s:5:"title";s:11:"Natalizumab";s:3:"nid";s:5:"81223";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81224;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:171:"A non-NHP because it is a drug obtained by recombinant DNA procedure, where drugs obtained by recombinant DNA procedures are listed in Schedule D of the Food and Drugs Act";s:25:"field_non_nhp_rationale_f";s:227:"Un non PSN parce qu'une drogue obtenue par procédure de recombinaison de l' ADN, de qui correspond à "Drogues obtenues par des procédures de recombinaison de l’ADN" dans l'Annexe D de la Loi sur les aliments et les drogues";s:19:"field_old_rationale";s:608:"Idursulfase, sold under the brand name Elaprase by Shire Human Genetic Therapies, is a drug which has been approved as an enzyme replacement therapy in patients with Hunter syndrome.  This disease, also known as mucopolysaccharoidosis Type II, is a lysosomal storage disease caused by a deficient (or absent) enzyme, Iduronate-2-sulfatase (I2S).  Idursulfase is a purified form of this enzyme, produced by recombinant DNA technology in a human cell line.  Since all drugs obtained by recombinant DNA procedures are listed in Schedule D to the Food and Drugs Act,  Idursulfase will not be considered as a NHP.";s:16:"field_legacy_nid";s:5:"76544";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Idursulfase";s:5:"title";s:11:"Idursulfase";s:3:"nid";s:5:"81224";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81225;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76590";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Guaifenesin";s:5:"title";s:11:"Guaifenesin";s:3:"nid";s:5:"81225";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81226;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:197:"A non-NHP because it is a monoclonal antibody obtained via recombinant DNA procedure, which falls under "Drugs Obtained By Recombinant DNA Procedures" listed in Schedule D of the Food and Drugs Act";s:25:"field_non_nhp_rationale_f";s:239:"Un non PSN parce qu'un anticorps monoclonal obtenu par procédure de recombinaison de l' ADN, de qui correspond à "Drogues obtenues par des procédures de recombinaison de l’ADN" dans l'Annexe D de la Loi sur les aliments et les drogues";s:19:"field_old_rationale";s:669:"Panitumumab (CAS no. 339177-26-3) [1] is an investigational fully human monoclonal antibody that targets the epidermal growth factor receptor (EGFr), a protein that plays a significant part in cancer cell signaling [2]. It was the first recombinant human immunoglobulin G2 monoclonal antibody approved by the US Food and Drug Administration for this purpose [3]. It was initially generated with a technology called XenoMouse(R), which creates a fully human monoclonal antibody that contains no murine (mouse) protein.  Panitumuman falls under Schedule D to the Food and Drugs Act (Drugs obtained by recombinant DNA procedures), and is therefore considered as a non-NHP.";s:16:"field_legacy_nid";s:5:"76598";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Panitumumab";s:5:"title";s:11:"Panitumumab";s:3:"nid";s:5:"81226";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81227;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:928:"Methylnaltrexone bromide (Figure 1) [1], sometimes only referred to as Methylnaltrexone (MNTX) is a derivative of naltrexone (Figure 2)[2], which is prepared from noroxymorphone, a derivative of morphine [3]. Naltrexone is not included in Schedules I to V of the Controlled Drugs and Substances Act.  Methylnaltrexone bromide is a chiral molecule and the quaternary nitrogen molecule can be either in an R or S configuration.  However, it is not clear if the different isomers have different chemical and biological properties.  Methylnaltrexone bromide is synthesized from naltrexone by methylation of the tertiary nitrogen atom [4].  It is believed that the addition of this methyl group enhances the polarity and decreases the liposolubility of the molecule, thus making it difficult to cross the blood-brain barrier in humans (unlike naltrexone).  Based on these details, Methylnaltrexone bromide is considered as a non-NHP.";s:16:"field_legacy_nid";s:5:"76599";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Methylnaltrexone bromide";s:5:"title";s:24:"Methylnaltrexone bromide";s:3:"nid";s:5:"81227";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81228;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1203:"Mircera [or continuous erythropoietin receptor activator (C.E.R.A.)] is marketed by Hoffmann-La Roche. It is a third-generation erythropoietic molecule created by integrating a large polymer chain into the molecule, thus increasing the molecular weight to twice that of epoetin at approximately 60 kDa. The methoxy-polyethylene glycol polymer chain is integrated via amide bonds between the N-terminal amino group or the e-amino group of lysine using a single succinimidyl butanoic acid linker. Mircera is an erythropoiesis-stimulating agent for the treatment of anemia [1]. Micera has been developed for the treatment of anaemia in patients with chronic kidney disease. Compared with other erythropoiesis-stimulating agents, C.E.R.A. has a unique pharmacological profile, including a longer elimination half-life and slower clearance rate [2]. Mircera showed clinical activity and safety in patients with non-small cell lung cancer (NSCLC) [3] .Mircera was approved for use in Europe by the European Commission [4] and by the FDA [5]. The active ingredient in Mircera, i.e. Methoxy polyethylene glycol-epoetin beta, is a synthetic material (not natural) and will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"76600";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:40:"Methoxy polyethylene glycol-epoetin beta";s:5:"title";s:40:"Methoxy polyethylene glycol-epoetin beta";s:3:"nid";s:5:"81228";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81229;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:291:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.Furthermore, as 6-Bromo-androst-1,4-diene-3,17-dione (both the alpha and beta isomers) is the brominated derivative of Androsta-1,4,6-triene-3,17-dione, hence this compound is also a non-NHP.";s:25:"field_non_nhp_rationale_f";s:342:"Un non PSN parce que ce n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels. En outre, étant donné que le 6-bromo-androst-1,4-diène-3,17-dione (isomères alpha et bêta) est un dérivé bromé d'androstatriène-1,4,6 dione-3,17 ce premier est également considéré comme un non-PSN";s:19:"field_old_rationale";s:2906:"Androsta-1,4,6-triene-3,17-dione (Fig. 1; also known as ATD) is one of the first inhibitors of aromatase, an enzyme responsible for the last step [conversion of androgens (such as androtenedione and testosterone) to estrogens, estradiol and estrone] in the transformations of cholesterol to the female sex hormones [1].  Consequently, this compound and other aromatase inhibitors are of interest in the treatment of estrogen-dependent breast cancers [2,3,4]. This  C19 3-Ketosteroid, which resemble the natural substrate of aromatase androstenedione, has been developed back in 1973 in a study initiated to determine the structural features of steroids in the inhibition of estrogen biosynthesis [5].  It is believed that the C(1)-C(2) double bond of this compound is one of the structural feature responsible for the inhibition of aromatase, demonstrated by the 'Suicide Substrate Inhibitor' mechanism of action hypothesis of aromatase [6].  Since,  a) no evidence have been found suggesting that ATD is naturally occurring, b) evidence found suggest that ATD is a synthetically prepared analog of the naturally occurring steroid androstenedione [5,7,8,9], and c) ATD cannot be considered as a source of androstenedione or other naturally occurring steroids based on its different pharmacological properties, ATD will not be considered as a NHP, but a drug.
[1] Brodie, A.M.H., Overview of Recent Development of Aromatase Inhibitors; Cancer Reseach (suppl.) 42, 3312s-3314s, August 1982.
[2] Brodie, A.M.H. et al., The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependnet progress in reproduction and breast cancer; Endocrinology  100; 1684-1695.
[3] Hervey H.A. et al., Aromatase: new perspectives for breast cancer; Cancer Reseach (suppl.) 42, 3261s-3269s
[4] Brodie, A.M.H. et al., Effect of an aromatase inhibitor, 1,4,6-androstatriene-3,17-dione, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat and its mechanism of action in vivo; Biochemical Pharmacology  Vol. 31, No. 11, pp. 2017-2023, 1982.
[5] Schwarzel, W.C. et al., Studies of the mechanism of estrogen biosynthesis.  VIII. Thedevelopment of inhibitors of the enzyme system in human placenta; Endocrinology  92; 866-880, 1973.
[6] Douglas, F. et al., A New Hypothesis Based on Suicide Substrate Inhibitor Studies for the Mechanism of Action of Aromatase; Cancer Research (suppl.) 42, 3327s-3333s, August 1982.
[7] Numazawa, M. et al., 6-Alkylandrosta-4,6-diene-3,17 diones and their 1,4,6-triene analogs as aromatase inhibitors; Steroids  62; 595-602, 1997.
[8] Marsh, D.A. et al., Aromatase inhibitors. Synthesis and Biological Activity of Androstenedione derivatives; J. Med. Chem. 1985, 28, 788-795.
[9] Li, P.-K. et al., 7-Substituted 1,4,6-Androstatriene-3,17-diones as Enzyme-Activated Irreversible Inhibitors of Aromatase; J. Steroid Biochem. Vol. 36, No. 6, pp. 533-539, 1990.";s:16:"field_legacy_nid";s:5:"76601";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:32:"Androsta-1,4,6-triene-3,17-dione";s:5:"title";s:32:"Androsta-1,4,6-triene-3,17-dione";s:3:"nid";s:5:"81229";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81230;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1023:"Nepafenac (Fig. 1) is a topical ocular anti-inflammatory drug with analgesic activity [1,2].  This compound is an Non-Steroidal Anti-Inflammatory Drug (NSAID) prodrug, as it is rapidly converted to its active metabolite Amfenac, a highly efficaceous NSAID [3]. Its prodrug nature have shown to be the reason of its superiority over other conventional NSAIDs, supported by in vivo pharmacokinetics and in vitro pharmacodynamics studies [4].  Indeed, Nepafenac has superior corneal permeability characteristics as a neutral drug, compared to other classial acidic NSAIDs.  It is believed that this faster penetration increases biodistribution and thus intraocular efficacy of its metabolite Amfenac [5].  This new and unique NSAID has been approved by the FDA in august 2005 for the treatment of pain and inflammation after cataract surgery [6], under the Alcon Laboratoried tradename Nevanac [7].  As Nepafenac [2,8] (and its acid Amfenac[9]) is a synthetically prepared compound, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76602";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Nepafenac";s:5:"title";s:9:"Nepafenac";s:3:"nid";s:5:"81230";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81231;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:767:"Potassium peroxymonosulfuric acid is the potassium salt of Peroxymonosulfuric acid [1]. It is used as an oxidizing agent [2]. Potassium peroxymonosulfuric acid is a component of a triple salt with the formula 2KHSO5·KHSO4·K2SO4 [3-4] which is widely used in synthesis (chemistry). Peroxymonosulfuric acid and its salts, including Potassium salt, are synthetic compounds (not natural) and are not sources for any natural products (although salts are potential source for the minerals such as Potassium). Potassium peroxymonosulfuric acid will not be considered as a NHP, but a drug.
[1] ChemID
[2] http://en.wikipedia.org/wiki/Potassium_peroxymonosulfate
[3] www.sigmaaldrich.com/catalog/search/ProductDetail/RIEDEL/12600
[4] www.dupont.com/oxone/techinfo/index.html";s:16:"field_legacy_nid";s:5:"76604";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"Potassium peroxymonosulfuric acid";s:5:"title";s:33:"Potassium peroxymonosulfuric acid";s:3:"nid";s:5:"81231";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81232;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:829:"Magnesium monoperoxyphthalate is a magnesium salt of a peroxy acid (monoperoxyphthalic acid) and a disinfectant [1]. It is a mild, general oxidizing agent which is a suitable replacement for peroxycarboxylic acids [2]. It can be used to carry out a wide variety of oxidation reactions [3]. Magnesium monoperoxyphthalate is a synthetic compound [4] . Although is is a potential source of Magnesium, the main action, which is its oxidizing property, excludes it from being a source of a natural product. Magnesium monoperoxyphthalate will not be considered as a NHP, but a drug.
[1] ChemID
[2] www.sigmaaldrich.com/catalog/search/ProductDetail/ALDRICH/283207
[3] H. Heaney, 'Oxidation reactions using magnesium monoperphthalate and urea hydrogen peroxide', Aldrichimica Acta 1993, 26(2), 35-45
[4] European Patent Appl. 27693, 1981";s:16:"field_legacy_nid";s:5:"76605";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Magnesium monoperoxyphthalate";s:5:"title";s:29:"Magnesium monoperoxyphthalate";s:3:"nid";s:5:"81232";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81233;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:569:"Peracetic acid is a peroxy acid and a strong oxidizing agent used as a disinfectant [1-2]. It is a synthetic compound which can be obtained for example by the action of hydrogen peoxide on acetic acid (or acetic anhydride) in presence of sulfuric acid as catalyst [2]. Peracetic acid is not natural and not a direct source of any natural product; its main action, as oxidizing agent, excludes it from being a source of a natural product such as acetic acid or hydrogen peroxide. Peracetic acid will not be considered as a NHP, but a drug.
[1] ChemID
[2] The Merck Index";s:16:"field_legacy_nid";s:5:"76606";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Peracetic acid";s:5:"title";s:14:"Peracetic acid";s:3:"nid";s:5:"81233";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81234;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:138:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations; Dabigatran and its derivatives(salts)";s:25:"field_non_nhp_rationale_f";s:165:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels: Dabigatran et ses dérivés (sels)";s:19:"field_old_rationale";s:1006:"Dabigatran and its derivative or prodrug Dabigatran etexilate ,developed by the company Boehringer-Ingelheim, are synthetic drugs (from the class of the direct thrombin inhibitors) used as anticoagulant [1-2], and their medicinal properties have been the subject of a few reviews [3-4]. In March 2008, the European Medicines Agency granted marketing authorisation for Dabigatran etexilate  [5]. Dabigatran etexilate is not a natural product and not a source for any natural product. It will not be considered as a NHP, but a drug.
References:
[1] ChemID
[2] Hauel NH. et al. 'Structure-based design of novel potent nonpeptide thrombin inhibitors' 2002, J. Med. Chem. 45 (9), 1757–66
[3] Gross PL. et al. ‘New anticoagulants for treatment of venous thromboembolism’ 2008, Arterioscler Thromb. Vasc. Biol. 28(3), 380-6 (Review)
[4] Ieko M. ‘Dabigatran etexilate, a thrombin inhibitor for the prevention of venous thromboembolism and stroke’, 2007, Curr. Opin. Investig. Drugs., 8(9), 758-68 Review)";s:16:"field_legacy_nid";s:5:"76607";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Dabigatran";s:5:"title";s:10:"Dabigatran";s:3:"nid";s:5:"81234";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81235;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:972:"Ceftobiprole is a broad spectrum antibiotic [1]. As a beta-lactam antibiotic, it is the first of a new generation of broad-spectrum cephalosporins in late-stage development with activity against methicillin-resistant Staphylococcus aureus (MRSA) in addition to broad-spectrum bactericidal activity against other Gram-positive and Gram-negative pathogens [2-3]. Ceftobiprole is a synthetic material, developed by Basilea and Johnson & Johnson [4]. It is not naturally occuring and is not a source for any natural product. Cetobiprole will not be considered as a NHP, but a drug.
[1] ChemID
[2] Noel GJ. ‘Clinical profile of ceftobiprole, a novel beta-lactam antibiotic’ 2007, Clin. Microbiol. Infect., 13 Suppl 2, 25-9 (Review)
[3] Murthy B. et al. ‘Pharmacokinetics and pharmacodynamics of ceftobiprole, an anti-MRSA cephalosporin with broad-spectrum activity’ 2008, Clin. Pharmacokinet. 47(1), 21-33 (Review)
[4] www.basilea.com/template_loader.php?tplpage_id=160";s:16:"field_legacy_nid";s:5:"76680";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Ceftobiprole";s:5:"title";s:12:"Ceftobiprole";s:3:"nid";s:5:"81235";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81236;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1357:"Romiplostim is a recombinant protein, known as a peptibody, made up of two disulfide-bonded IgG1 heavy-chain and kappa light-chain constant regions (fragment crystallizable [Fc] fragments), each of which is covalently bound at residue 228 of the heavy chain with two identical peptide sequences linked via polyglycine [1].   Nplate (trade name by Amgen) is indicated for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.  It binds to and activates the human thrombopoietin receptor despite having no sequence homology with human thrombopoietin [2].  Although the details concerning the production of this protein is not available, it is known to be expressed in E. coli [1].  Because this protein is not naturally occurring, and presumably produced via recombinant DNA procedure (as it is described as a recombinant protein), Romiplostim will be considered as a drug.    

[1] Stasi R. et al., Novel Thrombopoietic Agents: A review of Their Use in Idiopathic Thrombocytopenic Purpura, Drugs  2008; 68 (7) 901-912.
[2] Kuter D. J. et al., Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomized controlled trial; Lancet  2008 Feb 2;371(9610):395-403.";s:16:"field_legacy_nid";s:5:"76681";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Romiplostim";s:5:"title";s:11:"Romiplostim";s:3:"nid";s:5:"81236";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81237;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:793:"Procaine (Procaine HCl) [1-2] is a local anesthetic in ester form with a short duration of action. Procaine is rapidly and almost completely hydrolyzed by plasma pseudocholinesterae to p-aminobenzoic acid (PABA) and diethylaminoethanol. Procaine is used for infiltration anesthesia and for peripheral or sympathetic nerve block and spinal anesthesia. It is also used in dentistry for infiltration anesthesia or nerve block. However, it has little topical activity [3]. Procaine is a synthetic material discovered by German scientist Einhorn in early 20th century [4]. It is not naturally occurring and is not used as a source for PABA. Procaine will not be considered as a NHP but a drug.
[1] The Merck Index
[2] ChemID
[3] AHFS Drug Information
[4] http://en.wikipedia.org/wiki/Albert_Einhorn";s:16:"field_legacy_nid";s:5:"76767";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Procaine";s:5:"title";s:8:"Procaine";s:3:"nid";s:5:"81237";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81238;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:469:"Hexetidine is a bactericidal and fungicidal antiseptic. It is used as a 0.1% mouthwash for local infections and oral hygiene [1-2]. It has local-anesthetic, astringent and deodorant activity [3]. Hexetidine is a synthetic material (not found in nature) and is not a source of any natural product. Hexetidine will not be considered as a NHP, but a drug.
[1] The Merck Index
[2] ChemID
[3] Kapić E. et al. 'Hexetidine--an oral antiseptic' 2002, Med. Arh., 56 (1), 43–8";s:16:"field_legacy_nid";s:5:"77058";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Hexetidine";s:5:"title";s:10:"Hexetidine";s:3:"nid";s:5:"81238";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81239;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:726:"Chlorine dioxide is synthetic oxide of Chlorine. It is a reddish-yellow gas which can be prepared from chlorine and sodium chlorite, from potassium chlorate and sulfuric acid, by passing NO2 through a column of sodium chlorate, etc. [1]. It is equal or superior to chlorine when used as waste water disinfectant [2]. It has been used in bleaching cellulose, paper-pulp, flour, leather, fats and oils, textiles, beeswax; purification of water; taste and odor control of water; cleaning and detanning leather; manuf of chlorite salts; oxidizing agent; bactericide, antiseptic and deodorizer [1]. Chlorine dioxide is not naturally occuring substance and will not be considered as a NHP, but a drug.
[1] The Merck Index
[2] ChemID";s:16:"field_legacy_nid";s:5:"77408";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Chlorine dioxide";s:5:"title";s:16:"Chlorine dioxide";s:3:"nid";s:5:"81239";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81240;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:582:"Tromethamine (Trometamol) is an organic amine proton-acceptor that upon administration becomes a component of the body buffering system. It is used in the synthesis of surface-active agents and pharmaceuticals; as an emulsifying agent for cosmetic creams and lotions, mineral oil and paraffin wax emulsions, as a biological buffer, and used as an alkalizer [1-3]. Tromethamine is a synthetic material (not natural) and is not used as a source for any natural product. Tromethamine will not be considered as a NHP, but a drug.
[1] The Merck Index
[2] ChemID
[3] AHFS Drug Information";s:16:"field_legacy_nid";s:5:"77417";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Tromethamine";s:5:"title";s:12:"Tromethamine";s:3:"nid";s:5:"81240";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81241;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:646:"Rivaroxaban (Fig. 1) is an oxazolidine derivative designed to bind and inhibit the coagulation factor Xa, indicated for the prophylaxis of venous thromboembolic events [1,2].  This compound is absorbed rapidly (with 60-80% bioavailability after oral administration); its pharmacokinetics is dose-dependent with peak plasma concentrations occurring 2.5-4 hours after administration (about 90% is bound to plasma proteins); and about 30% is excreted unchanged in the urine with the rest being fecal eliminated or metabolized in the liver [3].  As this compound is synthetically prepared [4] and not found in nature, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"77418";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Rivaroxaban";s:5:"title";s:11:"Rivaroxaban";s:3:"nid";s:5:"81241";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81242;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1450:"Melamine is a synthetic material, a trimer of cyanamide, that can be prepared by heating of dicyandiamide under pressure, or using urea [1]. Most melamine is reacted with formaldehyde to produce resins for laminating and adhesive applications. One of the major uses of melamine is in the upper sheet of laminated counter- and tabletops. Another important use of melamine is as the amino cross-linker in heat-cured paint systems. Other uses include the preparation of wet-strength resins for paper, water clarifying resins, ion-exchange resins, plastic molding compounds, adhesives, fire retardants in polyurethane foams, and intumescent paints. Important new applications are under development in the field of fire retardants for polymeric materials, especially polyurethane foams [2-3]. Pathological evaluation of cats and dogs that had died from the acute renal failure indicated the presence of crystals (a melamine-cyanuric acid complex - as a proposed form) in kidney tubules [4]. Melamine is not naturally occuring and will not be considered as a NHP.
[1] The Merck Index
[2] 'Melamine Resins', Kirk-Othmer Encyclopedia of Chemical Technology, 2001
[3] 'Melamine and Guanamines', Ullmann's Encyclopedia of Industrial Chemistry, 2008
[4] Dobson RL. Et al. ‘Identification and Characterization of Toxicity of Contaminants in Pet Food Leading to an Outbreak of Renal Toxicity in Cats and Dogs’ 2008, Aug. 9, Toxicol. Sci. (Epub ahead of print)";s:16:"field_legacy_nid";s:5:"77419";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Melamine";s:5:"title";s:8:"Melamine";s:3:"nid";s:5:"81242";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81243;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:147:"A non-NHP because listed in Schedule IV of the Controlled Drugs and Substances Act as follows: Androstenediol (androst–5–ene–3ß,17ß–diol)";s:25:"field_non_nhp_rationale_f";s:110:"A non-NHP because listed in Schedule IV of the Controlled Drugs and Substances Act as follows: Androstènediol";s:16:"field_legacy_nid";s:5:"77420";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Androstenediol";s:5:"title";s:14:"Androstenediol";s:3:"nid";s:5:"81243";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81244;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:874:"Bis(picolinato)oxovanadium(IV) [VO(pic)2] is one of the most potent insulin-mimetic vanadium complexes [1]. This product is synthesized from picolinic acid and vanadyl sulphate (VS) which is less toxic than vanadate [2].
Studies in rats have demonstrated that after administration, some the vanadium complex  remained unchanged in the liver and kidney, and the slow elimination of the picolinate complex from the circulation blood of rats was attributed to its interaction with blood components [3]
Based on the above facts, Bis(picolinato)oxovanadium(IV) [VO(pic)2] is not considered as an NHP, nor as a source of an NHP.Reference:

[1] Journal of Inorganic biochemistry, Volume 77, Number 3, 30 November 1999 , pp. 215-224(10)
[2] Biochemical and Biophysical Research Communications, Vol 214, No. 3, 1995
[3] Journal of  Inorganic biochemistry, Volume 91, 2002, pp 327-338";s:16:"field_legacy_nid";s:5:"77421";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:38:"Bis(picolinato)oxovanadium(IV) complex";s:5:"title";s:38:"Bis(picolinato)oxovanadium(IV) complex";s:3:"nid";s:5:"81244";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81245;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1289:"3-7-bis-(2-hydroxyethyl)-icaritin is a recently made synthetic derivative of icariin and icaritin (natural products [1]). In its synthesis, 2 sugars in icariin replaced by hydroxyethyl group. This modification was performed to improve the inhibitoty activity of icariin against phosphodiesterase-5A1 (PDE5A1). Results showed that 3-7-bis-(2-hydroxyethyl)-icaritin was 80 times more potent than icariin, and its selectivity versus phosphodiesterase-6 (PDE6) and cyclic adenosine monophosphate-phosphodiesterase (cAMP-PDE) was much higher in comparison with sildenafil (viagra- used in treatment of male impotence). The improved pharmacodynamic profile and lack of cytotoxicity on human fibroblasts [2] proved that there is a significant difference between 3-7-bis-(2-hydroxyethyl)-icaritin and icariin (and even icaritin which is 3 times more potent than icariin). 3-7-bis-(2-hydroxyethyl)-icaritin as a synthetic compound which is not used as a source of icariin or icaritin, with signicant differences in pharmacological properties with icaritin, will not be considered as a NHP, but a drug.

References:
[1] Dictionary of Natural Products
[2] Mario Dell’Agli et al. ‘Potent Inhibition of Human Phosphodiesterase-5 by Icariin Derivatives’ 2008, J. Nat. Prod., 71 (9), p. 1513–1517";s:16:"field_legacy_nid";s:5:"77422";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"3-7-bis-(2-hydroxyethyl)-icaritin";s:5:"title";s:33:"3-7-bis-(2-hydroxyethyl)-icaritin";s:3:"nid";s:5:"81245";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81246;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:125:"A non-NHP because not a naturally occurring substance included in Schedule 2 (excluded NHP substances) of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:155:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 2 (substances PSN excluses) du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77423";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Aztreonam lysine";s:5:"title";s:16:"Aztreonam lysine";s:3:"nid";s:5:"81246";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81248;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77425";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Dibutyl sebacate";s:5:"title";s:16:"Dibutyl sebacate";s:3:"nid";s:5:"81248";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81249;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77426";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Disodium EDTA";s:5:"title";s:13:"Disodium EDTA";s:3:"nid";s:5:"81249";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81250;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because it is an antibiotic substance included in Schedule 2 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN car une substance antibiotique comprise dans l'Annexe 2 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:494:"Telavancin (Fig. 1) is a broad spectrum, semi-synthetic glycopeptide antibiotic [1].  Its hydrochloride salt is indicated for treatment of complicated skin and skin structure infections caused by susceptible strains of Gram-positive microorganisms, and administered by intravenous infusion [2].  As such, it is excluded from the NHP Regulations by being captured under item 5 and 6 of Schedule 2 (Excluded Natural Health Product Substances).  Therefore, Telavancin will be considered as a drug.";s:16:"field_legacy_nid";s:5:"77427";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Telavancin hydrochloride";s:5:"title";s:24:"Telavancin hydrochloride";s:3:"nid";s:5:"81250";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81251;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77428";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Edetate calcium disodium";s:5:"title";s:24:"Edetate calcium disodium";s:3:"nid";s:5:"81251";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81252;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77429";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:32:"Calcium disodium EDTA, dihydrate";s:5:"title";s:32:"Calcium disodium EDTA, dihydrate";s:3:"nid";s:5:"81252";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81253;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77430";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Edetate sodium";s:5:"title";s:14:"Edetate sodium";s:3:"nid";s:5:"81253";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81254;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77431";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Edetate dipotassium";s:5:"title";s:19:"Edetate dipotassium";s:3:"nid";s:5:"81254";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81255;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:7:"67;5945";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77432";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Trisodium edetate";s:5:"title";s:17:"Trisodium edetate";s:3:"nid";s:5:"81255";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81256;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77433";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:50:"Disodium (ethylenedinitrilo)tetraacetate dihydrate";s:5:"title";s:50:"Disodium (ethylenedinitrilo)tetraacetate dihydrate";s:3:"nid";s:5:"81256";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81257;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:721:"Quercetin chalcone (Figure 1) is a modified version of Quercetin (a flavanoid that occurs naturally in many plants, Figure 2) [1][2].  The conversion of quercetin to the chalcone is done by reduction, through alkali treatment which causes ring opening of the flavone ring. The formation of quercetin chalcone is described in patent # 5,997,184[3].  The addition of the phenolic hydroxy group increases the hydrophilicity effect, and accounts for the greater absorption and bioavailibility of Quercetin chalcone, compared to the parent molecule.  
However, based on the fact that Quercetin chalcone does not occur naturally, and its conversion from Quercetin is through a synthetic pathway, it is not considered as an NHP.";s:16:"field_legacy_nid";s:5:"77434";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Quercetin chalcone";s:5:"title";s:18:"Quercetin chalcone";s:3:"nid";s:5:"81257";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81258;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"66";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77435";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Methylsynephrine hydrochloride";s:5:"title";s:30:"Methylsynephrine hydrochloride";s:3:"nid";s:5:"81258";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81259;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"105";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:936:"Desvenlafaxine succinate (Fig. 1), sold under the name Pristiq, is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class of compounds from Wyeth Pharmaceuticals, where it is a synthetic form of a known active metabolite of venlafaxine, another SNRI [1,2].  This novel SNRI has recently been approved by the USFDA for the treatment of major depressive disorder (MDD) and still under clinical developement relative to other ailments, such as for the treatment of menopause-associated vasomotor symptoms, diabetic peripheral neurophathy and fibromyalgia syndrome [3].  Compared to its parent drug venlafaxine, Desvenlafaxine is believed to be similar in terms of efficacy, safety, and pharmacologic parameters, but in terms of pharmacokinetic and cost, Desvenlafaxine is believed to be somewhat superior [4].  As Desvenlafaxine succinate is a synthetic drug not found in nature, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"77436";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Desvenlafaxine succinate";s:5:"title";s:24:"Desvenlafaxine succinate";s:3:"nid";s:5:"81259";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81260;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77437";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Calcium hypochlorite";s:5:"title";s:20:"Calcium hypochlorite";s:3:"nid";s:5:"81260";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81261;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"132";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77438";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Hexamidine";s:5:"title";s:10:"Hexamidine";s:3:"nid";s:5:"81261";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81262;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:7:"132;684";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77439";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Hexamidine diisethionate";s:5:"title";s:24:"Hexamidine diisethionate";s:3:"nid";s:5:"81262";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81263;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"133";s:25:"field_non_nhp_rationale_e";s:190:"A non-nhp because listed in Schedule D of the Food and Drug Regulations. Cord serum complex will be considered as biologics and products containing such substances will be evaluated by BGTD.";s:25:"field_non_nhp_rationale_f";s:190:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues. Le sérum de corde est considéré comme un produit biologique qui doit être évalué par DPBTG.";s:16:"field_legacy_nid";s:5:"77441";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cord blood";s:5:"title";s:10:"Cord blood";s:3:"nid";s:5:"81263";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81264;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"147";s:25:"field_non_nhp_rationale_e";s:111:"A non-nhp because listed in Schedule D of the Food and Drugs act (Drugs obtained by recombinant DNA procedures)";s:25:"field_non_nhp_rationale_f";s:158:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues (Drogues obtenues par des procédures de recombinaison de l’AND)";s:16:"field_legacy_nid";s:5:"77442";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Soliris";s:5:"title";s:7:"Soliris";s:3:"nid";s:5:"81264";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81265;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"143";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:814:"2-Methyl-1,3,5-trinitro-4-tertbutyl-benzene (CAS #: 547-94-4, Figure 1), also known as Artificial Musk, is a synthetic compound that was first discovered accidentally by the German chemist Albert Baur in 1988 [2] [3] while searching new types of explosives (Amer. Jour. Pharm. , 1890, p. 489, and 1892, p. 31). He reported that the product of the Friedel–Crafts reaction of trinitrotoluene (TNT) with tert-butyl halides (in the presence of aluminum chloride) produced a compound with a musky smell. Since then, many similar artificial musk compounds have been made, based upon substituted nitrobenzenes, as they represent a cheap supply of musk odorants [4]. 2-Methyl-1,3,5-trinitro-4-tertbutyl-benzene is not found in nature and is not acting as a source of NHP and therefore it will be considered as a non-NHP.";s:16:"field_legacy_nid";s:5:"77443";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:43:"2-Methyl-1,3,5-trinitro-4-tertbutyl-benzene";s:5:"title";s:43:"2-Methyl-1,3,5-trinitro-4-tertbutyl-benzene";s:3:"nid";s:5:"81265";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81266;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"103";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77444";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Cephaloridine";s:5:"title";s:13:"Cephaloridine";s:3:"nid";s:5:"81266";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81267;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"174";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:328:"Mitratapide [1-2] is a microsomal triglyceride transfer protein (MTP) inhibitor which is used as a veterinary drug for the treatment or management of obesity in dogs [3]. It is a synthetic substance (not natural) and is not considered as a source for any natural product. Mitratapide will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77445";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Mitratapide";s:5:"title";s:11:"Mitratapide";s:3:"nid";s:5:"81267";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81268;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:2:"67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:509:"Aripiprazole is a synthetic drug introduced by Otsuka (Japan), which has both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity[1-2]. Aripiprazole (Abilify- commercial) was approved by the FDA for the treatment of schizophrenia, acute mania or mixed episodes in bipolar disorder, etc  [3-4]. Aripiprazole is not a natural product and is not used as a direct source of a natural product. Therefore, Aripiprazole will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77446";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Aripiprazole";s:5:"title";s:12:"Aripiprazole";s:3:"nid";s:5:"81268";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81269;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"218";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:577:"11-Ketotestosterone (Figure 1, CAS # 53187-98-7) (ChemID) is an androgen that occurs in fish and was first isolated in 1960 from the blood of male sockeye salmon (Cuisset et al). It has been shown to have much higher androgenic potency than testosterone. It is known to be the main sex hormone in male rainbow and brown trout (Balm et al).
This substance is often referred to as ‘a naturally occurring anabolic’ on many body-building website. Sex hormones are included in Schedule F of the Food and Drug Regs and therefore11-Ketotestosterone is not considered to be an NHP.";s:16:"field_legacy_nid";s:5:"77448";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"11-Ketotestosterone";s:5:"title";s:19:"11-Ketotestosterone";s:3:"nid";s:5:"81269";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81270;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"337";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:633:"Nelarabine is an antineoplastic used in the treatment of T-cell malignancies (US-NLM 2009). It is a prodrug of 9-β-D-arabinofurasonyl guanine (ara-G), a cyctotoxic analog of deoxyguanosine. When nelarabine converted to triphosphorylated ara-G, it is incorporated into DNA (preferentially into T-cells) inducing fragmentation and apoptosis (Skeel 2007).This modification is due to the poor solubility of ara-G as nelarabine is water-soluble. Nelarabine is given intravenously. Both Nelarabine and ara-G are synthetic materials (not occur in nature) (Buie, Epstein et al. 2007). Nelarabine will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77452";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nelarabine";s:5:"title";s:10:"Nelarabine";s:3:"nid";s:5:"81270";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81271;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"323";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:811:"Citricidal (Grapefruit-seed extract or GSE) is apparently made by a catalytic conversion and ammoniation of the polyphenolic compounds extracted from grapefruit seed and pulp into a quaternary ammonium compounds (Reagor et al. 2002). Other reference has also confirmed that the active component of Citricidal is a quaternary ammonium chloride compound similar to Benzethonium chloride that is already classified as a non-NHP (Allwellness 2009, Nutriteam 2009). Note that the exact composition of Citricidal seems controversial, and that synthetic antimicrobials (such as Benzethonium chloride, Triclosan, and Methyl paraben) have been identified in commercially available Citricidal products (Brandin et al. 2007, Takeoka et al. 2001).

Based on the above information, Citricidal should be considered as a drug.";s:16:"field_legacy_nid";s:5:"77453";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Melanotan-1";s:5:"title";s:11:"Melanotan-1";s:3:"nid";s:5:"81271";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81272;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"407";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:693:"Fosaprepitant is a prodrug of Aprepitant (a chemical compound that belongs to a class of drugs called substance P antagonists. It mediates its effect by acting on neurokinin 1 receptor). Fosaprepitant dimeglumine, a derivative of fosaprepitant is an anti-emetic drug (similar to aprepitant). It is particularly useful for the prevention of chemotherapy induced nausea and vomiting (Navari 2007) (Hesketh 2008). Fosaprepitant was developed by Merck Co. and approved by the FDA and European Medicines Agency (EMA) for its action (Van Belle and Cocquyt 2008). Since fosaprepitant is not naturally occurring and is not a source of a natural product, it will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77455";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Fosaprepitant";s:5:"title";s:13:"Fosaprepitant";s:3:"nid";s:5:"81272";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81273;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"421";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:651:"Unlike many hydroxystearic acids (such as 2-, 3-, and 17-hydroxystearic acid), 12-hydroxystearic acid is not found naturally (CRC-DNP 2009). Some reported materials indicating the occurring of 12-hydroxystearic acid in castor oil are not scientifically correct. In fact, 12-hydroxystearic acid can be obtained from the hydrogenated castor oil (Ishchuk 2005). 12-hydroxystearic acid is used as surfactant and cleansing agent (Gottschalck and Bailey 2008). 12-hydroxystearic acid is a synthetic material (not found in nature and not a source of a natural product); therefore, it will not be considered as a NHP, but a drug or a non-medicinal ingredient.";s:16:"field_legacy_nid";s:5:"77457";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"12-Hydroxystearic acid";s:5:"title";s:22:"12-Hydroxystearic acid";s:3:"nid";s:5:"81273";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81274;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:7:"381;103";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1862:"Hyoscine butylbromide is a derivative of the tertiary ammonium compound hyoscine. Hyoscine is an alkaloid present in plant genera of the family Solanaceae such as Datura, Duboisia, Hyoscyamus and Scopoliawhich grow in many countries. It is chemically processed by adding a butyl group to obtain a quaternary ammonium structure. This modification results in a molecule that still has anticholinergic activities comparable to those of hyoscine. But, in contrast with hyoscine, quaternary compounds such as hyoscine butylbromide should not be systemically absorbed. Limited systemic absorption may improve the adverse events profile compared with the parent compound hyoscine.  The main pharmacokinetic feature of quaternary ammonium derivatives is their poor systemic availability after enteral administration. The quaternisation of the ammonium group leads to a large molecule with a positive charge that is barely absorbed from the gut lumen. This results in local availability of the active compound and antagonism of the action of acetylcholine at local muscarinic receptors. Confirmation that oral hyoscine butylbromide is poorly absorbed is supported by the results of several pharmacokinetic studies in humans. The majority of these data have been obtained from the manufacturer. In these studies, oral hyoscine butylbromide was administered at dose levels ranging from 40 to 500mg. Since the intent of derivitization of Hyoscine to Hyoscine n-Butylbromide is to reduce the systemic absorption, improve delivery of the drug to the gastrointestinal tract, thus changing the pharmacokinetics, and reduce the adverse events profile compared to the parent compound hyoscine thus changing the toxicology, Hyoscine n-Butylbromide is not acting as a source of hyoscine and it differs significantly in its pharmacology, so it is classified as a drug and not an NHP.";s:16:"field_legacy_nid";s:5:"77459";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"N-Butylscopolammonium Bromide";s:5:"title";s:29:"N-Butylscopolammonium Bromide";s:3:"nid";s:5:"81274";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81275;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"381";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:699:"There are three forms of hesperidin; hesperidin complex, purified hesperidin and hesperidin methylchalcone. Hesperidin is considered as a NHP since it is isolated from sweet orange. However, Hesperidin methylchalcone that is manufactured from hesperidine in two steps; alkaline treatment followed by a methylation process in which during these two processes the hesperidine chemical structure is irreversibly converted to an open chain (containing chalcone moiety) structure (see below) which is totally different structure than hesperidine. Hesperidin methylchalcone is neither found in nature nor can be converted to the hesperidine moiety and therefore it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"77460";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Hesperidin methylchalcone";s:5:"title";s:25:"Hesperidin methylchalcone";s:3:"nid";s:5:"81275";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81276;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"381";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:507:"1-(3-methoxyphenyl)ethylamine is a useful intermediate in pharmaceutical industry. It can be prepared by chemical synthesis [1]. Although a commercial product (named DREN or DRENBUTEROL) containing this ingredient is claimed to be a mesolimbic beta agonist fat burning agent([2] and many other commercial web sites), no scientific reference(s) could be located. This ingredient is not natural and is not a source for any natural product. 1-(3-methoxyphenyl)ethylamine is not considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77461";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"(R)-1-(3-Methoxyphenyl)ethylamine";s:5:"title";s:33:"(R)-1-(3-Methoxyphenyl)ethylamine";s:3:"nid";s:5:"81276";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81277;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"381";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:293:"Zucapsaicin is the synthetic stereoisomer of Capsaicin (the naturally occurring compound). It has a 'Z' configuration around its double bond (compared to 'E' in Capsaicin). It is not found naturally and it is not a source for Capsaicin. Zucapsaicin will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77462";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Zucapsaicin";s:5:"title";s:11:"Zucapsaicin";s:3:"nid";s:5:"81277";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81278;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:7:"381;912";s:25:"field_non_nhp_rationale_e";s:363:"This ingredient is on the Restricted Substances list in the Natural Health Products Compliance Guide. Unauthorized products with this ingredient are subject to the risk-based approach to compliance. A product licence must be obtained prior to marketing in Canada . Reference:http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/complian-conform_guide-eng.php";s:25:"field_non_nhp_rationale_f";s:548:"Cet ingrédient apparaît sur la liste des substances prohibées du Guide de conformité concernant les produits de santé naturels.  Les produits contenant cet ingrédient qui n'ont pas d'autorisation de mise en marché sont sujets à une approche de conformité qui est prise conjointement avec une approche basée sur les risques.  Une licence de mise en marché doit être obtenue avec de pouvoir poursuivre la commercialisation du produit.  Référence:  http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/complian-conform_guide-fra.php";s:19:"field_old_rationale";s:663:"Sanguinarine, a benzophenanthridine alkaloid, is the principal alkaloid found in sanguinaria root extract (Sanguinaria canadensis L. or bloodroot). This molecule is commonly found in toothpaste and mouthwashes and known for its antimicrobial, anti-inflammatory, antioxidant and antiproliferative activity (Clinical Cancer Research Vol. 6, 1524-1528, April 2000). Despite the fact that sanguinarine is found naturally in plants, this product is listed under the Restricted Substances not in the Food and Drug Regulations and therefore Sanguinarinum nitricum is acceptable only in homeopathic medicines at potencies of 4X or higher, but not permitted as an isolate.";s:16:"field_legacy_nid";s:5:"77463";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Sanguinarine";s:5:"title";s:12:"Sanguinarine";s:3:"nid";s:5:"81278";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81279;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"381";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:364:"Olmesartan is an angiotensin II receptor antagonist. It is an antihypertensive [1-2]. Olmesartan is a biphenyltetrazole derivative. It is a synthetic material. Olmesartan medoxomil is rapidly and completely bioactivated by ester hydrolysis to olmesartan during absorption from the gastrointestinal tract [3]. Olmesartan will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77464";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Olmesartan";s:5:"title";s:10:"Olmesartan";s:3:"nid";s:5:"81279";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81280;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"381";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:325:"Moclobemide is an antidepressant and a reversible monoamine oxidase A (MAO-A) inhibitor. It introduced by 'Hoffmann-La Roche' company [1-3]. Moclobemide is a synthetic material. It is neither found in nature nor recognized as a source of a natural product. Moclobemide, therefore, will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77465";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Moclobemide";s:5:"title";s:11:"Moclobemide";s:3:"nid";s:5:"81280";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81281;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"381";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:493:"4-Chloro-L-phenylalanine is the chloro derivative of L-Phenylalanine. Its medicinal actions (including safety and efficacy) differ from L-Phenylalanine. Just like its racemic form Fenclonine, 4-Chloro-L-phenylalanine is a selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin. Since 4-Chloro-L-phenylalanine is a synthetic material not considered as a source for L-Phenylalanine, it will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77466";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"4-Chloro-3-phenyl-L-alanine";s:5:"title";s:27:"4-Chloro-3-phenyl-L-alanine";s:3:"nid";s:5:"81281";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81282;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"381";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:398:"Methoxyisoflavone is a member of the family of flavonoids (isoflavones). Several substances similar to methoxyisoflavone are found in many plants and some foods, including soybeans. Methoxyisoflavone is similar to Ipriflavone (structurally and functionally); it is not found in nature. It is a synthetic material that is not found in nature and therefore it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"77467";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"5-Methyl-7-methoxyisoflavone";s:5:"title";s:28:"5-Methyl-7-methoxyisoflavone";s:3:"nid";s:5:"81282";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81283;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"338";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:809:"Citricidal (Grapefruit-seed extract or GSE) is apparently made by a catalytic conversion and ammoniation of the polyphenolic compounds extracted from grapefruit seed and pulp into a quaternary ammonium compounds (Reagor et al. 2002). Other reference has also confirmed that the active component of Citricidal is a quaternary ammonium chloride compound similar to Benzethonium chloride that is already classified as a non-NHP (Allwellness 2009, Nutriteam 2009). Note that the exact composition of Citricidal seems controversial, and that synthetic antimicrobials (such as Benzethonium chloride, Triclosan, and Methyl paraben) have been identified in commercially available Citricidal products (Brandin et al. 2007, Takeoka et al. 2001).Based on the above information, Citricidal should be considered as a drug.";s:16:"field_legacy_nid";s:5:"77468";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Citricidal";s:5:"title";s:10:"Citricidal";s:3:"nid";s:5:"81283";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81284;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"381";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:635:"Cadmium iodide can be prepared from the elements (Cadmium and Iodine) or from cadmium sulfate and potassium iodide. It has been used in electrodeposition of Cd; as nematocide; in manufacturing of phosphors; as lubricant; in photoconductors; in photography, process engraving; lithography and in analytical chemistry. Cadmium iodide (as 'Cadmium iodatum') has also been used as a homeopathic medicine (OTC; 2X). However, Cadmium iodide cannot be considered as an acceptable source for Iodine due to Cadmium toxicity.Cadmium iodide is acceptable only in homeopathic medicines at potencies of 2X or higher, but not permitted as a mineral.";s:16:"field_legacy_nid";s:5:"77469";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Cadmium Iodide";s:5:"title";s:14:"Cadmium Iodide";s:3:"nid";s:5:"81284";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81285;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"457";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:48:"Synthetic substance that is not found in nature.";s:16:"field_legacy_nid";s:5:"77470";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Calcium polystyrene sulfonate";s:5:"title";s:29:"Calcium polystyrene sulfonate";s:3:"nid";s:5:"81285";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81286;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"418";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1256:"Bis(maltolato)oxovanadium IV (BMOV) is an insulin-mimetic agent. BMOV is synthesized by a simple metathesis of vanadyl sulfate trihydrate and Maltol. [Thompson, 1999]. Vanadyl sulfate (VS) is an NHP according to the Ingredient Classification Database and Maltol is a naturally occurring organic compound found in the bark of the larch tree and is isolated from Passiflora incarnata [PubChem].

One study used 48 V (Vanadium radio-isotope) as a tracer and showed that 48 V-BMOV had enhanced uptake and slower excretion than 48 VS and tissue distribution patterns of 48 V-BMOV differed from 48 VS, with relatively higher 48 V liver-to-kidney ratio for the organovanadium complex. Concentrations of 48 V in the kidney were 3 times higher and in the Liver were 4 times higher when 48 V-BMOV was administered as compared to 48 VS [Setyawati, 1998]. In a study looking at the interaction of BMOV with serum proteins, the interaction of BMOV with serum albumin appears to result in slightly different reaction products than Vanadium Oxide Sulfate (VOSO 4) [Liboiron, 2005].

Based on the difference in the pharmacokinetic profile of Bis(maltolato)oxovanadium IV to vanadyl sulfate, Bis(maltolato)oxovanadium IV is not considered an NHP, nor as a source of an NHP.";s:16:"field_legacy_nid";s:5:"77471";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Bis(maltolato)oxovanadium(IV)";s:5:"title";s:29:"Bis(maltolato)oxovanadium(IV)";s:3:"nid";s:5:"81286";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81287;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"463";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:978:"Tykerb, also known as lapatinib or N--[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine (CAS no. 231277-92-2) is an antineoplastic reversible dual inhibitor of ErbB1 and ErbB2 tyrosine kinases [Merck, 2006]. Lapatinib was developed based on the observation that overexpression of EGFR and HER2 in a range of cancers, it is used with the medicine capecitabine for the treatment of patients with advanced or metastatic breast cancer, and who have already had certain other breast cancer treatments. . Drugs such as trastuzumab and erlotinib were developed to inhibit EGFR kinase and based on the characteristics of signalling within the EGFR family, it was hypothesized that a more effective anticancer agent would be a molecule that could inhibit both EGFR and HER2. This led to the development of lapatinib [Moy, 2007]. As this molecule is synthetic and does not appear in nature, it is considered a non-NHP.";s:16:"field_legacy_nid";s:5:"77472";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Lapatinib";s:5:"title";s:9:"Lapatinib";s:3:"nid";s:5:"81287";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81288;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"466";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:858:"Clolar, also known as clofarabine or 2-Chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purin-6-amine (CAS # 123318-82-1) is a second generation purine nucleoside analog that inhibits DNA synthesis and resists deamination by adenosine deaminase and is used as a chemotherapeutic agent [Merck, 2006]. Clofarabine synthesis involved reacting 2-chloroadenine with 1-bromo-2-deoxy-2fluoro-3,5-di-O-benzoyl-α-D-ribofuranose and potassium tert-butoxide in a mixture of 3 solvents followed by deprotection and crystallization [Bauta, 2004]. Since Clolar is a synthetic drug that is neither found in nature nor acting as a source for NHP, it is classified as non-NHP substance. In addition, Clolar is normally administered via intravenous infusion and therefore is captured under Schedule 2 item 5 of the NHP regulations and is considered as a drug accordingly.";s:16:"field_legacy_nid";s:5:"77473";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Clofarabine";s:5:"title";s:11:"Clofarabine";s:3:"nid";s:5:"81288";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81289;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:11:"543;67;1351";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:48:"Synthetic substance that is not found in nature.";s:16:"field_legacy_nid";s:5:"77474";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Erythrosine";s:5:"title";s:11:"Erythrosine";s:3:"nid";s:5:"81289";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81290;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:6:"457;67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77475";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Chlorobutanol";s:5:"title";s:13:"Chlorobutanol";s:3:"nid";s:5:"81290";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81291;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"457";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:499:"Hydrobromide salt of a synthetic substance that is not found in nature: - prepared from mandelic acid and tropine (O’Neil et al. 2006); - closely related chemically to atropine, having one less methyl group (Bryant et al. 2006); - semi-synthetic derivative of atropine (Madagula et al. 2006, Marcos et al. 1997);
prepared synthetically by esterification of mandelic acid with 3α-tropine (Cherkaoui et al. 1997). - 1 citation found for ‘Homatropine’ in NAPRALERTsm 2009: article not available.";s:16:"field_legacy_nid";s:5:"77476";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Homatropine hydrobromide";s:5:"title";s:24:"Homatropine hydrobromide";s:3:"nid";s:5:"81291";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81292;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"457";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:48:"Synthetic substance that is not found in nature.";s:16:"field_legacy_nid";s:5:"77477";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Isosorbide dinitrate";s:5:"title";s:20:"Isosorbide dinitrate";s:3:"nid";s:5:"81292";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81293;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"457";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:48:"Synthetic substance that is not found in nature.";s:16:"field_legacy_nid";s:5:"77478";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Nitroglycerine";s:5:"title";s:14:"Nitroglycerine";s:3:"nid";s:5:"81293";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81294;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"457";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:307:"Derivative of the naturally occurring compound anethole (DNP 2009, O’Neil et al. 2006, Supported by 125 citations found in NAPRALERTsm). Not considered as a source for anethole: Sweetman S.C. 2002 indicates, as a note, to distinguish from anethole, as well as outlining different pharmacological profiles.";s:16:"field_legacy_nid";s:5:"77479";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Anethole trithione";s:5:"title";s:18:"Anethole trithione";s:3:"nid";s:5:"81294";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81295;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:6:"465;67";s:25:"field_non_nhp_rationale_e";s:326:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:387:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:19:"field_old_rationale";s:699:"Although there are two references indicating that acetic anhydride is found in watercress Nasturtium officinale (DNP 2009) and in watercress (Naturtium officinale r. br.) (Burdock 2005), it is well known that acetic anhydride is not stable in water and reacts with the moisture in the air to produce acetic acid and therefore, it is unlikely to be found as stable substance in plants. Acetic anhydride is produced by carbonylation of methyl acetate or by the reaction of ketene with acetic acid.Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:16:"field_legacy_nid";s:5:"77480";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Acetic anhydride";s:5:"title";s:16:"Acetic anhydride";s:3:"nid";s:5:"81295";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81296;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"465";s:25:"field_non_nhp_rationale_e";s:326:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:387:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:19:"field_old_rationale";s:568:"(+)-form is an alkaloid from ergot (Claviceps purpurea) and several spp. in the genera Argyreia, Stictocardia, Rivea and Ipomoea (Convolvulvaceae) (DNP 2009). From some ergots (O’Neil et al. 2006). Supported by 14 citations found in NAPRALERTsm 2009. ‘Ergot alkaloids and their salts’ are listed on Schedule F to the Food and Drugs Act (Justice Canada 1985).Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:16:"field_legacy_nid";s:5:"77481";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ergometrine";s:5:"title";s:11:"Ergometrine";s:3:"nid";s:5:"81296";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81297;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"465";s:25:"field_non_nhp_rationale_e";s:326:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:387:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:19:"field_old_rationale";s:495:"Alkaloid from ergot (Claviceps purpurea) (DNP 2009). Vasoconstrictor found in ergot of Central Europe (O’Neil et al. 2006). Supported by 34 citations found in NAPRALERTsm 2009. ‘Ergot alkaloids and their salts’ are listed on Schedule F to the Food and Drugs Act (Justice Canada 1985). Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:16:"field_legacy_nid";s:5:"77482";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ergotamine";s:5:"title";s:10:"Ergotamine";s:3:"nid";s:5:"81297";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81298;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"465";s:25:"field_non_nhp_rationale_e";s:326:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:387:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:19:"field_old_rationale";s:662:"(+)-form is an alkaloid from Claviceps purpurea; obtained by the hydrolysis of the ergotaman group of alkaloids (DNP 2009). Lysergic acid and isolysergic acid are the main cleavage products formed on alkaline hydrolysis of the alkaloids which are characteristic of ergot (O’Neil et al. 2006). Supported by 8 citations found in NAPRALERTsm 2009. ‘Ergot alkaloids and their salts’ are listed on Schedule F to the Food and Drugs Act (Justice Canada 1985).Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:16:"field_legacy_nid";s:5:"77483";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Lysergic acid";s:5:"title";s:13:"Lysergic acid";s:3:"nid";s:5:"81298";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81299;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"465";s:25:"field_non_nhp_rationale_e";s:326:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:387:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:19:"field_old_rationale";s:575:"Not found in nature. Produced by the Wacker oxidation (p-benzoquinone and palladium chloride in methanol) of safrole (Cox and Klass 2006), oxidation (H2O2 and formic acid in acetone) of isosafrole, or by the reduction (iron in acetic acid) of 1-(3,4-methylenedioxyphenyl-2-nitropropene, which is prepared by consensation of Piperonal and nitroethane (Swist et al. 2005). Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:16:"field_legacy_nid";s:5:"77484";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:36:"3,4-Methylenedioxyphenyl-2-propanone";s:5:"title";s:36:"3,4-Methylenedioxyphenyl-2-propanone";s:3:"nid";s:5:"81299";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81300;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"465";s:25:"field_non_nhp_rationale_e";s:326:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:387:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:19:"field_old_rationale";s:397:"Synthetic substance that can not be found in nature. It can be synthesized by the Friedel-Crafts alkylation of benzene with chloroacetone, or by reaction of phenylacetic acid with lead acetate.Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:16:"field_legacy_nid";s:5:"77485";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"1-Phenyl-2-propanone";s:5:"title";s:20:"1-Phenyl-2-propanone";s:3:"nid";s:5:"81300";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81301;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"465";s:25:"field_non_nhp_rationale_e";s:326:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:387:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:19:"field_old_rationale";s:729:"Nothing found on its natural occurrence.  Not used as a source of either potassium or manganese: due to its strong oxidizing properties, potassium permanganate possesses disinfectant and deodorising properties, and thus solutions of this compound have been used in the management (cleansing) of wounds, ulcers, and abscesses; as wet dressings and in baths in eczematous conditions and acute dermatose, as well as in bromhidrosis, in mycotic infections such as athlete’s foot, and in poison ivy dermatitis (Sweetmann 2002). Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:16:"field_legacy_nid";s:5:"77486";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Potassium permanganate";s:5:"title";s:22:"Potassium permanganate";s:3:"nid";s:5:"81301";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81302;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"465";s:25:"field_non_nhp_rationale_e";s:326:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:387:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:19:"field_old_rationale";s:526:"Hypophosphorous acid is not found in nature. It is prepared industrially via a two step process: reaction of hypophosphite salts with hot aqueous solution, e.g. Ca(OH)2, or by oxidation of phosphine with iodine in water.Hypophosphates were used in tonics; however, are not a suitable source of phosphorus (Sweetman 2009). Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:16:"field_legacy_nid";s:5:"77487";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Hypophosphorous acid";s:5:"title";s:20:"Hypophosphorous acid";s:3:"nid";s:5:"81302";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81303;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"465";s:25:"field_non_nhp_rationale_e";s:326:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:387:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:19:"field_old_rationale";s:365:"Not found in nature. The industrial preparation of HI involves the reaction of I2 with hydrazine. Hydriodic acid has been used as an expectorant (Sweetman 2009).Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:16:"field_legacy_nid";s:5:"77488";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Hydriodic acid";s:5:"title";s:14:"Hydriodic acid";s:3:"nid";s:5:"81303";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81304;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"465";s:25:"field_non_nhp_rationale_e";s:326:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:25:"field_non_nhp_rationale_f";s:387:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:19:"field_old_rationale";s:1084:"Although ethyl ether is detected in hop oil (Humulus lupulus) (DNP 2009, Buttery et al. 1963,  NAPRALERTsm 2009) and identified in the volatile fraction of 5 mushrooms extracts, namely Gyromitra esculenta, Boletus edulis, Lactarius trivialis, Lactarius torminosus, and Agaricus bisporus (Pyysalo 1976); detected as a headspace component of malabar- nightshade (Basella rubra L.) (Kameoka et al. 1991), Pyysalo 1976 and Kameoka et al. 1991 identified (in the experimental and materials/methods section, respectively), this is likely an artifact since diethyl ether/ether is used as one of the solvents in the preparation of the samples analyzed. Diethyl ether, also known as ether, is a common laboratory solvent used for extraction and in synthesis. It can be prepared both in laboratories and on an industrial scale by mixing ethanol with a strong acid, typically sulfuric acid.
Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:16:"field_legacy_nid";s:5:"77489";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ethyl ether";s:5:"title";s:11:"Ethyl ether";s:3:"nid";s:5:"81304";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81305;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"493";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:347:"The above information strongly suggest that 1) Vorinostat is a synthetic compound not found in nature and 2) that Vorinostat is not acting as a source for any naturally occurring compounds.  Therefore, Vorinostat does not meet the substance aspect of the Natural Health Product definition, as outlined in the NHP Regulations (Justice Canada 2003).";s:16:"field_legacy_nid";s:5:"77490";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vorinostat";s:5:"title";s:10:"Vorinostat";s:3:"nid";s:5:"81305";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81306;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"531";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77492";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"N-mono-desmethyl sibutramine";s:5:"title";s:28:"N-mono-desmethyl sibutramine";s:3:"nid";s:5:"81306";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81307;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:6:"494;67";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:580:"Troxerutin is a hydroxyethyl derivative (an ether) of Rutin. Both Trexerutin and Rutin are categorized as Vasoprotectant (Merck 2009). Both TrexoRutin and Rutin are categorized as ‘Drug acting on the complex of varicose symptoms’ and ‘Vascular protectant’ (SPS 1995). However, Troxerutin is not acting as a source of Rutin and is not a pro-drug for Rutin. Because Troxerutin have different pharmacological, bioavailability, absorption and solubility than Rutin, and the fact that Troxerutin is not acting as a source material for Rutin, Troxerutin is classified as a drug.";s:16:"field_legacy_nid";s:5:"77493";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Troxerutin";s:5:"title";s:10:"Troxerutin";s:3:"nid";s:5:"81307";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81308;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"613";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:624:"Doripenem is a broad spectrum 1β-methyl-carbapenem (β-Lactam) antibiotic/antibacterial (Merck 2009; US-NLM 2009). Doripenem is claimed to have particular activity against Pseudomonas aeruginosa (Sweetman 2009). European Union (EU) and US-FDA approved Doripenem for the treatment of complicated intra-abdominal infections and complicated urinary tract infections (Dedhia and McKnight 2009; Livermore 2009; Matthews and Lancaster 2009; Paterson and DePestel 2009). Doripenem is a synthetic compound that is not found in nature and is used as antibiotic. Therefore, Doripenem will not be considered as a non- NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77494";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Doripenem";s:5:"title";s:9:"Doripenem";s:3:"nid";s:5:"81308";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81309;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"628";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77495";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Dexamethasone acetate";s:5:"title";s:21:"Dexamethasone acetate";s:3:"nid";s:5:"81309";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81310;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"698";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77497";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Drometrizole trisiloxane";s:5:"title";s:24:"Drometrizole trisiloxane";s:3:"nid";s:5:"81310";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81311;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"695";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:419:"Diethylene glycol monoethyl ether is mostly used as a non-medicinal ingredient in the fragrance industry, as a solvent or viscosity-decreasing agent;  which is why its closely related cousin (Diethylene glycol monopropyl ether) is currently listed in the NHPD acceptable NMIs list.  Diethylene glycol monoethyl ether is a synthetically prepared compound, not found in nature; therefore, it will be considered as a drug.";s:16:"field_legacy_nid";s:5:"77519";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Ethoxydiglycol";s:5:"title";s:14:"Ethoxydiglycol";s:3:"nid";s:5:"81311";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81312;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"756";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:525:"Dronedarone (Fig. 1) is a synthetic benzofuran derivative structurally related to the Schedule F drug amiodarone (noniodinated analog); two molecules possessing antiarrhythmic properties (Justice Canada 2009a, O'Neil et al. 2009, Sweetman 2009, Gubin et al. 1993). As a synthetic compound not found to be naturally occurring, Dronedarone (and its hydrochloride salt) does not meet the substance aspect of the NHP definition, as outlined in the NHP Regulations (Justice Canada 2009b), and therefore it is classified as a drug.";s:16:"field_legacy_nid";s:5:"77520";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Dronedarone";s:5:"title";s:11:"Dronedarone";s:3:"nid";s:5:"81312";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81313;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"756";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:525:"Dronedarone (Fig. 1) is a synthetic benzofuran derivative structurally related to the Schedule F drug amiodarone (noniodinated analog); two molecules possessing antiarrhythmic properties (Justice Canada 2009a, O'Neil et al. 2009, Sweetman 2009, Gubin et al. 1993). As a synthetic compound not found to be naturally occurring, Dronedarone (and its hydrochloride salt) does not meet the substance aspect of the NHP definition, as outlined in the NHP Regulations (Justice Canada 2009b), and therefore it is classified as a drug.";s:16:"field_legacy_nid";s:5:"77521";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Dronedarone hydrochloride";s:5:"title";s:25:"Dronedarone hydrochloride";s:3:"nid";s:5:"81313";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81314;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"815";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:489:"Glycopyrrolate/ Glycopyrronium bromide, (CAS # 596-51-0), is a synthetic, quaternary ammonium anticholigernic agent (ChemID Plus, O’Neil 2009) whose synthesis is the subject of Patent US 2956062 (Free Patent Fetcher) starting from a 1-hydrocarbon substituted-3-pyrrolidinol ring. It is also known to be a long-acting muscarinic antagonist (Casarosa 2009).
Glycopyrrolate does not occur naturally, and can be made only via a synthetic route, therefore, it will be considered as a non-NHP.";s:16:"field_legacy_nid";s:5:"77522";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Glycopyrrolate";s:5:"title";s:14:"Glycopyrrolate";s:3:"nid";s:5:"81314";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81315;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"815";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:440:"usually used as the bromide salt (CAS # 50-34-0), is a synthetic quarternary ammonium salt which was first prepared in 1951 via the tertiary basic followed by bromination using ethylbromide (O’Neil 2009, Cusic 1951). It possesses anticholinergic properties and is also used to treat urinary incontinence, better than oxybutin (George 2007). It will be considered as a non-NHP, since it does not occur naturally, and can only be synthetic.";s:16:"field_legacy_nid";s:5:"77523";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Propantheline";s:5:"title";s:13:"Propantheline";s:3:"nid";s:5:"81315";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81316;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"831";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:77:"Carboxymethylcellulose is a synthetic drug when it has a therapeutic activity";s:16:"field_legacy_nid";s:5:"77525";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Carboxymethylcellulose";s:5:"title";s:22:"Carboxymethylcellulose";s:3:"nid";s:5:"81316";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81317;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"726";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1084:"Methyl tetradecylthioacetic acid (Fig. 1) is the alpha-methylated derivative of tetradecylthioacetic acid (TTA), a sulfur-substituted fatty acid.  As such, this compound has been studied experimentally for its effect(s) on fatty acid metabolism (Granlund et al. 2005, Larsen et al. 2005, Vaagenes et al. 1999); as well as clinically, formulated with many other ingredients in a weight loss supplement, for its thermogenic effects (Hoffman et al. 2009).   The first three references outlined above, in combination with Spydevold and Bremer (1989), indicates that Methyl TTA is obtained through the reaction between tetradecylbromide and thiolactic acid.  The other reference (i.e. Hoffman et al. 2009) seems to correlate Methyl TTA (erroneously interchange with TTA in the article) with herbal and botanical ingredients.  However, evidences on the natural occurrence of Methyl TTA have not been found.  Consequently,  Methyl tetradecylthioacetic acid does not meet the substance aspect of the natural health product definition, as outlined in the NHP Regulations (Justice Canada 2009).";s:16:"field_legacy_nid";s:5:"77526";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:38:"alpha-Methyl tetradecylthioacetic acid";s:5:"title";s:38:"alpha-Methyl tetradecylthioacetic acid";s:3:"nid";s:5:"81317";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81318;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"877";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:851:"Benzophenone-5 is the sodium salt of Benzophenone-4 (Gottschalck and Bailey 2008; US-NLM 2009). It has been used as ultraviolet light absorber (photostabilizer) in cosmetics and in concentration of < 0.3%. Benzophenone-4 is approved by the FDA for use as safe and effective OTC sunscreen ingredient at concentration equal or greater than the one used in cosmetics, i.e. ≥ 0.3% (CIR 2009) but should not be more than 10% (Steinberg 1996). Although there are no animal toxicology or clinical data for Benzophenone-5 but since this ingredient is simply the sodium salt of Benzophenone-4, it would be expected that Benzophenones-4 and -5 have similar biological properties (Liebert 1983). Benzophenone-5 is a synthetic material. It is neither found in nature nor a source of a natural product. Benzophenone-5 will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77527";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Benzophenone-5";s:5:"title";s:14:"Benzophenone-5";s:3:"nid";s:5:"81318";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81319;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"924";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:865:"Apomorphine is a derivative of morphine and a dopamine D1 and D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning (as emetic). It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use (SPS 1995; US-NLM 2009). Apomorphine is also among a wide range of drugs that has been used in the management of erectile dysfunction (Sweetman 2009). It is not indicated as a controlled drug substance (Department-of-Justice-Canada 1996). Apomorphine is a synthetic substance prepared by treating morphine with concentrated hydrochloric acid (Merck 2009). There are fundamental differences between the structure of morphine and apomorphine. Moreover, apomorphine is not a source for any natural product. Since apomorphine is not found in nature, it will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77528";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Apomorphine";s:5:"title";s:11:"Apomorphine";s:3:"nid";s:5:"81319";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81320;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"930";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:549:"Ethylenediamine dihydrochloride is a derivative of ethylenediamine (CRC-DNP 2009; US-NLM 2009). It used as a preservative in creams. It has also been used as a urinary acidifier in animals (Merck 2009). Ethylenediamine dihydrochloride can be an occupational allergen but sensitization in work circumstances is rather rare (Bruynzeel, Andersen et al. 1995). Ethylenediamine dihydrochloride is a source of ethylenediamine but both of them are not found in nature. Therefore, ethylenediamine dihydrochloride will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77529";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:31:"Ethylenediamine dihydrochloride";s:5:"title";s:31:"Ethylenediamine dihydrochloride";s:3:"nid";s:5:"81320";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81321;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"930";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:567:"CPPD (N-cyclohexyl-N'-phenyl-p-phenylenediamine) (US-NLM 2009) is used as an antioxidant and antiozonant for natural and synthetic elastomers, as a stabilizer of polymers and as a monomer polymerization inhibitor. CPPD is not regulated for use in food contact applications. Derivatives of p-Phenylenediamine (such as CPPD) are added to rubber products to retard degradation by oxidants and ozone (CL21-South-Korea 2009). CPPD is a synthetic substance (not found naturally). It is not a source for any natural product. CPPD will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77530";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:44:"1,4-Benzenediamine, N1-cyclohexyl-N4-phenyl-";s:5:"title";s:44:"1,4-Benzenediamine, N1-cyclohexyl-N4-phenyl-";s:3:"nid";s:5:"81321";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81322;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"930";s:25:"field_non_nhp_rationale_e";s:260:"A non-nhp because listed in Schedule D of the Food and Drug Regulations as follows: Blood and Blood derivatives. Fibronectin, which is a blood plasma derivative, will be considered as biologics and products containing such substances will be evaluated by BGTD.";s:25:"field_non_nhp_rationale_f";s:331:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues: Sang et dérivés du sang.  La fibronectine, qui est un dérivé du plasma sanguin, sera considérée comme étant parmi les produits biologiques et tous les produits contenant ces types de substances doivent être évalués par la DPBTG.";s:16:"field_legacy_nid";s:5:"77531";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Fibronectin";s:5:"title";s:11:"Fibronectin";s:3:"nid";s:5:"81322";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81323;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"930";s:25:"field_non_nhp_rationale_e";s:252:"A non-nhp because listed in Schedule D of the Food and Drug Regulations as follows: Blood and Blood derivatives. Factor XIII, which is a blood derivative will be considered as biologics and products containing such substances will be evaluated by BGTD.";s:25:"field_non_nhp_rationale_f";s:321:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues: Sang et dérivés du sang.  Le facteur XIII, qui est un dérivé du sang, sera considérée comme étant parmi les produits biologiques et tous les produits contenant ces types de substances doivent être évalués par la DPBTG.";s:16:"field_legacy_nid";s:5:"77532";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Factor XIII";s:5:"title";s:11:"Factor XIII";s:3:"nid";s:5:"81323";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81324;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"970";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:378:"Sulfacetamide sodium (CAS #: 6209-17-2) is a synthetic bacterial agent, first synthesized in 1939 by the reaction of crude N 4 -acetylsulfanilimide and solid powdered sodium hydroxide (ChemID Plus, Crossley 1939, O'Neil 2009). It is mostly used in opthalmic and topical products (Blasco 1994).Sulfacetamide sodium will be considered as a drug, since it does not occur naturally.";s:16:"field_legacy_nid";s:5:"77533";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Sulfacetamide sodium anhydrous";s:5:"title";s:30:"Sulfacetamide sodium anhydrous";s:3:"nid";s:5:"81324";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81325;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1127";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1722:"Phenibut (PB),  is a chiral molecule which only R -Phenibut is active (Dambrova, Zvejniece et al. 2008). It  was synthesized in 1960’s by Perekalin and his associates at the Department of Organic Chemistry of the Herzen Pedagogic, Institute in St. Petersburg, Russia. Incorporation of a phenyl ring into the GABA molecule improve the entry of the molecule into the brain. For example, following incorporation, researchers demonstrated that in mice and rats, PB penetrates the blood-brain barrier significantly better than GABA. Unlike GABA, PB completely lacks anticonvulsant activity by either systemic or intracerebroventricular administration. The lack of anticonvulsant activity of PB may be related to the reduction in norepinephrine-independent [3H]-GABA binding to brain synaptic membranes by β-substituted GABA derivatives. In addition, certain neuropharmacological effects of GABA were lost with β-substitution (Lapin 2001). Compared to GABA, Phenibut has pronounced neuropsychopharmacological effects including nootropic, tranquilizing, and anxiolytic activity. It was found recently that PB has also a strong immunocorrective activity (Tyurenkov and Samotrueva 2009). Unlike GABA, following intravenous administration to either rabbits or rats, PB is not metabolized but largely excreted in the urine. The acidity of GABA and PB are also different; PH of 5 for GABA and around 2.5 for PB (Merck 2009). In summary, Phenibut have different pharmacological, bioavailability, absorption and physical properties than GABA. Phenibut is not naturally occurring compound. It is neither a derivative of GABA, nor a source for any natural products including GABA. Phenibut will not be considered as a NHP, but a drug.";s:16:"field_legacy_nid";s:5:"77534";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Phenibut";s:5:"title";s:8:"Phenibut";s:3:"nid";s:5:"81325";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81326;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1312";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77535";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"7-Methoxyisoflavone";s:5:"title";s:19:"7-Methoxyisoflavone";s:3:"nid";s:5:"81326";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81327;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"2342";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:713:"N,N′-bis(2-mercaptoethyl)isophthalamide (also known as 1,3-benzenediamidoethanethiol or BDETH2) is a chemical compound that has been designed and synthesized for its use as a precipitation agent for the removal of soft metals from water (Zaman 2008, Zaman et al. 2007).  Indeed, BDETH2  has shown effectiveness at removing metals from water and in producing non-leaching precipitates, as well as in metal removal from gold mining effluent, lead battery recycling, and acid mine drainage (Matlock et al. 2003). Since BDETH2 has not been found to occur in nature, it does not meet the substance aspect of the Natural Health Product (NHP) definition, as outlined in the NHP Regulations (Government of Canada 2010).";s:16:"field_legacy_nid";s:5:"77536";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"1,3-Benzenediamidoethanethiol";s:5:"title";s:29:"1,3-Benzenediamidoethanethiol";s:3:"nid";s:5:"81327";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81328;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"2507";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77537";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Prasugrel";s:5:"title";s:9:"Prasugrel";s:3:"nid";s:5:"81328";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81329;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"2507";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77538";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Prasugrel hydrochloride";s:5:"title";s:23:"Prasugrel hydrochloride";s:3:"nid";s:5:"81329";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81330;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"2425";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77539";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Palmitoyl tetrapeptide-7";s:5:"title";s:24:"Palmitoyl tetrapeptide-7";s:3:"nid";s:5:"81330";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81331;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"2604";s:25:"field_non_nhp_rationale_e";s:209:"A non-NHP because Tocilizumab falls under the Schedule D to the Food and Drugs Act listings ‘Drugs obtained by recombinant DNA procedures’ and ‘Monoclonal antibodies, their conjugates and derivatives’.";s:25:"field_non_nhp_rationale_f";s:236:"Un non PSN parce que le Tocilizumab se retrouve à l'Annexe D de la Loi sur les aliments et les drogues sous "Drogues obtenues par des procédures de recombinaison de l’ADN" et "Anticorps monoclonaux et leurs dérivés et conjugués".";s:16:"field_legacy_nid";s:5:"77540";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Tocilizumab";s:5:"title";s:11:"Tocilizumab";s:3:"nid";s:5:"81331";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81332;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77541";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Desloratadine";s:5:"title";s:13:"Desloratadine";s:3:"nid";s:5:"81332";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81333;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77542";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Hydroxypropylcellulose";s:5:"title";s:22:"Hydroxypropylcellulose";s:3:"nid";s:5:"81333";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81334;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77543";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Diclofenac diethylamine";s:5:"title";s:23:"Diclofenac diethylamine";s:3:"nid";s:5:"81334";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81335;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77544";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Pyrilamine maleate";s:5:"title";s:18:"Pyrilamine maleate";s:3:"nid";s:5:"81335";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81336;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77545";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Pheniramine maleate";s:5:"title";s:19:"Pheniramine maleate";s:3:"nid";s:5:"81336";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81337;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77546";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Chlorzoxazone";s:5:"title";s:13:"Chlorzoxazone";s:3:"nid";s:5:"81337";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81338;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77547";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Bismuth camphocarbonate";s:5:"title";s:23:"Bismuth camphocarbonate";s:3:"nid";s:5:"81338";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81339;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77548";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Antazoline phosphate";s:5:"title";s:20:"Antazoline phosphate";s:3:"nid";s:5:"81339";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81340;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77550";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:55:"Methyl heptyl colamino formylmethyl pyridinium chloride";s:5:"title";s:55:"Methyl heptyl colamino formylmethyl pyridinium chloride";s:3:"nid";s:5:"81340";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81341;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77551";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:44:"Alkyl dimethyl ethylbenzyl ammonium chloride";s:5:"title";s:44:"Alkyl dimethyl ethylbenzyl ammonium chloride";s:3:"nid";s:5:"81341";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81342;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77552";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Tyrothricin";s:5:"title";s:11:"Tyrothricin";s:3:"nid";s:5:"81342";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81343;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77553";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Amylmetacresol";s:5:"title";s:14:"Amylmetacresol";s:3:"nid";s:5:"81343";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81344;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77554";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Triprolidine hydrochloride";s:5:"title";s:26:"Triprolidine hydrochloride";s:3:"nid";s:5:"81344";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81345;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77555";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Piperonyl butoxide";s:5:"title";s:18:"Piperonyl butoxide";s:3:"nid";s:5:"81345";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81346;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77556";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Dexbrompheniramine maleate";s:5:"title";s:26:"Dexbrompheniramine maleate";s:3:"nid";s:5:"81346";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81347;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77557";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Aldioxa";s:5:"title";s:7:"Aldioxa";s:3:"nid";s:5:"81347";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81348;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77558";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Potassium chlorate";s:5:"title";s:18:"Potassium chlorate";s:3:"nid";s:5:"81348";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81349;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77559";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Oxyquinoline sulfate";s:5:"title";s:20:"Oxyquinoline sulfate";s:3:"nid";s:5:"81349";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81350;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77560";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Bronopol";s:5:"title";s:8:"Bronopol";s:3:"nid";s:5:"81350";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81351;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77561";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Hydroxyethyl cellulose";s:5:"title";s:22:"Hydroxyethyl cellulose";s:3:"nid";s:5:"81351";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81352;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77562";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Povidone";s:5:"title";s:8:"Povidone";s:3:"nid";s:5:"81352";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81353;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77563";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Phenoxyisopropanol";s:5:"title";s:18:"Phenoxyisopropanol";s:3:"nid";s:5:"81353";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81354;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77564";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Prilocaine";s:5:"title";s:10:"Prilocaine";s:3:"nid";s:5:"81354";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81355;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77565";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Cetrimide";s:5:"title";s:9:"Cetrimide";s:3:"nid";s:5:"81355";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81356;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"1013;2741";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77566";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Macrogol 400";s:5:"title";s:12:"Macrogol 400";s:3:"nid";s:5:"81356";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81357;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77567";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Brompheniramine maleate";s:5:"title";s:23:"Brompheniramine maleate";s:3:"nid";s:5:"81357";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81358;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77568";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Dipyrithione";s:5:"title";s:12:"Dipyrithione";s:3:"nid";s:5:"81358";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81359;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77569";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Sodium thiosulfate";s:5:"title";s:18:"Sodium thiosulfate";s:3:"nid";s:5:"81359";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81360;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77570";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Diphenylpyraline hydrochloride";s:5:"title";s:30:"Diphenylpyraline hydrochloride";s:3:"nid";s:5:"81360";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81361;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77571";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Guaiacol carbonate";s:5:"title";s:18:"Guaiacol carbonate";s:3:"nid";s:5:"81361";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81362;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77572";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Phenyl salicylate";s:5:"title";s:17:"Phenyl salicylate";s:3:"nid";s:5:"81362";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81363;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77573";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Triethanolamine Stearate";s:5:"title";s:24:"Triethanolamine Stearate";s:3:"nid";s:5:"81363";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81364;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77574";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Pamabrom";s:5:"title";s:8:"Pamabrom";s:3:"nid";s:5:"81364";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81365;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77575";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Clemastine Fumarate";s:5:"title";s:19:"Clemastine Fumarate";s:3:"nid";s:5:"81365";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81366;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77576";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Fexofenadine Hydrochloride";s:5:"title";s:26:"Fexofenadine Hydrochloride";s:3:"nid";s:5:"81366";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81367;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77577";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Levonorgestrel";s:5:"title";s:14:"Levonorgestrel";s:3:"nid";s:5:"81367";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81368;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77578";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Doxylamine Succinate";s:5:"title";s:20:"Doxylamine Succinate";s:3:"nid";s:5:"81368";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81369;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77580";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Loperamide Hydrochloride";s:5:"title";s:24:"Loperamide Hydrochloride";s:3:"nid";s:5:"81369";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81370;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77581";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Cromolyn Sodium";s:5:"title";s:15:"Cromolyn Sodium";s:3:"nid";s:5:"81370";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81371;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because it is an antibiotic substance included in Schedule 2 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN car une substance antibiotique comprise dans l'Annexe 2 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77582";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Nystatin";s:5:"title";s:8:"Nystatin";s:3:"nid";s:5:"81371";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81372;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77583";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Promethazine hydrochloride";s:5:"title";s:26:"Promethazine hydrochloride";s:3:"nid";s:5:"81372";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81373;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77584";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Cetrimonium Bromide";s:5:"title";s:19:"Cetrimonium Bromide";s:3:"nid";s:5:"81373";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81374;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77585";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Sodium hypochlorite";s:5:"title";s:19:"Sodium hypochlorite";s:3:"nid";s:5:"81374";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81375;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77586";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Bisoctrizole";s:5:"title";s:12:"Bisoctrizole";s:3:"nid";s:5:"81375";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81376;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77587";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Bemotrizinol";s:5:"title";s:12:"Bemotrizinol";s:3:"nid";s:5:"81376";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81377;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77589";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Chlorphenamine maleate";s:5:"title";s:22:"Chlorphenamine maleate";s:3:"nid";s:5:"81377";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81378;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77590";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Dextromethorphan hydrobromide";s:5:"title";s:29:"Dextromethorphan hydrobromide";s:3:"nid";s:5:"81378";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81379;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77591";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Oxymetazoline hydrochloride";s:5:"title";s:27:"Oxymetazoline hydrochloride";s:3:"nid";s:5:"81379";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81380;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77592";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Scarlet red";s:5:"title";s:11:"Scarlet red";s:3:"nid";s:5:"81380";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81381;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77593";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Orphenadrine citrate";s:5:"title";s:20:"Orphenadrine citrate";s:3:"nid";s:5:"81381";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81382;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77594";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Tetrahydrozoline Hydrochloride";s:5:"title";s:30:"Tetrahydrozoline Hydrochloride";s:3:"nid";s:5:"81382";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81383;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77595";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Xylometazoline Hydrochloride";s:5:"title";s:28:"Xylometazoline Hydrochloride";s:3:"nid";s:5:"81383";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81384;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77596";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Fluorescein sodium";s:5:"title";s:18:"Fluorescein sodium";s:3:"nid";s:5:"81384";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81385;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77597";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Bismuth tribromophenate";s:5:"title";s:23:"Bismuth tribromophenate";s:3:"nid";s:5:"81385";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81386;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77598";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Monobenzone";s:5:"title";s:11:"Monobenzone";s:3:"nid";s:5:"81386";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81387;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77600";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Naphazoline hydrochloride";s:5:"title";s:25:"Naphazoline hydrochloride";s:3:"nid";s:5:"81387";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81388;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77601";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Clofedanol hydrochloride";s:5:"title";s:24:"Clofedanol hydrochloride";s:3:"nid";s:5:"81388";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81389;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77602";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Dithranol";s:5:"title";s:9:"Dithranol";s:3:"nid";s:5:"81389";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81390;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77603";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Silicones";s:5:"title";s:9:"Silicones";s:3:"nid";s:5:"81390";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81391;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77604";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Methocarbamol";s:5:"title";s:13:"Methocarbamol";s:3:"nid";s:5:"81391";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81392;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"2696";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77605";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Psilocin";s:5:"title";s:8:"Psilocin";s:3:"nid";s:5:"81392";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81393;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"2696";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77606";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Psilocybin";s:5:"title";s:10:"Psilocybin";s:3:"nid";s:5:"81393";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81394;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"2680";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77608";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Pazopanib";s:5:"title";s:9:"Pazopanib";s:3:"nid";s:5:"81394";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81395;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77609";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Meclozine hydrochloride";s:5:"title";s:23:"Meclozine hydrochloride";s:3:"nid";s:5:"81395";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81396;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77610";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Bismuth dipropylacetate";s:5:"title";s:23:"Bismuth dipropylacetate";s:3:"nid";s:5:"81396";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81397;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77611";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Proxymetacaine hydrochloride";s:5:"title";s:28:"Proxymetacaine hydrochloride";s:3:"nid";s:5:"81397";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81398;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77612";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:39:"Trolamine polypeptide oleate-condensate";s:5:"title";s:39:"Trolamine polypeptide oleate-condensate";s:3:"nid";s:5:"81398";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81399;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77613";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Naphazoline nitrate";s:5:"title";s:19:"Naphazoline nitrate";s:3:"nid";s:5:"81399";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81400;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77614";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"D&C Red No. 28";s:5:"title";s:14:"D&C Red No. 28";s:3:"nid";s:5:"81400";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81401;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1013";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77615";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Polysorbate 80";s:5:"title";s:14:"Polysorbate 80";s:3:"nid";s:5:"81401";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81402;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"2780";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1004:"Lacosamide is a synthetic, functionalized amino acid possessing anticonvulsant and analgesic properties, through its ability to enhance slow activation of voltage-gated sodium channels and to bind to collapsing response mediator protein-2 (O’Neil et al. 2010). It is used, mostly orally but also by intravenous infusion, in the treatment of epilepsy as an adjunctive therapy for partial seizures with or without secondary generalisation (Sweetman 2010, Beyreuther et al. 2007). When given orally, Lacosamide is rapidly and completely absorbed, then almost exclusively excreted in the urine unchanged or as its O-desmethyl metabolite (Cross and Curran 2009, Doty et al. 2007).
Based on the above, Lacosamide does not meet the substance aspect of the natural health product (NHP) definition, as outlined in the Natural Health Products Regulations (Government of Canada 2010); nor considered as a derivative of any NHP substance, as defined in the Product Licensing guidance document (Health Canada 2006).";s:16:"field_legacy_nid";s:5:"77616";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Lacosamide";s:5:"title";s:10:"Lacosamide";s:3:"nid";s:5:"81402";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81403;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"2427";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77617";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Lauric arginate";s:5:"title";s:15:"Lauric arginate";s:3:"nid";s:5:"81403";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81404;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"2699";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77618";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Aminoguanidine";s:5:"title";s:14:"Aminoguanidine";s:3:"nid";s:5:"81404";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81405;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"3365";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:623:"Toltrazuril is a synthetic triazineone, which is an effective treatment for coccidial infections in poultry, rabbits, mice and sheep (Frandsen et al. 1992). Veterinarians use Toltrazuril to treat infections in poultry, pigs and cattle (O’Neil et al. 2006).Toltrazuril is classified as a non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.
References:
Frandsen JC, Blagburn BL, Arther RG. 1992. Toltrazuril (Bay Vi 9142) as an anticoccidial in naturally infected goats. Preventive Veterinary Medicine 12: 101-110.
O’Neil et al. 2010. Merck Index, electronic online version.";s:16:"field_legacy_nid";s:5:"77635";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Toltrazuril";s:5:"title";s:11:"Toltrazuril";s:3:"nid";s:5:"81405";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81406;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"3438";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77636";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Perflubron";s:5:"title";s:10:"Perflubron";s:3:"nid";s:5:"81406";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81407;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"3517";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77637";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Bromhexine";s:5:"title";s:10:"Bromhexine";s:3:"nid";s:5:"81407";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81408;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"3784";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:1366:"Febuxostat is a non-purine selective inhibitor of xanthine oxidase. Uric acid is the end product of purine metabolism generated during the enzymatic degradation of hypoxanthine and xanthine It is generated in the cascade of Hypoxanthine to Xanthine to Uric acid. Both steps in the above transformations are catalyzed by xanthine oxidase. Febuxostat decreases serum uric acid by selectively inhibiting xanthine oxidase (2).
Uric acid metabolism and sites of action of febuxostat (xanthine oxidase inhibitor*).
Febuxostat is known to synthesize starting from 4-Nitrobenzonitrile (3).
Since Febuxostat is a synthetic product that is not found in nature, it will be considered as a drug, not a NHP.
References:
1. O’Neil M.J., Heckelman P.E., Koch C.B., Roman K.J. (Eds). 2010. The Merck Index: an encyclopedia of chemicals, drugs, and Biologicals, Fourteenth Edition (2006). Merck & Co. Inc., Whitehouse Station, NJ, USA. Electronic versions
2. Yu, K. 2007. Febuxostat: A Novel Non-Purine Selective Inhibitor of Xanthine Oxidase
for the Treatment of Hyperuricemia in Gout. Recent Patents on Inflammation & Allergy Drug Discovery. 1: 69-75.
3. Hasegawa, M. 1998. Facile One-Pot Synthesis of 4-Alkoxy-1,3-benzenedicarbonitrile Heterocycles 47: 857-864.
4. Sweetman S. (Ed.) 2010. Martindale: The Complete Drug Reference, Pharmaceutical Press, London. Electronic Version";s:16:"field_legacy_nid";s:5:"77638";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Febuxostat";s:5:"title";s:10:"Febuxostat";s:3:"nid";s:5:"81408";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81409;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"5151";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77684";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Silodosin";s:5:"title";s:9:"Silodosin";s:3:"nid";s:5:"81409";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81410;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77685";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"2-(4-Morpholino)thiobenzothiazole";s:5:"title";s:33:"2-(4-Morpholino)thiobenzothiazole";s:3:"nid";s:5:"81410";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81411;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77686";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Amyl cinnamal";s:5:"title";s:13:"Amyl cinnamal";s:3:"nid";s:5:"81411";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81412;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:40:"A non-NHP only as an allergenic extract.";s:25:"field_non_nhp_rationale_f";s:48:"Un non PSN seulement comme extrait allergénique";s:16:"field_legacy_nid";s:5:"77687";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Benzocaine";s:5:"title";s:10:"Benzocaine";s:3:"nid";s:5:"81412";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81413;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:40:"A non-NHP only as an allergenic extract.";s:25:"field_non_nhp_rationale_f";s:48:"Un non PSN seulement comme extrait allergénique";s:16:"field_legacy_nid";s:5:"77688";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Benzylparaben";s:5:"title";s:13:"Benzylparaben";s:3:"nid";s:5:"81413";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81414;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77689";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:37:"Bis(1-piperidylthiocarbonyl)disulfide";s:5:"title";s:37:"Bis(1-piperidylthiocarbonyl)disulfide";s:3:"nid";s:5:"81414";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81415;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:40:"A non-NHP only as an allergenic extract.";s:25:"field_non_nhp_rationale_f";s:48:"Un non PSN seulement comme extrait allergénique";s:16:"field_legacy_nid";s:5:"77690";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Butylparaben";s:5:"title";s:12:"Butylparaben";s:3:"nid";s:5:"81415";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81416;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77691";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Chlorquinaldol";s:5:"title";s:14:"Chlorquinaldol";s:3:"nid";s:5:"81416";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81417;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77692";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"1,3-Diphenylguanidine";s:5:"title";s:21:"1,3-Diphenylguanidine";s:3:"nid";s:5:"81417";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81418;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77693";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"2,2′-Dithiobisbenzothiazole";s:5:"title";s:29:"2,2′-Dithiobisbenzothiazole";s:3:"nid";s:5:"81418";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81419;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77694";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Epoxy resin";s:5:"title";s:11:"Epoxy resin";s:3:"nid";s:5:"81419";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81420;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77695";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Fibrinogen";s:5:"title";s:10:"Fibrinogen";s:3:"nid";s:5:"81420";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81421;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:40:"A non-NHP only as an allergenic extract.";s:25:"field_non_nhp_rationale_f";s:48:"Un non PSN seulement comme extrait allergénique";s:16:"field_legacy_nid";s:5:"77696";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Geraniol";s:5:"title";s:8:"Geraniol";s:3:"nid";s:5:"81421";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81422;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:40:"A non-NHP only as an allergenic extract.";s:25:"field_non_nhp_rationale_f";s:48:"Un non PSN seulement comme extrait allergénique";s:16:"field_legacy_nid";s:5:"77697";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Hydroxycitronellal";s:5:"title";s:18:"Hydroxycitronellal";s:3:"nid";s:5:"81422";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81423;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:40:"A non-NHP only as an allergenic extract.";s:25:"field_non_nhp_rationale_f";s:48:"Un non PSN seulement comme extrait allergénique";s:16:"field_legacy_nid";s:5:"77698";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Isoeugenol";s:5:"title";s:10:"Isoeugenol";s:3:"nid";s:5:"81423";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81424;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77699";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Mercaptobenzothiazole";s:5:"title";s:21:"Mercaptobenzothiazole";s:3:"nid";s:5:"81424";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81425;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77700";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Methylchloroisothiazolinone";s:5:"title";s:27:"Methylchloroisothiazolinone";s:3:"nid";s:5:"81425";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81426;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77701";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:34:"N,N′-Diphenyl-p-phenylenediamine";s:5:"title";s:34:"N,N′-Diphenyl-p-phenylenediamine";s:3:"nid";s:5:"81426";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81427;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77702";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:36:"2-(Cyclohexylaminothio)benzothiazole";s:5:"title";s:36:"2-(Cyclohexylaminothio)benzothiazole";s:3:"nid";s:5:"81427";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81428;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77703";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Neomycin sulfate";s:5:"title";s:16:"Neomycin sulfate";s:3:"nid";s:5:"81428";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81429;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77704";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"N-Hydroxymethylsuccinimide";s:5:"title";s:26:"N-Hydroxymethylsuccinimide";s:3:"nid";s:5:"81429";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81430;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:40:"A non-NHP only as an allergenic extract.";s:25:"field_non_nhp_rationale_f";s:48:"Un non PSN seulement comme extrait allergénique";s:16:"field_legacy_nid";s:5:"77705";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Nickel sulfate";s:5:"title";s:14:"Nickel sulfate";s:3:"nid";s:5:"81430";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81431;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77706";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:31:"4-(Isopropylamino)diphenylamine";s:5:"title";s:31:"4-(Isopropylamino)diphenylamine";s:3:"nid";s:5:"81431";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81432;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77707";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Peginterferon alfa-2a";s:5:"title";s:21:"Peginterferon alfa-2a";s:3:"nid";s:5:"81432";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81433;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77708";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Peginterferon alfa-2b";s:5:"title";s:21:"Peginterferon alfa-2b";s:3:"nid";s:5:"81433";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81434;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"963;10553";s:25:"field_non_nhp_rationale_e";s:260:"A non-nhp because listed in Schedule D of the Food and Drug Regulations as follows: Blood and Blood derivatives. Fibronectin, which is a blood plasma derivative, will be considered as biologics and products containing such substances will be evaluated by BGTD.";s:25:"field_non_nhp_rationale_f";s:330:"Un non PSN à cause de sa présence à l'Annexe D de la Loi sur les aliments et les drogues: Sang et dérivés du sang. La fibronectine, qui est un dérivé du plasma sanguin, sera considérée comme étant parmi les produits biologiques et tous les produits contenant ces types de substances doivent être évalués par la DPBTG.";s:16:"field_legacy_nid";s:5:"77709";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Plasma fibronectin";s:5:"title";s:18:"Plasma fibronectin";s:3:"nid";s:5:"81434";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81435;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77710";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Plasminogen";s:5:"title";s:11:"Plasminogen";s:3:"nid";s:5:"81435";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81436;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77711";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Potassium dichromate";s:5:"title";s:20:"Potassium dichromate";s:3:"nid";s:5:"81436";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81437;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77712";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:38:"p-tert-Butylphenol, formaldehyde resin";s:5:"title";s:38:"p-tert-Butylphenol, formaldehyde resin";s:3:"nid";s:5:"81437";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81438;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77713";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:37:"Cholera Toxin, B Subunit, Recombinant";s:5:"title";s:37:"Cholera Toxin, B Subunit, Recombinant";s:3:"nid";s:5:"81438";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81439;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77714";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Rotavirus vaccine";s:5:"title";s:17:"Rotavirus vaccine";s:3:"nid";s:5:"81439";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81440;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77715";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Tetracaine hydrochloride";s:5:"title";s:24:"Tetracaine hydrochloride";s:3:"nid";s:5:"81440";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81441;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77716";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Tetramethylthiuram monosulfide";s:5:"title";s:30:"Tetramethylthiuram monosulfide";s:3:"nid";s:5:"81441";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81442;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77717";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Thimerosal";s:5:"title";s:10:"Thimerosal";s:3:"nid";s:5:"81442";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81443;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77718";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Thiram";s:5:"title";s:6:"Thiram";s:3:"nid";s:5:"81443";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81444;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77719";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Thrombin";s:5:"title";s:8:"Thrombin";s:3:"nid";s:5:"81444";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81445;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77720";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Zinc dibutyldithiocarbamate";s:5:"title";s:27:"Zinc dibutyldithiocarbamate";s:3:"nid";s:5:"81445";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81446;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:3:"963";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77721";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Zinc diethyldithiocarbamate";s:5:"title";s:27:"Zinc diethyldithiocarbamate";s:3:"nid";s:5:"81446";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81447;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77722";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Antimony potassium tartrate";s:5:"title";s:27:"Antimony potassium tartrate";s:3:"nid";s:5:"81447";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81448;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77723";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Menthyl salicylate";s:5:"title";s:18:"Menthyl salicylate";s:3:"nid";s:5:"81448";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81449;a:11:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77724";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Platinic chloride";s:5:"title";s:17:"Platinic chloride";s:3:"nid";s:5:"81449";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81450;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77726";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"N-stearoyl-DL-erythro-sphinganine";s:5:"title";s:33:"N-stearoyl-DL-erythro-sphinganine";s:3:"nid";s:5:"81450";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81451;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77727";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Lithium chloride";s:5:"title";s:16:"Lithium chloride";s:3:"nid";s:5:"81451";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81452;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77728";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:38:"1,6-Octadiene, 3-methoxy-3,7-dimethyl-";s:5:"title";s:38:"1,6-Octadiene, 3-methoxy-3,7-dimethyl-";s:3:"nid";s:5:"81452";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81453;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77729";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Petroleum";s:5:"title";s:9:"Petroleum";s:3:"nid";s:5:"81453";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81454;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77730";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Polyhexamethylene biguanide";s:5:"title";s:27:"Polyhexamethylene biguanide";s:3:"nid";s:5:"81454";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81455;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77731";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Pilocarpine nitrate";s:5:"title";s:19:"Pilocarpine nitrate";s:3:"nid";s:5:"81455";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81456;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77732";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Molybdic(VI) acid";s:5:"title";s:17:"Molybdic(VI) acid";s:3:"nid";s:5:"81456";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81457;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77733";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Mercuric nitrate";s:5:"title";s:16:"Mercuric nitrate";s:3:"nid";s:5:"81457";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81458;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77734";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Mercurous nitrate";s:5:"title";s:17:"Mercurous nitrate";s:3:"nid";s:5:"81458";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81459;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77735";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:32:"Potassium tetraiodomercurate(II)";s:5:"title";s:32:"Potassium tetraiodomercurate(II)";s:3:"nid";s:5:"81459";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81460;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77736";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Mercuric thiocyanate";s:5:"title";s:20:"Mercuric thiocyanate";s:3:"nid";s:5:"81460";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81461;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"1010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:172:"An ester of Salicylic acid; Hydrolysis gives two natural products (salicylic acid and 2-butyl-1-octanol) but is not used as a source of any natural products; Used as an NMI";s:16:"field_legacy_nid";s:5:"77737";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Butyloctyl salicylate";s:5:"title";s:21:"Butyloctyl salicylate";s:3:"nid";s:5:"81461";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81462;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"6004";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77738";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Poloxalene";s:5:"title";s:10:"Poloxalene";s:3:"nid";s:5:"81462";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81463;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"6459";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77739";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Dyclonine hydrochloride";s:5:"title";s:23:"Dyclonine hydrochloride";s:3:"nid";s:5:"81463";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81464;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"7333";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77741";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"L-glucose";s:5:"title";s:9:"L-glucose";s:3:"nid";s:5:"81464";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81465;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"7141";s:25:"field_non_nhp_rationale_e";s:113:"Classified as a non-NHP because not a substance set out in Schedule 1 of the Natural Health Products Regulations.";s:25:"field_non_nhp_rationale_f";s:142:"Classifié comme non PSN parce que n'est pas une substance tel que stipulé dans l'Annexe 1 du Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:5:"77742";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:82:"Ethylenediamine/Hydrogenated Dimer Dilinoleate Copolymer Bis-Di-C14-18 Alkyl Amide";s:5:"title";s:82:"Ethylenediamine/Hydrogenated Dimer Dilinoleate Copolymer Bis-Di-C14-18 Alkyl Amide";s:3:"nid";s:5:"81465";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81466;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"9271";s:25:"field_non_nhp_rationale_e";s:113:"Classified as a non-NHP because not a substance set out in Schedule 1 of the Natural Health Products Regulations.";s:25:"field_non_nhp_rationale_f";s:142:"Classifié comme non PSN parce que n'est pas une substance tel que stipulé dans l'Annexe 1 du Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:5:"77745";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Polyethylene naphthalate";s:5:"title";s:24:"Polyethylene naphthalate";s:3:"nid";s:5:"81466";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81467;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"10601";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:130:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:5:"77746";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Fucoxanthinol";s:5:"title";s:13:"Fucoxanthinol";s:3:"nid";s:5:"81467";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81468;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"13010";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:130:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:5:"77748";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Trametinib";s:5:"title";s:10:"Trametinib";s:3:"nid";s:5:"81468";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81469;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"13446";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:130:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:5:"77750";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Olodaterol";s:5:"title";s:10:"Olodaterol";s:3:"nid";s:5:"81469";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81470;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"13461";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:130:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:5:"77751";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Regorafenib";s:5:"title";s:11:"Regorafenib";s:3:"nid";s:5:"81470";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81471;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"13441";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:130:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:5:"77752";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vilanterol";s:5:"title";s:10:"Vilanterol";s:3:"nid";s:5:"81471";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81472;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"13484";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:130:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:5:"77753";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Ulipristal Acetate";s:5:"title";s:18:"Ulipristal Acetate";s:3:"nid";s:5:"81472";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81473;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"13455";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77754";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pertuzumab";s:5:"title";s:10:"Pertuzumab";s:3:"nid";s:5:"81473";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81474;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"13457";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77755";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Brentuximab vedotin";s:5:"title";s:19:"Brentuximab vedotin";s:3:"nid";s:5:"81474";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81475;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"14210";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77759";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Triheptanoin";s:5:"title";s:12:"Triheptanoin";s:3:"nid";s:5:"81475";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";}i:81479;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:4:"7671";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76325";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:39:"Polyaminopropyl biguanide hydrochloride";s:5:"title";s:39:"Polyaminopropyl biguanide hydrochloride";s:3:"nid";s:5:"81479";s:7:"changed";s:10:"2013-12-20";s:14:"workflow_state";s:9:"Published";}i:81480;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"12355";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77756";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Nicotinoyl-GABA";s:5:"title";s:15:"Nicotinoyl-GABA";s:3:"nid";s:5:"81480";s:7:"changed";s:10:"2013-12-20";s:14:"workflow_state";s:9:"Published";}i:81481;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"13452";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77757";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Vortioxetine";s:5:"title";s:12:"Vortioxetine";s:3:"nid";s:5:"81481";s:7:"changed";s:10:"2013-12-20";s:14:"workflow_state";s:9:"Published";}i:81482;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"13448";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77758";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Dabrafenib";s:5:"title";s:10:"Dabrafenib";s:3:"nid";s:5:"81482";s:7:"changed";s:10:"2013-12-20";s:14:"workflow_state";s:9:"Published";}i:81483;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"14661";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"77760";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Denatured alcohol";s:5:"title";s:17:"Denatured alcohol";s:3:"nid";s:5:"81483";s:7:"changed";s:10:"2013-12-20";s:14:"workflow_state";s:9:"Published";}i:81484;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"15691";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:130:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:5:"77762";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Lauryl isoquinolinium bromide";s:20:"field_limitation_ref";s:4:"NHPD";s:5:"title";s:29:"Lauryl isoquinolinium bromide";s:3:"nid";s:5:"81484";s:7:"changed";s:10:"2013-12-20";s:14:"workflow_state";s:9:"Published";}i:81489;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:147:"A non-NHP because listed in the Prescription Drug List as follows: Collagenase when recommended for the debridement of severe burns and skin ulcers";s:25:"field_non_nhp_rationale_f";s:174:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Collagénase lorsque recommandée pour le débridement de brûlures graves et d'ulcères cutanés";s:16:"field_legacy_nid";s:6:"106169";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Collagenase";s:5:"title";s:11:"Collagenase";s:3:"nid";s:5:"81489";s:7:"changed";s:10:"2014-01-28";s:14:"workflow_state";s:9:"Published";}i:81490;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Sapropterin  or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Saproptérine ou ses sels";s:16:"field_legacy_nid";s:6:"106170";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Sapropterin";s:5:"title";s:11:"Sapropterin";s:3:"nid";s:5:"81490";s:7:"changed";s:10:"2014-01-28";s:14:"workflow_state";s:9:"Published";}i:81491;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Ranibizumab";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Ranibizumab";s:19:"field_old_rationale";s:592:"Ranibizunab, sold under the brand name Lucentis by Novartis Pharmaceuticals, is a recombinant, humanized monoclonal antibody fragment approved for the treatment of "wet" type age-related macular degeneration, which is a common form of age-related vision loss.  This drug acts by binding and inhibiting all subtypes of vascular endothelial growth factor A (VEGF-A) and it is administered only by intravitreal injections, meaning into the vitreous humour of the eye.  Since monoclonal antibodies are listed in Schedule D to the Food and Drugs Act , Ranibizunab will not be considered as an NHP.";s:16:"field_legacy_nid";s:5:"76543";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ranibizumab";s:5:"title";s:11:"Ranibizumab";s:3:"nid";s:5:"81491";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81492;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Polysulfated glycosaminoglycan";s:25:"field_non_nhp_rationale_f";s:108:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Glycosaminoglycan polysulfaté";s:16:"field_legacy_nid";s:5:"76546";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Polysulfated glycosaminoglycan";s:5:"title";s:30:"Polysulfated glycosaminoglycan";s:3:"nid";s:5:"81492";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81493;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Isotretinoin or its salts";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Isotrétinoïne ou ses sels";s:16:"field_legacy_nid";s:5:"76547";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Isotretinoin";s:5:"title";s:12:"Isotretinoin";s:3:"nid";s:5:"81493";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81494;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:84:"A non-NHP because listed in the Prescription Drug List as follows: Strontium bromide";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromure de strontium";s:16:"field_legacy_nid";s:5:"76548";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Strontium bromide";s:5:"title";s:17:"Strontium bromide";s:3:"nid";s:5:"81494";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81495;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:107:"A non-NHP because listed in the Prescription Drug List as follows: Eflornithine or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:114:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Éflornithine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"76549";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Eflornithine";s:5:"title";s:12:"Eflornithine";s:3:"nid";s:5:"81495";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81496;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:14:"304;8246;17412";s:25:"field_non_nhp_rationale_e";s:139:"As per the Prescription Drug List, Gold or its salts or derivatives, when sold for administration by injection, are classified as non-NHPs.";s:25:"field_non_nhp_rationale_f";s:166:"Selon la Liste des drogues sur ordonnance, l'Or ou ses sels ou dérivés, lorsqu’ils sont vendus pour administration par injection, sont classifiés comme non PSNs.";s:19:"field_old_rationale";s:273:"Amendment: Gold and its salts in Part I of Schedule F to the Regulations is replaced by the following: Gold and its salts and derivatives, when sold for administration by injection. Canada Gazette Part II: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/pdf/g2-14525.pdf.";s:16:"field_legacy_nid";s:5:"76550";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:4:"Gold";s:5:"title";s:4:"Gold";s:3:"nid";s:5:"81496";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81497;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Theophylline or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Théophylline ou ses sels";s:16:"field_legacy_nid";s:5:"76551";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Theophylline";s:5:"title";s:12:"Theophylline";s:3:"nid";s:5:"81497";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81498;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:104:"A non-NHP because listed in the Prescription Drug List as follows: Tretinoin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:113:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trétinoïne, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"76552";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Tretinoin";s:5:"title";s:9:"Tretinoin";s:3:"nid";s:5:"81498";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81499;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Oxytocin";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Oxytocine";s:16:"field_legacy_nid";s:5:"76553";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Oxytocin";s:5:"title";s:8:"Oxytocin";s:3:"nid";s:5:"81499";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81500;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Aminophylline";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aminophylline";s:16:"field_legacy_nid";s:5:"76554";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Aminophylline";s:5:"title";s:13:"Aminophylline";s:3:"nid";s:5:"81500";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81501;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Calcitonin";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Calcitonine";s:16:"field_legacy_nid";s:5:"76555";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Calcitonin";s:5:"title";s:10:"Calcitonin";s:3:"nid";s:5:"81501";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81502;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:82:"A non-NHP because listed in the Prescription Drug List as follows: Calcium bromide";s:25:"field_non_nhp_rationale_f";s:96:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromure de calcium";s:16:"field_legacy_nid";s:5:"76557";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Calcium bromide";s:5:"title";s:15:"Calcium bromide";s:3:"nid";s:5:"81502";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81503;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Somatropin";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Somatropine";s:16:"field_legacy_nid";s:5:"76558";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Somatropin";s:5:"title";s:10:"Somatropin";s:3:"nid";s:5:"81503";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81504;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:98:"A non-NHP because it is a sex hormone, where sex hormones are listed in the Prescription Drug List";s:25:"field_non_nhp_rationale_f";s:123:"Un non PSN parce qu'une hormone sexuelle, et les hormones sexuelles sont présentes sur la Liste des drogues sur ordonnance";s:16:"field_legacy_nid";s:5:"76560";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Progesterone";s:5:"title";s:12:"Progesterone";s:3:"nid";s:5:"81504";s:7:"changed";s:10:"2014-01-31";s:14:"workflow_state";s:9:"Published";}i:81505;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:189:"A non-NHP because listed in the Prescription Drug List as follows: Polymyxin B or its salts or derivatives, (except for topical use or for local action in the oral cavity or nasal passages)";s:25:"field_non_nhp_rationale_f";s:198:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Polymyxine B, ses sels ou dérivés, (sauf pour usage topique ou local dans la cavité buccale ou dans les voies nasales)";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76349";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Polymixin B sulfate";s:5:"title";s:19:"Polymixin B sulfate";s:3:"nid";s:5:"81505";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81506;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:14:"588;3213;17412";s:25:"field_non_nhp_rationale_e";s:141:"A non-NHP because listed in the Prescription Drug List as follows: Iodochlorohydroxyquin (except in preparations for topical use on the skin)";s:25:"field_non_nhp_rationale_f";s:198:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Polymyxine B, ses sels ou dérivés, (sauf pour usage topique ou local dans la cavité buccale ou dans les voies nasales)";s:19:"field_old_rationale";s:53:"As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76379";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Clioquinol";s:5:"title";s:10:"Clioquinol";s:3:"nid";s:5:"81506";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81507;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Aliskiren or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aliskirène ou ses sels";s:19:"field_old_rationale";s:774:"Aliskiren is an orally active nonpeptidic renin inhibitor made by Novartis. It was approved by the FDA in 2007 for the treatment of hypertension. The trade name for aliskiren hemifumarate (fumarate salt of Aliskiren) is Tekturna (USA), and Rasilez (UK). Aliskiren is a synthetic material (not natural) and will not be considered as a NHP, but a drug.                                                                                                                                   References:
[1] ChemID
[2] Gradman A. et al.  'Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients'. Circulation 111 (8), 2005, 1012-8
[3] www.fda.gov/cder/foi/label/2007/021985lbl.pdf";s:16:"field_legacy_nid";s:5:"76500";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Aliskiren";s:5:"title";s:9:"Aliskiren";s:3:"nid";s:5:"81507";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81508;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Edrophonium chloride";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Édrophonium (chlorure d’)";s:16:"field_legacy_nid";s:5:"76874";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Edrophonium chloride";s:5:"title";s:20:"Edrophonium chloride";s:3:"nid";s:5:"81508";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81509;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Efavirenz";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Éfavirenz";s:16:"field_legacy_nid";s:5:"76876";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Efavirenz";s:5:"title";s:9:"Efavirenz";s:3:"nid";s:5:"81509";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81510;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Eletriptan or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Élétriptan ou ses sels";s:16:"field_legacy_nid";s:5:"76877";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Eletriptan";s:5:"title";s:10:"Eletriptan";s:3:"nid";s:5:"81510";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81511;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Embutramide";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Embutramide";s:16:"field_legacy_nid";s:5:"76878";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Embutramide";s:5:"title";s:11:"Embutramide";s:3:"nid";s:5:"81511";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81512;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Emedastine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Émédastine ou ses sels";s:16:"field_legacy_nid";s:5:"76879";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Emedastine";s:5:"title";s:10:"Emedastine";s:3:"nid";s:5:"81512";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81513;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Emtricitabine";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Emtricitabine";s:16:"field_legacy_nid";s:5:"76880";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Emtricitabine";s:5:"title";s:13:"Emtricitabine";s:3:"nid";s:5:"81513";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81514;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Emylcamate";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Émylcamate";s:16:"field_legacy_nid";s:5:"76881";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Emylcamate";s:5:"title";s:10:"Emylcamate";s:3:"nid";s:5:"81514";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81515;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Enalaprilat or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Énalaprilate ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76882";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Enalaprilat";s:5:"title";s:11:"Enalaprilat";s:3:"nid";s:5:"81515";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81516;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Enflurane";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Enflurane";s:16:"field_legacy_nid";s:5:"76883";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Enflurane";s:5:"title";s:9:"Enflurane";s:3:"nid";s:5:"81516";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81517;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Enfuvirtide";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Enfuvirtide";s:16:"field_legacy_nid";s:5:"76884";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Enfuvirtide";s:5:"title";s:11:"Enfuvirtide";s:3:"nid";s:5:"81517";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81518;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Enoxaparin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Énoxaparine ou ses sels";s:16:"field_legacy_nid";s:5:"76885";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Enoxaparin";s:5:"title";s:10:"Enoxaparin";s:3:"nid";s:5:"81518";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81519;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Enrofloxacin";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Enrofloxacine";s:16:"field_legacy_nid";s:5:"76886";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Enrofloxacin";s:5:"title";s:12:"Enrofloxacin";s:3:"nid";s:5:"81519";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81520;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Entacapone";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Entacapone";s:16:"field_legacy_nid";s:5:"76887";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Entacapone";s:5:"title";s:10:"Entacapone";s:3:"nid";s:5:"81520";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81521;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Epsiprantel";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Epsiprantel";s:16:"field_legacy_nid";s:5:"76891";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Epsiprantel";s:5:"title";s:11:"Epsiprantel";s:3:"nid";s:5:"81521";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81522;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Eprosartan or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Éprosartan ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76890";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Eprosartan";s:5:"title";s:10:"Eprosartan";s:3:"nid";s:5:"81522";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81523;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Epoprostenol or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Époprosténol ou ses sels";s:16:"field_legacy_nid";s:5:"76889";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Epoprostenol";s:5:"title";s:12:"Epoprostenol";s:3:"nid";s:5:"81523";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81524;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Epirubicine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Épirubicine ou ses sels";s:16:"field_legacy_nid";s:5:"76888";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Epirubicine";s:5:"title";s:11:"Epirubicine";s:3:"nid";s:5:"81524";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81525;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Eptifibatide or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Eptifibatide ou ses sels";s:16:"field_legacy_nid";s:5:"76892";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Eptifibatide";s:5:"title";s:12:"Eptifibatide";s:3:"nid";s:5:"81525";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81526;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Ertapenem or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ertapénem ou ses sels";s:16:"field_legacy_nid";s:5:"76893";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ertapenem";s:5:"title";s:9:"Ertapenem";s:3:"nid";s:5:"81526";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81527;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:81:"A non-NHP because listed in the Prescription Drug List as follows: Erythropoietin";s:25:"field_non_nhp_rationale_f";s:95:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Érythropoiétine";s:16:"field_legacy_nid";s:5:"76894";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Erythropoietin";s:5:"title";s:14:"Erythropoietin";s:3:"nid";s:5:"81527";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81528;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Escitalopram or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Escitalopram ou ses sels";s:16:"field_legacy_nid";s:5:"76895";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Escitalopram";s:5:"title";s:12:"Escitalopram";s:3:"nid";s:5:"81528";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81529;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Estramustine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Estramustine ou ses sels";s:16:"field_legacy_nid";s:5:"76896";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Estramustine";s:5:"title";s:12:"Estramustine";s:3:"nid";s:5:"81529";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81530;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Etanercept";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Étanercept";s:16:"field_legacy_nid";s:5:"76897";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Etanercept";s:5:"title";s:10:"Etanercept";s:3:"nid";s:5:"81530";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81531;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:82:"A non-NHP because listed in the Prescription Drug List as follows: Ethacrynic acid";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Étacrynique (acide)";s:16:"field_legacy_nid";s:5:"76898";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Ethacrynic acid";s:5:"title";s:15:"Ethacrynic acid";s:3:"nid";s:5:"81531";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81532;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Ethambutol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Éthambutol ou ses sels";s:16:"field_legacy_nid";s:5:"76899";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ethambutol";s:5:"title";s:10:"Ethambutol";s:3:"nid";s:5:"81532";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81533;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Ethionamide or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Éthionamide ou ses sels";s:16:"field_legacy_nid";s:5:"76900";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ethionamide";s:5:"title";s:11:"Ethionamide";s:3:"nid";s:5:"81533";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81534;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:81:"A non-NHP because listed in the Prescription Drug List as follows: Poractant alfa";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Poractant alfa";s:16:"field_legacy_nid";s:5:"77195";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Poractant alfa";s:5:"title";s:14:"Poractant alfa";s:3:"nid";s:5:"81534";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81535;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Ethomoxane or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Éthomoxane ou ses sels";s:16:"field_legacy_nid";s:5:"76901";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ethomoxane";s:5:"title";s:10:"Ethomoxane";s:3:"nid";s:5:"81535";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81536;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Ethotoin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Éthotoine ou ses sels";s:16:"field_legacy_nid";s:5:"76902";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Ethotoin";s:5:"title";s:8:"Ethotoin";s:3:"nid";s:5:"81536";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81537;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Porfimer or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Porfimère ou ses sels";s:16:"field_legacy_nid";s:5:"77196";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Porfimer";s:5:"title";s:8:"Porfimer";s:3:"nid";s:5:"81537";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81538;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:148:"A non-NHP because listed in the Prescription Drug List as follows: Potassium para-aminobenzoate (except in preparations for topical use on the skin)";s:25:"field_non_nhp_rationale_f";s:172:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Potassium (para-aminobenzoate de) (sauf dans les préparations pour usage topique sur la peau)";s:16:"field_legacy_nid";s:5:"77197";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Potassium para-aminobenzoate";s:5:"title";s:28:"Potassium para-aminobenzoate";s:3:"nid";s:5:"81538";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81539;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Levodopa or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lévodopa ou ses sels";s:16:"field_legacy_nid";s:5:"76562";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Levodopa";s:5:"title";s:8:"Levodopa";s:3:"nid";s:5:"81539";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81540;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Pralidoxime or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pralidoxime ou ses sels";s:16:"field_legacy_nid";s:5:"77198";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pralidoxime";s:5:"title";s:11:"Pralidoxime";s:3:"nid";s:5:"81540";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81541;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:94:"A non-NHP because listed in the Prescription Drug List as follows: Etidronic acid or its salts";s:25:"field_non_nhp_rationale_f";s:110:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Étidronique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"76903";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Etidronic acid";s:5:"title";s:14:"Etidronic acid";s:3:"nid";s:5:"81541";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81542;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because listed in the Prescription Drug List as follows: Ursodeoxycholic acid or its salts";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ursodéoxycholique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"76568";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Ursodiol";s:5:"title";s:8:"Ursodiol";s:3:"nid";s:5:"81542";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81543;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Pramipexole or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pramipexole ou ses sels";s:16:"field_legacy_nid";s:5:"77199";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pramipexole";s:5:"title";s:11:"Pramipexole";s:3:"nid";s:5:"81543";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81544;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Etodolac or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Étodolac ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76904";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Etodolac";s:5:"title";s:8:"Etodolac";s:3:"nid";s:5:"81544";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81545;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:96:"A non-NHP because listed in the Prescription Drug List as follows: Etoposide and its derivatives";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Étoposide et ses dérivés";s:16:"field_legacy_nid";s:5:"76905";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Etoposide";s:5:"title";s:9:"Etoposide";s:3:"nid";s:5:"81545";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81546;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Pravastatin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pravastatine ou ses sels";s:16:"field_legacy_nid";s:5:"77200";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pravastatin";s:5:"title";s:11:"Pravastatin";s:3:"nid";s:5:"81546";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81547;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:166:"A non-NHP because listed in the Prescription Drug List as follows: Praziquantel, except when sold for the treatment of the tapeworm Anoplocephala perfoliata in horses";s:25:"field_non_nhp_rationale_f";s:189:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Praziquantel, sauf s'il est vendu pour le traitement du ver solitaire Anoplocephala perfoliata chez les chevaux";s:16:"field_legacy_nid";s:5:"77201";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Praziquantel";s:5:"title";s:12:"Praziquantel";s:3:"nid";s:5:"81547";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81548;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Etymemazine or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Étymémazine ou ses sels";s:16:"field_legacy_nid";s:5:"76906";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Etymemazine";s:5:"title";s:11:"Etymemazine";s:3:"nid";s:5:"81548";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81549;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Exemestane";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Exémestane";s:16:"field_legacy_nid";s:5:"76907";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Exemestane";s:5:"title";s:10:"Exemestane";s:3:"nid";s:5:"81549";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81550;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Prazosin or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Prazosine ou ses sels";s:16:"field_legacy_nid";s:5:"77202";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Prazosin";s:5:"title";s:8:"Prazosin";s:3:"nid";s:5:"81550";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81551;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Lithium or its salts";s:25:"field_non_nhp_rationale_f";s:97:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lithium ou ses sels";s:16:"field_legacy_nid";s:5:"76569";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Lithium";s:5:"title";s:7:"Lithium";s:3:"nid";s:5:"81551";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81552;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Prenylamine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Prénylamine ou ses sels";s:16:"field_legacy_nid";s:5:"77203";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Prenylamine";s:5:"title";s:11:"Prenylamine";s:3:"nid";s:5:"81552";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81553;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Primaquine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Primaquine ou ses sels";s:16:"field_legacy_nid";s:5:"77204";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Primaquine";s:5:"title";s:10:"Primaquine";s:3:"nid";s:5:"81553";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81554;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Ezetimibe";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ézétimibe";s:16:"field_legacy_nid";s:5:"76908";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ezetimibe";s:5:"title";s:9:"Ezetimibe";s:3:"nid";s:5:"81554";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81555;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Famciclovir or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Famciclovir ou ses sels";s:16:"field_legacy_nid";s:5:"76909";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Famciclovir";s:5:"title";s:11:"Famciclovir";s:3:"nid";s:5:"81555";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81556;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Probenecid or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Probénécide ou ses sels";s:16:"field_legacy_nid";s:5:"77205";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Probenecid";s:5:"title";s:10:"Probenecid";s:3:"nid";s:5:"81556";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81557;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Probucol";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Probucol";s:16:"field_legacy_nid";s:5:"77206";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Probucol";s:5:"title";s:8:"Probucol";s:3:"nid";s:5:"81557";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81558;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Felodipine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Félodipine ou ses sels";s:16:"field_legacy_nid";s:5:"76910";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Felodipine";s:5:"title";s:10:"Felodipine";s:3:"nid";s:5:"81558";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81559;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:98:"A non-NHP because it is a sex hormone, where sex hormones are listed in the Prescription Drug List";s:25:"field_non_nhp_rationale_f";s:123:"Un non PSN parce qu'une hormone sexuelle, et les hormones sexuelles sont présentes sur la Liste des drogues sur ordonnance";s:19:"field_old_rationale";s:562:"Pregnenolone, like DHEA, is a steroidal hormone manufactured in the body. Pregnenolone is a precursor hormone synthesized from cholesterol, principally in the adrenal glands, but also in the liver, skin, brain, testicles, ovaries, and retina of the eyes. Pregnenolone is considered as the grand precursor for almost all of the other steroid hormones including DHEA, progesterone, testosterone, the estrogens, and cortisol. Since pregnenolone is included in the sex hormones of the Schedule F to the Food and Drug Regulations, it is considered as a drug, not NHP.";s:16:"field_legacy_nid";s:5:"76570";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Pregnenolone";s:5:"title";s:12:"Pregnenolone";s:3:"nid";s:5:"81559";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81560;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Procainamide or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Procainamide ou ses sels";s:16:"field_legacy_nid";s:5:"77207";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Procainamide";s:5:"title";s:12:"Procainamide";s:3:"nid";s:5:"81560";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81561;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Fenoprofen or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fénoprofène ou ses sels";s:16:"field_legacy_nid";s:5:"76911";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Fenoprofen";s:5:"title";s:10:"Fenoprofen";s:3:"nid";s:5:"81561";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81562;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Fenoterol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fénotérol ou ses sels";s:16:"field_legacy_nid";s:5:"76912";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Fenoterol";s:5:"title";s:9:"Fenoterol";s:3:"nid";s:5:"81562";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81563;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:81:"A non-NHP because listed in the Prescription Drug List as follows: L-Asparaginase";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : L-Asparaginase";s:16:"field_legacy_nid";s:5:"76571";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Asparaginase";s:5:"title";s:12:"Asparaginase";s:3:"nid";s:5:"81563";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81564;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:81:"A non-NHP because listed in the Prescription Drug List as follows: Sodium bromide";s:25:"field_non_nhp_rationale_f";s:95:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromure de sodium";s:16:"field_legacy_nid";s:5:"76572";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Sodium bromide";s:5:"title";s:14:"Sodium bromide";s:3:"nid";s:5:"81564";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81565;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Finasteride";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Finastéride";s:16:"field_legacy_nid";s:5:"76913";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Finasteride";s:5:"title";s:11:"Finasteride";s:3:"nid";s:5:"81565";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81566;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Procarbazine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Procarbazine ou ses sels";s:16:"field_legacy_nid";s:5:"77208";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Procarbazine";s:5:"title";s:12:"Procarbazine";s:3:"nid";s:5:"81566";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81567;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Flavoxate or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Flavoxate ou ses sels";s:16:"field_legacy_nid";s:5:"76914";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Flavoxate";s:5:"title";s:9:"Flavoxate";s:3:"nid";s:5:"81567";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81568;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Flecainide or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Flécaïnide ou ses sels";s:16:"field_legacy_nid";s:5:"76915";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Flecainide";s:5:"title";s:10:"Flecainide";s:3:"nid";s:5:"81568";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81569;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Fleroxacin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fleroxacin ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76916";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Fleroxacin";s:5:"title";s:10:"Fleroxacin";s:3:"nid";s:5:"81569";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81570;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Procaterol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Procatérol ou ses sels";s:16:"field_legacy_nid";s:5:"77209";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Procaterol";s:5:"title";s:10:"Procaterol";s:3:"nid";s:5:"81570";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81571;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Floctafenine";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Floctafénine";s:16:"field_legacy_nid";s:5:"76917";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Floctafenine";s:5:"title";s:12:"Floctafenine";s:3:"nid";s:5:"81571";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81572;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:96:"A non-NHP because listed in the Prescription Drug List as follows: Prochlorperazine or its salts";s:25:"field_non_nhp_rationale_f";s:107:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Prochlorpérazine ou ses sels";s:16:"field_legacy_nid";s:5:"77210";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Prochlorperazine";s:5:"title";s:16:"Prochlorperazine";s:3:"nid";s:5:"81572";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81573;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:98:"A non-NHP because listed in the Prescription Drug List as follows: Florfenicol and its derivatives";s:25:"field_non_nhp_rationale_f";s:107:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Florfénicol et ses dérivés";s:16:"field_legacy_nid";s:5:"76918";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Florfenicol";s:5:"title";s:11:"Florfenicol";s:3:"nid";s:5:"81573";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81574;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:105:"A non-NHP because listed in the Prescription Drug List as follows: Gabapentin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Gabapentin, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"76575";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Gabapentin";s:5:"title";s:10:"Gabapentin";s:3:"nid";s:5:"81574";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81575;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Procyclidine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Procyclidine ou ses sels";s:16:"field_legacy_nid";s:5:"77211";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Procyclidine";s:5:"title";s:12:"Procyclidine";s:3:"nid";s:5:"81575";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81576;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Flucytosine";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Flucytosine";s:16:"field_legacy_nid";s:5:"76919";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Flucytosine";s:5:"title";s:11:"Flucytosine";s:3:"nid";s:5:"81576";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81577;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Fludarabine or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fludarabine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76920";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Fludarabine";s:5:"title";s:11:"Fludarabine";s:3:"nid";s:5:"81577";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81578;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Prodilidine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Prodilidine ou ses sels";s:16:"field_legacy_nid";s:5:"77212";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Prodilidine";s:5:"title";s:11:"Prodilidine";s:3:"nid";s:5:"81578";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81579;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:14:"304;8247;17412";s:25:"field_non_nhp_rationale_e";s:122:"As per the Prescription Drug List, Uracil or its salts, when sold for the treatment of cancer, are classified as non-NHPs.";s:25:"field_non_nhp_rationale_f";s:153:"Selon la Liste des drogues sur ordonnance, l'Uracile ou ses sels, lorsqu’ils sont vendus pour le traitement du cancer, sont classifiès comme non PSNs.";s:19:"field_old_rationale";s:257:"Amendment: Uracil and its salts in Part I of Schedule F to the Regulations is replaced by the following: Uracil and its salts, when sold for the treatment of cancer. Canada Gazette Part II: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/pdf/g2-14525.pdf.";s:16:"field_legacy_nid";s:5:"76576";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Uracil";s:5:"title";s:6:"Uracil";s:3:"nid";s:5:"81579";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81580;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Flunarizine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Flunarizine ou ses sels";s:16:"field_legacy_nid";s:5:"76921";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Flunarizine";s:5:"title";s:11:"Flunarizine";s:3:"nid";s:5:"81580";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81581;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Flunixin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Flunixine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76922";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Flunixin";s:5:"title";s:8:"Flunixin";s:3:"nid";s:5:"81581";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81582;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:135:"A non-NHP because listed in the Prescription Drug List as follows: Chlorhexidine or its salts, when used as a topical oral preparation.";s:25:"field_non_nhp_rationale_f";s:152:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chlorhexidine ou ses sels, dans les préparations pour usage oral topique.";s:16:"field_legacy_nid";s:5:"76574";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Chlorhexidine gluconate";s:5:"title";s:23:"Chlorhexidine gluconate";s:3:"nid";s:5:"81582";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81583;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because listed in the Prescription Drug List as follows: Fluorouracil and its derivatives";s:25:"field_non_nhp_rationale_f";s:108:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fluorouracile et ses dérivés";s:16:"field_legacy_nid";s:5:"76923";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Fluorouracil";s:5:"title";s:12:"Fluorouracil";s:3:"nid";s:5:"81583";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81584;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Profenamine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Profénamine ou ses sels";s:16:"field_legacy_nid";s:5:"77213";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Profenamine";s:5:"title";s:11:"Profenamine";s:3:"nid";s:5:"81584";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81585;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Fluoxetine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fluoxétine ou ses sels";s:16:"field_legacy_nid";s:5:"76924";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Fluoxetine";s:5:"title";s:10:"Fluoxetine";s:3:"nid";s:5:"81585";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81586;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:84:"A non-NHP because listed in the Prescription Drug List as follows: Potassium bromide";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromure de potassium";s:16:"field_legacy_nid";s:5:"76577";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Potassium bromide";s:5:"title";s:17:"Potassium bromide";s:3:"nid";s:5:"81586";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81587;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Proguanil or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Proguanil ou ses sels";s:16:"field_legacy_nid";s:5:"77214";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Proguanil";s:5:"title";s:9:"Proguanil";s:3:"nid";s:5:"81587";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81588;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Propafenone or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Propafénone ou ses sels";s:16:"field_legacy_nid";s:5:"77215";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Propafenone";s:5:"title";s:11:"Propafenone";s:3:"nid";s:5:"81588";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81589;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Xanthinol nicotinate";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Xantinol (nicotinate de)";s:16:"field_legacy_nid";s:5:"76578";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Xanthinol niacinate";s:5:"title";s:19:"Xanthinol niacinate";s:3:"nid";s:5:"81589";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81590;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Propofol";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Propofol";s:16:"field_legacy_nid";s:5:"77216";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Propofol";s:5:"title";s:8:"Propofol";s:3:"nid";s:5:"81590";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81591;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:104:"A non-NHP because listed in the Prescription Drug List as follows: Acitretin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:112:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acitrétine, ses sels ou dérivés";s:19:"field_old_rationale";s:410:"Acitretin is a second generation retinoid, mainly used orally as a antipsoriatic.  This synthetically prepared chemical is the free acid form and major metabolite of Etretinate.  This chemical is also known to be teratogenic, since women patients using this drug must avoid becoming pregnant for at least 3 years after discontinuing Acitretin. Acitretin is listed on Schedule F to the Food and Drug Regulations";s:16:"field_legacy_nid";s:5:"76579";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Acitretin";s:5:"title";s:9:"Acitretin";s:3:"nid";s:5:"81591";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81592;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Propranolol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Propranolol ou ses sels";s:16:"field_legacy_nid";s:5:"77217";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Propranolol";s:5:"title";s:11:"Propranolol";s:3:"nid";s:5:"81592";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81593;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:114:"A non-NHP because listed in the Prescription Drug List as follows: Prostaglandins or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:122:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Prostaglandines ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77218";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Prostaglandins";s:5:"title";s:14:"Prostaglandins";s:3:"nid";s:5:"81593";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81594;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Etretinate";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Étrétinate";s:19:"field_old_rationale";s:483:"Etretinate is the aromatic analog of retinoic acid, which just like its free acid derivative acitretin, has been used for the treatment of severe psoriasis.  However, unlike its cousin, this chemical was removed from the market (1998 and 1996 in US and Canada respectively) because of high risk of birth defects,  as it was not recommended at all for women who planned to become pregnant.  Since etretinate is listed in Schedule F, etretinate will be considered as a Schedule F drug.";s:16:"field_legacy_nid";s:5:"76580";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Etretinate";s:5:"title";s:10:"Etretinate";s:3:"nid";s:5:"81594";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81595;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Prothipendyl hydrochloride";s:25:"field_non_nhp_rationale_f";s:108:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Prothipendyl (chlorhydrate de)";s:16:"field_legacy_nid";s:5:"77219";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Prothipendyl hydrochloride";s:5:"title";s:26:"Prothipendyl hydrochloride";s:3:"nid";s:5:"81595";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81596;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Protirelin";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Protireline";s:16:"field_legacy_nid";s:5:"77220";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Protirelin";s:5:"title";s:10:"Protirelin";s:3:"nid";s:5:"81596";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81597;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Protriptyline or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Protriptyline ou ses sels";s:16:"field_legacy_nid";s:5:"77221";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Protriptyline";s:5:"title";s:13:"Protriptyline";s:3:"nid";s:5:"81597";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81598;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Pyrazinamide";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pyrazinamide";s:16:"field_legacy_nid";s:5:"77222";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Pyrazinamide";s:5:"title";s:12:"Pyrazinamide";s:3:"nid";s:5:"81598";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81599;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Pyridostigmine bromide";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pyridostigmine (bromure de)";s:16:"field_legacy_nid";s:5:"77223";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Pyridostigmine bromide";s:5:"title";s:22:"Pyridostigmine bromide";s:3:"nid";s:5:"81599";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81600;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Pyrimethamine or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pyriméthamine ou ses sels";s:16:"field_legacy_nid";s:5:"77224";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Pyrimethamine";s:5:"title";s:13:"Pyrimethamine";s:3:"nid";s:5:"81600";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81601;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Quetiapine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Quétiapine ou ses sels";s:16:"field_legacy_nid";s:5:"77225";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Quetiapine";s:5:"title";s:10:"Quetiapine";s:3:"nid";s:5:"81601";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81602;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Quinagolide or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Quinagolide ou ses sels";s:16:"field_legacy_nid";s:5:"77226";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Quinagolide";s:5:"title";s:11:"Quinagolide";s:3:"nid";s:5:"81602";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81603;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Calcipotriol";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Calcipotriol";s:19:"field_old_rationale";s:337:"Calcipotriol is a vitamin D3  analog mostly used in  topical medications against "plaque-type" psoriasis.  This synthetically prepared product is sold under the tradenames Dovonex, Daivonex or Psorcutan.  Since Calcipotriol is currently listed in Schedule F to the Food and Drugs Regulations, it will be considered as such, not as a NHP.";s:16:"field_legacy_nid";s:5:"76581";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Calcipotriene";s:5:"title";s:13:"Calcipotriene";s:3:"nid";s:5:"81603";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81604;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Quinapril or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Quinapril ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77227";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Quinapril";s:5:"title";s:9:"Quinapril";s:3:"nid";s:5:"81604";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81605;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:94:"A non-NHP because listed in the Prescription Drug List as follows: Piperacetazine or its salts";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pipéracétazine ou ses sels";s:16:"field_legacy_nid";s:5:"76582";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Piperacetazine";s:5:"title";s:14:"Piperacetazine";s:3:"nid";s:5:"81605";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81606;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Quinupristin or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Quinupristine ou ses sels";s:16:"field_legacy_nid";s:5:"77228";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Quinupristin";s:5:"title";s:12:"Quinupristin";s:3:"nid";s:5:"81606";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81607;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Rabeprazole or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rabéprazole ou ses sels";s:16:"field_legacy_nid";s:5:"77229";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Rabeprazole";s:5:"title";s:11:"Rabeprazole";s:3:"nid";s:5:"81607";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81608;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Raloxifene or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Raloxifene ou ses sels";s:16:"field_legacy_nid";s:5:"77230";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Raloxifene";s:5:"title";s:10:"Raloxifene";s:3:"nid";s:5:"81608";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81609;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Folinic acid or its salts";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acide folinique ou ses sels";s:19:"field_old_rationale";s:731:"Folinic acid (also known as Leucovorin), which is usually administered as its calcium salt Calcium folinate (of Leucovorin calcium), is an intermediate product in the metabolism of Folic acid; where Folinic acid is known to be the active form of Folic acid.  Folinic acid has been used as an adjuvant in cancer chemotherapy with the drug Methotrexate; as well as synergistically with the chemotherapy drug 5-Fluorouracil, being an antidote to Folic acid antagonists and used as an antianemic (in folate deficiency). Despite the fact that Folinic acid is a naturally occurring compound, it will be considered as a Schedule F drug, since Folinic acid and its salts are currently listed in Schedule F to the Food and Drug Regulations.";s:16:"field_legacy_nid";s:5:"76583";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Folinic acid";s:5:"title";s:12:"Folinic acid";s:3:"nid";s:5:"81609";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81610;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Raltitrexed or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Raltitrexed ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77231";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Raltitrexed";s:5:"title";s:11:"Raltitrexed";s:3:"nid";s:5:"81610";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81611;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Ramipril or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:115:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ramipril ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77232";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Ramipril";s:5:"title";s:8:"Ramipril";s:3:"nid";s:5:"81611";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81612;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Rasburicase";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rasburicase";s:16:"field_legacy_nid";s:5:"77233";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Rasburicase";s:5:"title";s:11:"Rasburicase";s:3:"nid";s:5:"81612";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81613;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Botulinum Toxin Type A";s:25:"field_non_nhp_rationale_f";s:108:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Antitoxine botulinique, type A";s:19:"field_old_rationale";s:337:"Botulinum toxins are neurotoxic proteins produced by the bacterium Clostridium botulinum.  These are known to be one of the most toxic naturally occurring substances in the world.  Botulinum toxin, Type A is currently listed in the Schedule F to the Food and Drug Regulations; therefore, it will be considered as such, a Schedule F drug.";s:16:"field_legacy_nid";s:5:"76584";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Botulinum toxin type A";s:5:"title";s:22:"Botulinum toxin type A";s:3:"nid";s:5:"81613";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81614;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Raubasine or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Raubasine ou ses sels";s:16:"field_legacy_nid";s:5:"77234";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Raubasine";s:5:"title";s:9:"Raubasine";s:3:"nid";s:5:"81614";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81615;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Diclofenac or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Diclofénac ou ses sels";s:19:"field_old_rationale";s:658:"Diclofenac is a non-steroidal anti-inflammatory drug, more commonly known as NSAID), used to reduce inflammation and as an analgesic reducing pain in conditions related to arthritis, acute injury, kidney stones, menstrual pain, etc...  This well-tolerated drug is generally sold as its sodium or potassium salt, under several brandnames (e.g. Voltaren®, Voltarol®, Diclon®, Dicloflex® Difen, Difene, Cataflam®, Rhumalgan® and Abitren) and in several countries, both under prescription and OTC.  Currently, this synthetically prepared drug is listed in Schedule F to the Food and Drugs Regulations, therefore, it will be considered as a Schedule F drug.";s:16:"field_legacy_nid";s:5:"76585";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Diclofenac";s:5:"title";s:10:"Diclofenac";s:3:"nid";s:5:"81615";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81616;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Methoxsalen";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthoxsalène";s:19:"field_old_rationale";s:561:"Methoxsalen (sold under the trade name Oxsoralen) is a compound used with UV light in treatment of psoriasis and other skin disorders.  It has also antiinflammatory and antifungal properties; as well as being radioprotectant and a photosensitiser.  This chemical is a naturally occurring substance, which has been isolated from many plants, such as Psoralea corylifolia, Cnidium dubium, Evodia hupehensis and Ruta graveolens.  However, since Methoxsalen is listed in Schedule F to the Food and Drug Regulations, it will be considered as such, a Schedule F drug.";s:16:"field_legacy_nid";s:5:"76586";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Methoxsalen";s:5:"title";s:11:"Methoxsalen";s:3:"nid";s:5:"81616";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81617;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Remoxipride or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rémoxipride ou ses sels";s:16:"field_legacy_nid";s:5:"77235";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Remoxipride";s:5:"title";s:11:"Remoxipride";s:3:"nid";s:5:"81617";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81618;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Clenbuterol or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Clenbutérol ou ses sels";s:19:"field_old_rationale";s:561:"Clenbuterol is a substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. Clenbuterol is a drug prescribed to sufferers of breathing disorders as a decongestant and bronchodilator. Clenbuterol is a synthetic material (not natural) and will not be considered as a NHP, but a drug. Clenbuterol and its salts are also listed under Schedule F ingredients.                                                                                                                                    References:
[1] The Merck Index
[2] ChemID";s:16:"field_legacy_nid";s:5:"76587";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Clenbuterol";s:5:"title";s:11:"Clenbuterol";s:3:"nid";s:5:"81618";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81619;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Repaglinide or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Répaglinide ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77236";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Repaglinide";s:5:"title";s:11:"Repaglinide";s:3:"nid";s:5:"81619";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81620;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Rescinnamine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rescinnamine ou ses sels";s:16:"field_legacy_nid";s:5:"77237";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Rescinnamine";s:5:"title";s:12:"Rescinnamine";s:3:"nid";s:5:"81620";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81621;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Resocortol and its derivatives";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Résocortol et ses dérivés";s:16:"field_legacy_nid";s:5:"77238";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Resocortol";s:5:"title";s:10:"Resocortol";s:3:"nid";s:5:"81621";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81622;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Ribavirin";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ribavirine";s:16:"field_legacy_nid";s:5:"77239";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ribavirin";s:5:"title";s:9:"Ribavirin";s:3:"nid";s:5:"81622";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81623;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Rifabutin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rifabutine ou ses sels";s:16:"field_legacy_nid";s:5:"77240";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Rifabutin";s:5:"title";s:9:"Rifabutin";s:3:"nid";s:5:"81623";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81624;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Rifampin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rifampine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77241";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Rifampin";s:5:"title";s:8:"Rifampin";s:3:"nid";s:5:"81624";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81625;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Fenfluramine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fenfluramine ou ses sels";s:19:"field_old_rationale";s:490:"Fenfluramine is the racemic mixture of two enantiomers, dexfenfluramine and levofenfluramine.  A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release [1].  Fenfluramine is a synthetic material.  Since Fenfluramine and its salts are listed under Schedule F ingredients, it will not be considered as a NHP, but a drug.                                                                      References:
[1] ChemID
[2] Merck index";s:16:"field_legacy_nid";s:5:"76588";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Fenfluramine";s:5:"title";s:12:"Fenfluramine";s:3:"nid";s:5:"81625";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81626;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Riluzole or its salts";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Riluzole ou ses sels";s:16:"field_legacy_nid";s:5:"77242";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Riluzole";s:5:"title";s:8:"Riluzole";s:3:"nid";s:5:"81626";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81627;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"832;17412";s:25:"field_non_nhp_rationale_e";s:95:"As per the Prescription Drug List, Vitamin K is not allowed orally as an NHP above 0.12 mg/day.";s:25:"field_non_nhp_rationale_f";s:138:"Comme indiqué sur la Liste des drogues sur ordonnance, la Vitamine K n'est pas permise par voie orale comme PSN au-delà de 0.12 mg/jour.";s:16:"field_legacy_nid";s:5:"76596";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vitamin K1";s:5:"title";s:10:"Vitamin K1";s:3:"nid";s:5:"81627";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81628;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"As per the Prescription Drug List, Vitamin K is not allowed orally as an NHP above 0.12 mg/day.";s:25:"field_non_nhp_rationale_f";s:138:"Comme indiqué sur la Liste des drogues sur ordonnance, la Vitamine K n'est pas permise par voie orale comme PSN au-delà de 0.12 mg/jour.";s:16:"field_legacy_nid";s:5:"76597";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vitamin K2";s:5:"title";s:10:"Vitamin K2";s:3:"nid";s:5:"81628";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81629;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:102:"A non-NHP because listed in the Prescription Drug List as follows: Abacavir and its derivatives(salts)";s:25:"field_non_nhp_rationale_f";s:97:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Abacavir ou ses sels";s:16:"field_legacy_nid";s:5:"76603";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Abacavir";s:5:"title";s:8:"Abacavir";s:3:"nid";s:5:"81629";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81630;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Risedronic acid or its salts";s:25:"field_non_nhp_rationale_f";s:109:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acide risédronique ou ses sels";s:16:"field_legacy_nid";s:5:"77243";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Risedronic acid";s:5:"title";s:15:"Risedronic acid";s:3:"nid";s:5:"81630";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81631;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Abciximab";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Abciximab";s:16:"field_legacy_nid";s:5:"76608";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Abciximab";s:5:"title";s:9:"Abciximab";s:3:"nid";s:5:"81631";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81632;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Risperidone or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rispéridone ou ses sels";s:16:"field_legacy_nid";s:5:"77244";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Risperidone";s:5:"title";s:11:"Risperidone";s:3:"nid";s:5:"81632";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81633;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Acarbose and its derivatives";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acarbose et ses dérivés";s:16:"field_legacy_nid";s:5:"76609";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Acarbose";s:5:"title";s:8:"Acarbose";s:3:"nid";s:5:"81633";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81634;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Ritodrine or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ritodrine ou ses sels";s:16:"field_legacy_nid";s:5:"77245";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ritodrine";s:5:"title";s:9:"Ritodrine";s:3:"nid";s:5:"81634";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81635;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Ritonavir";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ritonavir";s:16:"field_legacy_nid";s:5:"77246";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ritonavir";s:5:"title";s:9:"Ritonavir";s:3:"nid";s:5:"81635";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81636;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Rituximab";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rituximab";s:16:"field_legacy_nid";s:5:"77247";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Rituximab";s:5:"title";s:9:"Rituximab";s:3:"nid";s:5:"81636";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81637;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Acebutolol and its derivatives";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acébutolol ou ses sels";s:16:"field_legacy_nid";s:5:"76610";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Acebutolol";s:5:"title";s:10:"Acebutolol";s:3:"nid";s:5:"81637";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81638;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Rivastigmine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rivastigmine ou ses sels";s:16:"field_legacy_nid";s:5:"77248";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Rivastigmine";s:5:"title";s:12:"Rivastigmine";s:3:"nid";s:5:"81638";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81639;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Rizatriptan or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rizatriptan ou ses sels";s:16:"field_legacy_nid";s:5:"77249";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Rizatriptan";s:5:"title";s:11:"Rizatriptan";s:3:"nid";s:5:"81639";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81640;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:85:"A non-NHP because listed in the Prescription Drug List as follows: Rocuronium bromide";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rocuronium (bromure de)";s:16:"field_legacy_nid";s:5:"77250";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Rocuronium bromide";s:5:"title";s:18:"Rocuronium bromide";s:3:"nid";s:5:"81640";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81641;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Rofecoxib";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rofécoxib";s:16:"field_legacy_nid";s:5:"77251";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Rofecoxib";s:5:"title";s:9:"Rofecoxib";s:3:"nid";s:5:"81641";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81642;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Romifidine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Romifidine ou ses sels";s:16:"field_legacy_nid";s:5:"77252";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Romifidine";s:5:"title";s:10:"Romifidine";s:3:"nid";s:5:"81642";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81643;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Ropinirole or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ropinirole ou ses sels";s:16:"field_legacy_nid";s:5:"77253";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ropinirole";s:5:"title";s:10:"Ropinirole";s:3:"nid";s:5:"81643";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81644;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Rosiglitazone or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rosiglitazone ou ses sels";s:16:"field_legacy_nid";s:5:"77254";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Rosiglitazone";s:5:"title";s:13:"Rosiglitazone";s:3:"nid";s:5:"81644";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81645;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Rosoxacin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rosoxacine ou ses sels";s:16:"field_legacy_nid";s:5:"77255";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Rosoxacin";s:5:"title";s:9:"Rosoxacin";s:3:"nid";s:5:"81645";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81646;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Rosuvastatin or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Rosuvastatine ou ses sels";s:16:"field_legacy_nid";s:5:"77256";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Rosuvastatin";s:5:"title";s:12:"Rosuvastatin";s:3:"nid";s:5:"81646";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81647;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Salbutamol or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Salbutamol ou ses sels";s:16:"field_legacy_nid";s:5:"77257";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Salbutamol";s:5:"title";s:10:"Salbutamol";s:3:"nid";s:5:"81647";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81648;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Salmeterol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Salmetérol ou ses sels";s:16:"field_legacy_nid";s:5:"77258";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Salmeterol";s:5:"title";s:10:"Salmeterol";s:3:"nid";s:5:"81648";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81649;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Salsalate or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Salsalate ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77259";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Salsalate";s:5:"title";s:9:"Salsalate";s:3:"nid";s:5:"81649";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81650;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Saquinavir or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Saquinavir ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77260";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Saquinavir";s:5:"title";s:10:"Saquinavir";s:3:"nid";s:5:"81650";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81651;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Sargramostim";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sargramostim";s:16:"field_legacy_nid";s:5:"77262";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Sargramostim";s:5:"title";s:12:"Sargramostim";s:3:"nid";s:5:"81651";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81652;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Selegiline or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sélégiline ou ses sels";s:16:"field_legacy_nid";s:5:"77263";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Selegiline";s:5:"title";s:10:"Selegiline";s:3:"nid";s:5:"81652";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81653;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Sermorelin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sermoréline ou ses sels";s:16:"field_legacy_nid";s:5:"77264";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Sermorelin";s:5:"title";s:10:"Sermorelin";s:3:"nid";s:5:"81653";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81654;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Sertraline or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sertraline ou ses sels";s:16:"field_legacy_nid";s:5:"77265";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Sertraline";s:5:"title";s:10:"Sertraline";s:3:"nid";s:5:"81654";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81655;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Sevelamer or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sévélamer ou ses sels";s:16:"field_legacy_nid";s:5:"77266";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Sevelamer";s:5:"title";s:9:"Sevelamer";s:3:"nid";s:5:"81655";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81656;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Sibutramine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sibutramine ou ses sels";s:16:"field_legacy_nid";s:5:"77267";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Sibutramine";s:5:"title";s:11:"Sibutramine";s:3:"nid";s:5:"81656";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81657;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Acetazolamide";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acétazolamide";s:16:"field_legacy_nid";s:5:"76611";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Acetazolamide";s:5:"title";s:13:"Acetazolamide";s:3:"nid";s:5:"81657";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81658;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Sildenafil or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sildénafil ou ses sels";s:16:"field_legacy_nid";s:5:"77268";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Sildenafil";s:5:"title";s:10:"Sildenafil";s:3:"nid";s:5:"81658";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81659;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Simvastatin";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Simvastatine";s:16:"field_legacy_nid";s:5:"77269";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Simvastatin";s:5:"title";s:11:"Simvastatin";s:3:"nid";s:5:"81659";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81660;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:96:"A non-NHP because listed in the Prescription Drug List as follows: Sirolimus and its derivatives";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sirolimus et ses dérivés";s:16:"field_legacy_nid";s:5:"77270";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Sirolimus";s:5:"title";s:9:"Sirolimus";s:3:"nid";s:5:"81660";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81661;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Sodium aurothiomalate";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aurothiomalate de sodium";s:16:"field_legacy_nid";s:5:"77271";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Sodium aurothiomalate";s:5:"title";s:21:"Sodium aurothiomalate";s:3:"nid";s:5:"81661";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81662;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because listed in the Prescription Drug List as follows: Sodium nitroprusside or its salts";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sodium (nitroprussiate de) ou ses sels";s:16:"field_legacy_nid";s:5:"77272";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Sodium nitroprusside";s:5:"title";s:20:"Sodium nitroprusside";s:3:"nid";s:5:"81662";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81663;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Solifenacin or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Solifénacine ou ses sels";s:16:"field_legacy_nid";s:5:"77273";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Solifenacin";s:5:"title";s:11:"Solifenacin";s:3:"nid";s:5:"81663";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81664;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Somatostatin";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Somatostatine";s:16:"field_legacy_nid";s:5:"77274";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Somatostatin";s:5:"title";s:12:"Somatostatin";s:3:"nid";s:5:"81664";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81665;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Somatrem";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Somatrem";s:16:"field_legacy_nid";s:5:"77275";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Somatrem";s:5:"title";s:8:"Somatrem";s:3:"nid";s:5:"81665";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81666;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Sotalol or its salts";s:25:"field_non_nhp_rationale_f";s:97:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sotalol ou ses sels";s:16:"field_legacy_nid";s:5:"77276";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Sotalol";s:5:"title";s:7:"Sotalol";s:3:"nid";s:5:"81666";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81667;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:81:"A non-NHP because listed in the Prescription Drug List as follows: Spironolactone";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Spironolactone";s:16:"field_legacy_nid";s:5:"77277";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Spironolactone";s:5:"title";s:14:"Spironolactone";s:3:"nid";s:5:"81667";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81668;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Stavudine";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Stavudine";s:16:"field_legacy_nid";s:5:"77278";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Stavudine";s:5:"title";s:9:"Stavudine";s:3:"nid";s:5:"81668";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81669;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Streptozocin";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Streptozocine";s:16:"field_legacy_nid";s:5:"77279";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Streptozocin";s:5:"title";s:12:"Streptozocin";s:3:"nid";s:5:"81669";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81670;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:166:"A non-NHP because listed in the Prescription Drug List as follows: Saquinavir or its salts and its derivatives (except those compounds used for decontaminating water)";s:25:"field_non_nhp_rationale_f";s:174:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Saquinavir ou ses sels et ses dérivés (sauf les produits utilisés pour décontaminer l’eau)";s:16:"field_legacy_nid";s:5:"77280";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Succinimide";s:5:"title";s:11:"Succinimide";s:3:"nid";s:5:"81670";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81671;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Sucralfate";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sucralfate";s:16:"field_legacy_nid";s:5:"77281";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Sucralfate";s:5:"title";s:10:"Sucralfate";s:3:"nid";s:5:"81671";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81672;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Sulconazole or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sulconazole ou ses sels";s:16:"field_legacy_nid";s:5:"77282";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Sulconazole";s:5:"title";s:11:"Sulconazole";s:3:"nid";s:5:"81672";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81673;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:94:"A non-NHP because listed in the Prescription Drug List as follows: Sulfinpyrazone or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sulfinpyrazone ou ses sels";s:16:"field_legacy_nid";s:5:"77283";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Sulfinpyrazone";s:5:"title";s:14:"Sulfinpyrazone";s:3:"nid";s:5:"81673";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81674;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Sulindac or its salts";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sulindac ou ses sels";s:16:"field_legacy_nid";s:5:"77284";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Sulindac";s:5:"title";s:8:"Sulindac";s:3:"nid";s:5:"81674";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81675;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Sumatriptan or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Sumatriptan ou ses sels";s:16:"field_legacy_nid";s:5:"77285";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Sumatriptan";s:5:"title";s:11:"Sumatriptan";s:3:"nid";s:5:"81675";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81676;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Suprofen or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Suprofène ou ses sels";s:16:"field_legacy_nid";s:5:"77286";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Suprofen";s:5:"title";s:8:"Suprofen";s:3:"nid";s:5:"81676";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81677;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Suxamethonium chloride";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Suxaméthonium (chlorure de)";s:16:"field_legacy_nid";s:5:"77287";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Suxamethonium chloride";s:5:"title";s:22:"Suxamethonium chloride";s:3:"nid";s:5:"81677";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81678;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Tacrolimus and its derivatives";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tacrolimus et ses dérivés";s:16:"field_legacy_nid";s:5:"77288";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tacrolimus";s:5:"title";s:10:"Tacrolimus";s:3:"nid";s:5:"81678";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81679;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Tadalafil or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tadalafil ou ses sels";s:16:"field_legacy_nid";s:5:"77289";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Tadalafil";s:5:"title";s:9:"Tadalafil";s:3:"nid";s:5:"81679";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81680;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Tamoxifen or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tamoxifène ou ses sels";s:16:"field_legacy_nid";s:5:"77290";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Tamoxifen";s:5:"title";s:9:"Tamoxifen";s:3:"nid";s:5:"81680";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81681;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Tamsulosin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tamsulosine ou ses sels";s:16:"field_legacy_nid";s:5:"77291";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tamsulosin";s:5:"title";s:10:"Tamsulosin";s:3:"nid";s:5:"81681";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81682;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Tazarotene";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tazarotène";s:16:"field_legacy_nid";s:5:"77292";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tazarotene";s:5:"title";s:10:"Tazarotene";s:3:"nid";s:5:"81682";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81683;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Tazobactam or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tazobactam ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77293";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tazobactam";s:5:"title";s:10:"Tazobactam";s:3:"nid";s:5:"81683";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81684;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Teflubenzuron";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Teflubenzuron";s:16:"field_legacy_nid";s:5:"77294";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Teflubenzuron";s:5:"title";s:13:"Teflubenzuron";s:3:"nid";s:5:"81684";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81685;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Tegafur or its salts";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tégafur ou ses sels";s:16:"field_legacy_nid";s:5:"77295";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Tegafur";s:5:"title";s:7:"Tegafur";s:3:"nid";s:5:"81685";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81686;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Tegaserod or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tégasérod ou ses sels";s:16:"field_legacy_nid";s:5:"77296";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Tegaserod";s:5:"title";s:9:"Tegaserod";s:3:"nid";s:5:"81686";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81687;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:113:"A non-NHP because listed in the Prescription Drug List as follows: Telithromycin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Telithromycin ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77297";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Telithromycin";s:5:"title";s:13:"Telithromycin";s:3:"nid";s:5:"81687";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81688;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Telmisartan or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Telmisartan ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77298";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Telmisartan";s:5:"title";s:11:"Telmisartan";s:3:"nid";s:5:"81688";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81689;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Temozolomide or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Témozolomide ou ses sels";s:16:"field_legacy_nid";s:5:"77299";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Temozolomide";s:5:"title";s:12:"Temozolomide";s:3:"nid";s:5:"81689";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81690;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:112:"A non-NHP because listed in the Prescription Drug List as follows: Tenecteplase or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ténectéplase ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77300";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Tenecteplase";s:5:"title";s:12:"Tenecteplase";s:3:"nid";s:5:"81690";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81691;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Teniposide";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Téniposide";s:16:"field_legacy_nid";s:5:"77301";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Teniposide";s:5:"title";s:10:"Teniposide";s:3:"nid";s:5:"81691";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81692;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Tenofovir or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ténofovir ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77302";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Tenofovir";s:5:"title";s:9:"Tenofovir";s:3:"nid";s:5:"81692";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81693;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Tenoxicam or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ténoxicam ou ses sels";s:16:"field_legacy_nid";s:5:"77303";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Tenoxicam";s:5:"title";s:9:"Tenoxicam";s:3:"nid";s:5:"81693";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81694;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:82:"A non-NHP because listed in the Prescription Drug List as follows: Acetylcarbromal";s:25:"field_non_nhp_rationale_f";s:94:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acétylcarbromal";s:16:"field_legacy_nid";s:5:"76613";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Acetylcarbromal";s:5:"title";s:15:"Acetylcarbromal";s:3:"nid";s:5:"81694";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81695;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"578;17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Acetylcholine Chloride";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acétylcholine (chlorure d')";s:16:"field_legacy_nid";s:5:"76614";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Acetylcholine chloride";s:5:"title";s:22:"Acetylcholine chloride";s:3:"nid";s:5:"81695";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81696;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Aconiazide or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aconiazide ou ses sels";s:16:"field_legacy_nid";s:5:"76615";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Aconiazide";s:5:"title";s:10:"Aconiazide";s:3:"nid";s:5:"81696";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81697;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Acyclovir or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acyclovir ou ses sels";s:16:"field_legacy_nid";s:5:"76616";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Acyclovir";s:5:"title";s:9:"Acyclovir";s:3:"nid";s:5:"81697";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81698;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Adapalene or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Adapalene ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76617";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Adapalene";s:5:"title";s:9:"Adapalene";s:3:"nid";s:5:"81698";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81699;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Adefovir or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Adéfovir ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76618";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Adefovir";s:5:"title";s:8:"Adefovir";s:3:"nid";s:5:"81699";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81700;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:114:"A non-NHP because listed in the Prescription Drug List as follows: Alatrofloxacin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:122:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Alatrofloxacine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76619";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Alatrofloxacin";s:5:"title";s:14:"Alatrofloxacin";s:3:"nid";s:5:"81700";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81701;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Aldesleukin";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Adlésleukine";s:16:"field_legacy_nid";s:5:"76620";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Aldesleukin";s:5:"title";s:11:"Aldesleukin";s:3:"nid";s:5:"81701";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81702;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Alendronic acid or its salts";s:25:"field_non_nhp_rationale_f";s:110:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Alendronique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"76621";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Alendronic acid";s:5:"title";s:15:"Alendronic acid";s:3:"nid";s:5:"81702";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81703;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Alfacacidol";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Alfacalcidol";s:16:"field_legacy_nid";s:5:"76622";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Alfacalcidol";s:5:"title";s:12:"Alfacalcidol";s:3:"nid";s:5:"81703";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81704;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Alfuzosin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Alfuzosine ou ses sels";s:16:"field_legacy_nid";s:5:"76623";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Alfuzosin";s:5:"title";s:9:"Alfuzosin";s:3:"nid";s:5:"81704";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81705;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Allopurinol";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Allopurinol";s:16:"field_legacy_nid";s:5:"76624";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Allopurinol";s:5:"title";s:11:"Allopurinol";s:3:"nid";s:5:"81705";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81706;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Terazosin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Térazosine ou ses sels";s:16:"field_legacy_nid";s:5:"77304";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Terazosin";s:5:"title";s:9:"Terazosin";s:3:"nid";s:5:"81706";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81707;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Terbinafine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Terbinafine ou ses sels";s:16:"field_legacy_nid";s:5:"77305";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Terbinafine";s:5:"title";s:11:"Terbinafine";s:3:"nid";s:5:"81707";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81708;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Terbutaline or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Terbutaline ou ses sels";s:16:"field_legacy_nid";s:5:"77306";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Terbutaline";s:5:"title";s:11:"Terbutaline";s:3:"nid";s:5:"81708";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81709;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:13:"67;3213;17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Allylyisopropylacetylurea";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Allylisopropylacétylurée";s:16:"field_legacy_nid";s:5:"76625";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Allylisopropylacetylurea";s:5:"title";s:24:"Allylisopropylacetylurea";s:3:"nid";s:5:"81709";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81710;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Terconazole or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Terconazole ou ses sels";s:16:"field_legacy_nid";s:5:"77307";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Terconazole";s:5:"title";s:11:"Terconazole";s:3:"nid";s:5:"81710";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81711;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Almotriptan or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Almotriptan ou ses sels";s:16:"field_legacy_nid";s:5:"76626";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Almotriptan";s:5:"title";s:11:"Almotriptan";s:3:"nid";s:5:"81711";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81712;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Terfenadine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Terfénadine ou ses sels";s:16:"field_legacy_nid";s:5:"77308";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Terfenadine";s:5:"title";s:11:"Terfenadine";s:3:"nid";s:5:"81712";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81713;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:83:"A non-NHP because listed in the Prescription Drug List as follows: Alpha-chloralose";s:25:"field_non_nhp_rationale_f";s:94:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Alpha-chloralose";s:16:"field_legacy_nid";s:5:"76627";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Alpha-chloralose";s:5:"title";s:16:"Alpha-chloralose";s:3:"nid";s:5:"81713";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81714;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Teriparatide or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tériparatide ou ses sels";s:16:"field_legacy_nid";s:5:"77309";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Teriparatide";s:5:"title";s:12:"Teriparatide";s:3:"nid";s:5:"81714";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81715;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Alphadolone or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Alphadolone ou ses sels";s:16:"field_legacy_nid";s:5:"76628";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Alphadolone";s:5:"title";s:11:"Alphadolone";s:3:"nid";s:5:"81715";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81716;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Terlipressin or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Terlipressine ou ses sels";s:16:"field_legacy_nid";s:5:"77310";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Terlipressin";s:5:"title";s:12:"Terlipressin";s:3:"nid";s:5:"81716";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81717;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Tetrabenazine or its salts";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tétrabénazine ou ses sels";s:16:"field_legacy_nid";s:5:"77311";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Tetrabenazine";s:5:"title";s:13:"Tetrabenazine";s:3:"nid";s:5:"81717";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81718;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Thalidomide";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thalidomide";s:16:"field_legacy_nid";s:5:"77312";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Thalidomide";s:5:"title";s:11:"Thalidomide";s:3:"nid";s:5:"81718";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81719;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Alphaxalone or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Alphaxalone ou ses sels";s:16:"field_legacy_nid";s:5:"76629";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Alphaxalone";s:5:"title";s:11:"Alphaxalone";s:3:"nid";s:5:"81719";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81720;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Alteplase or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Altéplase ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76630";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Alteplase";s:5:"title";s:9:"Alteplase";s:3:"nid";s:5:"81720";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81721;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Altrenogest";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Altrénogest";s:16:"field_legacy_nid";s:5:"76631";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Altrenogest";s:5:"title";s:11:"Altrenogest";s:3:"nid";s:5:"81721";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81722;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Altretamine";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Altrétamine";s:16:"field_legacy_nid";s:5:"76632";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Altretamine";s:5:"title";s:11:"Altretamine";s:3:"nid";s:5:"81722";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81723;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:96:"A non-NHP because listed in the Prescription Drug List as follows: Thiethylperazine or its salts";s:25:"field_non_nhp_rationale_f";s:108:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thiéthylpérazine ou ses sels";s:16:"field_legacy_nid";s:5:"77313";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Thiethylperazine";s:5:"title";s:16:"Thiethylperazine";s:3:"nid";s:5:"81723";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81724;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Thiocarlide";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thiocarlide";s:16:"field_legacy_nid";s:5:"77314";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Thiocarlide";s:5:"title";s:11:"Thiocarlide";s:3:"nid";s:5:"81724";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81725;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Thioguanine";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thioguanine";s:16:"field_legacy_nid";s:5:"77315";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Thioguanine";s:5:"title";s:11:"Thioguanine";s:3:"nid";s:5:"81725";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81726;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Amantadine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amantadine ou ses sels";s:16:"field_legacy_nid";s:5:"76633";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Amantadine";s:5:"title";s:10:"Amantadine";s:3:"nid";s:5:"81726";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81727;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:86:"A non-NHP because listed in the Prescription Drug List as follows: Ambenonium Chloride";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ambénonium (chlorurde d')";s:16:"field_legacy_nid";s:5:"76634";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Ambenonium Chloride";s:5:"title";s:19:"Ambenonium Chloride";s:3:"nid";s:5:"81727";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81728;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Thiopropazate or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thiopropazate ou ses sels";s:16:"field_legacy_nid";s:5:"77316";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Thiopropazate";s:5:"title";s:13:"Thiopropazate";s:3:"nid";s:5:"81728";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81729;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Thioproperazine or its salts";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thiopropérazine ou ses sels";s:16:"field_legacy_nid";s:5:"77317";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Thioproperazine";s:5:"title";s:15:"Thioproperazine";s:3:"nid";s:5:"81729";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81730;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Amifostine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amifostine ou ses sels";s:16:"field_legacy_nid";s:5:"76635";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Amifostine";s:5:"title";s:10:"Amifostine";s:3:"nid";s:5:"81730";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81731;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Amikacin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amikacine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76636";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Amikacin";s:5:"title";s:8:"Amikacin";s:3:"nid";s:5:"81731";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81732;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Thioridazine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thioridazine ou ses sels";s:16:"field_legacy_nid";s:5:"77318";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Thioridazine";s:5:"title";s:12:"Thioridazine";s:3:"nid";s:5:"81732";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81733;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Amiloride or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amiloride ou ses sels";s:16:"field_legacy_nid";s:5:"76637";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Amiloride";s:5:"title";s:9:"Amiloride";s:3:"nid";s:5:"81733";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81734;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Thiotepa";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thiotépa";s:16:"field_legacy_nid";s:5:"77319";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Thiotepa";s:5:"title";s:8:"Thiotepa";s:3:"nid";s:5:"81734";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81735;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Thiothixene or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thiothixène ou ses sels";s:16:"field_legacy_nid";s:5:"77320";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Thiothixene";s:5:"title";s:11:"Thiothixene";s:3:"nid";s:5:"81735";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81736;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Thiouracil and its derivatives";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thiouracile et ses dérivés";s:16:"field_legacy_nid";s:5:"77321";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Thiouracil";s:5:"title";s:10:"Thiouracil";s:3:"nid";s:5:"81736";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81737;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:84:"A non-NHP because listed in the Prescription Drug List as follows: Aminocaproic acid";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aminocaproïque (acide)";s:16:"field_legacy_nid";s:5:"76638";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Aminocaproic acid";s:5:"title";s:17:"Aminocaproic acid";s:3:"nid";s:5:"81737";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81738;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:119:"A non-NHP because listed in the Prescription Drug List as follows: Aminolevulinic acid or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:132:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aminolévulinique (acide) ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76640";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Aminolevulinic acid";s:5:"title";s:19:"Aminolevulinic acid";s:3:"nid";s:5:"81738";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81739;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Aminopterin or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aminoptérine ou ses sels";s:16:"field_legacy_nid";s:5:"76641";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Aminopterin";s:5:"title";s:11:"Aminopterin";s:3:"nid";s:5:"81739";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81740;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: 4-Amino-pteroyl aspartic acid or its salts";s:25:"field_non_nhp_rationale_f";s:125:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amino-4-ptéroyl asPARTique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"76642";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"4-Amino-pteroyl aspartic acid";s:5:"title";s:29:"4-Amino-pteroyl aspartic acid";s:3:"nid";s:5:"81740";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81741;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: 5-Aminosalicylic acid";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amino-5-salicylique (acide)";s:16:"field_legacy_nid";s:5:"76643";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"5-Aminosalicylic acid";s:5:"title";s:21:"5-Aminosalicylic acid";s:3:"nid";s:5:"81741";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81742;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:83:"A non-NHP because listed in the Prescription Drug List as follows: Thyrotropin alfa";s:25:"field_non_nhp_rationale_f";s:95:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thyrotropine alfa";s:16:"field_legacy_nid";s:5:"77322";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Thyrotropin alfa";s:5:"title";s:16:"Thyrotropin alfa";s:3:"nid";s:5:"81742";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81743;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:101:"A non-NHP because listed in the Prescription Drug List as follows: 4-Aminosalicylic acid or its salts";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amino-4-salicylique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"76644";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"4-Aminosalicylic Acid";s:5:"title";s:21:"4-Aminosalicylic Acid";s:3:"nid";s:5:"81743";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81744;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Thyroxin or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Thyroxine ou ses sels";s:16:"field_legacy_nid";s:5:"77323";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Thyroxin";s:5:"title";s:8:"Thyroxin";s:3:"nid";s:5:"81744";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81745;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Amiodarone or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amiodarone ou ses sels";s:16:"field_legacy_nid";s:5:"76645";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Amiodarone";s:5:"title";s:10:"Amiodarone";s:3:"nid";s:5:"81745";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81746;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:96:"A non-NHP because listed in the Prescription Drug List as follows: Tiaprofenic acid or its salts";s:25:"field_non_nhp_rationale_f";s:112:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tiaprofénique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"77324";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Tiaprofenic acid";s:5:"title";s:16:"Tiaprofenic acid";s:3:"nid";s:5:"81746";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81747;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:74:"A non-NHP because listed in the Prescription Drug List as follows: Amitraz";s:25:"field_non_nhp_rationale_f";s:85:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amitraz";s:16:"field_legacy_nid";s:5:"76646";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Amitraz";s:5:"title";s:7:"Amitraz";s:3:"nid";s:5:"81747";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81748;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Amitriptyline or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance :  Amitriptyline ou ses sels";s:16:"field_legacy_nid";s:5:"76647";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Amitriptyline";s:5:"title";s:13:"Amitriptyline";s:3:"nid";s:5:"81748";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81749;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Amlexanox or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amlexanox ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76648";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Amlexanox";s:5:"title";s:9:"Amlexanox";s:3:"nid";s:5:"81749";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81750;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Ticarcillin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ticarcilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77325";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ticarcillin";s:5:"title";s:11:"Ticarcillin";s:3:"nid";s:5:"81750";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81751;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Ticlopidine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ticlopidine ou ses sels";s:16:"field_legacy_nid";s:5:"77326";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ticlopidine";s:5:"title";s:11:"Ticlopidine";s:3:"nid";s:5:"81751";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81752;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:146:"A non-NHP because listed in the Prescription Drug List as follows: Tilmicosin, except in preparations for veterinary use to be administered orally";s:25:"field_non_nhp_rationale_f";s:192:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tilmicosine, sauf dans les préparations pour usage vétérinaire destinées à être administrées par voie orale";s:16:"field_legacy_nid";s:5:"77327";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tilmicosin";s:5:"title";s:10:"Tilmicosin";s:3:"nid";s:5:"81752";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81753;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Tiludronic acid or its salts";s:25:"field_non_nhp_rationale_f";s:110:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tiludronique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"77328";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Tiludronic acid";s:5:"title";s:15:"Tiludronic acid";s:3:"nid";s:5:"81753";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81754;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Timolol or its salts";s:25:"field_non_nhp_rationale_f";s:97:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Timolol ou ses sels";s:16:"field_legacy_nid";s:5:"77329";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Timolol";s:5:"title";s:7:"Timolol";s:3:"nid";s:5:"81754";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81755;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Tinidazole";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tinidazole";s:16:"field_legacy_nid";s:5:"77330";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tinidazole";s:5:"title";s:10:"Tinidazole";s:3:"nid";s:5:"81755";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81756;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Tinzaparin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tinzaparine ou ses sels";s:16:"field_legacy_nid";s:5:"77331";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tinzaparin";s:5:"title";s:10:"Tinzaparin";s:3:"nid";s:5:"81756";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81757;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:85:"A non-NHP because listed in the Prescription Drug List as follows: Tiotropium bromide";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tiotropium (bromure de)";s:16:"field_legacy_nid";s:5:"77332";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Tiotropium bromide";s:5:"title";s:18:"Tiotropium bromide";s:3:"nid";s:5:"81757";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81758;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Tipranavir or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tipranavir ou ses sels";s:16:"field_legacy_nid";s:5:"77333";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tipranavir";s:5:"title";s:10:"Tipranavir";s:3:"nid";s:5:"81758";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81759;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Tirofiban or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tirofiban ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77334";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Tirofiban";s:5:"title";s:9:"Tirofiban";s:3:"nid";s:5:"81759";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81760;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Tizanidine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tizanidine ou ses sels";s:16:"field_legacy_nid";s:5:"77335";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tizanidine";s:5:"title";s:10:"Tizanidine";s:3:"nid";s:5:"81760";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81761;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Tobramycin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tobramycine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77336";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tobramycin";s:5:"title";s:10:"Tobramycin";s:3:"nid";s:5:"81761";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81762;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Tocainide or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tocaïnide ou ses sels";s:16:"field_legacy_nid";s:5:"77337";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Tocainide";s:5:"title";s:9:"Tocainide";s:3:"nid";s:5:"81762";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81763;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Tolazamide";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tolazamide";s:16:"field_legacy_nid";s:5:"77338";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tolazamide";s:5:"title";s:10:"Tolazamide";s:3:"nid";s:5:"81763";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81764;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Tolazoline or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tolazoline ou ses sels";s:16:"field_legacy_nid";s:5:"77339";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tolazoline";s:5:"title";s:10:"Tolazoline";s:3:"nid";s:5:"81764";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81765;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Amlodipine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amlodipine ou ses sels";s:16:"field_legacy_nid";s:5:"76649";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Amlodipine";s:5:"title";s:10:"Amlodipine";s:3:"nid";s:5:"81765";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81766;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Tolcapone";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tolcapone";s:16:"field_legacy_nid";s:5:"77341";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Tolcapone";s:5:"title";s:9:"Tolcapone";s:3:"nid";s:5:"81766";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81767;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:84:"A non-NHP because listed in the Prescription Drug List as follows:  Ammonium bromide";s:25:"field_non_nhp_rationale_f";s:96:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromure d'ammonium";s:16:"field_legacy_nid";s:5:"76650";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Ammonium bromide";s:5:"title";s:16:"Ammonium bromide";s:3:"nid";s:5:"81767";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81768;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:115:"A non-NHP because listed in the Prescription Drug List as follows: Tolfenamic acid or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:128:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tolfénamique (acide) ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77342";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Tolfenamic acid";s:5:"title";s:15:"Tolfenamic acid";s:3:"nid";s:5:"81768";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81769;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Tolmetin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tolmétine ou ses sels";s:16:"field_legacy_nid";s:5:"77343";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Tolmetin";s:5:"title";s:8:"Tolmetin";s:3:"nid";s:5:"81769";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81770;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Tolterodine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Toltérodine ou ses sels";s:16:"field_legacy_nid";s:5:"77344";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Tolterodine";s:5:"title";s:11:"Tolterodine";s:3:"nid";s:5:"81770";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81771;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Topiramate";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Topiramate";s:16:"field_legacy_nid";s:5:"77345";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Topiramate";s:5:"title";s:10:"Topiramate";s:3:"nid";s:5:"81771";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81772;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Topotecan or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Topotécane ou ses sels";s:16:"field_legacy_nid";s:5:"77346";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Topotecan";s:5:"title";s:9:"Topotecan";s:3:"nid";s:5:"81772";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81773;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Torasemide or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Torasémide ou ses sels";s:16:"field_legacy_nid";s:5:"77347";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Torasemide";s:5:"title";s:10:"Torasemide";s:3:"nid";s:5:"81773";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81774;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Toremifene or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Torémifène ou ses sels";s:16:"field_legacy_nid";s:5:"77348";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Toremifene";s:5:"title";s:10:"Toremifene";s:3:"nid";s:5:"81774";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81775;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:82:"A non-NHP because listed in the Prescription Drug List as follows: Tranexamic acid";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tranexamique (acide)";s:16:"field_legacy_nid";s:5:"77349";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Tranexamic acid";s:5:"title";s:15:"Tranexamic acid";s:3:"nid";s:5:"81775";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81776;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:82:"A non-NHP because listed in the Prescription Drug List as follows: Tranylcypromine";s:25:"field_non_nhp_rationale_f";s:93:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tranylcypromine";s:16:"field_legacy_nid";s:5:"77350";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Tranylcypromine";s:5:"title";s:15:"Tranylcypromine";s:3:"nid";s:5:"81776";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";}i:81777;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Flupentixol or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Flupentixol ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76925";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Flupentixol";s:5:"title";s:11:"Flupentixol";s:3:"nid";s:5:"81777";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81778;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Fluphenazine or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fluphénazine ou ses sels";s:16:"field_legacy_nid";s:5:"76926";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Fluphenazine";s:5:"title";s:12:"Fluphenazine";s:3:"nid";s:5:"81778";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81779;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:112:"A non-NHP because listed in the Prescription Drug List as follows: Fluprostenol or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fluprosténol ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76927";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Fluprostenol";s:5:"title";s:12:"Fluprostenol";s:3:"nid";s:5:"81779";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81780;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Flurbiprofen or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Flurbiprofène ou ses sels";s:16:"field_legacy_nid";s:5:"76928";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Flurbiprofen";s:5:"title";s:12:"Flurbiprofen";s:3:"nid";s:5:"81780";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81781;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Fluspirilene";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fluspirilène";s:16:"field_legacy_nid";s:5:"76929";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Fluspirilene";s:5:"title";s:12:"Fluspirilene";s:3:"nid";s:5:"81781";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81782;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Flutamide";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Flutamide";s:16:"field_legacy_nid";s:5:"76930";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Flutamide";s:5:"title";s:9:"Flutamide";s:3:"nid";s:5:"81782";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81783;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Fluvastatin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fluvastatine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76931";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Fluvastatin";s:5:"title";s:11:"Fluvastatin";s:3:"nid";s:5:"81783";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81784;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Fluvoxamine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fluvoxamine ou ses sels";s:16:"field_legacy_nid";s:5:"76932";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Fluvoxamine";s:5:"title";s:11:"Fluvoxamine";s:3:"nid";s:5:"81784";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81785;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Follicle stimulating hormone";s:25:"field_non_nhp_rationale_f";s:108:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Folliculo-stimulante (hormone)";s:16:"field_legacy_nid";s:5:"76933";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Follicle stimulating hormone";s:5:"title";s:28:"Follicle stimulating hormone";s:3:"nid";s:5:"81785";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81786;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Fomepizole or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fomépizole ou ses sels";s:16:"field_legacy_nid";s:5:"76934";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Fomepizole";s:5:"title";s:10:"Fomepizole";s:3:"nid";s:5:"81786";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81787;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:86:"A non-NHP because listed in the Prescription Drug List as follows: Fondaparinux sodium";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fondaparinux sodique";s:16:"field_legacy_nid";s:5:"76935";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Fondaparinux sodium";s:5:"title";s:19:"Fondaparinux sodium";s:3:"nid";s:5:"81787";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81788;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Formestane and its derivatives";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Formestane et ses dérivés";s:16:"field_legacy_nid";s:5:"76936";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Formestane";s:5:"title";s:10:"Formestane";s:3:"nid";s:5:"81788";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81789;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Formoterol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Formotérol ou ses sels";s:16:"field_legacy_nid";s:5:"76937";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Formoterol";s:5:"title";s:10:"Formoterol";s:3:"nid";s:5:"81789";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81790;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:83:"A non-NHP because listed in the Prescription Drug List as follows: Foscarnet sodium";s:25:"field_non_nhp_rationale_f";s:95:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Foscarnet sodique";s:16:"field_legacy_nid";s:5:"76938";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Foscarnet sodium";s:5:"title";s:16:"Foscarnet sodium";s:3:"nid";s:5:"81790";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81791;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Fosfomycin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fosfomycine ou ses sels";s:16:"field_legacy_nid";s:5:"76939";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Fosfomycin";s:5:"title";s:10:"Fosfomycin";s:3:"nid";s:5:"81791";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81792;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Fosinopril or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fosinopril ou ses sels";s:16:"field_legacy_nid";s:5:"76940";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Fosinopril";s:5:"title";s:10:"Fosinopril";s:3:"nid";s:5:"81792";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81793;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Fosphenytoin or its salts";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fosphénytoïne ou ses sels";s:16:"field_legacy_nid";s:5:"76941";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Fosphenytoin";s:5:"title";s:12:"Fosphenytoin";s:3:"nid";s:5:"81793";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81794;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Frovatriptan or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Frovatriptan ou ses sels";s:16:"field_legacy_nid";s:5:"76942";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Frovatriptan";s:5:"title";s:12:"Frovatriptan";s:3:"nid";s:5:"81794";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81795;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Fulvestrant";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fulvestrant";s:16:"field_legacy_nid";s:5:"76943";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Fulvestrant";s:5:"title";s:11:"Fulvestrant";s:3:"nid";s:5:"81795";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81796;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Fusidic acid or its salts";s:25:"field_non_nhp_rationale_f";s:107:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fusidique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"76944";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Fusidic acid";s:5:"title";s:12:"Fusidic acid";s:3:"nid";s:5:"81796";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81797;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Galantamine or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Galantamine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76945";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Galantamine";s:5:"title";s:11:"Galantamine";s:3:"nid";s:5:"81797";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81798;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Gallamine triethiodide";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Gallamine (triéthiodure de)";s:16:"field_legacy_nid";s:5:"76946";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Gallamine triethiodide";s:5:"title";s:22:"Gallamine triethiodide";s:3:"nid";s:5:"81798";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81799;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Gallium or its salts";s:25:"field_non_nhp_rationale_f";s:97:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Gallium ou ses sels";s:16:"field_legacy_nid";s:5:"76947";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Gallium";s:5:"title";s:7:"Gallium";s:3:"nid";s:5:"81799";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81800;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Ganciclovir or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ganciclovir ou ses sels";s:16:"field_legacy_nid";s:5:"76948";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ganciclovir";s:5:"title";s:11:"Ganciclovir";s:3:"nid";s:5:"81800";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81801;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Ganirelix or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ganirélix ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76949";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ganirelix";s:5:"title";s:9:"Ganirelix";s:3:"nid";s:5:"81801";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81802;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:112:"A non-NHP because listed in the Prescription Drug List as follows: Gatifloxacin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Gatifloxacine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76950";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Gatifloxacin";s:5:"title";s:12:"Gatifloxacin";s:3:"nid";s:5:"81802";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81803;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Gefitinib";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Géfitinib";s:16:"field_legacy_nid";s:5:"76951";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Gefitinib";s:5:"title";s:9:"Gefitinib";s:3:"nid";s:5:"81803";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81804;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Gemcitabine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Gemcitabine ou ses sels";s:16:"field_legacy_nid";s:5:"76952";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Gemcitabine";s:5:"title";s:11:"Gemcitabine";s:3:"nid";s:5:"81804";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81805;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Gemfibrozil or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Gemfibrozil ou ses sel";s:16:"field_legacy_nid";s:5:"76953";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Gemfibrozil";s:5:"title";s:11:"Gemfibrozil";s:3:"nid";s:5:"81805";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81806;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Ibandronic acid or its salts";s:25:"field_non_nhp_rationale_f";s:108:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acide ibandronique ou ses sels";s:16:"field_legacy_nid";s:5:"76954";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Ibandronic acid";s:5:"title";s:15:"Ibandronic acid";s:3:"nid";s:5:"81806";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81807;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Ibutilide or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ibutilide ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76955";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ibutilide";s:5:"title";s:9:"Ibutilide";s:3:"nid";s:5:"81807";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81808;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Idarubicin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Idarubicine ou ses sels";s:16:"field_legacy_nid";s:5:"76956";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Idarubicin";s:5:"title";s:10:"Idarubicin";s:3:"nid";s:5:"81808";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81809;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Idoxuridine";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Idoxuridine";s:16:"field_legacy_nid";s:5:"76957";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Idoxuridine";s:5:"title";s:11:"Idoxuridine";s:3:"nid";s:5:"81809";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81810;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Ifosfamide";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ifosfamide";s:16:"field_legacy_nid";s:5:"76958";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ifosfamide";s:5:"title";s:10:"Ifosfamide";s:3:"nid";s:5:"81810";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81811;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Imatinib or its salts";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Imatinib ou ses sels";s:16:"field_legacy_nid";s:5:"76959";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Imatinib";s:5:"title";s:8:"Imatinib";s:3:"nid";s:5:"81811";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81812;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Imiglucerase";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Imiglucérase";s:16:"field_legacy_nid";s:5:"76960";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Imiglucerase";s:5:"title";s:12:"Imiglucerase";s:3:"nid";s:5:"81812";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81813;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Imipenem or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Imipénem ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76961";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Imipenem";s:5:"title";s:8:"Imipenem";s:3:"nid";s:5:"81813";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81814;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Imipramine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Imipramine ou ses sels";s:16:"field_legacy_nid";s:5:"76962";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Imipramine";s:5:"title";s:10:"Imipramine";s:3:"nid";s:5:"81814";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81815;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Imiquimod or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Imiquimod ou ses sels";s:16:"field_legacy_nid";s:5:"76963";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Imiquimod";s:5:"title";s:9:"Imiquimod";s:3:"nid";s:5:"81815";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81816;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Indapamide or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Indapamide ou ses sels";s:16:"field_legacy_nid";s:5:"76964";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Indapamide";s:5:"title";s:10:"Indapamide";s:3:"nid";s:5:"81816";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81817;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Indinavir or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Indinavir ou ses sels";s:16:"field_legacy_nid";s:5:"76965";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Indinavir";s:5:"title";s:9:"Indinavir";s:3:"nid";s:5:"81817";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81818;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Indomethacin";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Indométhacine";s:16:"field_legacy_nid";s:5:"76966";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Indomethacin";s:5:"title";s:12:"Indomethacin";s:3:"nid";s:5:"81818";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81819;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Infliximab";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Infliximab";s:16:"field_legacy_nid";s:5:"76967";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Infliximab";s:5:"title";s:10:"Infliximab";s:3:"nid";s:5:"81819";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81820;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Inosiplex";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Inosiplex";s:16:"field_legacy_nid";s:5:"76968";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Inosiplex";s:5:"title";s:9:"Inosiplex";s:3:"nid";s:5:"81820";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81821;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Amoxapine";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amoxapine";s:16:"field_legacy_nid";s:5:"76651";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Amoxapine";s:5:"title";s:9:"Amoxapine";s:3:"nid";s:5:"81821";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81822;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:19:"304;2662;8248;17412";s:25:"field_non_nhp_rationale_e";s:183:"As per the Prescription Drug List, Dimethyl sulfoxide, for veterinary use or when sold for the treatment of interstitial cystitis or scleroderma in humans, is classified as a non-NHP.";s:25:"field_non_nhp_rationale_f";s:234:"Selon la Liste des drogues sur ordonnance, le Diméthylsulfoxyde, lorsqu’il est vendu pour usage vétérinaire ou pour le traitement de la cystite interstitielle ou de la sclérodermie chez les humains, est classifié comme non PSN.";s:19:"field_old_rationale";s:389:"Amendement: Dans la partie I de l’annexe F du Règlement sur les aliments et drogues, Diméthylsulfoxyde est remplacée par ce qui suit: Diméthylsulfoxide, s’il est vendu pour usage vétérinaire ou pour le traitement de la cystite interstitielle ou de la sclérodermie chez les humains. Gazette du Canada Partie II: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/pdf/g2-14525.pdf.";s:16:"field_legacy_nid";s:5:"76556";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Dimethyl sulfoxide";s:5:"title";s:18:"Dimethyl sulfoxide";s:3:"nid";s:5:"81822";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81823;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Ipratropium or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ipratropium ou ses sels";s:16:"field_legacy_nid";s:5:"76969";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ipratropium";s:5:"title";s:11:"Ipratropium";s:3:"nid";s:5:"81823";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81824;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:17:"304;67;8249;17412";s:25:"field_non_nhp_rationale_e";s:183:"As per the Prescription Drug List, Levocarnitine or its salts or derivatives, when sold for the treatment of primary or secondary levocarnitine deficiency, are classified as non-NHPs.";s:25:"field_non_nhp_rationale_f";s:220:"Selon la Liste des drogues sur ordonnance, la Lévocarnitine ou ses sels ou dérivés, lorsqu'ils sont vendu pour le traitement de la déficience primaire ou secondaire en lévocarnitine, sont classifiés comme non PSNs.";s:19:"field_old_rationale";s:342:"Amendment: Levocarnitine and its salts and derivatives in Part I of Schedule F to the Regulations is replaced by the following: Levocarnitine and its salts and derivatives, when sold for the treatment of primary or secondary levocarnitine deficiency. Canada Gazette Part II: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/pdf/g2-14525.pdf.";s:16:"field_legacy_nid";s:5:"76561";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Levocarnitine";s:5:"title";s:13:"Levocarnitine";s:3:"nid";s:5:"81824";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81825;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Iproniazid or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Iproniazide ou ses sels";s:16:"field_legacy_nid";s:5:"76970";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Iproniazid";s:5:"title";s:10:"Iproniazid";s:3:"nid";s:5:"81825";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81826;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:214:"A non-NHP because listed in the Prescription Drug List as follows: Podophyllum and the following extracts and active principles, when sold or recommended for topical use:
(a) podophyllotoxin
(b) podophyllum resin";s:25:"field_non_nhp_rationale_f";s:233:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Podophyllum, ses extraits et principes actifs suivants lorsque vendus ou recommandés pour usage topique:
a) podophyllotoxine
b) podophyllum (résine de)";s:16:"field_legacy_nid";s:5:"76563";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Podophyllotoxin";s:5:"title";s:15:"Podophyllotoxin";s:3:"nid";s:5:"81826";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81827;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Irbesartan or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Irbésartan ou ses sels";s:16:"field_legacy_nid";s:5:"76971";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Irbesartan";s:5:"title";s:10:"Irbesartan";s:3:"nid";s:5:"81827";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81828;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:247:"A non-NHP because listed in the Prescription Drug List as follows: Miconazole or its salts (except in preparations for topical and vaginal use).  Additionally, it is not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:278:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Miconazole ou ses sels (sauf dans les préparations pour usage topique et vagin).  De plus, n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76564";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Miconazole";s:5:"title";s:10:"Miconazole";s:3:"nid";s:5:"81828";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81829;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Irinotecan or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Irinotécan ou ses sels";s:16:"field_legacy_nid";s:5:"76972";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Irinotecan";s:5:"title";s:10:"Irinotecan";s:3:"nid";s:5:"81829";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81830;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:248:"A non-NHP because listed in the Prescription Drug List as follows: Tioconazole or its salts (except in preparations for topical and vaginal use).  Additionally, it is not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:280:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tioconazole ou ses sels (sauf dans les préparations pour usage topique et vaginal.  De plus, n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:5:"76565";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Tioconazole";s:5:"title";s:11:"Tioconazole";s:3:"nid";s:5:"81830";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81831;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Gemifloxacin or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Gémifloxacine ou ses sels";s:16:"field_legacy_nid";s:5:"76973";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Gemifloxacin";s:5:"title";s:12:"Gemifloxacin";s:3:"nid";s:5:"81831";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81832;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Gentamicin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Gentamicine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76974";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Gentamicin";s:5:"title";s:10:"Gentamicin";s:3:"nid";s:5:"81832";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81833;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"8250;17412";s:25:"field_non_nhp_rationale_e";s:383:"As per the Prescription Drug List, L-Tryptophan, when sold
(a) for human use in oral dosage form at a concentration of more than 220 mg per dosage unit or per daily dose, as a single ingredient or in combination with other ingredients; or
(b) for human or veterinary use as a single ingredient intended for any route of administration other than oral; 
is classified as a non-NHP.";s:25:"field_non_nhp_rationale_f";s:459:"Selon la Liste des drogues sur ordonnance, le L-Tryptophane, s’il est vendu 
a) pour usage humain sous forme posologique orale à une concentration de plus de 220 mg par unité posologique ou par dose quotidienne, comme ingrédient unique ou en combinaison avec d’autres ingrédients; ou
b) pour usage humain ou vétérinaire, comme ingrédient unique destiné à être administré par toute voie autre que la voie orale; 
est classifié comme non-PSN.";s:19:"field_old_rationale";s:542:"Amendment: L-Tryptophan, when sold as a single ingredient in Part I of Schedule F to the Regulations is replaced by the following: L-Tryptophan, when sold
(a) for human use in oral dosage form at a concentration of more than 220 mg per dosage unit or per daily dose, as a single ingredient or in combination with other ingredients; or
(b) for human or veterinary use as a single ingredient intended for any route of administration other than oral.
Canada Gazette Part II: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/pdf/g2-14525.pdf.";s:16:"field_legacy_nid";s:5:"76566";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tryptophan";s:5:"title";s:10:"Tryptophan";s:3:"nid";s:5:"81833";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81834;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Esomeprazole or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ésoméprazole ou ses sels";s:16:"field_legacy_nid";s:5:"76567";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Esomeprazole";s:5:"title";s:12:"Esomeprazole";s:3:"nid";s:5:"81834";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81835;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:293:"A non-NHP because listed in the Prescription Drug List as follows: Ranitidine or its salts (except when sold in a dosage form containing not more than the equivalent of 75 mg of ranitidine).  Additionally, it is not a naturally occurring substance included in Schedule 1 of the NHP Regulations";s:25:"field_non_nhp_rationale_f";s:330:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ranitidine ou ses sels (sauf s'ils sont vendus en une forme posologique contenant pas plus que l'équivalent de 75 mg de ranitidine).  De plus, n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:19:"field_old_rationale";s:649:"Ranitidine is a histamine H2-receptor antagonist which inhibits the production of stomach acid, it is used for the treatment of peptic ulcer disease and gastroesophageal reflux disease.  This product is currently marketed by the company GlaxoSmithKline under the brand name Zantac, which is actually the hydrochloride salt of Ranitidine, Ranitidine hydrochloride.  It was developped by the company Glaxo, which is now GlaxoSmithKline, using a model of the histamine H2-receptor and quantitative structure-activity relationships.  Since Ranitidine is a synthetically prepared compound, not found in nature, it will be considered as a drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76573";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ranitidine";s:5:"title";s:10:"Ranitidine";s:3:"nid";s:5:"81835";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81836;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3943;17412";s:25:"field_non_nhp_rationale_e";s:163:"As per the Prescription Drug List, the dose of Vitamin A in oral NHPs must not exceed 10 000 IU/day, and above 10 000 IU/day, Vitamin A is classified as a non-NHP.";s:25:"field_non_nhp_rationale_f";s:239:"Comme indiqué à la Liste des drogues sur ordonnance, la dose de Vitamine A dans les PSN oraux ne doit pas dépasser 10 000 UI/jour, et, lorsque cette dose est supérieure à 10 000 UI/jour, la Vitamine A est classifiée comme un non PSN.";s:16:"field_legacy_nid";s:5:"76591";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Vitamin A";s:5:"title";s:9:"Vitamin A";s:3:"nid";s:5:"81836";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81837;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3943;17412";s:25:"field_non_nhp_rationale_e";s:159:"As per the Prescription Drug List, the dose of Vitamin D in oral NHPs must not exceed 1000 IU/day, and above 1000 IU/day, Vitamin D is classified as a non-NHP.";s:25:"field_non_nhp_rationale_f";s:235:"Comme indiqué à la Liste des drogues sur ordonnance, la dose de Vitamine D dans les PSN oraux ne doit pas dépasser 1000 UI/jour, et, lorsque cette dose est supérieure à 1000 UI/jour, la Vitamine D est classifiée comme un non PSN.";s:16:"field_legacy_nid";s:5:"76592";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Vitamin D";s:5:"title";s:9:"Vitamin D";s:3:"nid";s:5:"81837";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81838;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3943;17412";s:25:"field_non_nhp_rationale_e";s:159:"As per the Prescription Drug List, the dose of Vitamin D in oral NHPs must not exceed 1000 IU/day, and above 1000 IU/day, Vitamin D is classified as a non-NHP.";s:25:"field_non_nhp_rationale_f";s:235:"Comme indiqué à la Liste des drogues sur ordonnance, la dose de Vitamine D dans les PSN oraux ne doit pas dépasser 1000 UI/jour, et, lorsque cette dose est supérieure à 1000 UI/jour, la Vitamine D est classifiée comme un non PSN.";s:16:"field_legacy_nid";s:5:"76593";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Cholecalciferol";s:5:"title";s:15:"Cholecalciferol";s:3:"nid";s:5:"81838";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81839;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3943;17412";s:25:"field_non_nhp_rationale_e";s:159:"As per the Prescription Drug List, the dose of Vitamin D in oral NHPs must not exceed 1000 IU/day, and above 1000 IU/day, Vitamin D is classified as a non-NHP.";s:25:"field_non_nhp_rationale_f";s:235:"Comme indiqué à la Liste des drogues sur ordonnance, la dose de Vitamine D dans les PSN oraux ne doit pas dépasser 1000 UI/jour, et, lorsque cette dose est supérieure à 1000 UI/jour, la Vitamine D est classifiée comme un non PSN.";s:16:"field_legacy_nid";s:5:"76594";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Ergocalciferol";s:5:"title";s:14:"Ergocalciferol";s:3:"nid";s:5:"81839";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81840;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Trastuzumab";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trastuzumab";s:16:"field_legacy_nid";s:5:"77351";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Trastuzumab";s:5:"title";s:11:"Trastuzumab";s:3:"nid";s:5:"81840";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81841;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Trazodone or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trazodone ou ses sels";s:16:"field_legacy_nid";s:5:"77352";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Trazodone";s:5:"title";s:9:"Trazodone";s:3:"nid";s:5:"81841";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81842;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:14:"103;3943;17412";s:25:"field_non_nhp_rationale_e";s:155:"As per the Prescription Drug List, the dose of Folic acid in oral NHPs must not exceed 1 mg/day, and above 1 mg/day, Folic acid is classified as a non-NHP.";s:25:"field_non_nhp_rationale_f";s:239:"Comme indiqué à la Liste des drogues sur ordonnance, la dose de l'Acide folique dans les PSN oraux ne doit pas dépasser 1 mg/jour, et, lorsque cette dose est supérieure à 1 mg/jour, la l'Acide folique est classifiée comme un non PSN.";s:16:"field_legacy_nid";s:5:"76595";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Folate";s:5:"title";s:6:"Folate";s:3:"nid";s:5:"81842";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81843;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Treosulfan";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tréosulfan";s:16:"field_legacy_nid";s:5:"77353";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Treosulfan";s:5:"title";s:10:"Treosulfan";s:3:"nid";s:5:"81843";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81844;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Amoxicillin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amoxicilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76652";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Amoxicillin";s:5:"title";s:11:"Amoxicillin";s:3:"nid";s:5:"81844";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81845;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:114:"A non-NHP because listed in the Prescription Drug List as follows: Amphotericin B or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:123:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amphotéricine B ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76653";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Amphotericin B";s:5:"title";s:14:"Amphotericin B";s:3:"nid";s:5:"81845";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81846;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Ampicillin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ampicilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76654";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ampicillin";s:5:"title";s:10:"Ampicillin";s:3:"nid";s:5:"81846";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81847;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Amprenavir or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amprénavir ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76655";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Amprenavir";s:5:"title";s:10:"Amprenavir";s:3:"nid";s:5:"81847";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81848;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Amrinone or its salts";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amrinone ou ses sels";s:16:"field_legacy_nid";s:5:"76656";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Amrinone";s:5:"title";s:8:"Amrinone";s:3:"nid";s:5:"81848";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81849;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Amsacrine or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amsacrine ou ses sels";s:16:"field_legacy_nid";s:5:"76657";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Amsacrine";s:5:"title";s:9:"Amsacrine";s:3:"nid";s:5:"81849";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81850;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Anagrelide or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Anagrélide ou ses sels";s:16:"field_legacy_nid";s:5:"76658";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Anagrelide";s:5:"title";s:10:"Anagrelide";s:3:"nid";s:5:"81850";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81851;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Anakinra or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:115:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Anakinra ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76659";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Anakinra";s:5:"title";s:8:"Anakinra";s:3:"nid";s:5:"81851";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81852;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Anastrozole";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Anastrozole";s:16:"field_legacy_nid";s:5:"76660";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Anastrozole";s:5:"title";s:11:"Anastrozole";s:3:"nid";s:5:"81852";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81853;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Treprostinil or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tréprostinil ou ses sels";s:16:"field_legacy_nid";s:5:"77354";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Treprostinil";s:5:"title";s:12:"Treprostinil";s:3:"nid";s:5:"81853";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81854;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Tretamine";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trétamine";s:16:"field_legacy_nid";s:5:"77355";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Tretamine";s:5:"title";s:9:"Tretamine";s:3:"nid";s:5:"81854";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81855;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Triamterene or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Triamtérène ou ses sels";s:16:"field_legacy_nid";s:5:"77356";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Triamterene";s:5:"title";s:11:"Triamterene";s:3:"nid";s:5:"81855";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81856;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Tricaine or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tricaïne ou ses sels";s:16:"field_legacy_nid";s:5:"77357";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Tricaine";s:5:"title";s:8:"Tricaine";s:3:"nid";s:5:"81856";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81857;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Trifluoperazine or its salts";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trifluopérazine ou ses sels";s:16:"field_legacy_nid";s:5:"77358";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Trifluoperazine";s:5:"title";s:15:"Trifluoperazine";s:3:"nid";s:5:"81857";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81858;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Triflupromazine or its salts";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Triflupromazine ou ses sels";s:16:"field_legacy_nid";s:5:"77359";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Triflupromazine";s:5:"title";s:15:"Triflupromazine";s:3:"nid";s:5:"81858";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81859;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Trifluridine";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trifluridine";s:16:"field_legacy_nid";s:5:"77360";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Trifluridine";s:5:"title";s:12:"Trifluridine";s:3:"nid";s:5:"81859";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81860;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Trihexyphenidyl or its salts";s:25:"field_non_nhp_rationale_f";s:107:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trihexyphénidyle ou ses sels";s:16:"field_legacy_nid";s:5:"77361";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Trihexyphenidyl";s:5:"title";s:15:"Trihexyphenidyl";s:3:"nid";s:5:"81860";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81861;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Trilostane";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trilostane";s:16:"field_legacy_nid";s:5:"77362";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Trilostane";s:5:"title";s:10:"Trilostane";s:3:"nid";s:5:"81861";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81862;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Trimebutine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trimébutine ou ses sels";s:16:"field_legacy_nid";s:5:"77363";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Trimebutine";s:5:"title";s:11:"Trimebutine";s:3:"nid";s:5:"81862";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81863;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Trimethadione";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Triméthadione";s:16:"field_legacy_nid";s:5:"77364";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Trimethadione";s:5:"title";s:13:"Trimethadione";s:3:"nid";s:5:"81863";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81864;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Trimethaphan camsylate";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trimétaphan (camsilate de)";s:16:"field_legacy_nid";s:5:"77365";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Trimethaphan camsylate";s:5:"title";s:22:"Trimethaphan camsylate";s:3:"nid";s:5:"81864";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81865;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Trimethoprim or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Triméthoprime ou ses sels";s:16:"field_legacy_nid";s:5:"77366";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Trimethoprim";s:5:"title";s:12:"Trimethoprim";s:3:"nid";s:5:"81865";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81866;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Trimetrexate or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trimétrexate ou ses sels";s:16:"field_legacy_nid";s:5:"77367";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Trimetrexate";s:5:"title";s:12:"Trimetrexate";s:3:"nid";s:5:"81866";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81867;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Trimipramine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trimipramine ou ses sels";s:16:"field_legacy_nid";s:5:"77368";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Trimipramine";s:5:"title";s:12:"Trimipramine";s:3:"nid";s:5:"81867";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81868;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Trioxsalen";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trioxysalène";s:16:"field_legacy_nid";s:5:"77369";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Trioxsalen";s:5:"title";s:10:"Trioxsalen";s:3:"nid";s:5:"81868";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81869;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Troglitazone";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Troglitazone";s:16:"field_legacy_nid";s:5:"77370";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Troglitazone";s:5:"title";s:12:"Troglitazone";s:3:"nid";s:5:"81869";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81870;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:244:"A non-NHP because listed in the Prescription Drug List as follows: Tropicamide or its salts in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada";s:25:"field_non_nhp_rationale_f";s:266:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tropicamide ou ses sels dans les préparations pour usage ophtalmique ou parentéral, sauf lorsque vendu pour usage diagnostique à un optométriste enregistré dans une province du Canada";s:16:"field_legacy_nid";s:5:"77371";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Tropicamide";s:5:"title";s:11:"Tropicamide";s:3:"nid";s:5:"81870";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81871;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:113:"A non-NHP because listed in the Prescription Drug List as follows: Trovafloxacin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trovafloxacine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77372";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Trovafloxacin";s:5:"title";s:13:"Trovafloxacin";s:3:"nid";s:5:"81871";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81872;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Tubocurarine chloride";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tubocurarine (chlorure de)";s:16:"field_legacy_nid";s:5:"77373";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Tubocurarine chloride";s:5:"title";s:21:"Tubocurarine chloride";s:3:"nid";s:5:"81872";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81873;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Tybamate";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tybamate";s:16:"field_legacy_nid";s:5:"77374";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Tybamate";s:5:"title";s:8:"Tybamate";s:3:"nid";s:5:"81873";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81874;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:158:"A non-NHP because listed in the Prescription Drug List as follows: Tylosin or its salts or derivatives, when sold for the treatment of chronic colitis in dogs";s:25:"field_non_nhp_rationale_f";s:180:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tylosine, ses sels ou dérivés, lorsque vendu pour le traitement de la colite chronique chez le chien";s:16:"field_legacy_nid";s:5:"77375";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Tylosin";s:5:"title";s:7:"Tylosin";s:3:"nid";s:5:"81874";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81875;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Unoprostone or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Unoprostone ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77376";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Unoprostone";s:5:"title";s:11:"Unoprostone";s:3:"nid";s:5:"81875";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81876;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:94:"A non-NHP because listed in the Prescription Drug List as follows: Uracil mustard or its salts";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Uracile (moutarde à l’) ou ses sels";s:16:"field_legacy_nid";s:5:"77377";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Uracil mustard";s:5:"title";s:14:"Uracil mustard";s:3:"nid";s:5:"81876";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81877;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Valaciclovir or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Valaciclovir ou ses sels";s:16:"field_legacy_nid";s:5:"77378";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Valaciclovir";s:5:"title";s:12:"Valaciclovir";s:3:"nid";s:5:"81877";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81878;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Valdecoxib or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Valdécoxib ou ses sels";s:16:"field_legacy_nid";s:5:"77379";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Valdecoxib";s:5:"title";s:10:"Valdecoxib";s:3:"nid";s:5:"81878";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81879;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:114:"A non-NHP because listed in the Prescription Drug List as follows: Valganciclovir or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Valganciclovir ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77380";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Valganciclovir";s:5:"title";s:14:"Valganciclovir";s:3:"nid";s:5:"81879";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81880;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Valproic acid or its salts";s:25:"field_non_nhp_rationale_f";s:109:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Valproïque (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"77381";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Valproic acid";s:5:"title";s:13:"Valproic acid";s:3:"nid";s:5:"81880";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81881;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Valrubicin and its derivatives";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Valrubicine et ses dérivés";s:16:"field_legacy_nid";s:5:"77382";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Valrubicin";s:5:"title";s:10:"Valrubicin";s:3:"nid";s:5:"81881";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81882;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Valsartan or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Valsartan ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77383";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Valsartan";s:5:"title";s:9:"Valsartan";s:3:"nid";s:5:"81882";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81883;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Vancomycin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vancomycine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77384";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vancomycin";s:5:"title";s:10:"Vancomycin";s:3:"nid";s:5:"81883";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81884;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Vardenafil or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vardenafil ou ses sels";s:16:"field_legacy_nid";s:5:"77385";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vardenafil";s:5:"title";s:10:"Vardenafil";s:3:"nid";s:5:"81884";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81885;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:85:"A non-NHP because listed in the Prescription Drug List as follows: Vecuronium bromide";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vecuronium (bromure de)";s:16:"field_legacy_nid";s:5:"77386";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Vecuronium bromide";s:5:"title";s:18:"Vecuronium bromide";s:3:"nid";s:5:"81885";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81886;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Vedaprofen or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Védaprofène ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77387";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vedaprofen";s:5:"title";s:10:"Vedaprofen";s:3:"nid";s:5:"81886";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81887;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Venlafaxine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Venlafaxine ou ses sels";s:16:"field_legacy_nid";s:5:"77388";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Venlafaxine";s:5:"title";s:11:"Venlafaxine";s:3:"nid";s:5:"81887";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81888;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Verapamil or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vérapamil ou ses sels";s:16:"field_legacy_nid";s:5:"77389";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Verapamil";s:5:"title";s:9:"Verapamil";s:3:"nid";s:5:"81888";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81889;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Verteporfin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vertéporfine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77390";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Verteporfin";s:5:"title";s:11:"Verteporfin";s:3:"nid";s:5:"81889";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81890;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Vigabatrin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vigabatrine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77391";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vigabatrin";s:5:"title";s:10:"Vigabatrin";s:3:"nid";s:5:"81890";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81891;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Vinblastine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vinblastine ou ses sels";s:16:"field_legacy_nid";s:5:"77392";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Vinblastine";s:5:"title";s:11:"Vinblastine";s:3:"nid";s:5:"81891";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81892;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Vincristine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vincristine ou ses sels";s:16:"field_legacy_nid";s:5:"77393";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Vincristine";s:5:"title";s:11:"Vincristine";s:3:"nid";s:5:"81892";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81893;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Vindesine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vindésine ou ses sels";s:16:"field_legacy_nid";s:5:"77394";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Vindesine";s:5:"title";s:9:"Vindesine";s:3:"nid";s:5:"81893";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81894;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Vinorelbine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vinorelbine ou ses sels";s:16:"field_legacy_nid";s:5:"77395";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Vinorelbine";s:5:"title";s:11:"Vinorelbine";s:3:"nid";s:5:"81894";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81895;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Viomycin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Viomycine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77396";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Viomycin";s:5:"title";s:8:"Viomycin";s:3:"nid";s:5:"81895";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81896;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Voriconazole";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Voriconazole";s:16:"field_legacy_nid";s:5:"77397";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Voriconazole";s:5:"title";s:12:"Voriconazole";s:3:"nid";s:5:"81896";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81897;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Xanthinol nicotinate";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Xantinol (nicotinate de)";s:16:"field_legacy_nid";s:5:"77398";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Xanthinol nicotinate";s:5:"title";s:20:"Xanthinol nicotinate";s:3:"nid";s:5:"81897";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81898;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Xylazine";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Xylazine";s:16:"field_legacy_nid";s:5:"77399";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Xylazine";s:5:"title";s:8:"Xylazine";s:3:"nid";s:5:"81898";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81899;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Zafirlukast or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Zafirlukast ou ses sels";s:16:"field_legacy_nid";s:5:"77400";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Zafirlukast";s:5:"title";s:11:"Zafirlukast";s:3:"nid";s:5:"81899";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81900;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Zalcitabine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Zalcitabine ou ses sels";s:16:"field_legacy_nid";s:5:"77401";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Zalcitabine";s:5:"title";s:11:"Zalcitabine";s:3:"nid";s:5:"81900";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81901;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Gliclazide";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Gliclazide";s:16:"field_legacy_nid";s:5:"76975";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Gliclazide";s:5:"title";s:10:"Gliclazide";s:3:"nid";s:5:"81901";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81902;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Zanamivir or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Zanamivir ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77402";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Zanamivir";s:5:"title";s:9:"Zanamivir";s:3:"nid";s:5:"81902";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81903;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Glimepiride";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Glimepiride";s:16:"field_legacy_nid";s:5:"76976";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Glimepiride";s:5:"title";s:11:"Glimepiride";s:3:"nid";s:5:"81903";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81904;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Zidovudine";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Zidovudine";s:16:"field_legacy_nid";s:5:"77403";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Zidovudine";s:5:"title";s:10:"Zidovudine";s:3:"nid";s:5:"81904";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81905;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:115:"A non-NHP because listed in the Prescription Drug List as follows: Zoledronic acid or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:126:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acide zolédronique ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77404";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Zoledronic acid";s:5:"title";s:15:"Zoledronic acid";s:3:"nid";s:5:"81905";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81906;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Zomepirac or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Zomépirac ou ses sels";s:16:"field_legacy_nid";s:5:"77405";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Zomepirac";s:5:"title";s:9:"Zomepirac";s:3:"nid";s:5:"81906";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81907;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Zopiclone or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Zopiclone ou ses sels";s:16:"field_legacy_nid";s:5:"77406";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Zopiclone";s:5:"title";s:9:"Zopiclone";s:3:"nid";s:5:"81907";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81908;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:114:"A non-NHP because listed in the Prescription Drug List as follows: Zuclopenthixol or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Zuclopenthixol ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77407";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Zuclopenthixol";s:5:"title";s:14:"Zuclopenthixol";s:3:"nid";s:5:"81908";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81909;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"589;17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Vidarabine";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vidarabine";s:16:"field_legacy_nid";s:5:"77409";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vidarabine";s:5:"title";s:10:"Vidarabine";s:3:"nid";s:5:"81909";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81910;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:114:"A non-NHP because listed in the Prescription Drug List as follows: Trandolaprilat or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Trandolaprilat ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77410";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Trandolaprilat";s:5:"title";s:14:"Trandolaprilat";s:3:"nid";s:5:"81910";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81911;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Esmolol or its salts";s:25:"field_non_nhp_rationale_f";s:97:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Esmolol ou ses sels";s:16:"field_legacy_nid";s:5:"77411";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Esmolol";s:5:"title";s:7:"Esmolol";s:3:"nid";s:5:"81911";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81912;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Naltrexone or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Naltrexone ou ses sels";s:16:"field_legacy_nid";s:5:"77412";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Naltrexone";s:5:"title";s:10:"Naltrexone";s:3:"nid";s:5:"81912";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81913;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:84:"A non-NHP because listed in the Prescription Drug List as follows: Neostigmine salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Néostigmine (les sels de)";s:16:"field_legacy_nid";s:5:"77413";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Neostigmine salts";s:5:"title";s:17:"Neostigmine salts";s:3:"nid";s:5:"81913";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81914;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Mitomycin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mitomycine ou ses sels";s:16:"field_legacy_nid";s:5:"77414";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Mitomycin";s:5:"title";s:9:"Mitomycin";s:3:"nid";s:5:"81914";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81915;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Vasopressin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Vasopressine ou ses sels";s:16:"field_legacy_nid";s:5:"77415";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Vasopressin";s:5:"title";s:11:"Vasopressin";s:3:"nid";s:5:"81915";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81916;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Filgrastim";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Filgrastime";s:16:"field_legacy_nid";s:5:"77416";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Filgrastim";s:5:"title";s:10:"Filgrastim";s:3:"nid";s:5:"81916";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81917;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:149:"A non-NHP because listed in the Prescription Drug List as follows: Betaine or its salts when sold or recommended for the treatment of homocystinuria.";s:25:"field_non_nhp_rationale_f";s:174:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bétaïne ou ses sels s’ils sont vendus ou recommandés pour le traitement de l’homocystinu.";s:16:"field_legacy_nid";s:5:"77440";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Betaine";s:5:"title";s:7:"Betaine";s:3:"nid";s:5:"81917";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81918;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:14:"405;1149;17412";s:25:"field_non_nhp_rationale_e";s:308:"A non-NHP because listed in the Prescription Drug List as follows: Nicotinic acid when sold in (a) a modified-release oral dosage form that provides 500 mg or more per dosage unit or per daily dose; or (b) an immediate-release oral dosage form that provides more than 500 mg per dosage unit or per daily dose";s:25:"field_non_nhp_rationale_f";s:487:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acide nicotinique vendu sous l’une des forme suivantes (a) en forme posologique à libération modifiée fournissant, par unité posologique ou par dose quotidienne, 500 mg ou plus d’acide nicotinique administré par voie orale; (b) en forme posologique à libération immédiate fournissant, par unité posologique ou par dose quotidienne, plus de 500 mg d’acide nicotinique administré par voie orale.";s:16:"field_legacy_nid";s:5:"77454";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Niacin";s:5:"title";s:6:"Niacin";s:3:"nid";s:5:"81918";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81919;a:14:{s:4:"body";s:0:"";s:23:"field_ingredient_name_f";s:25:"Chlorhydrate de yohimbine";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"411;17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Yohimbine or its salts";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Yohimbine ou ses sels";s:16:"field_legacy_nid";s:5:"77456";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Yohimbine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:5:"title";s:27:"Yohimbine hydrochloride_ACN";s:3:"nid";s:5:"81919";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81920;a:14:{s:4:"body";s:0:"";s:23:"field_ingredient_name_f";s:9:"Yohimbine";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:12:"381;67;17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Yohimbine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance:   Yohimbine ou ses sels";s:16:"field_legacy_nid";s:5:"77458";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Yohimbine";s:20:"field_ingredient_cat";s:3:"ACN";s:5:"title";s:13:"Yohimbine_ACN";s:3:"nid";s:5:"81920";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81921;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"540;17412";s:25:"field_non_nhp_rationale_e";s:121:"A non-NHP because listed in the Prescription Drug List as follows: Adrenocortical hormones and their salts or derivatives";s:25:"field_non_nhp_rationale_f";s:130:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Hormones corticosurrénales, leurs sels ou dérivés";s:19:"field_old_rationale";s:676:"Adrenosterone is an aromatase (estrogen synthetase) inhibitor and a male sex hormone (Numazawa, Mutsumi et al. 1996; CRC-DNP 2009). It was isolated from the adrenal cortex. Adrenosterone occurs in humans as well as most mammals and is the primary androgenic precursor in fish. It is a steroid hormone with weak androgenic effect. Since androgens are classified as ‘Adrenocortical hormones’ (Gard 2001), Adrenosterone is considered as an adrenocotical hormone. Adrenocortical hormones are listed in schedule F as follow (Justice 2009):“Adrenocortical hormones and their salts and derivatives”. Adrenosterone will not be considered as a NHP, but a schedule F ingredient.";s:16:"field_legacy_nid";s:5:"77491";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Adrenosterone";s:5:"title";s:13:"Adrenosterone";s:3:"nid";s:5:"81921";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81922;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"661;17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Pilocarpine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance :  Pilocarpine ou ses sels";s:19:"field_old_rationale";s:379:"Pilocarpine (CAS # 92-13-7) is an alkaloid isolated from Pilocarpus microphyllus and several other Pilocarpus spp. (Rutaceae) (ChemID Plus, DNP).
Pilocarpine  and its salts are listed under Schedule F of the Food and Drug Regulations. Pilocarpine will be considered a non-NHP, as it is listed on Schedule F, and therefore excluded from bing an NHP by Schedule 2 of the NHP regs.";s:16:"field_legacy_nid";s:5:"77496";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pilocarpine";s:5:"title";s:11:"Pilocarpine";s:3:"nid";s:5:"81922";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81923;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:14:"764;9065;17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Azelaic Acid";s:25:"field_non_nhp_rationale_f";s:96:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance :  Acide azélaïque";s:19:"field_old_rationale";s:91:"Azelaic acid is included in the Schedule F list, and therefore, it is classified as a drug.";s:16:"field_legacy_nid";s:5:"77498";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Azelaic acid";s:5:"title";s:12:"Azelaic acid";s:3:"nid";s:5:"81923";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81924;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Adalimumab";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Adalimumab";s:16:"field_legacy_nid";s:5:"77499";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Adalimumab";s:5:"title";s:10:"Adalimumab";s:3:"nid";s:5:"81924";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81925;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Alefacept";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Abatacept";s:16:"field_legacy_nid";s:5:"77500";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Alefacept";s:5:"title";s:9:"Alefacept";s:3:"nid";s:5:"81925";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81926;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Alemtuzumab";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Alemtuzumab";s:16:"field_legacy_nid";s:5:"77501";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Alemtuzumab";s:5:"title";s:11:"Alemtuzumab";s:3:"nid";s:5:"81926";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81927;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Atomoxetine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Atomoxétine ou ses sels";s:16:"field_legacy_nid";s:5:"77502";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Atomoxetine";s:5:"title";s:11:"Atomoxetine";s:3:"nid";s:5:"81927";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81928;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Beractant";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Béractant";s:16:"field_legacy_nid";s:5:"77503";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Beractant";s:5:"title";s:9:"Beractant";s:3:"nid";s:5:"81928";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81929;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Bleomycin";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bléomycine";s:16:"field_legacy_nid";s:5:"77504";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Bleomycin";s:5:"title";s:9:"Bleomycin";s:3:"nid";s:5:"81929";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81930;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Carbromal";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carbromal";s:16:"field_legacy_nid";s:5:"77505";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Carbromal";s:5:"title";s:9:"Carbromal";s:3:"nid";s:5:"81930";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81931;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Chloralimide";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chloralimide";s:16:"field_legacy_nid";s:5:"77506";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Chloralimide";s:5:"title";s:12:"Chloralimide";s:3:"nid";s:5:"81931";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81932;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Diethylbromacetamide";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Diéthylbromacétamide";s:16:"field_legacy_nid";s:5:"77507";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Diethylbromacetamide";s:5:"title";s:20:"Diethylbromacetamide";s:3:"nid";s:5:"81932";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81933;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Disopyramide or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Disopyramide ou ses sels";s:16:"field_legacy_nid";s:5:"77508";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Disopyramide";s:5:"title";s:12:"Disopyramide";s:3:"nid";s:5:"81933";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81934;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Glipizide";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Glipizide";s:16:"field_legacy_nid";s:5:"76977";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Glipizide";s:5:"title";s:9:"Glipizide";s:3:"nid";s:5:"81934";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81935;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Ecothiophate or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Écothiophate ou ses sels";s:16:"field_legacy_nid";s:5:"77509";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Echothiophate";s:5:"title";s:13:"Echothiophate";s:3:"nid";s:5:"81935";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81936;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Glyburide or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Glyburide ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76978";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Glyburide";s:5:"title";s:9:"Glyburide";s:3:"nid";s:5:"81936";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81937;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:86:"A non-NHP because listed in the Prescription Drug List as follows: Ethyl trichloramate";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Éthyle (trichloramate d’)";s:16:"field_legacy_nid";s:5:"77510";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Ethyl trichloramate";s:5:"title";s:19:"Ethyl trichloramate";s:3:"nid";s:5:"81937";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81938;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Gonadorelin or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Gonadoréline ou ses sels";s:16:"field_legacy_nid";s:5:"76979";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Gonadorelin";s:5:"title";s:11:"Gonadorelin";s:3:"nid";s:5:"81938";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81939;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Glatiramer or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance:Glatiramère ou ses sels";s:16:"field_legacy_nid";s:5:"77511";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Glatiramer";s:5:"title";s:10:"Glatiramer";s:3:"nid";s:5:"81939";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81940;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Goserelin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Goséréline ou ses sels";s:16:"field_legacy_nid";s:5:"76980";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Goserelin";s:5:"title";s:9:"Goserelin";s:3:"nid";s:5:"81940";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81941;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Micafungin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Micafungine ou ses sels";s:16:"field_legacy_nid";s:5:"77512";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Micafungin";s:5:"title";s:10:"Micafungin";s:3:"nid";s:5:"81941";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81942;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Pancuronium or its salts.";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Pancuronium ou ses sels";s:16:"field_legacy_nid";s:5:"77513";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Pancuronium bromide";s:5:"title";s:19:"Pancuronium bromide";s:3:"nid";s:5:"81942";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81943;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Granisetron or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Granisetron ou ses sels";s:16:"field_legacy_nid";s:5:"76981";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Granisetron";s:5:"title";s:11:"Granisetron";s:3:"nid";s:5:"81943";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81944;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Pegaptanib or its salts.";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Pegaptanib ou ses sels";s:16:"field_legacy_nid";s:5:"77514";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Pegaptanib sodium";s:5:"title";s:17:"Pegaptanib sodium";s:3:"nid";s:5:"81944";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81945;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:113:"A non-NHP because listed in the Prescription Drug List as follows: Grepafloxacin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:122:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Grépafloxacine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76982";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Grepafloxacin";s:5:"title";s:13:"Grepafloxacin";s:3:"nid";s:5:"81945";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81946;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Phenthoxate or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Phentoxate ou ses sels";s:16:"field_legacy_nid";s:5:"77515";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Phenthoxate";s:5:"title";s:11:"Phenthoxate";s:3:"nid";s:5:"81946";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81947;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Guanethidine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Guanethidine ou ses sels";s:16:"field_legacy_nid";s:5:"76983";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Guanethidine";s:5:"title";s:12:"Guanethidine";s:3:"nid";s:5:"81947";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81948;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Halofantrine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Halofantrine ou ses sels";s:16:"field_legacy_nid";s:5:"76984";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Halofantrine";s:5:"title";s:12:"Halofantrine";s:3:"nid";s:5:"81948";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81949;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Sitaxentan or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Sitaxentan ou ses sels";s:16:"field_legacy_nid";s:5:"77516";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Sitaxentan";s:5:"title";s:10:"Sitaxentan";s:3:"nid";s:5:"81949";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81950;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Haloperidol";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Halopéridol";s:16:"field_legacy_nid";s:5:"76985";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Haloperidol";s:5:"title";s:11:"Haloperidol";s:3:"nid";s:5:"81950";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81951;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:13:"641;103;17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Triiodothyropropionic acid";s:25:"field_non_nhp_rationale_f";s:108:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Triiodothyropropionique (acide)";s:16:"field_legacy_nid";s:5:"77517";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Triiodothyropropionic acid";s:5:"title";s:26:"Triiodothyropropionic acid";s:3:"nid";s:5:"81951";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81952;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Halothane";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Halothane";s:16:"field_legacy_nid";s:5:"76986";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Halothane";s:5:"title";s:9:"Halothane";s:3:"nid";s:5:"81952";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81953;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"641;17412";s:25:"field_non_nhp_rationale_e";s:84:"A non-NHP because listed in the Prescription Drug List as follows: Neostigmine salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Néostigmine (les sels de)";s:16:"field_legacy_nid";s:5:"77518";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Neostigmine";s:5:"title";s:11:"Neostigmine";s:3:"nid";s:5:"81953";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81954;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Hetacillin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Hétacilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76987";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Hetacillin";s:5:"title";s:10:"Hetacillin";s:3:"nid";s:5:"81954";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81955;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:9:"815;17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Oxybutynin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Oxybutynine ou ses sels";s:19:"field_old_rationale";s:319:"is the hydrochloride salt of oxybutynin hydrochloride (CAS # 1508-65-2) (ChemID Plus, Sweetman 2009). Its therapeutic application is in the treatment of urinary incontinence (O’Neil 2009). Oxybutynin and its salts are listed under Schedule F of the Food and Drug Regulations, and therefore will be considered as drug.";s:16:"field_legacy_nid";s:5:"77524";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Oxybutynin";s:5:"title";s:10:"Oxybutynin";s:3:"nid";s:5:"81955";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81956;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Hetastarch and its derivatives";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Hetastarch et ses dérivés";s:16:"field_legacy_nid";s:5:"76988";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Hetastarch";s:5:"title";s:10:"Hetastarch";s:3:"nid";s:5:"81956";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81957;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:15:"1013;3213;17412";s:25:"field_non_nhp_rationale_e";s:115:"A non-NHP because listed in the Prescription Drug List as follows: Antipyrine (except preparations for topical use)";s:25:"field_non_nhp_rationale_f";s:136:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Antipyrine (sauf dans les préparations pour usage topique)";s:16:"field_legacy_nid";s:5:"77549";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Antipyrine";s:5:"title";s:10:"Antipyrine";s:3:"nid";s:5:"81957";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81958;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Hexachlorophene or its salts";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Hexachlorophène ou ses sels";s:16:"field_legacy_nid";s:5:"76989";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Hexachlorophene";s:5:"title";s:15:"Hexachlorophene";s:3:"nid";s:5:"81958";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81959;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:15:"1013;3213;17412";s:25:"field_non_nhp_rationale_e";s:261:"A non-NHP because listed in the Prescription Drug List as follows: Adrenocortical hormones and their salts or derivatives, except clobetasone butyrate, when sold in a concentration of 0.05% clobetasone butyrate in cream preparations for topical use on the skin.";s:25:"field_non_nhp_rationale_f";s:280:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Hormones corticosurrénales, leurs sels ou dérivés sauf les suivants :le butyrate de clobétasone vendu sous forme de crème contenant 0,05 % de butyrate de clobétasone pour usage topique sur la peau.";s:16:"field_legacy_nid";s:5:"77579";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Clobetasone Butyrate";s:5:"title";s:20:"Clobetasone Butyrate";s:3:"nid";s:5:"81959";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81960;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Hexacyclonate sodium";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Hexacyclonate sodique";s:16:"field_legacy_nid";s:5:"76990";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Hexacyclonate sodium";s:5:"title";s:20:"Hexacyclonate sodium";s:3:"nid";s:5:"81960";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81961;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:15:"1013;3213;17412";s:25:"field_non_nhp_rationale_e";s:189:"A non-NHP because listed in the Prescription Drug List as follows: Polymyxin B or its salts or derivatives, (except for topical use or for local action in the oral cavity or nasal passages)";s:25:"field_non_nhp_rationale_f";s:198:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Polymyxine B, ses sels ou dérivés, (sauf pour usage topique ou local dans la cavité buccale ou dans les voies nasales)";s:16:"field_legacy_nid";s:5:"77588";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Polymyxin B";s:5:"title";s:11:"Polymyxin B";s:3:"nid";s:5:"81961";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81962;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Hexamethonium or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Hexaméthonium ou ses sels";s:16:"field_legacy_nid";s:5:"76991";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Hexamethonium";s:5:"title";s:13:"Hexamethonium";s:3:"nid";s:5:"81962";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81963;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:15:"1013;3213;17412";s:25:"field_non_nhp_rationale_e";s:134:"A non-NHP because listed in the Prescription Drug List as follows: Chlorhexidine or its salts, when used as a topical oral preparation";s:25:"field_non_nhp_rationale_f";s:151:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Chlorhexidine ou ses sels, dans les préparations pour usage oral topique.";s:16:"field_legacy_nid";s:5:"77599";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Chlorhexidine acetate";s:5:"title";s:21:"Chlorhexidine acetate";s:3:"nid";s:5:"81963";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81964;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"2678;17412";s:25:"field_non_nhp_rationale_e";s:106:"A non-NHP because listed in the Prescription Drug List as follows: Trabectedin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:113:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Trabectedin ou ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77607";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Trabectedin";s:5:"title";s:11:"Trabectedin";s:3:"nid";s:5:"81964";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81965;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Histrelin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Histréline ou ses sels";s:16:"field_legacy_nid";s:5:"76992";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Histrelin";s:5:"title";s:9:"Histrelin";s:3:"nid";s:5:"81965";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81966;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Acamprosate or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acamprosate ou ses sels";s:16:"field_legacy_nid";s:5:"77619";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Acamprosate";s:5:"title";s:11:"Acamprosate";s:3:"nid";s:5:"81966";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81967;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:82:"A non-NHP because listed in the Prescription Drug List as follows: Agalsidase alfa";s:25:"field_non_nhp_rationale_f";s:93:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Agalsidase alfa";s:16:"field_legacy_nid";s:5:"77620";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Agalsidase alfa";s:5:"title";s:15:"Agalsidase alfa";s:3:"nid";s:5:"81967";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81968;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Hydralazine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Hydralazine ou ses sels";s:16:"field_legacy_nid";s:5:"76993";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Hydralazine";s:5:"title";s:11:"Hydralazine";s:3:"nid";s:5:"81968";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81969;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Aprepitant and its derivatives";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aprépitant et ses dérivés";s:16:"field_legacy_nid";s:5:"77621";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Aprepitant";s:5:"title";s:10:"Aprepitant";s:3:"nid";s:5:"81969";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81970;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Butyl chloral hydrate";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Butylchloral (hydrate de)";s:16:"field_legacy_nid";s:5:"77622";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Butyl chloral hydrate";s:5:"title";s:21:"Butyl chloral hydrate";s:3:"nid";s:5:"81970";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81971;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:98:"A non-NHP because listed in the Prescription Drug List as follows: Hydroxychloroquine or its salts";s:25:"field_non_nhp_rationale_f";s:108:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Hydroxychloroquine ou ses sels";s:16:"field_legacy_nid";s:5:"76994";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Hydroxychloroquine";s:5:"title";s:18:"Hydroxychloroquine";s:3:"nid";s:5:"81971";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81972;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:137:"A non-NHP because listed in the Prescription Drug List as follows: Choline salicylate, when sold in combination with magnesium salicylate";s:25:"field_non_nhp_rationale_f";s:166:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Choline (salicylate de) s’il est vendu en association avec le salicylate de magnésium";s:16:"field_legacy_nid";s:5:"77623";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Choline salicylate";s:5:"title";s:18:"Choline salicylate";s:3:"nid";s:5:"81972";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81973;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:147:"A non-NHP because listed in the Prescription Drug List as follows: 4-Hydroxycoumarin and its derivatives when sold or recommended as anticoagulants";s:25:"field_non_nhp_rationale_f";s:172:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Hydroxy-4 coumarine et ses dérivés, s’ils sont vendus ou recommandés comme anticoagulants";s:16:"field_legacy_nid";s:5:"76995";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"4-Hydroxycoumarin";s:5:"title";s:17:"4-Hydroxycoumarin";s:3:"nid";s:5:"81973";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81974;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Cyclosporine";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance :Cyclosporine";s:16:"field_legacy_nid";s:5:"77624";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Cyclosporine";s:5:"title";s:12:"Cyclosporine";s:3:"nid";s:5:"81974";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81975;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Drotrecogin";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance :Drotrécogine";s:16:"field_legacy_nid";s:5:"77625";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Drotrecogin";s:5:"title";s:11:"Drotrecogin";s:3:"nid";s:5:"81975";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81976;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Ecothiophate or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Écothiophate ou ses sels";s:16:"field_legacy_nid";s:5:"77626";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Ecothiophate";s:5:"title";s:12:"Ecothiophate";s:3:"nid";s:5:"81976";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81977;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:98:"A non-NHP because listed in the Prescription Drug List as follows: Gonadotropin, chorionic (human)";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Gonadotropine chorionique (humain)";s:16:"field_legacy_nid";s:5:"77627";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Chorionic Gonadotrophin";s:5:"title";s:23:"Chorionic Gonadotrophin";s:3:"nid";s:5:"81977";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81978;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Gonadotropins, serum (human)";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Gonadotropines sériques (humains)";s:16:"field_legacy_nid";s:5:"77628";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Gonadotropins, serum (human)";s:5:"title";s:28:"Gonadotropins, serum (human)";s:3:"nid";s:5:"81978";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81979;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Inhaled human insulin";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Insuline humaine inhalée";s:16:"field_legacy_nid";s:5:"77629";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Inhaled human insulin";s:5:"title";s:21:"Inhaled human insulin";s:3:"nid";s:5:"81979";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81980;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Milbemycin and its derivatives";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Milbémycine et ses dérivés";s:16:"field_legacy_nid";s:5:"77630";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Milbemycin";s:5:"title";s:10:"Milbemycin";s:3:"nid";s:5:"81980";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81981;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:14:"3213;103;17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Reviparin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Réviparine ou ses sels";s:16:"field_legacy_nid";s:5:"77631";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Reviparin";s:5:"title";s:9:"Reviparin";s:3:"nid";s:5:"81981";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81982;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:14:"3213;103;17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Sitagliptin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Sitagliptine ou ses sels";s:16:"field_legacy_nid";s:5:"77632";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Sitagliptin";s:5:"title";s:11:"Sitagliptin";s:3:"nid";s:5:"81982";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81983;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:14:"3213;103;17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Acepromazine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Sitagliptine ou ses sels";s:16:"field_legacy_nid";s:5:"77633";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Acepromazine";s:5:"title";s:12:"Acepromazine";s:3:"nid";s:5:"81983";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81984;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:15:"3213;6315;17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Acetanilide";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Acétanilide";s:16:"field_legacy_nid";s:5:"77634";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Acetanilide";s:5:"title";s:11:"Acetanilide";s:3:"nid";s:5:"81984";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81985;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Aminopyrine et ses dérivés";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acamprosate ou ses sels";s:16:"field_legacy_nid";s:5:"77640";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Aminopyrine";s:5:"title";s:11:"Aminopyrine";s:3:"nid";s:5:"81985";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81986;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Hydroxyurea";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Hydroxyurée";s:16:"field_legacy_nid";s:5:"76996";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Hydroxyurea";s:5:"title";s:11:"Hydroxyurea";s:3:"nid";s:5:"81986";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81987;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Amprolium or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Amprolium ou ses sels";s:16:"field_legacy_nid";s:5:"77641";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Amprolium";s:5:"title";s:9:"Amprolium";s:3:"nid";s:5:"81987";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81988;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Hydroxyzine or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Hydroxyzine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76997";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Hydroxyzine";s:5:"title";s:11:"Hydroxyzine";s:3:"nid";s:5:"81988";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81989;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Apramycin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Apramycine ou ses sels";s:16:"field_legacy_nid";s:5:"77642";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Apramycin";s:5:"title";s:9:"Apramycin";s:3:"nid";s:5:"81989";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81990;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:107:"A non-NHP because listed in the Prescription Drug List as follows: Azithromycin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:113:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Azithromycine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77643";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Azithromycin";s:5:"title";s:12:"Azithromycin";s:3:"nid";s:5:"81990";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81991;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Isocarboxazid or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Isocarboxazide ou ses sels";s:16:"field_legacy_nid";s:5:"76998";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Isocarboxazid";s:5:"title";s:13:"Isocarboxazid";s:3:"nid";s:5:"81991";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81992;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Isoflurane";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Isoflurane";s:16:"field_legacy_nid";s:5:"76999";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Isoflurane";s:5:"title";s:10:"Isoflurane";s:3:"nid";s:5:"81992";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81993;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:15:"3213;5761;17412";s:25:"field_non_nhp_rationale_e";s:135:"A non-NHP because listed in the Prescription Drug List as follows: Chlorhexidine or its salts, when used as a topical oral preparation.";s:25:"field_non_nhp_rationale_f";s:151:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Chlorhexidine ou ses sels, dans les préparations pour usage oral topique.";s:16:"field_legacy_nid";s:5:"77644";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Chlorhexidine";s:5:"title";s:13:"Chlorhexidine";s:3:"nid";s:5:"81993";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81994;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Isoniazid";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Isoniazide";s:16:"field_legacy_nid";s:5:"77000";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Isoniazid";s:5:"title";s:9:"Isoniazid";s:3:"nid";s:5:"81994";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81995;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Chlorothiazide or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:114:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Chlorothiazide, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77645";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Chlorothiazide";s:5:"title";s:14:"Chlorothiazide";s:3:"nid";s:5:"81995";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81996;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Isoproterenol (Isoprenaline) or its salts";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Isoprotérénol (Isoprénaline) ou ses sels";s:16:"field_legacy_nid";s:5:"77001";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Isoproterenol (Isoprenaline)";s:5:"title";s:28:"Isoproterenol (Isoprenaline)";s:3:"nid";s:5:"81996";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81997;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Cholestyramine resin.";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance:Colestyramine (résine de).";s:16:"field_legacy_nid";s:5:"77646";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Chlorpromazine";s:5:"title";s:14:"Chlorpromazine";s:3:"nid";s:5:"81997";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81998;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Isoxsuprine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Isoxsuprine ou ses sels";s:16:"field_legacy_nid";s:5:"77002";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Isoxsuprine";s:5:"title";s:11:"Isoxsuprine";s:3:"nid";s:5:"81998";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:81999;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Cholestyramine resin.";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance:Colestyramine (résine de).";s:16:"field_legacy_nid";s:5:"77647";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Cholestyramine";s:5:"title";s:14:"Cholestyramine";s:3:"nid";s:5:"81999";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82000;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:106:"A non-NHP because listed in the Prescription Drug List as follows: Clarithromycine, ses sels et dérivés.";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance:Colestyramine (résine de).";s:16:"field_legacy_nid";s:5:"77648";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Clarithromycin";s:5:"title";s:14:"Clarithromycin";s:3:"nid";s:5:"82000";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82001;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Isradipine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Isradipine ou ses sels";s:16:"field_legacy_nid";s:5:"77003";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Isradipine";s:5:"title";s:10:"Isradipine";s:3:"nid";s:5:"82001";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82002;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Cyclizine";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance:Colestyramine (résine de).";s:16:"field_legacy_nid";s:5:"77649";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Cyclizine";s:5:"title";s:9:"Cyclizine";s:3:"nid";s:5:"82002";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82003;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Itraconazole or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Itraconazole ou ses sels";s:16:"field_legacy_nid";s:5:"77004";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Itraconazole";s:5:"title";s:12:"Itraconazole";s:3:"nid";s:5:"82003";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82004;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:228:"A non-NHP because listed in the Prescription Drug List as follows: Ivermectin and its derivatives, for human use or for veterinary use when sold for intramuscular injection into horses or for oral administration to dogs and cats";s:25:"field_non_nhp_rationale_f";s:287:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ivermectine et ses dérivés, destinés à l'usage humain ou à l'usage vétérinaire, s'ils sont vendus pour injection intramusculaire aux chevaux ou pour administration par voie orale aux chiens et aux chats";s:16:"field_legacy_nid";s:5:"77005";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ivermectin";s:5:"title";s:10:"Ivermectin";s:3:"nid";s:5:"82004";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82005;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Erythromycin or its salts or derivatives.";s:25:"field_non_nhp_rationale_f";s:115:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Érythromycine, ses sels ou dérivés.";s:16:"field_legacy_nid";s:5:"77651";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Erythromycin";s:5:"title";s:12:"Erythromycin";s:3:"nid";s:5:"82005";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82006;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Ketanserin or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Kétansérine ou ses sels";s:16:"field_legacy_nid";s:5:"77006";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ketanserin";s:5:"title";s:10:"Ketanserin";s:3:"nid";s:5:"82006";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82007;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:106:"A non-NHP because listed in the Prescription Drug List as follows: Framycetin or its salts or derivatives.";s:25:"field_non_nhp_rationale_f";s:113:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Framycétine, ses sels ou dérivés.";s:16:"field_legacy_nid";s:5:"77652";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Framycetin";s:5:"title";s:10:"Framycetin";s:3:"nid";s:5:"82007";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82008;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:11:"12491;17412";s:25:"field_non_nhp_rationale_e";s:277:"A non-NHP because listed in the Prescription Drug List as follows: Ketoconazole or its salts (except in preparations for topical use as a shampoo). Also a non-NHP because it is not a naturally occurring substance.

A non-NHP because it is not a naturally occurring substance.";s:25:"field_non_nhp_rationale_f";s:318:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Kétoconazole ou ses sels (excepté pour les préparations pour usage topique sous la forme d’un shampooing).

Un non-PSN car ce n'est pas une substance d'origine naturelle.
Un non-PSN car ce n'est pas une substance d'origine naturelle.";s:16:"field_legacy_nid";s:5:"77007";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Ketoconazole";s:5:"title";s:12:"Ketoconazole";s:3:"nid";s:5:"82008";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82009;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Furaltadone or its salts.";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Furaltadone ou ses sels.";s:16:"field_legacy_nid";s:5:"77653";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Furaltadone";s:5:"title";s:11:"Furaltadone";s:3:"nid";s:5:"82009";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82010;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Furazolidone or its salts.";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Furazolidone ou ses sels";s:16:"field_legacy_nid";s:5:"77654";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Furazolidone";s:5:"title";s:12:"Furazolidone";s:3:"nid";s:5:"82010";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82011;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Ketoprofene or its saltss";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Kétoprofène ou ses sels";s:16:"field_legacy_nid";s:5:"77008";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ketoprofene";s:5:"title";s:11:"Ketoprofene";s:3:"nid";s:5:"82011";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82012;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Ketorolac or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Kétorolac ou ses sels";s:16:"field_legacy_nid";s:5:"77009";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ketorolac";s:5:"title";s:9:"Ketorolac";s:3:"nid";s:5:"82012";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82013;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Furosemide";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Furosémide";s:16:"field_legacy_nid";s:5:"77655";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Furosemide";s:5:"title";s:10:"Furosemide";s:3:"nid";s:5:"82013";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82014;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Ketotifen or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Kétotifène ou ses sels";s:16:"field_legacy_nid";s:5:"77010";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ketotifen";s:5:"title";s:9:"Ketotifen";s:3:"nid";s:5:"82014";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82015;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:107:"A non-NHP because listed in the Prescription Drug List as follows: Griseofulvin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:114:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Griséofulvine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77656";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Griseofulvin";s:5:"title";s:12:"Griseofulvin";s:3:"nid";s:5:"82015";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82016;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:104:"A non-NHP because listed in the Prescription Drug List as follows: Kanamycin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:110:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Kanamycine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77657";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Kanamycin";s:5:"title";s:9:"Kanamycin";s:3:"nid";s:5:"82016";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82017;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Levamisole or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Lévamisole ou ses sels";s:16:"field_legacy_nid";s:5:"77658";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Levamisole";s:5:"title";s:10:"Levamisole";s:3:"nid";s:5:"82017";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82018;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Labetalol or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Labétalol ou ses sels";s:16:"field_legacy_nid";s:5:"77011";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Labetalol";s:5:"title";s:9:"Labetalol";s:3:"nid";s:5:"82018";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82019;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:105:"A non-NHP because listed in the Prescription Drug List as follows: Lincomycin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Lincomycine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77659";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Lincomycin";s:5:"title";s:10:"Lincomycin";s:3:"nid";s:5:"82019";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82020;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Lamivudine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lamivudine ou ses sels";s:16:"field_legacy_nid";s:5:"77012";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Lamivudine";s:5:"title";s:10:"Lamivudine";s:3:"nid";s:5:"82020";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82021;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Liothyronine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Liothyronine ou ses sels";s:16:"field_legacy_nid";s:5:"77660";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Liothyronine";s:5:"title";s:12:"Liothyronine";s:3:"nid";s:5:"82021";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82022;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Lamotrigine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lamotrigue ou ses sels";s:16:"field_legacy_nid";s:5:"77013";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Lamotrigine";s:5:"title";s:11:"Lamotrigine";s:3:"nid";s:5:"82022";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82023;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Mebendazole";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Mébendazole";s:16:"field_legacy_nid";s:5:"77661";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Mebendazole";s:5:"title";s:11:"Mebendazole";s:3:"nid";s:5:"82023";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82024;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:152:"A non-NHP because listed in the Prescription Drug List as follows: Meclizine or its salts when sold in concentrations greater than 25 mg per dosage unit";s:25:"field_non_nhp_rationale_f";s:184:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Méclizine ou ses sels s’ils sont vendus en une concentration supérieure à 25 mg par unité posologique";s:16:"field_legacy_nid";s:5:"77662";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Meclizine";s:5:"title";s:9:"Meclizine";s:3:"nid";s:5:"82024";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82025;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Lansoprazole or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lansoprazole ou ses sels";s:16:"field_legacy_nid";s:5:"77014";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Lansoprazole";s:5:"title";s:12:"Lansoprazole";s:3:"nid";s:5:"82025";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82026;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:103:"A non-NHP because listed in the Prescription Drug List as follows: Neomycin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:110:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Néomycine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77663";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Neomycin";s:5:"title";s:8:"Neomycin";s:3:"nid";s:5:"82026";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82027;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Nicarbazin";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Nicarbazin";s:16:"field_legacy_nid";s:5:"77664";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nicarbazin";s:5:"title";s:10:"Nicarbazin";s:3:"nid";s:5:"82027";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82028;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Laronidase";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Laronidase";s:16:"field_legacy_nid";s:5:"77015";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Laronidase";s:5:"title";s:10:"Laronidase";s:3:"nid";s:5:"82028";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82029;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Latanoprost";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Latanoprost";s:16:"field_legacy_nid";s:5:"77016";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Latanoprost";s:5:"title";s:11:"Latanoprost";s:3:"nid";s:5:"82029";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82030;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:94:"A non-NHP because listed in the Prescription Drug List as follows: Nitrofurantoin or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Nitrofurantoine ou ses sels";s:16:"field_legacy_nid";s:5:"77665";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Nitrofurantoin";s:5:"title";s:14:"Nitrofurantoin";s:3:"nid";s:5:"82030";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82031;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:105:"A non-NHP because listed in the Prescription Drug List as follows: Novobiocin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Novobiocine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77666";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Novobiocin";s:5:"title";s:10:"Novobiocin";s:3:"nid";s:5:"82031";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82032;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Leflunomide or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Léflunomide ou ses sels";s:16:"field_legacy_nid";s:5:"77017";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Leflunomide";s:5:"title";s:11:"Leflunomide";s:3:"nid";s:5:"82032";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82033;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:107:"A non-NHP because listed in the Prescription Drug List as follows: Oleandomycin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:114:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Oléandomycine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77667";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Oleandomycin";s:5:"title";s:12:"Oleandomycin";s:3:"nid";s:5:"82033";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82034;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:105:"A non-NHP because listed in the Prescription Drug List as follows: Penicillin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:112:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Pénicilline, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77668";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Penicillin";s:5:"title";s:10:"Penicillin";s:3:"nid";s:5:"82034";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82035;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:143:"A non-NHP because listed in the Prescription Drug List as follows: Physostigmine salicylate (except preparations for oral or topical use only).";s:25:"field_non_nhp_rationale_f";s:175:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Physostigmine (salicylate de), (sauf dans les préparations pour usage oral et topique seulement).";s:16:"field_legacy_nid";s:5:"77669";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Physostigmine salicylate";s:5:"title";s:24:"Physostigmine salicylate";s:3:"nid";s:5:"82035";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82036;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Primidone";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Primidone";s:16:"field_legacy_nid";s:5:"77670";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Primidone";s:5:"title";s:9:"Primidone";s:3:"nid";s:5:"82036";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82037;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Letrozole";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Létrozole";s:16:"field_legacy_nid";s:5:"77018";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Letrozole";s:5:"title";s:9:"Letrozole";s:3:"nid";s:5:"82037";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82038;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Leuprolide or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Leuproréline ou ses sels";s:16:"field_legacy_nid";s:5:"77019";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Leuprolide";s:5:"title";s:10:"Leuprolide";s:3:"nid";s:5:"82038";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82039;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Promazine et ses sels";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Primidone";s:16:"field_legacy_nid";s:5:"77671";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Promazine";s:5:"title";s:9:"Promazine";s:3:"nid";s:5:"82039";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82040;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Reserpine or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Réserpine ou ses sels";s:16:"field_legacy_nid";s:5:"77672";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Reserpine";s:5:"title";s:9:"Reserpine";s:3:"nid";s:5:"82040";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82041;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:105:"A non-NHP because listed in the Prescription Drug List as follows: Ronidazole or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:110:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Ronidazole, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77673";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ronidazole";s:5:"title";s:10:"Ronidazole";s:3:"nid";s:5:"82041";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82042;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:162:"A non-NHP because listed in the Prescription Drug List as follows: Sodium fluoride (in solid oral dosage forms containing more than one milligram of fluoride ion)";s:25:"field_non_nhp_rationale_f";s:183:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Sodium (fluorure de) (sous forme posologique solide orale contenant plus d’un milligramme d’ion fluor)";s:16:"field_legacy_nid";s:5:"77674";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Sodium fluoride";s:5:"title";s:15:"Sodium fluoride";s:3:"nid";s:5:"82042";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82043;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Levetiracetam";s:25:"field_non_nhp_rationale_f";s:94:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lévétiracétam";s:16:"field_legacy_nid";s:5:"77020";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Levetiracetam";s:5:"title";s:13:"Levetiracetam";s:3:"nid";s:5:"82043";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82044;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Spectinomycin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:114:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Spectinomycine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77675";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Spectinomycin";s:5:"title";s:13:"Spectinomycin";s:3:"nid";s:5:"82044";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82045;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:105:"A non-NHP because listed in the Prescription Drug List as follows: Spiramycin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Spiramycine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77676";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Spiramycin";s:5:"title";s:10:"Spiramycin";s:3:"nid";s:5:"82045";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82046;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:15:"3213;5761;17412";s:25:"field_non_nhp_rationale_e";s:107:"A non-NHP because listed in the Prescription Drug List as follows: Streptomycin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:113:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Streptomycine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77677";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Streptomycin";s:5:"title";s:12:"Streptomycin";s:3:"nid";s:5:"82046";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82047;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Levobunolol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Levobunolol ou ses sels";s:16:"field_legacy_nid";s:5:"77021";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Levobunolol";s:5:"title";s:11:"Levobunolol";s:3:"nid";s:5:"82047";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82048;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:186:"A non-NHP because listed in the Prescription Drug List as follows: Tetracycline or its salts or derivatives (except doxycycline when sold for intramuscular administration in caged birds)";s:25:"field_non_nhp_rationale_f";s:207:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Tétracycline, ses sels ou dérivés (sauf doxycycline si elle est vendue pour administration intramusculaire aux oiseaux en cage)";s:16:"field_legacy_nid";s:5:"77678";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Tetracycline";s:5:"title";s:12:"Tetracycline";s:3:"nid";s:5:"82048";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82049;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Levocabastine or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lévocabastine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77022";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Levocabastine";s:5:"title";s:13:"Levocabastine";s:3:"nid";s:5:"82049";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82050;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Thiabendazole";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Thiabendazole";s:16:"field_legacy_nid";s:5:"77679";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Thiabendazole";s:5:"title";s:13:"Thiabendazole";s:3:"nid";s:5:"82050";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82051;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Trimeprazine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Triméprazine ou ses sels";s:16:"field_legacy_nid";s:5:"77680";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Trimeprazine";s:5:"title";s:12:"Trimeprazine";s:3:"nid";s:5:"82051";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82052;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Linezolid or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Linézolide ou ses sels";s:16:"field_legacy_nid";s:5:"77023";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Linezolid";s:5:"title";s:9:"Linezolid";s:3:"nid";s:5:"82052";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82053;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Virginiamycin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:114:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Virginiamycine, ses sels ou dérivés";s:16:"field_legacy_nid";s:5:"77681";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Virginiamycin";s:5:"title";s:13:"Virginiamycin";s:3:"nid";s:5:"82053";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82054;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:105:"A non-NHP because listed in the Prescription Drug List as follows: Lisinopril or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lisinopril ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77024";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Lisinopril";s:5:"title";s:10:"Lisinopril";s:3:"nid";s:5:"82054";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82055;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3997;17412";s:25:"field_non_nhp_rationale_e";s:74:"A non-NHP because listed in the Prescription Drug List as follows: Thyroid";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Thyroïde";s:16:"field_legacy_nid";s:5:"77683";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Thyroid";s:5:"title";s:7:"Thyroid";s:3:"nid";s:5:"82055";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82056;a:13:{s:4:"body";s:0:"";s:23:"field_ingredient_name_f";s:52:"Vitamine B12 avec concentré de facteur intrinsèque";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"7088;17412";s:25:"field_non_nhp_rationale_e";s:112:"A non-NHP because listed in the Prescription Drug List as follows: Vitamin B12 with Intrinsic Factor Concentrate";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Vitamine B12 avec concentré de facteur intrinsèque";s:16:"field_legacy_nid";s:5:"77740";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:45:"Vitamin B12 with Intrinsic Factor Concentrate";s:5:"title";s:45:"Vitamin B12 with Intrinsic Factor Concentrate";s:3:"nid";s:5:"82056";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82057;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:15:"8666;8249;17412";s:25:"field_non_nhp_rationale_e";s:183:"As per the Prescription Drug List, Levocarnitine or its salts or derivatives, when sold for the treatment of primary or secondary levocarnitine deficiency, are classified as non-NHPs.";s:25:"field_non_nhp_rationale_f";s:220:"Selon la Liste des drogues sur ordonnance, la Lévocarnitine ou ses sels ou dérivés, lorsqu'ils sont vendu pour le traitement de la déficience primaire ou secondaire de lévocarnitine, sont classifiés comme non PSNs.";s:19:"field_old_rationale";s:342:"Amendment: Levocarnitine and its salts and derivatives in Part I of Schedule F to the Regulations is replaced by the following: Levocarnitine and its salts and derivatives, when sold for the treatment of primary or secondary levocarnitine deficiency. Canada Gazette Part II: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/pdf/g2-14525.pdf.";s:16:"field_legacy_nid";s:5:"77743";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Propionyl-L-carnitine";s:5:"title";s:21:"Propionyl-L-carnitine";s:3:"nid";s:5:"82057";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82058;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:15:"8759;8249;17412";s:25:"field_non_nhp_rationale_e";s:183:"As per the Prescription Drug List, Levocarnitine or its salts or derivatives, when sold for the treatment of primary or secondary levocarnitine deficiency, are classified as non-NHPs.";s:25:"field_non_nhp_rationale_f";s:220:"Selon la Liste des drogues sur ordonnance, la Lévocarnitine ou ses sels ou dérivés, lorsqu'ils sont vendu pour le traitement de la déficience primaire ou secondaire de lévocarnitine, sont classifiés comme non PSNs.";s:19:"field_old_rationale";s:342:"Amendment: Levocarnitine and its salts and derivatives in Part I of Schedule F to the Regulations is replaced by the following: Levocarnitine and its salts and derivatives, when sold for the treatment of primary or secondary levocarnitine deficiency. Canada Gazette Part II: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/pdf/g2-14525.pdf.";s:16:"field_legacy_nid";s:5:"77744";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Acetyl-L-Carnitine";s:5:"title";s:18:"Acetyl-L-Carnitine";s:3:"nid";s:5:"82058";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82059;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:11:"11866;17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because Androstenone is a sex hormone falling under the Prescription Drug List.";s:25:"field_non_nhp_rationale_f";s:105:"Un Non-PSN car Androsténone est une hormone sexuelle qui relève de la Liste des drogues sur ordonnance.";s:16:"field_legacy_nid";s:5:"77747";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Androstenone";s:5:"title";s:12:"Androstenone";s:3:"nid";s:5:"82059";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82060;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"2911;17412";s:25:"field_non_nhp_rationale_e";s:235:"As per the Prescription Drug List, the dose of Quinine or its salts or derivatives, per dosage unit or per daily dose, in oral NHPs must not exceed 50 mg; and above 50 mg, Quinine or its salts or derivatives are classified as non-NHPs.";s:25:"field_non_nhp_rationale_f";s:296:"Selon la Liste des drogues sur ordonnance. la dose de Quinine ou ses sels ou dérivés, par unité posologique ou par dose quotidienne, dans les PSN oraux ne doit pas dépasser 50 mg; et lorsque cette dose est supérieure à 50 mg, Quinine ou ses sels ou dérivés sont classifiés comme non PSN.";s:16:"field_legacy_nid";s:6:"105980";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Quinine";s:5:"title";s:7:"Quinine";s:3:"nid";s:5:"82060";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82061;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"1203;17412";s:25:"field_non_nhp_rationale_e";s:296:"As per the Prescription Drug List, the dose of Pancreatin, in terms of lipase activity, must not exceed 20 000 USP units per dosage unit; and above 20 000 USP units of lipase activity or when indicated for the treatment of pancreatic exocrine insufficiency, Pancreatin is classified as a non-NHP.";s:25:"field_non_nhp_rationale_f";s:364:"Selon la Liste des drogues sur ordonnance, la dose de Pancréatine, en fonction d'activité lipasique, ne doit pas dépasser 20 000 unités USP par unité posologique; et lorsque la dose est supérieure à 20 000 unités USP d'activité lipasique ou indiquée pour le traitement de l'insuffisance pancréatique exocrine, Pancréatine est classifié common non-PSN.";s:16:"field_legacy_nid";s:6:"105981";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pancreatin";s:5:"title";s:10:"Pancreatin";s:3:"nid";s:5:"82061";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82062;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"1203;17412";s:25:"field_non_nhp_rationale_e";s:300:"As per the Prescription Drug List, the dose of Pancrelipase, in terms of lipase activity, must not exceed 20 000 USP units per dosage unit; and above 20 000 USP units of lipase activity or when indicated for the treatment of pancreatic exocrine insufficiency, Pancrelipase is classified as a non-NHP.";s:25:"field_non_nhp_rationale_f";s:366:"Selon la Liste des drogues sur ordonnance, la dose de Pancrélipase, en fonction d'activité lipasique, ne doit pas dépasser 20 000 unités USP par unité posologique; et lorsque la dose est supérieure à 20 000 unités USP d'activité lipasique ou indiquée pour le traitement de l'insuffisance pancréatique exocrine, Pancrélipase est classifié common non-PSN.";s:16:"field_legacy_nid";s:6:"105982";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Pancrelipase";s:5:"title";s:12:"Pancrelipase";s:3:"nid";s:5:"82062";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82063;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"8249;17412";s:25:"field_non_nhp_rationale_e";s:183:"As per the Prescription Drug List, Levocarnitine or its salts or derivatives, when sold for the treatment of primary or secondary levocarnitine deficiency, are classified as non-NHPs.";s:25:"field_non_nhp_rationale_f";s:223:"Selon la Liste des drogues sur ordonnance, la Lévocarnitine ou ses sels ou dérivés, lorsqu'ils sont vendu pour le traitement de la déficience primaire ou secondaire de la lévocarnitine, sont classifiés comme non PSNs.";s:16:"field_legacy_nid";s:6:"105983";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:43:"Glycine propionyl L-carnitine hydrochloride";s:5:"title";s:43:"Glycine propionyl L-carnitine hydrochloride";s:3:"nid";s:5:"82063";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82064;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:105:"A non-NHP because listed in the Prescription Drug List as follows: Lodoxamide or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lodoxamide ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77025";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Lodoxamide";s:5:"title";s:10:"Lodoxamide";s:3:"nid";s:5:"82064";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82065;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Lomefloxacin or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Loméfloxacine ou ses sels";s:16:"field_legacy_nid";s:5:"77026";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Lomefloxacin";s:5:"title";s:12:"Lomefloxacin";s:3:"nid";s:5:"82065";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82066;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Lomustine";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lomustine";s:16:"field_legacy_nid";s:5:"77027";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Lomustine";s:5:"title";s:9:"Lomustine";s:3:"nid";s:5:"82066";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82067;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Lopinavir";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lopinavir";s:16:"field_legacy_nid";s:5:"77028";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Lopinavir";s:5:"title";s:9:"Lopinavir";s:3:"nid";s:5:"82067";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82068;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:105:"A non-NHP because listed in the Prescription Drug List as follows: Loracarbef or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Loracarbef ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77029";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Loracarbef";s:5:"title";s:10:"Loracarbef";s:3:"nid";s:5:"82068";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82069;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Losartan or its salts";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Losartan ou ses sels";s:16:"field_legacy_nid";s:5:"77030";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Losartan";s:5:"title";s:8:"Losartan";s:3:"nid";s:5:"82069";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82070;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Losoxantrone or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Losoxantrone ou ses sels";s:16:"field_legacy_nid";s:5:"77031";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Losoxantrone";s:5:"title";s:12:"Losoxantrone";s:3:"nid";s:5:"82070";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82071;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Loxapine or its salts";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Loxapine ou ses sels";s:16:"field_legacy_nid";s:5:"77033";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Loxapine";s:5:"title";s:8:"Loxapine";s:3:"nid";s:5:"82071";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82072;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:99:"A non-NHP because listed in the Prescription Drug List as follows: Magnesium glutamate hydrobromide";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromhydrate de glutamate de magnésium";s:16:"field_legacy_nid";s:5:"77034";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:32:"Magnesium glutamate hydrobromide";s:5:"title";s:32:"Magnesium glutamate hydrobromide";s:3:"nid";s:5:"82072";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82073;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Maprotiline or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Maprotiline ou ses sels";s:16:"field_legacy_nid";s:5:"77035";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Maprotiline";s:5:"title";s:11:"Maprotiline";s:3:"nid";s:5:"82073";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82074;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Marbofloxacin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Marbofloxacine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77036";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Marbofloxacin";s:5:"title";s:13:"Marbofloxacin";s:3:"nid";s:5:"82074";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82075;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Mecamylamine or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mécamylamine ou ses sels";s:16:"field_legacy_nid";s:5:"77037";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Mecamylamine";s:5:"title";s:12:"Mecamylamine";s:3:"nid";s:5:"82075";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82076;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:8:"67;17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Mechlorethamine or its salts";s:25:"field_non_nhp_rationale_f";s:107:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méchloréthamine ou ses sels";s:16:"field_legacy_nid";s:5:"77038";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Mechlorethamine";s:5:"title";s:15:"Mechlorethamine";s:3:"nid";s:5:"82076";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82077;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:105:"A non-NHP because listed in the Prescription Drug List as follows: Mecillinam or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mécillinam ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77039";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Mecillinam";s:5:"title";s:10:"Mecillinam";s:3:"nid";s:5:"82077";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82078;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Meclofenamic acid or its salts";s:25:"field_non_nhp_rationale_f";s:114:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méclofénamique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"77040";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Meclofenamic acid";s:5:"title";s:17:"Meclofenamic acid";s:3:"nid";s:5:"82078";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82079;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Medetomidine or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Médétomidine ou ses sels";s:16:"field_legacy_nid";s:5:"77041";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Medetomidine";s:5:"title";s:12:"Medetomidine";s:3:"nid";s:5:"82079";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82080;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:94:"A non-NHP because listed in the Prescription Drug List as follows: Mefenamic acid or its salts";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méfénamique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"77042";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Mefenamic acid";s:5:"title";s:14:"Mefenamic acid";s:3:"nid";s:5:"82080";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82081;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:105:"A non-NHP because listed in the Prescription Drug List as follows: Mefloquine or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méfloquine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77043";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Mefloquine";s:5:"title";s:10:"Mefloquine";s:3:"nid";s:5:"82081";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82082;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:141:"A non-NHP because listed in the Prescription Drug List as follows: Melarsomine or its salts, when sold for the treatment of heartworm in dogs";s:25:"field_non_nhp_rationale_f";s:170:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mélarsomine ou ses sels, s'ils sont vendus pour le traitement du ver du coeur chez le chien";s:16:"field_legacy_nid";s:5:"77045";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Melarsomine";s:5:"title";s:11:"Melarsomine";s:3:"nid";s:5:"82082";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82083;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:104:"A non-NHP because listed in the Prescription Drug List as follows: Meloxicam or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méloxicam ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77046";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Meloxicam";s:5:"title";s:9:"Meloxicam";s:3:"nid";s:5:"82083";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82084;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Melphalan";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Melphalan";s:16:"field_legacy_nid";s:5:"77047";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Melphalan";s:5:"title";s:9:"Melphalan";s:3:"nid";s:5:"82084";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82085;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Memantine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mémantine ou ses sels";s:16:"field_legacy_nid";s:5:"77048";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Memantine";s:5:"title";s:9:"Memantine";s:3:"nid";s:5:"82085";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82086;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:86:"A non-NHP because listed in the Prescription Drug List as follows: Menotropins (human)";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ménotropines (humains)";s:16:"field_legacy_nid";s:5:"77049";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Menotropins (human)";s:5:"title";s:19:"Menotropins (human)";s:3:"nid";s:5:"82086";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82087;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Mepacrine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mépacrine ou ses sels";s:16:"field_legacy_nid";s:5:"77050";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Mepacrine";s:5:"title";s:9:"Mepacrine";s:3:"nid";s:5:"82087";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82088;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Mepazine or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mépazine ou ses sels";s:16:"field_legacy_nid";s:5:"77051";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Mepazine";s:5:"title";s:8:"Mepazine";s:3:"nid";s:5:"82088";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82089;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Mephenoxalone";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méphenoxalone";s:16:"field_legacy_nid";s:5:"77052";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Mephenoxalone";s:5:"title";s:13:"Mephenoxalone";s:3:"nid";s:5:"82089";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82090;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Mephentermine or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méphentermine ou ses sels";s:16:"field_legacy_nid";s:5:"77053";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Mephentermine";s:5:"title";s:13:"Mephentermine";s:3:"nid";s:5:"82090";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82091;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:81:"A non-NHP because listed in the Prescription Drug List as follows: Mercaptopurine";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mercaptopurine";s:16:"field_legacy_nid";s:5:"77054";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Mercaptopurine";s:5:"title";s:14:"Mercaptopurine";s:3:"nid";s:5:"82091";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82092;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Ancestim";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ancestim";s:16:"field_legacy_nid";s:5:"76661";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Ancestim";s:5:"title";s:8:"Ancestim";s:3:"nid";s:5:"82092";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82093;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Apraclonidine or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Apraclonidine ou ses sels";s:16:"field_legacy_nid";s:5:"76662";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Apraclonidine";s:5:"title";s:13:"Apraclonidine";s:3:"nid";s:5:"82093";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82094;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Argatroban or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Argatroban ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76663";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Argatroban";s:5:"title";s:10:"Argatroban";s:3:"nid";s:5:"82094";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82095;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Astemizole or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Astémizole ou ses sels";s:16:"field_legacy_nid";s:5:"76664";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Astemizole";s:5:"title";s:10:"Astemizole";s:3:"nid";s:5:"82095";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82096;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Atazanavir or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Atazanavir ou ses sels";s:16:"field_legacy_nid";s:5:"76665";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Atazanavir";s:5:"title";s:10:"Atazanavir";s:3:"nid";s:5:"82096";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82097;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Atenolol or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aténolol ou ses sels";s:16:"field_legacy_nid";s:5:"76666";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Atenolol";s:5:"title";s:8:"Atenolol";s:3:"nid";s:5:"82097";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82098;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Atipamezole or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Atipamézole ou ses sels";s:16:"field_legacy_nid";s:5:"76667";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Atipamezole";s:5:"title";s:11:"Atipamezole";s:3:"nid";s:5:"82098";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82099;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Atorvastatin or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Atorvastatine ou ses sels";s:16:"field_legacy_nid";s:5:"76668";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Atorvastatin";s:5:"title";s:12:"Atorvastatin";s:3:"nid";s:5:"82099";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82100;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Atovaquone";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Atovaquone";s:16:"field_legacy_nid";s:5:"76669";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Atovaquone";s:5:"title";s:10:"Atovaquone";s:3:"nid";s:5:"82100";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82101;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:86:"A non-NHP because listed in the Prescription Drug List as follows: Atracurium besilate";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Atracurium (bésilate d')";s:16:"field_legacy_nid";s:5:"76670";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Atracurium besilate";s:5:"title";s:19:"Atracurium besilate";s:3:"nid";s:5:"82101";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82102;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:104:"A non-NHP because listed in the Prescription Drug List as follows: Meropenem or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méropénem ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77055";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Meropenem";s:5:"title";s:9:"Meropenem";s:3:"nid";s:5:"82102";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82103;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Mesoridazine or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mésoridazine ou ses sels";s:16:"field_legacy_nid";s:5:"77056";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Mesoridazine";s:5:"title";s:12:"Mesoridazine";s:3:"nid";s:5:"82103";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82104;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Metaldehyde";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Métaldéhyde";s:16:"field_legacy_nid";s:5:"77057";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Metaldehyde";s:5:"title";s:11:"Metaldehyde";s:3:"nid";s:5:"82104";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82105;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:104:"A non-NHP because listed in the Prescription Drug List as follows: Metformin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Metformine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77059";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Metformin";s:5:"title";s:9:"Metformin";s:3:"nid";s:5:"82105";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82106;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Methacholine chloride";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthacholine (chlorure de)";s:16:"field_legacy_nid";s:5:"77060";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Methacholine chloride";s:5:"title";s:21:"Methacholine chloride";s:3:"nid";s:5:"82106";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82107;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Methazolamide or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthazolamide ou ses sels";s:16:"field_legacy_nid";s:5:"77061";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Methazolamide";s:5:"title";s:13:"Methazolamide";s:3:"nid";s:5:"82107";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82108;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:106:"A non-NHP because listed in the Prescription Drug List as follows: Methicillin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthicilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77062";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Methicillin";s:5:"title";s:11:"Methicillin";s:3:"nid";s:5:"82108";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82109;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Methimazole";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthimazole";s:16:"field_legacy_nid";s:5:"77063";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Methimazole";s:5:"title";s:11:"Methimazole";s:3:"nid";s:5:"82109";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82110;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Methisazone";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthisazone";s:16:"field_legacy_nid";s:5:"77064";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Methisazone";s:5:"title";s:11:"Methisazone";s:3:"nid";s:5:"82110";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82111;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:101:"A non-NHP because listed in the Prescription Drug List as follows: Methoin (Mephenytoin) or its salts";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthoïne (méphénytoine) ou ses sels";s:16:"field_legacy_nid";s:5:"77065";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Methoin (Mephenytoin)";s:5:"title";s:21:"Methoin (Mephenytoin)";s:3:"nid";s:5:"82111";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82112;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Methotrexate or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthotrexate ou ses sels";s:16:"field_legacy_nid";s:5:"77066";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Methotrexate";s:5:"title";s:12:"Methotrexate";s:3:"nid";s:5:"82112";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82113;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Methotrimeprazine or its salts";s:25:"field_non_nhp_rationale_f";s:109:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthotriméprazine ou ses sels";s:16:"field_legacy_nid";s:5:"77067";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Methotrimeprazine";s:5:"title";s:17:"Methotrimeprazine";s:3:"nid";s:5:"82113";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82114;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Methoxamine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthoxamine ou ses sels";s:16:"field_legacy_nid";s:5:"77068";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Methoxamine";s:5:"title";s:11:"Methoxamine";s:3:"nid";s:5:"82114";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82115;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Methyldopa or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthyldopa ou ses sels";s:16:"field_legacy_nid";s:5:"77069";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Methyldopa";s:5:"title";s:10:"Methyldopa";s:3:"nid";s:5:"82115";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82116;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:82:"A non-NHP because listed in the Prescription Drug List as follows: Methylparafynol";s:25:"field_non_nhp_rationale_f";s:94:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthylparafynol";s:16:"field_legacy_nid";s:5:"77070";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Methylparafynol";s:5:"title";s:15:"Methylparafynol";s:3:"nid";s:5:"82116";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82117;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:107:"A non-NHP because listed in the Prescription Drug List as follows: Methysergide or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Méthysergide ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77071";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Methysergide";s:5:"title";s:12:"Methysergide";s:3:"nid";s:5:"82117";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82118;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:81:"A non-NHP because listed in the Prescription Drug List as follows: Metoclopramide";s:25:"field_non_nhp_rationale_f";s:93:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Métoclopramide";s:16:"field_legacy_nid";s:5:"77072";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Metoclopramide";s:5:"title";s:14:"Metoclopramide";s:3:"nid";s:5:"82118";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82119;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Metolazone or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Métolazone ou ses sels";s:16:"field_legacy_nid";s:5:"77073";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Metolazone";s:5:"title";s:10:"Metolazone";s:3:"nid";s:5:"82119";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82120;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Metomidate or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Métomidate ou ses sels";s:16:"field_legacy_nid";s:5:"77074";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Metomidate";s:5:"title";s:10:"Metomidate";s:3:"nid";s:5:"82120";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82121;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Metopimazine or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Métopimazine ou ses sels";s:16:"field_legacy_nid";s:5:"77075";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Metopimazine";s:5:"title";s:12:"Metopimazine";s:3:"nid";s:5:"82121";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82122;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Metoprolol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Métoprolol ou ses sels";s:16:"field_legacy_nid";s:5:"77076";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Metoprolol";s:5:"title";s:10:"Metoprolol";s:3:"nid";s:5:"82122";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82123;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Metronidazole";s:25:"field_non_nhp_rationale_f";s:93:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Métronïdazole";s:16:"field_legacy_nid";s:5:"77077";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Metronidazole";s:5:"title";s:13:"Metronidazole";s:3:"nid";s:5:"82123";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82124;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Metyrapone or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Métyrapone ou ses sels";s:16:"field_legacy_nid";s:5:"77078";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Metyrapone";s:5:"title";s:10:"Metyrapone";s:3:"nid";s:5:"82124";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82125;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Mexiletine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mésiletine ou ses sels";s:16:"field_legacy_nid";s:5:"77079";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Mexiletine";s:5:"title";s:10:"Mexiletine";s:3:"nid";s:5:"82125";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82126;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:106:"A non-NHP because listed in the Prescription Drug List as follows: Mezlocillin or its salts or derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mézlocilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77080";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Mezlocillin";s:5:"title";s:11:"Mezlocillin";s:3:"nid";s:5:"82126";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82127;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Midodrine or its salts";s:25:"field_non_nhp_rationale_f";s:115:"Un non PSN à cause de sa présence à l'Annexe F de la Loi sur les aliments et les drogues : Midodrine et ses sels";s:16:"field_legacy_nid";s:5:"77081";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Midodrine";s:5:"title";s:9:"Midodrine";s:3:"nid";s:5:"82127";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82128;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Miglustat";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Miglustat";s:16:"field_legacy_nid";s:5:"77082";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Miglustat";s:5:"title";s:9:"Miglustat";s:3:"nid";s:5:"82128";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82129;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Milrinone or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Milrinone ou ses sels";s:16:"field_legacy_nid";s:5:"77083";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Milrinone";s:5:"title";s:9:"Milrinone";s:3:"nid";s:5:"82129";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82130;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Mirtazapine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mirtazapine ou ses sels";s:16:"field_legacy_nid";s:5:"77084";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Mirtazapine";s:5:"title";s:11:"Mirtazapine";s:3:"nid";s:5:"82130";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82131;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Mitotane (o,p’-DDD)";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mitotane (o,p’-DDD)";s:16:"field_legacy_nid";s:5:"77085";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Mitotane (o,p’-DDD)";s:5:"title";s:21:"Mitotane (o,p’-DDD)";s:3:"nid";s:5:"82131";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82132;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Mitoxantrone or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mitoxantrone ou ses sels";s:16:"field_legacy_nid";s:5:"77086";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Mitoxantrone";s:5:"title";s:12:"Mitoxantrone";s:3:"nid";s:5:"82132";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82133;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:86:"A non-NHP because listed in the Prescription Drug List as follows: Mivacurium chloride";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mivacurium (chlorure de)";s:16:"field_legacy_nid";s:5:"77087";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Mivacurium chloride";s:5:"title";s:19:"Mivacurium chloride";s:3:"nid";s:5:"82133";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82134;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Modafinil or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Modafinil ou ses sels";s:16:"field_legacy_nid";s:5:"77088";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Modafinil";s:5:"title";s:9:"Modafinil";s:3:"nid";s:5:"82134";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82135;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Molgramostim";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Molgramostim";s:16:"field_legacy_nid";s:5:"77089";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Molgramostim";s:5:"title";s:12:"Molgramostim";s:3:"nid";s:5:"82135";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82136;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Montelukast or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Montélukast ou ses sels";s:16:"field_legacy_nid";s:5:"77090";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Montelukast";s:5:"title";s:11:"Montelukast";s:3:"nid";s:5:"82136";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82137;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:148:"A non-NHP because listed in the Prescription Drug List as follows: Moxidectin and its derivatives, when sold for the prevention of heartworm in dogs";s:25:"field_non_nhp_rationale_f";s:175:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Moxidectine et ses dérivés, s'ils sont vendus pour la prévention du ver du coeur chez le chien";s:16:"field_legacy_nid";s:5:"77091";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Moxidectin";s:5:"title";s:10:"Moxidectin";s:3:"nid";s:5:"82137";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82138;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:112:"A non-NHP because listed in the Prescription Drug List as follows: Moxifloxacin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Moxifloxacine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77092";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Moxifloxacin";s:5:"title";s:12:"Moxifloxacin";s:3:"nid";s:5:"82138";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82139;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Muromonab-CD3";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Muromonab-CD3";s:16:"field_legacy_nid";s:5:"77093";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Muromonab-CD3";s:5:"title";s:13:"Muromonab-CD3";s:3:"nid";s:5:"82139";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82140;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:117:"A non-NHP because listed in the Prescription Drug List as follows: Mycophenolic acid or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:130:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mycophénolique (acide) ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77094";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Mycophenolic acid";s:5:"title";s:17:"Mycophenolic acid";s:3:"nid";s:5:"82140";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82141;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Nabumetone";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nabumétone";s:16:"field_legacy_nid";s:5:"77095";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nabumetone";s:5:"title";s:10:"Nabumetone";s:3:"nid";s:5:"82141";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82142;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Nadolol or its salts";s:25:"field_non_nhp_rationale_f";s:97:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nadolol ou ses sels";s:16:"field_legacy_nid";s:5:"77096";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Nadolol";s:5:"title";s:7:"Nadolol";s:3:"nid";s:5:"82142";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82143;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Nadroparin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nadroparine ou ses sels";s:16:"field_legacy_nid";s:5:"77097";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nadroparin";s:5:"title";s:10:"Nadroparin";s:3:"nid";s:5:"82143";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82144;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Nafarelin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nafaréline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77098";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Nafarelin";s:5:"title";s:9:"Nafarelin";s:3:"nid";s:5:"82144";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82145;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Nafcillin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nafcilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77099";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Nafcillin";s:5:"title";s:9:"Nafcillin";s:3:"nid";s:5:"82145";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82146;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:81:"A non-NHP because listed in the Prescription Drug List as follows: Nalidixic acid";s:25:"field_non_nhp_rationale_f";s:97:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nalidixique (acide)";s:16:"field_legacy_nid";s:5:"77100";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Nalidixic acid";s:5:"title";s:14:"Nalidixic acid";s:3:"nid";s:5:"82146";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";}i:82147;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Nalmefene or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nalméfène ou ses sels";s:16:"field_legacy_nid";s:5:"77101";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Nalmefene";s:5:"title";s:9:"Nalmefene";s:3:"nid";s:5:"82147";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82148;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Naloxone or its salts";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Naloxone ou ses sels";s:16:"field_legacy_nid";s:5:"77102";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Naloxone";s:5:"title";s:8:"Naloxone";s:3:"nid";s:5:"82148";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82149;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Naratriptan or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Naratriptan ou ses sels";s:16:"field_legacy_nid";s:5:"77103";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Naratriptan";s:5:"title";s:11:"Naratriptan";s:3:"nid";s:5:"82149";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82150;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Nateglinide or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Natéglinide ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77104";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Nateglinide";s:5:"title";s:11:"Nateglinide";s:3:"nid";s:5:"82150";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82151;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Nedocromil or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nédocromil ou ses sels";s:16:"field_legacy_nid";s:5:"77105";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nedocromil";s:5:"title";s:10:"Nedocromil";s:3:"nid";s:5:"82151";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82152;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Nefazodone or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Néfazodone ou ses sels";s:16:"field_legacy_nid";s:5:"77106";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nefazodone";s:5:"title";s:10:"Nefazodone";s:3:"nid";s:5:"82152";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82153;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Nelfinavir or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nelfinavir ou ses sels";s:16:"field_legacy_nid";s:5:"77107";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nelfinavir";s:5:"title";s:10:"Nelfinavir";s:3:"nid";s:5:"82153";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82154;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Neocinchophen or its salts";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Néocinchophène ou ses sels";s:16:"field_legacy_nid";s:5:"77108";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Neocinchophen";s:5:"title";s:13:"Neocinchophen";s:3:"nid";s:5:"82154";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82155;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Netilmicin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nétilmicine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77109";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Netilmicin";s:5:"title";s:10:"Netilmicin";s:3:"nid";s:5:"82155";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82156;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Nevirapine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Névirapine ou ses sels";s:16:"field_legacy_nid";s:5:"77110";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nevirapine";s:5:"title";s:10:"Nevirapine";s:3:"nid";s:5:"82156";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82157;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Nialamide or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nialamide ou ses sels";s:16:"field_legacy_nid";s:5:"77111";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Nialamide";s:5:"title";s:9:"Nialamide";s:3:"nid";s:5:"82157";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82158;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Nicardipine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nicardipine ou ses sels";s:16:"field_legacy_nid";s:5:"77112";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Nicardipine";s:5:"title";s:11:"Nicardipine";s:3:"nid";s:5:"82158";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82159;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Nifedipine";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nifédipine";s:16:"field_legacy_nid";s:5:"77113";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nifedipine";s:5:"title";s:10:"Nifedipine";s:3:"nid";s:5:"82159";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82160;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Nilutamide";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nilutamide";s:16:"field_legacy_nid";s:5:"77114";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nilutamide";s:5:"title";s:10:"Nilutamide";s:3:"nid";s:5:"82160";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82161;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Nimodipine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nimodipine ou ses sels";s:16:"field_legacy_nid";s:5:"77115";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nimodipine";s:5:"title";s:10:"Nimodipine";s:3:"nid";s:5:"82161";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82162;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Nitroscanate";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nitroscanate";s:16:"field_legacy_nid";s:5:"77116";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Nitroscanate";s:5:"title";s:12:"Nitroscanate";s:3:"nid";s:5:"82162";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82163;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:195:"A non-NHP because listed in the Prescription Drug List as follows: Nizatidine or its salts (except when sold in an oral dosage form containing not more than the equivalent of 75 mg of nizatidine)";s:25:"field_non_nhp_rationale_f";s:212:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nizatidine ou ses sels (sauf lorsque vendue sous une forme posologique orale contenant au plus l’équivalent de 75 mg de nizatidine)";s:16:"field_legacy_nid";s:5:"77117";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Nizatidine";s:5:"title";s:10:"Nizatidine";s:3:"nid";s:5:"82163";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82164;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Nomifensine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nomifensine ou ses sels";s:16:"field_legacy_nid";s:5:"77118";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Nomifensine";s:5:"title";s:11:"Nomifensine";s:3:"nid";s:5:"82164";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82165;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Norfloxacin";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Norfloxacine";s:16:"field_legacy_nid";s:5:"77119";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Norfloxacin";s:5:"title";s:11:"Norfloxacin";s:3:"nid";s:5:"82165";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82166;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Nortriptyline or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nortriptyline ou ses sels";s:16:"field_legacy_nid";s:5:"77120";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Nortriptyline";s:5:"title";s:13:"Nortriptyline";s:3:"nid";s:5:"82166";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82167;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Nylidrin or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Nylidrine ou ses sels";s:16:"field_legacy_nid";s:5:"77121";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Nylidrin";s:5:"title";s:8:"Nylidrin";s:3:"nid";s:5:"82167";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82168;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Octatropine methylbromide";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Octatropine (méthylbromure d’)";s:16:"field_legacy_nid";s:5:"77122";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Octatropine methylbromide";s:5:"title";s:25:"Octatropine methylbromide";s:3:"nid";s:5:"82168";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82169;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Octreotide";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Octréotide";s:16:"field_legacy_nid";s:5:"77123";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Octreotide";s:5:"title";s:10:"Octreotide";s:3:"nid";s:5:"82169";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82170;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Ofloxacin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ofloxacine ou ses sels";s:16:"field_legacy_nid";s:5:"77124";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ofloxacin";s:5:"title";s:9:"Ofloxacin";s:3:"nid";s:5:"82170";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82171;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Olanzapine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Olanzapine ou ses sels";s:16:"field_legacy_nid";s:5:"77125";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Olanzapine";s:5:"title";s:10:"Olanzapine";s:3:"nid";s:5:"82171";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82172;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Olopatadine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Olopatadine ou ses sels";s:16:"field_legacy_nid";s:5:"77126";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Olopatadine";s:5:"title";s:11:"Olopatadine";s:3:"nid";s:5:"82172";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82173;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Olsalazine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Olsalazine ou ses sels";s:16:"field_legacy_nid";s:5:"77127";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Olsalazine";s:5:"title";s:10:"Olsalazine";s:3:"nid";s:5:"82173";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82174;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Omalizumab";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Omalizumab";s:16:"field_legacy_nid";s:5:"77128";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Omalizumab";s:5:"title";s:10:"Omalizumab";s:3:"nid";s:5:"82174";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82175;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Omeprazole or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Oméprazole ou ses sels";s:16:"field_legacy_nid";s:5:"77129";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Omeprazole";s:5:"title";s:10:"Omeprazole";s:3:"nid";s:5:"82175";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82176;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Ondansetron or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ondansétron ou ses sels";s:16:"field_legacy_nid";s:5:"77130";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ondansetron";s:5:"title";s:11:"Ondansetron";s:3:"nid";s:5:"82176";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82177;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:112:"A non-NHP because listed in the Prescription Drug List as follows: Orbifloxacin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Orbifloxacine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77131";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Orbifloxacin";s:5:"title";s:12:"Orbifloxacin";s:3:"nid";s:5:"82177";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82178;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Orciprenaline (Metaproterenol) or its salts";s:25:"field_non_nhp_rationale_f";s:124:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Orciprénaline (Métaprotérénol) ou ses sels";s:16:"field_legacy_nid";s:5:"77132";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Orciprenaline (Metaproterenol)";s:5:"title";s:30:"Orciprenaline (Metaproterenol)";s:3:"nid";s:5:"82178";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82179;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Orlistat";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Orlistat";s:16:"field_legacy_nid";s:5:"77133";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Orlistat";s:5:"title";s:8:"Orlistat";s:3:"nid";s:5:"82179";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82180;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Ormetoprim or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ormétoprime ou ses sels";s:16:"field_legacy_nid";s:5:"77134";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ormetoprim";s:5:"title";s:10:"Ormetoprim";s:3:"nid";s:5:"82180";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82181;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Ornidazole";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ornidazole";s:16:"field_legacy_nid";s:5:"77135";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ornidazole";s:5:"title";s:10:"Ornidazole";s:3:"nid";s:5:"82181";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82182;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Oseltamivir or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Oséltamivir ou ses sels";s:16:"field_legacy_nid";s:5:"77136";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Oseltamivir";s:5:"title";s:11:"Oseltamivir";s:3:"nid";s:5:"82182";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82183;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Oxacillin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Oxacilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77137";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Oxacillin";s:5:"title";s:9:"Oxacillin";s:3:"nid";s:5:"82183";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82184;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Oxanamide";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Oxanamide";s:16:"field_legacy_nid";s:5:"77138";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Oxanamide";s:5:"title";s:9:"Oxanamide";s:3:"nid";s:5:"82184";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82185;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Oxaprozin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Oxaprozine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"77139";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Oxaprozin";s:5:"title";s:9:"Oxaprozin";s:3:"nid";s:5:"82185";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82186;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Oxcarbazepine";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Oxcarbazépine";s:16:"field_legacy_nid";s:5:"77140";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Oxcarbazepine";s:5:"title";s:13:"Oxcarbazepine";s:3:"nid";s:5:"82186";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82187;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Oxolinic acid or its salts";s:25:"field_non_nhp_rationale_f";s:108:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Oxolinique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"77141";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Oxolinic acid";s:5:"title";s:13:"Oxolinic acid";s:3:"nid";s:5:"82187";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82188;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Oxprenolol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Oxprénolol ou ses sels";s:16:"field_legacy_nid";s:5:"77142";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Oxprenolol";s:5:"title";s:10:"Oxprenolol";s:3:"nid";s:5:"82188";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82189;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Oxyphenbutazone or its salts";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Oxyphenbutazone ou ses sels";s:16:"field_legacy_nid";s:5:"77143";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Oxyphenbutazone";s:5:"title";s:15:"Oxyphenbutazone";s:3:"nid";s:5:"82189";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82190;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Palifermin";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Palifermine";s:16:"field_legacy_nid";s:5:"77144";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Palifermin";s:5:"title";s:10:"Palifermin";s:3:"nid";s:5:"82190";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82191;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Palivizumab";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Palivizumab";s:16:"field_legacy_nid";s:5:"77145";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Palivizumab";s:5:"title";s:11:"Palivizumab";s:3:"nid";s:5:"82191";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82192;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Pamidronic acid or its salts";s:25:"field_non_nhp_rationale_f";s:110:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pamidronique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"77146";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Pamidronic acid";s:5:"title";s:15:"Pamidronic acid";s:3:"nid";s:5:"82192";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82193;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Pantoprazole or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pantoprazole ou ses sels";s:16:"field_legacy_nid";s:5:"77147";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Pantoprazole";s:5:"title";s:12:"Pantoprazole";s:3:"nid";s:5:"82193";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82194;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Paraldehyde";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Paraldéhyde";s:16:"field_legacy_nid";s:5:"77148";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Paraldehyde";s:5:"title";s:11:"Paraldehyde";s:3:"nid";s:5:"82194";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82195;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:81:"A non-NHP because listed in the Prescription Drug List as follows: Paramethadione";s:25:"field_non_nhp_rationale_f";s:93:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Paraméthadione";s:16:"field_legacy_nid";s:5:"77149";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Paramethadione";s:5:"title";s:14:"Paramethadione";s:3:"nid";s:5:"82195";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82196;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Pargyline or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pargyline ou ses sels";s:16:"field_legacy_nid";s:5:"77150";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Pargyline";s:5:"title";s:9:"Pargyline";s:3:"nid";s:5:"82196";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82197;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Paricalcitol";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Paricalcitol";s:16:"field_legacy_nid";s:5:"77151";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Paricalcitol";s:5:"title";s:12:"Paricalcitol";s:3:"nid";s:5:"82197";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82198;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Paroxetine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Paroxétine ou ses sels";s:16:"field_legacy_nid";s:5:"77152";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Paroxetine";s:5:"title";s:10:"Paroxetine";s:3:"nid";s:5:"82198";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82199;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Pegfilgrastim";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pegfilgrastim";s:16:"field_legacy_nid";s:5:"77153";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Pegfilgrastim";s:5:"title";s:13:"Pegfilgrastim";s:3:"nid";s:5:"82199";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82200;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Pegvisomant";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pegvisomant";s:16:"field_legacy_nid";s:5:"77154";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pegvisomant";s:5:"title";s:11:"Pegvisomant";s:3:"nid";s:5:"82200";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82201;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Pemetrexed or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pémétrexed ou ses sels";s:16:"field_legacy_nid";s:5:"77155";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pemetrexed";s:5:"title";s:10:"Pemetrexed";s:3:"nid";s:5:"82201";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82202;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Penciclovir or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Penciclovir ou ses sels";s:16:"field_legacy_nid";s:5:"77156";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Penciclovir";s:5:"title";s:11:"Penciclovir";s:3:"nid";s:5:"82202";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82203;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Penicillamine";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pénicillamine";s:16:"field_legacy_nid";s:5:"77157";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Penicillamine";s:5:"title";s:13:"Penicillamine";s:3:"nid";s:5:"82203";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82204;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Pentamidine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pentamidine ou ses sels";s:16:"field_legacy_nid";s:5:"77158";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pentamidine";s:5:"title";s:11:"Pentamidine";s:3:"nid";s:5:"82204";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82205;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Pentolinium tartrate";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pentolinium (tartrate de)";s:16:"field_legacy_nid";s:5:"77159";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Pentolinium tartrate";s:5:"title";s:20:"Pentolinium tartrate";s:3:"nid";s:5:"82205";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82206;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because listed in the Prescription Drug List as follows: Pentosan polysulfate or its salts";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pentosane polysulfate ou ses sels";s:16:"field_legacy_nid";s:5:"77160";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Pentosan polysulfate";s:5:"title";s:20:"Pentosan polysulfate";s:3:"nid";s:5:"82206";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82207;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Pentostatin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pentostatine ou ses sels";s:16:"field_legacy_nid";s:5:"77161";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pentostatin";s:5:"title";s:11:"Pentostatin";s:3:"nid";s:5:"82207";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82208;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:94:"A non-NHP because listed in the Prescription Drug List as follows: Pentoxifylline or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pentoxifylline ou ses sels";s:16:"field_legacy_nid";s:5:"77162";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Pentoxifylline";s:5:"title";s:14:"Pentoxifylline";s:3:"nid";s:5:"82208";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82209;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Perflutren";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Perflutrène";s:16:"field_legacy_nid";s:5:"77163";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Perflutren";s:5:"title";s:10:"Perflutren";s:3:"nid";s:5:"82209";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82210;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Pergolide or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pergolide ou ses sels";s:16:"field_legacy_nid";s:5:"77164";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Pergolide";s:5:"title";s:9:"Pergolide";s:3:"nid";s:5:"82210";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82211;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Pericyazine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Péricyazine ou ses sels";s:16:"field_legacy_nid";s:5:"77165";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pericyazine";s:5:"title";s:11:"Pericyazine";s:3:"nid";s:5:"82211";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82212;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Perindopril or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Périndopril ou ses sels";s:16:"field_legacy_nid";s:5:"77166";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Perindopril";s:5:"title";s:11:"Perindopril";s:3:"nid";s:5:"82212";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82213;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Perphenazine or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Perphénazine ou ses sels";s:16:"field_legacy_nid";s:5:"77167";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Perphenazine";s:5:"title";s:12:"Perphenazine";s:3:"nid";s:5:"82213";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82214;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Phacetoperane or its salts";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phacétopérane ou ses sels";s:16:"field_legacy_nid";s:5:"77168";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Phacetoperane";s:5:"title";s:13:"Phacetoperane";s:3:"nid";s:5:"82214";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82215;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Phenacemide";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phénacémide";s:16:"field_legacy_nid";s:5:"77169";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Phenacemide";s:5:"title";s:11:"Phenacemide";s:3:"nid";s:5:"82215";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82216;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Phenacetin";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phénacétine";s:16:"field_legacy_nid";s:5:"77170";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Phenacetin";s:5:"title";s:10:"Phenacetin";s:3:"nid";s:5:"82216";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82217;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Phenaglycodol";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phénaglycodol";s:16:"field_legacy_nid";s:5:"77171";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Phenaglycodol";s:5:"title";s:13:"Phenaglycodol";s:3:"nid";s:5:"82217";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82218;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Phenazopyridine or its salts";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phénazopyridine ou ses sels";s:16:"field_legacy_nid";s:5:"77172";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Phenazopyridine";s:5:"title";s:15:"Phenazopyridine";s:3:"nid";s:5:"82218";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82219;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Phenelzine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phénelzine ou ses sels";s:16:"field_legacy_nid";s:5:"77173";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Phenelzine";s:5:"title";s:10:"Phenelzine";s:3:"nid";s:5:"82219";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82220;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Phenformin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phenformine ou ses sels";s:16:"field_legacy_nid";s:5:"77174";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Phenformin";s:5:"title";s:10:"Phenformin";s:3:"nid";s:5:"82220";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82221;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Pheniprazine or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phéniprazine ou ses sels";s:16:"field_legacy_nid";s:5:"77175";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Pheniprazine";s:5:"title";s:12:"Pheniprazine";s:3:"nid";s:5:"82221";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82222;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Phentolamine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phentolamine ou ses sels";s:16:"field_legacy_nid";s:5:"77176";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Phentolamine";s:5:"title";s:12:"Phentolamine";s:3:"nid";s:5:"82222";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82223;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:94:"A non-NHP because listed in the Prescription Drug List as follows: Phenylbutazone or its salts";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phénylbutazone ou ses sels";s:16:"field_legacy_nid";s:5:"77177";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Phenylbutazone";s:5:"title";s:14:"Phenylbutazone";s:3:"nid";s:5:"82223";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82224;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:178:"A non-NHP because listed in the Prescription Drug List as follows: Phenylephrine or its salts in preparations for ophthalmic or parenteral use in concentrations greater than 2.5%";s:25:"field_non_nhp_rationale_f";s:217:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phényléphrine ou ses sels dans les préparations pour usage ophtalmique ou parentéral lorsqu’il constitue plus de 2,5% d’un mélange";s:16:"field_legacy_nid";s:5:"77178";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Phenylephrine";s:5:"title";s:13:"Phenylephrine";s:3:"nid";s:5:"82224";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82225;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:104:"A non-NHP because listed in the Prescription Drug List as follows: Phenylindanedione and its derivatives";s:25:"field_non_nhp_rationale_f";s:114:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phénylindanédione et ses dérivés";s:16:"field_legacy_nid";s:5:"77179";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Phenylindanedione";s:5:"title";s:17:"Phenylindanedione";s:3:"nid";s:5:"82225";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82226;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:133:"A non-NHP because listed in the Prescription Drug List as follows: Phenylpropanolamine or its salts or derivatives for veterinary use";s:25:"field_non_nhp_rationale_f";s:157:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Phénylpropanolamine, ses sels ou dérivés, destinés à l'usage vétérinaire";s:16:"field_legacy_nid";s:5:"77180";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Phenylpropanolamine";s:5:"title";s:19:"Phenylpropanolamine";s:3:"nid";s:5:"82226";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82227;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Pimecrolimus";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pimécrolimus";s:16:"field_legacy_nid";s:5:"77181";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Pimecrolimus";s:5:"title";s:12:"Pimecrolimus";s:3:"nid";s:5:"82227";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82228;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Pimozide";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pimozide";s:16:"field_legacy_nid";s:5:"77182";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Pimozide";s:5:"title";s:8:"Pimozide";s:3:"nid";s:5:"82228";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82229;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:85:"A non-NHP because listed in the Prescription Drug List as follows: Pinaverium bromide";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pinavérium (bromure de)";s:16:"field_legacy_nid";s:5:"77183";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Pinaverium bromide";s:5:"title";s:18:"Pinaverium bromide";s:3:"nid";s:5:"82229";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82230;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Pindolol or its salts";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pindolol ou ses sels";s:16:"field_legacy_nid";s:5:"77184";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Pindolol";s:5:"title";s:8:"Pindolol";s:3:"nid";s:5:"82230";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82231;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Pioglitazone or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pioglitazone ou ses sels";s:16:"field_legacy_nid";s:5:"77185";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Pioglitazone";s:5:"title";s:12:"Pioglitazone";s:3:"nid";s:5:"82231";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82232;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Pipecuronium bromide";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pipécuronium (bromure de)";s:16:"field_legacy_nid";s:5:"77186";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Pipecuronium bromide";s:5:"title";s:20:"Pipecuronium bromide";s:3:"nid";s:5:"82232";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82233;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Piperilate or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pipérilate ou ses sels";s:16:"field_legacy_nid";s:5:"77187";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Piperilate";s:5:"title";s:10:"Piperilate";s:3:"nid";s:5:"82233";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82234;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Auranofin";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Auranofine";s:16:"field_legacy_nid";s:5:"76671";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Auranofin";s:5:"title";s:9:"Auranofin";s:3:"nid";s:5:"82234";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82235;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Pipotiazine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pipotiazine ou ses sels";s:16:"field_legacy_nid";s:5:"77188";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pipotiazine";s:5:"title";s:11:"Pipotiazine";s:3:"nid";s:5:"82235";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82236;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Pipobroman";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pipobroman";s:16:"field_legacy_nid";s:5:"77189";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pipobroman";s:5:"title";s:10:"Pipobroman";s:3:"nid";s:5:"82236";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82237;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Pirbuterol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pirbutérol ou ses sels";s:16:"field_legacy_nid";s:5:"77190";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pirbuterol";s:5:"title";s:10:"Pirbuterol";s:3:"nid";s:5:"82237";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82238;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Pirenzepine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pirenzépine ou ses sels";s:16:"field_legacy_nid";s:5:"77191";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pirenzepine";s:5:"title";s:11:"Pirenzepine";s:3:"nid";s:5:"82238";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82239;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Piroxicam or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Piroxicam ou ses sels";s:16:"field_legacy_nid";s:5:"77192";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Piroxicam";s:5:"title";s:9:"Piroxicam";s:3:"nid";s:5:"82239";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82240;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Pizotyline or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Pizotyline ou ses sels";s:16:"field_legacy_nid";s:5:"77193";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pizotyline";s:5:"title";s:10:"Pizotyline";s:3:"nid";s:5:"82240";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82241;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Ponazuril";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ponazuril";s:16:"field_legacy_nid";s:5:"77194";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ponazuril";s:5:"title";s:9:"Ponazuril";s:3:"nid";s:5:"82241";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82242;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:82:"A non-NHP because listed in the Prescription Drug List as follows: Aurothioglucose";s:25:"field_non_nhp_rationale_f";s:93:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aurothioglucose";s:16:"field_legacy_nid";s:5:"76672";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Aurothioglucose";s:5:"title";s:15:"Aurothioglucose";s:3:"nid";s:5:"82242";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82243;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Azacyclonol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Azacyclonol ou ses sels";s:16:"field_legacy_nid";s:5:"76673";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Azacyclonol";s:5:"title";s:11:"Azacyclonol";s:3:"nid";s:5:"82243";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82244;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Azaribine";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Azaribine";s:16:"field_legacy_nid";s:5:"76674";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Azaribine";s:5:"title";s:9:"Azaribine";s:3:"nid";s:5:"82244";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82245;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Azathioprine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Azathioprine ou ses sels";s:16:"field_legacy_nid";s:5:"76675";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Azathioprine";s:5:"title";s:12:"Azathioprine";s:3:"nid";s:5:"82245";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82246;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Azatidine or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Azatadine ou ses sels";s:16:"field_legacy_nid";s:5:"76676";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Azatidine";s:5:"title";s:9:"Azatidine";s:3:"nid";s:5:"82246";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82247;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Azlocillin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Azlocilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76677";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Azlocillin";s:5:"title";s:10:"Azlocillin";s:3:"nid";s:5:"82247";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82248;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Aztreonam or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aztréonam ou ses sels";s:16:"field_legacy_nid";s:5:"76678";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Aztreonam";s:5:"title";s:9:"Aztreonam";s:3:"nid";s:5:"82248";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82249;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Fluconazole.";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Fluconazole.";s:19:"field_old_rationale";s:975:"Fluconazole is a triazole antifungal agent that is used to treat oropharyngeal candidiasis, cryptococcal meningitis in AIDS and also in the treatment and prevention of superficial and systemic fungal infections [1-3]. Fluconazole is a synthetic drug made by many pharmaceutical companies including Pfizer (as Diflucan) [4]. It is structurally related to imidazole-derivative azole antifungal agents (e.g. Clotrimazole). However, Fluconazole contains triazole ring (instead of imidazole) which results in increased antifungal activity [5]. Several synthetic methods for the preparation of Fluconazole have been reported [6]. Fluconazole is not naturally occuring. Currently, it is listed in Schedule F. Fluconazole will not be considered as a NHP, but a drug.
[1] ChemID
[2] The Merck Index
[3] Martindale: The complete drug reference
[4] www.pfizer.com/files/products/uspi_diflucan.pdf
[5] AHFS Drug Information 
[6] www.ch.ic.ac.uk/local/projects/nyemite/synthesis.htm";s:16:"field_legacy_nid";s:5:"76679";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Fluconazole";s:5:"title";s:11:"Fluconazole";s:3:"nid";s:5:"82249";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82250;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Baclofen or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Baclofène ou ses sels";s:16:"field_legacy_nid";s:5:"76682";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Baclofen";s:5:"title";s:8:"Baclofen";s:3:"nid";s:5:"82250";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82251;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Bambuterol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bambutérol ou ses sels";s:16:"field_legacy_nid";s:5:"76683";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Bambuterol";s:5:"title";s:10:"Bambuterol";s:3:"nid";s:5:"82251";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82252;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Basiliximab";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Basiliximab";s:16:"field_legacy_nid";s:5:"76684";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Basiliximab";s:5:"title";s:11:"Basiliximab";s:3:"nid";s:5:"82252";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82253;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Becaplermin";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bécaplermine";s:16:"field_legacy_nid";s:5:"76685";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Becaplermin";s:5:"title";s:11:"Becaplermin";s:3:"nid";s:5:"82253";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82254;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Bemegride";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bémégride";s:16:"field_legacy_nid";s:5:"76686";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Bemegride";s:5:"title";s:9:"Bemegride";s:3:"nid";s:5:"82254";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82255;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Benactyzine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Benactyzine ou ses sels";s:16:"field_legacy_nid";s:5:"76687";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Benactyzine";s:5:"title";s:11:"Benactyzine";s:3:"nid";s:5:"82255";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82256;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Benazepril or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bénazépril ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76688";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Benazepril";s:5:"title";s:10:"Benazepril";s:3:"nid";s:5:"82256";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82257;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Bendazac or its salts";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bendazac ou ses sels";s:16:"field_legacy_nid";s:5:"76689";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Bendazac";s:5:"title";s:8:"Bendazac";s:3:"nid";s:5:"82257";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82258;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Benoxaprofen or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Benoxaprofène ou ses sels";s:16:"field_legacy_nid";s:5:"76690";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Benoxaprofen";s:5:"title";s:12:"Benoxaprofen";s:3:"nid";s:5:"82258";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82259;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Benserazide or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bensérazide ou ses sels";s:16:"field_legacy_nid";s:5:"76691";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Benserazide";s:5:"title";s:11:"Benserazide";s:3:"nid";s:5:"82259";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82260;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:121:"A non-NHP because listed in the Prescription Drug List as follows: Benzathine penicillin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:130:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Benzathine pénicilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76692";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Benzathine penicillin";s:5:"title";s:21:"Benzathine penicillin";s:3:"nid";s:5:"82260";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82261;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Benztropine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Benzatropine ou ses sels";s:16:"field_legacy_nid";s:5:"76693";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Benztropine";s:5:"title";s:11:"Benztropine";s:3:"nid";s:5:"82261";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82262;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Benzydamine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Benzydamine ou ses sels";s:16:"field_legacy_nid";s:5:"76694";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Benzydamine";s:5:"title";s:11:"Benzydamine";s:3:"nid";s:5:"82262";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82263;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Betahistine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bétahistine ou ses sels";s:16:"field_legacy_nid";s:5:"76695";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Betahistine";s:5:"title";s:11:"Betahistine";s:3:"nid";s:5:"82263";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82264;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Betaxolol or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Betaxolol ou ses sels";s:16:"field_legacy_nid";s:5:"76696";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Betaxolol";s:5:"title";s:9:"Betaxolol";s:3:"nid";s:5:"82264";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82265;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Bethanechol Chloride";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Béthanéchol (chlorure de)";s:16:"field_legacy_nid";s:5:"76697";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Bethanechol chloride";s:5:"title";s:20:"Bethanechol chloride";s:3:"nid";s:5:"82265";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82266;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Bethanidine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Béthanidine ou ses sels";s:16:"field_legacy_nid";s:5:"76698";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Bethanidine";s:5:"title";s:11:"Bethanidine";s:3:"nid";s:5:"82266";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82267;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Bevacizumab";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bévacizumab";s:16:"field_legacy_nid";s:5:"76699";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Bevacizumab";s:5:"title";s:11:"Bevacizumab";s:3:"nid";s:5:"82267";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82268;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Bezafibrate or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bezafibrate ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76700";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Bezafibrate";s:5:"title";s:11:"Bezafibrate";s:3:"nid";s:5:"82268";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82269;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Bicalutamide";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bicalutamide";s:16:"field_legacy_nid";s:5:"76701";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Bicalutamide";s:5:"title";s:12:"Bicalutamide";s:3:"nid";s:5:"82269";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82270;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:98:"A non-NHP because listed in the Prescription Drug List as follows: Bimatoprost and its derivatives";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bimatoprost et ses dérivés";s:16:"field_legacy_nid";s:5:"76702";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Bimatoprost";s:5:"title";s:11:"Bimatoprost";s:3:"nid";s:5:"82270";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82271;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Biperiden or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bipéridène ou ses sels";s:16:"field_legacy_nid";s:5:"76703";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Biperiden";s:5:"title";s:9:"Biperiden";s:3:"nid";s:5:"82271";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82272;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:118:"A non-NHP because listed in the Prescription Drug List as follows: Bishydroxycoumarin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:126:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bishydroxycoumarine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76704";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Bishydroxycoumarin";s:5:"title";s:18:"Bishydroxycoumarin";s:3:"nid";s:5:"82272";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82273;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Bisoprolol or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bisoprolol ou ses sels";s:16:"field_legacy_nid";s:5:"76705";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Bisoprolol";s:5:"title";s:10:"Bisoprolol";s:3:"nid";s:5:"82273";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82274;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Bitolterol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bitoltérol ou ses sels";s:16:"field_legacy_nid";s:5:"76706";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Bitolterol";s:5:"title";s:10:"Bitolterol";s:3:"nid";s:5:"82274";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82275;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Bivalirudin";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bivalirudine";s:16:"field_legacy_nid";s:5:"76707";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Bivalirudin";s:5:"title";s:11:"Bivalirudin";s:3:"nid";s:5:"82275";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82276;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Bortezomib";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bortezomib";s:16:"field_legacy_nid";s:5:"76708";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Bortezomib";s:5:"title";s:10:"Bortezomib";s:3:"nid";s:5:"82276";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82277;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Bosentan or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:115:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bosentan ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76709";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Bosentan";s:5:"title";s:8:"Bosentan";s:3:"nid";s:5:"82277";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82278;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Botulinum toxin type B";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Toxine botulinique, type B";s:16:"field_legacy_nid";s:5:"76710";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Botulinum Toxin Type B";s:5:"title";s:22:"Botulinum Toxin Type B";s:3:"nid";s:5:"82278";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82279;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:85:"A non-NHP because listed in the Prescription Drug List as follows: Bretylium tosylate";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Brétylium (tosylate de)";s:16:"field_legacy_nid";s:5:"76711";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Bretylium tosylate";s:5:"title";s:18:"Bretylium tosylate";s:3:"nid";s:5:"82279";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82280;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Brimonidine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Brimonidine ou ses sels";s:16:"field_legacy_nid";s:5:"76712";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Brimonidine";s:5:"title";s:11:"Brimonidine";s:3:"nid";s:5:"82280";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82281;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:73:"A non-NHP because listed in the Prescription Drug List as follows: Bromal";s:25:"field_non_nhp_rationale_f";s:84:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromal";s:16:"field_legacy_nid";s:5:"76713";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Bromal";s:5:"title";s:6:"Bromal";s:3:"nid";s:5:"82281";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82282;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:81:"A non-NHP because listed in the Prescription Drug List as follows: Bromal hydrate";s:25:"field_non_nhp_rationale_f";s:97:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromal (hydrate de)";s:16:"field_legacy_nid";s:5:"76714";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Bromal hydrate";s:5:"title";s:14:"Bromal hydrate";s:3:"nid";s:5:"82282";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82283;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Brometone";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Brométone";s:16:"field_legacy_nid";s:5:"76715";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Brometone";s:5:"title";s:9:"Brometone";s:3:"nid";s:5:"82283";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82284;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Bromisoval";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromisoval";s:16:"field_legacy_nid";s:5:"76716";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Bromisoval";s:5:"title";s:10:"Bromisoval";s:3:"nid";s:5:"82284";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82285;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Bromocriptine or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromocriptine ou ses sels";s:16:"field_legacy_nid";s:5:"76717";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Bromocriptine";s:5:"title";s:13:"Bromocriptine";s:3:"nid";s:5:"82285";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82286;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Bromoform";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromoforme";s:16:"field_legacy_nid";s:5:"76718";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Bromoform";s:5:"title";s:9:"Bromoform";s:3:"nid";s:5:"82286";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82287;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Bumetanide or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bumétanide ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76719";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Bumetanide";s:5:"title";s:10:"Bumetanide";s:3:"nid";s:5:"82287";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82288;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Buproprion or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Buproprione ou ses sels";s:16:"field_legacy_nid";s:5:"76720";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Buproprion";s:5:"title";s:10:"Buproprion";s:3:"nid";s:5:"82288";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82289;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Buserelin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Buséréline ou ses sels";s:16:"field_legacy_nid";s:5:"76721";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Buserelin";s:5:"title";s:9:"Buserelin";s:3:"nid";s:5:"82289";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82290;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Buspirone or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Buspirone ou ses sels";s:16:"field_legacy_nid";s:5:"76722";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Buspirone";s:5:"title";s:9:"Buspirone";s:3:"nid";s:5:"82290";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82291;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Busulfan";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Busulfan";s:16:"field_legacy_nid";s:5:"76723";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Busulfan";s:5:"title";s:8:"Busulfan";s:3:"nid";s:5:"82291";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82292;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Butaperazine or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Butapérazine ou ses sels";s:16:"field_legacy_nid";s:5:"76724";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Butaperazine";s:5:"title";s:12:"Butaperazine";s:3:"nid";s:5:"82292";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82293;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Butoconazole or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Butoconazole ou ses sels";s:16:"field_legacy_nid";s:5:"76725";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Butoconazole";s:5:"title";s:12:"Butoconazole";s:3:"nid";s:5:"82293";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82294;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Cabergoline or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cabergoline ou ses sels";s:16:"field_legacy_nid";s:5:"76726";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Cabergoline";s:5:"title";s:11:"Cabergoline";s:3:"nid";s:5:"82294";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82295;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Calcitriol";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Calcitriol";s:16:"field_legacy_nid";s:5:"76727";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Calcitriol";s:5:"title";s:10:"Calcitriol";s:3:"nid";s:5:"82295";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82296;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Calcium bromolactobionate";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Bromolactobionate de calcium";s:16:"field_legacy_nid";s:5:"76728";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Calcium bromolactobionate";s:5:"title";s:25:"Calcium bromolactobionate";s:3:"nid";s:5:"82296";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82297;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:84:"A non-NHP because listed in the Prescription Drug List as follows: Calcium carbimide";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Calcium (carbimide de)";s:16:"field_legacy_nid";s:5:"76729";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Calcium carbimide";s:5:"title";s:17:"Calcium carbimide";s:3:"nid";s:5:"82297";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82298;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Candesartan or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Candésartan ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76730";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Candesartan";s:5:"title";s:11:"Candesartan";s:3:"nid";s:5:"82298";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82299;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Candicidin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Candicidine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76731";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Candicidin";s:5:"title";s:10:"Candicidin";s:3:"nid";s:5:"82299";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82300;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:112:"A non-NHP because listed in the Prescription Drug List as follows: Capecitabine or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Capécitabine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76732";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Capecitabine";s:5:"title";s:12:"Capecitabine";s:3:"nid";s:5:"82300";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82301;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Capreomycin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Capréomycine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76733";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Capreomycin";s:5:"title";s:11:"Capreomycin";s:3:"nid";s:5:"82301";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82302;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Captodiamine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Captodiamine ou ses sels";s:16:"field_legacy_nid";s:5:"76734";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Captodiamine";s:5:"title";s:12:"Captodiamine";s:3:"nid";s:5:"82302";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82303;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Captopril or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Captopril ou ses sels";s:16:"field_legacy_nid";s:5:"76735";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Captopril";s:5:"title";s:9:"Captopril";s:3:"nid";s:5:"82303";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82304;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Carbachol";s:25:"field_non_nhp_rationale_f";s:87:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carbachol";s:16:"field_legacy_nid";s:5:"76736";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Carbachol";s:5:"title";s:9:"Carbachol";s:3:"nid";s:5:"82304";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82305;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Carbamazepine";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carbamazépine";s:16:"field_legacy_nid";s:5:"76737";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Carbamazepine";s:5:"title";s:13:"Carbamazepine";s:3:"nid";s:5:"82305";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82306;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:113:"A non-NHP because listed in the Prescription Drug List as follows: Carbenicillin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:122:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carbénicilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76738";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Carbenicillin";s:5:"title";s:13:"Carbenicillin";s:3:"nid";s:5:"82306";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82307;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Carbenoxolone or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carbenoxolone ou ses sels";s:16:"field_legacy_nid";s:5:"76739";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Carbenoxolone";s:5:"title";s:13:"Carbenoxolone";s:3:"nid";s:5:"82307";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82308;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Carbetocin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carbétocine ou ses sels";s:16:"field_legacy_nid";s:5:"76740";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Carbetocin";s:5:"title";s:10:"Carbetocin";s:3:"nid";s:5:"82308";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82309;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Carbidopa or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carbidopa ou ses sels";s:16:"field_legacy_nid";s:5:"76741";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Carbidopa";s:5:"title";s:9:"Carbidopa";s:3:"nid";s:5:"82309";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82310;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Carbimazole";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carbimazole";s:16:"field_legacy_nid";s:5:"76742";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Carbimazole";s:5:"title";s:11:"Carbimazole";s:3:"nid";s:5:"82310";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82311;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Carbocisteine";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carbocistéine";s:16:"field_legacy_nid";s:5:"76743";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Carbocisteine";s:5:"title";s:13:"Carbocisteine";s:3:"nid";s:5:"82311";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82312;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Carbomycin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carbomycine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76744";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Carbomycin";s:5:"title";s:10:"Carbomycin";s:3:"nid";s:5:"82312";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82313;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Carboplatin";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carboplatine";s:16:"field_legacy_nid";s:5:"76745";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Carboplatin";s:5:"title";s:11:"Carboplatin";s:3:"nid";s:5:"82313";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82314;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Carisoprodol";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carisoprodol";s:16:"field_legacy_nid";s:5:"76746";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Carisoprodol";s:5:"title";s:12:"Carisoprodol";s:3:"nid";s:5:"82314";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82315;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Carmustine";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carmustine";s:16:"field_legacy_nid";s:5:"76747";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Carmustine";s:5:"title";s:10:"Carmustine";s:3:"nid";s:5:"82315";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82316;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Carphenazine or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carphénazine ou ses sels";s:16:"field_legacy_nid";s:5:"76748";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Carphenazine";s:5:"title";s:12:"Carphenazine";s:3:"nid";s:5:"82316";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82317;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Carprofen or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carprofène ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76749";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Carprofen";s:5:"title";s:9:"Carprofen";s:3:"nid";s:5:"82317";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82318;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Carvedilol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Carvédilol ou ses sels";s:16:"field_legacy_nid";s:5:"76750";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Carvedilol";s:5:"title";s:10:"Carvedilol";s:3:"nid";s:5:"82318";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82319;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Caspofungin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Caspofungine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76751";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Caspofungin";s:5:"title";s:11:"Caspofungin";s:3:"nid";s:5:"82319";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82320;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Cefdinir or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:115:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cefdinir ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76752";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Cefdinir";s:5:"title";s:8:"Cefdinir";s:3:"nid";s:5:"82320";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82321;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Cefepime or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Céfépime ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76753";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Cefepime";s:5:"title";s:8:"Cefepime";s:3:"nid";s:5:"82321";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82322;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Cefonicide or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Céfonicide ou ses sels";s:16:"field_legacy_nid";s:5:"76754";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cefonicide";s:5:"title";s:10:"Cefonicide";s:3:"nid";s:5:"82322";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82323;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:112:"A non-NHP because listed in the Prescription Drug List as follows: Cefoperazone or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Céfopérazone ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76755";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Cefoperazone";s:5:"title";s:12:"Cefoperazone";s:3:"nid";s:5:"82323";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82324;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Cefprozil or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cefprozil ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76756";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Cefprozil";s:5:"title";s:9:"Cefprozil";s:3:"nid";s:5:"82324";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82325;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Ceftibuten or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ceftibutène ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76757";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ceftibuten";s:5:"title";s:10:"Ceftibuten";s:3:"nid";s:5:"82325";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82326;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Celecoxib or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Célécoxib ou ses sels";s:16:"field_legacy_nid";s:5:"76758";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Celecoxib";s:5:"title";s:9:"Celecoxib";s:3:"nid";s:5:"82326";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82327;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:115:"A non-NHP because listed in the Prescription Drug List as follows: Cephalosporin C or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:124:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Céphalosporine C ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76759";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Cephalosporin C";s:5:"title";s:15:"Cephalosporin C";s:3:"nid";s:5:"82327";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82328;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Cerivastatin or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cérivastatine ou ses sels";s:16:"field_legacy_nid";s:5:"76760";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Cerivastatin";s:5:"title";s:12:"Cerivastatin";s:3:"nid";s:5:"82328";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82329;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Cetrorelix or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cétrorélix ou ses sels";s:16:"field_legacy_nid";s:5:"76761";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cetrorelix";s:5:"title";s:10:"Cetrorelix";s:3:"nid";s:5:"82329";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82330;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Cetuximab";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cétuximab";s:16:"field_legacy_nid";s:5:"76762";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Cetuximab";s:5:"title";s:9:"Cetuximab";s:3:"nid";s:5:"82330";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82331;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:74:"A non-NHP because listed in the Prescription Drug List as follows: Chloral";s:25:"field_non_nhp_rationale_f";s:85:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chloral";s:16:"field_legacy_nid";s:5:"76763";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Chloral";s:5:"title";s:7:"Chloral";s:3:"nid";s:5:"82331";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82332;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:82:"A non-NHP because listed in the Prescription Drug List as follows: Chloral Hydrate";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chloral (hydrate de)";s:16:"field_legacy_nid";s:5:"76764";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Chloral hydrate";s:5:"title";s:15:"Chloral hydrate";s:3:"nid";s:5:"82332";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82333;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:83:"A non-NHP because listed in the Prescription Drug List as follows: Chloralformamide";s:25:"field_non_nhp_rationale_f";s:94:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chloralformamide";s:16:"field_legacy_nid";s:5:"76765";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Chloralformamide";s:5:"title";s:16:"Chloralformamide";s:3:"nid";s:5:"82333";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82334;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"4311;17412";s:25:"field_non_nhp_rationale_e";s:953:"A non-NHP because listed in the Prescription Drug List as follows: Nicotine or its salts, for human use, except (a) in natural substances; (b) in the form of a chewing gum containing 4 mg or less of nicotine per dosage unit; (c) in the form of a transdermal patch with a delivery rate of 22 mg or less of nicotine per day; (d) in a form to be administered orally by means of an inhalation device delivering 4 mg or less of nicotine per dosage unit; or (e) in the form of a lozenge containing 4 mg or less of nicotine per dosage unit. The listing of Nicotine in the Prescription Drug List exempts nicotine or its salts for human use, in natural substances. The Tobacco Act excludes drugs that contain nicotine to which the Food and Drugs Act applies. This means that natural substances containing nicotine that meet the definition of a natural health product, such as tabacum homeopathic medicines, are subject to the Natural Health Products Regulations.";s:25:"field_non_nhp_rationale_f";s:1135:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Nicotine ou ses sels, destinés à l'usage humain, sauf : a) dans les substances naturelles; b) sous forme de gomme à mâcher contenant 4 mg ou moins de nicotine par unité posologique; c) sous forme de timbre cutané ayant un taux de libération de 22 mg ou moins de nicotine par jour; d) sous une forme destinée à être administrée par voie orale au moyen d’un inhalateur libérant 4 mg ou moins de nicotine par unité posologique; e) sous forme de pastille contenant 4 mg ou moins de nicotine par unité posologique. La présence de la Nicotine sur la Liste des drogues sur ordonnance exempte la nicotine ou ses sels destinés à l'usage humain dans les substances naturelles. La Loi sur le tabac exclut les drogues contenant de la nicotine auxquelles s'applique la Loi sur les aliments et les drogues. Ceci veut dire que les subtances naturelles contenant de la nicotine qui respectent la définition d'un produit de santé naturel, tel que les médicaments homéopathiques de tabacum, sont sujets au Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:5:"76766";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Nicotine";s:5:"title";s:8:"Nicotine";s:3:"nid";s:5:"82334";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82335;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:112:"A non-NHP because listed in the Prescription Drug List as follows: Chlorambucil or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chlorambucil ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76768";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Chlorambucil";s:5:"title";s:12:"Chlorambucil";s:3:"nid";s:5:"82335";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82336;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:115:"A non-NHP because listed in the Prescription Drug List as follows: Chloramphenicol or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:123:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chloramphénicol ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76769";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Chloramphenicol";s:5:"title";s:15:"Chloramphenicol";s:3:"nid";s:5:"82336";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82337;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:141:"A non-NHP because listed in the Prescription Drug List as follows: Chlorcyclizine or its salts (except in preparations for external use only)";s:25:"field_non_nhp_rationale_f";s:163:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chlorcyclizine ou ses sels (sauf dans les préparations pour usage externe seulement)";s:16:"field_legacy_nid";s:5:"76770";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Chlorcyclizine";s:5:"title";s:14:"Chlorcyclizine";s:3:"nid";s:5:"82337";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82338;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Chlorisondamine or its salts";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chlorisondamine ou ses sels";s:16:"field_legacy_nid";s:5:"76771";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Chlorisondamine";s:5:"title";s:15:"Chlorisondamine";s:3:"nid";s:5:"82338";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82339;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Chlormezanone";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chlormézanone";s:16:"field_legacy_nid";s:5:"76772";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Chlormezanone";s:5:"title";s:13:"Chlormezanone";s:3:"nid";s:5:"82339";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82340;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Chloroquine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chloroquine ou ses sels";s:16:"field_legacy_nid";s:5:"76773";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Chloroquine";s:5:"title";s:11:"Chloroquine";s:3:"nid";s:5:"82340";s:7:"changed";s:10:"2014-02-05";s:14:"workflow_state";s:9:"Published";}i:82341;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Saralasin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Saralasine ou ses sels";s:16:"field_legacy_nid";s:5:"77261";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Saralasin";s:5:"title";s:9:"Saralasin";s:3:"nid";s:5:"82341";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82342;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Chlorprothixene or its salts";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chlorprothixène ou ses sels";s:16:"field_legacy_nid";s:5:"76774";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Chlorpropamide";s:5:"title";s:14:"Chlorpropamide";s:3:"nid";s:5:"82342";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82343;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Chlorprothixene or its salts";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Chlorprothixène ou ses sels";s:16:"field_legacy_nid";s:5:"76775";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Chlorprothixene";s:5:"title";s:15:"Chlorprothixene";s:3:"nid";s:5:"82343";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82344;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Choline theophyllinate";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Choline (théophyllinate de)";s:16:"field_legacy_nid";s:5:"76776";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Choline theophyllinate";s:5:"title";s:22:"Choline theophyllinate";s:3:"nid";s:5:"82344";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82345;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Ciclopirox or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ciclopirox ou ses sels";s:16:"field_legacy_nid";s:5:"76778";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ciclopirox";s:5:"title";s:10:"Ciclopirox";s:3:"nid";s:5:"82345";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82346;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Choriogonadotropin alfa";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Choriogonadotropine alfa";s:16:"field_legacy_nid";s:5:"76777";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Choriogonadotropin alfa";s:5:"title";s:23:"Choriogonadotropin alfa";s:3:"nid";s:5:"82346";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82347;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Cilastatin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cilastatine ou ses sels";s:16:"field_legacy_nid";s:5:"76779";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cilastatin";s:5:"title";s:10:"Cilastatin";s:3:"nid";s:5:"82347";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82348;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Cilazapril or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cilazapril ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76780";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cilazapril";s:5:"title";s:10:"Cilazapril";s:3:"nid";s:5:"82348";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82349;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:210:"A non-NHP because listed in the Prescription Drug List as follows: Cimetidine or its salts, except when sold in concentrations of 200 mg or less per oral dosage unit and indicated for the treatment of heartburn";s:25:"field_non_nhp_rationale_f";s:241:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cimétidine ou ses sels, sauf s’ils sont vendus en une concentration de 200 mg ou moins par unité posologique orale pour le traitement des brûlures d’estomac";s:16:"field_legacy_nid";s:5:"76781";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cimetidine";s:5:"title";s:10:"Cimetidine";s:3:"nid";s:5:"82349";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82350;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Cinacalcet or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cinacalcet ou ses sels";s:16:"field_legacy_nid";s:5:"76782";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cinacalcet";s:5:"title";s:10:"Cinacalcet";s:3:"nid";s:5:"82350";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82351;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Cinchophene or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cinchophène ou ses sels";s:16:"field_legacy_nid";s:5:"76783";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Cinchophene";s:5:"title";s:11:"Cinchophene";s:3:"nid";s:5:"82351";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82352;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Cinoxacin";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cinoxacine";s:16:"field_legacy_nid";s:5:"76784";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Cinoxacin";s:5:"title";s:9:"Cinoxacin";s:3:"nid";s:5:"82352";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82353;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Ciprofloxacin or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ciprofloxacine ou ses sels";s:16:"field_legacy_nid";s:5:"76785";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Ciprofloxacin";s:5:"title";s:13:"Ciprofloxacin";s:3:"nid";s:5:"82353";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82354;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Cisapride or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cisapride ou ses sels";s:16:"field_legacy_nid";s:5:"76786";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Cisapride";s:5:"title";s:9:"Cisapride";s:3:"nid";s:5:"82354";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82355;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Cisatracurium besilate";s:25:"field_non_nhp_rationale_f";s:106:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cisatracurium (bésilate de)";s:16:"field_legacy_nid";s:5:"76787";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Cisatracurium besilate";s:5:"title";s:22:"Cisatracurium besilate";s:3:"nid";s:5:"82355";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82356;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:76:"A non-NHP because listed in the Prescription Drug List as follows: Cisplatin";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cisplatine";s:16:"field_legacy_nid";s:5:"76788";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Cisplatin";s:5:"title";s:9:"Cisplatin";s:3:"nid";s:5:"82356";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82357;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Citalopram or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Citalopram ou ses sels";s:16:"field_legacy_nid";s:5:"76789";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Citalopram";s:5:"title";s:10:"Citalopram";s:3:"nid";s:5:"82357";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82358;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Cladribine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cladribine ou ses sels";s:16:"field_legacy_nid";s:5:"76790";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cladribine";s:5:"title";s:10:"Cladribine";s:3:"nid";s:5:"82358";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82359;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Clindamycin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Clindamycine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76791";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Clindamycin";s:5:"title";s:11:"Clindamycin";s:3:"nid";s:5:"82359";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82360;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:94:"A non-NHP because listed in the Prescription Drug List as follows: Clodronic acid or its salts";s:25:"field_non_nhp_rationale_f";s:109:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Clodronique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"76792";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Clodronic acid";s:5:"title";s:14:"Clodronic acid";s:3:"nid";s:5:"82360";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82361;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Clofibrate";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Clofibrate";s:16:"field_legacy_nid";s:5:"76793";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Clofibrate";s:5:"title";s:10:"Clofibrate";s:3:"nid";s:5:"82361";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82362;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Clomiphene or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Clomiphène ou ses sels";s:16:"field_legacy_nid";s:5:"76794";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Clomiphene";s:5:"title";s:10:"Clomiphene";s:3:"nid";s:5:"82362";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82363;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Clomipramine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Clomipramine ou ses sels";s:16:"field_legacy_nid";s:5:"76795";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Clomipramine";s:5:"title";s:12:"Clomipramine";s:3:"nid";s:5:"82363";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82364;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Clonidine or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Clonidine ou ses sels";s:16:"field_legacy_nid";s:5:"76796";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Clonidine";s:5:"title";s:9:"Clonidine";s:3:"nid";s:5:"82364";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82365;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Clopidogrel or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Clopidogrel ou ses sels";s:16:"field_legacy_nid";s:5:"76797";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Clopidogrel";s:5:"title";s:11:"Clopidogrel";s:3:"nid";s:5:"82365";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82366;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:112:"A non-NHP because listed in the Prescription Drug List as follows: Cloprostenol or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:120:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cloprosténol ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76798";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Cloprostenol";s:5:"title";s:12:"Cloprostenol";s:3:"nid";s:5:"82366";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82367;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Clorazepic acid or its salts";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Clorazépique (acide) ou ses sels";s:16:"field_legacy_nid";s:5:"76799";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Clorazepic acid";s:5:"title";s:15:"Clorazepic acid";s:3:"nid";s:5:"82367";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82368;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:111:"A non-NHP because listed in the Prescription Drug List as follows: Cloxacillin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cloxacilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76800";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Cloxacillin";s:5:"title";s:11:"Cloxacillin";s:3:"nid";s:5:"82368";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82369;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Clozapine or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Clozapine ou ses sels";s:16:"field_legacy_nid";s:5:"76801";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Clozapine";s:5:"title";s:9:"Clozapine";s:3:"nid";s:5:"82369";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82370;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Colchicine";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Colchicine";s:16:"field_legacy_nid";s:5:"76802";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Colchicine";s:5:"title";s:10:"Colchicine";s:3:"nid";s:5:"82370";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82371;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Colestipol or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Colestipol ou ses sels";s:16:"field_legacy_nid";s:5:"76803";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Colestipol";s:5:"title";s:10:"Colestipol";s:3:"nid";s:5:"82371";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82372;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:98:"A non-NHP because listed in the Prescription Drug List as follows: Colfosceril and its derivatives";s:25:"field_non_nhp_rationale_f";s:107:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Colfoscéril et ses dérivés";s:16:"field_legacy_nid";s:5:"76804";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Colfosceril";s:5:"title";s:11:"Colfosceril";s:3:"nid";s:5:"82372";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82373;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:108:"A non-NHP because listed in the Prescription Drug List as follows: Colistin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:116:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Colistine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76805";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Colistin";s:5:"title";s:8:"Colistin";s:3:"nid";s:5:"82373";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82374;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:198:"A non-NHP because listed in the Prescription Drug List as follows: Cromoglicic acid or its salts (except sodium cromoglicate in solutions for ophthalmic or nasal use in concentrations of 2% or less)";s:25:"field_non_nhp_rationale_f";s:228:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cromoglicique (acide) ou ses sels (sauf le cromoglicate de sodium dans les solutions pour usage ophtalmique ou nasal en concentration de 2 % ou moins)";s:16:"field_legacy_nid";s:5:"76806";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Cromoglicic acid";s:5:"title";s:16:"Cromoglicic acid";s:3:"nid";s:5:"82374";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82375;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Cyclobenzaprine or its salts";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cyclobenzaprine ou ses sels";s:16:"field_legacy_nid";s:5:"76807";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Cyclobenzaprine";s:5:"title";s:15:"Cyclobenzaprine";s:3:"nid";s:5:"82375";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82376;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:247:"A non-NHP because listed in the Prescription Drug List as follows: Cyclopentolate or its salts in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada";s:25:"field_non_nhp_rationale_f";s:276:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cyclopentolate ou ses sels dans les préparations pour usage parentéral ou ophtalmique, sauf lorsqu’ils sont vendus pour usage diagnostique à un optométriste agréé dans une province du Canada";s:16:"field_legacy_nid";s:5:"76808";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Cyclopentolate";s:5:"title";s:14:"Cyclopentolate";s:3:"nid";s:5:"82376";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82377;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:83:"A non-NHP because listed in the Prescription Drug List as follows: Cyclophosphamide";s:25:"field_non_nhp_rationale_f";s:94:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cyclophosphamide";s:16:"field_legacy_nid";s:5:"76809";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Cyclophosphamide";s:5:"title";s:16:"Cyclophosphamide";s:3:"nid";s:5:"82377";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82378;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Cycloserine";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cyclosérine";s:16:"field_legacy_nid";s:5:"76810";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Cycloserine";s:5:"title";s:11:"Cycloserine";s:3:"nid";s:5:"82378";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82379;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:86:"A non-NHP because listed in the Prescription Drug List as follows: Cyproterone acetate";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cyprotérone (acétate de)";s:16:"field_legacy_nid";s:5:"76811";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Cyproterone acetate";s:5:"title";s:19:"Cyproterone acetate";s:3:"nid";s:5:"82379";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82380;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Cytarabine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Cytarabine ou ses sels";s:16:"field_legacy_nid";s:5:"76812";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cytarabine";s:5:"title";s:10:"Cytarabine";s:3:"nid";s:5:"82380";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82381;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Dacarbazine";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dacarbazine";s:16:"field_legacy_nid";s:5:"76813";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Dacarbazine";s:5:"title";s:11:"Dacarbazine";s:3:"nid";s:5:"82381";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82382;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Daclizumab";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Daclizumab";s:16:"field_legacy_nid";s:5:"76814";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Daclizumab";s:5:"title";s:10:"Daclizumab";s:3:"nid";s:5:"82382";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82383;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Dactinomycin";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dactinomycine";s:16:"field_legacy_nid";s:5:"76815";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Dactinomycin";s:5:"title";s:12:"Dactinomycin";s:3:"nid";s:5:"82383";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82384;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Dalfopristin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dalfopristin ou ses sels";s:16:"field_legacy_nid";s:5:"76816";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Dalfopristin";s:5:"title";s:12:"Dalfopristin";s:3:"nid";s:5:"82384";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82385;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Dalteparin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Daltéparine ou ses sels";s:16:"field_legacy_nid";s:5:"76817";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Dalteparin";s:5:"title";s:10:"Dalteparin";s:3:"nid";s:5:"82385";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82386;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Danaparoid or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Danaparoïde ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76818";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Danaparoid";s:5:"title";s:10:"Danaparoid";s:3:"nid";s:5:"82386";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82387;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:74:"A non-NHP because listed in the Prescription Drug List as follows: Danazol";s:25:"field_non_nhp_rationale_f";s:85:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Danazol";s:16:"field_legacy_nid";s:5:"76819";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Danazol";s:5:"title";s:7:"Danazol";s:3:"nid";s:5:"82387";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82388;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Danofloxacin or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Danofloxacine ou ses sels";s:16:"field_legacy_nid";s:5:"76820";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Danofloxacin";s:5:"title";s:12:"Danofloxacin";s:3:"nid";s:5:"82388";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82389;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Dantrolene or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dantrolène ou ses sels";s:16:"field_legacy_nid";s:5:"76821";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Dantrolene";s:5:"title";s:10:"Dantrolene";s:3:"nid";s:5:"82389";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82390;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Dapiprazole or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dapiprazole ou ses sels";s:16:"field_legacy_nid";s:5:"76822";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Dapiprazole";s:5:"title";s:11:"Dapiprazole";s:3:"nid";s:5:"82390";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82391;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Darifenacin or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Darifénacine ou ses sels";s:16:"field_legacy_nid";s:5:"76823";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Darifenacin";s:5:"title";s:11:"Darifenacin";s:3:"nid";s:5:"82391";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82392;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Daunorubicin or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Daunorubicine ou ses sels";s:16:"field_legacy_nid";s:5:"76824";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Daunorubicin";s:5:"title";s:12:"Daunorubicin";s:3:"nid";s:5:"82392";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82393;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Debrisoquin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Debrisoquine ou ses sels";s:16:"field_legacy_nid";s:5:"76825";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Debrisoquin";s:5:"title";s:11:"Debrisoquin";s:3:"nid";s:5:"82393";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82394;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Deferoxamine or its salts";s:25:"field_non_nhp_rationale_f";s:104:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Déféroxamine ou ses sels";s:16:"field_legacy_nid";s:5:"76826";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Deferoxamine";s:5:"title";s:12:"Deferoxamine";s:3:"nid";s:5:"82394";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82395;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Delavirdine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Délavirdine ou ses sels";s:16:"field_legacy_nid";s:5:"76827";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Delavirdine";s:5:"title";s:11:"Delavirdine";s:3:"nid";s:5:"82395";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82396;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Deserpidine and its alkaloids or its salts";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Déserpidine et ses alcaloïdes ou ses sels";s:16:"field_legacy_nid";s:5:"76828";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Deserpidine";s:5:"title";s:11:"Deserpidine";s:3:"nid";s:5:"82396";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82397;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Desflurane";s:25:"field_non_nhp_rationale_f";s:88:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Desflurane";s:16:"field_legacy_nid";s:5:"76829";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Desflurane";s:5:"title";s:10:"Desflurane";s:3:"nid";s:5:"82397";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82398;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Desipramine or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Désipramine ou ses sels";s:16:"field_legacy_nid";s:5:"76830";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Desipramine";s:5:"title";s:11:"Desipramine";s:3:"nid";s:5:"82398";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82399;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:92:"A non-NHP because listed in the Prescription Drug List as follows: Desmopressin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Desmopressin ou ses sels";s:16:"field_legacy_nid";s:5:"76831";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Desmopressin";s:5:"title";s:12:"Desmopressin";s:3:"nid";s:5:"82399";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82400;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Detomidine or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Détomidine ou ses sels";s:16:"field_legacy_nid";s:5:"76832";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Detomidine";s:5:"title";s:10:"Detomidine";s:3:"nid";s:5:"82400";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82401;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:95:"A non-NHP because listed in the Prescription Drug List as follows: Dexfenfluramine or its salts";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence à l'Annexe F de la Loi sur les aliments et les drogues : Dexfenfluramine et ses sels";s:16:"field_legacy_nid";s:5:"76833";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Dexfenfluramine";s:5:"title";s:15:"Dexfenfluramine";s:3:"nid";s:5:"82401";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82402;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Dexrazoxane or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dexrazoxane ou ses sels";s:16:"field_legacy_nid";s:5:"76834";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Dexrazoxane";s:5:"title";s:11:"Dexrazoxane";s:3:"nid";s:5:"82402";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82403;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Diazoxide or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Diazoxide ou ses sels";s:16:"field_legacy_nid";s:5:"76835";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Diazoxide";s:5:"title";s:9:"Diazoxide";s:3:"nid";s:5:"82403";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82404;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:86:"A non-NHP because listed in the Prescription Drug List as follows: Dichloroacetic Acid";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dichloroacétique (acide)";s:16:"field_legacy_nid";s:5:"76836";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Dichloroacetic Acid";s:5:"title";s:19:"Dichloroacetic Acid";s:3:"nid";s:5:"82404";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82405;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:113:"A non-NHP because listed in the Prescription Drug List as follows: Dicloxacillin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:121:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dicloxacilline ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76837";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Dicloxacillin";s:5:"title";s:13:"Dicloxacillin";s:3:"nid";s:5:"82405";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82406;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Didanosine or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:117:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Didanosine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76838";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Didanosine";s:5:"title";s:10:"Didanosine";s:3:"nid";s:5:"82406";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82407;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:98:"A non-NHP because listed in the Prescription Drug List as follows: Diethylcarbamazine or its salts";s:25:"field_non_nhp_rationale_f";s:108:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Diethylcarbamazine ou ses sels";s:16:"field_legacy_nid";s:5:"76839";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Diethylcarbamazine";s:5:"title";s:18:"Diethylcarbamazine";s:3:"nid";s:5:"82407";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82408;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:118:"A non-NHP because listed in the Prescription Drug List as follows: Diethylstilbestrol or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:126:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Diéthylstilbestrol ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76840";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Diethylstilbestrol";s:5:"title";s:18:"Diethylstilbestrol";s:3:"nid";s:5:"82408";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82409;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:110:"A non-NHP because listed in the Prescription Drug List as follows: Difloxacin or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:118:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Difloxacine ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76841";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Difloxacin";s:5:"title";s:10:"Difloxacin";s:3:"nid";s:5:"82409";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82410;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Diflunisal or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Diflunisal ou ses sels";s:16:"field_legacy_nid";s:5:"76842";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Diflunisal";s:5:"title";s:10:"Diflunisal";s:3:"nid";s:5:"82410";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82411;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:85:"A non-NHP because listed in the Prescription Drug List as follows: Dihydrotachysterol";s:25:"field_non_nhp_rationale_f";s:97:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dihydrotachystérol";s:16:"field_legacy_nid";s:5:"76843";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Dihydrotachysterol";s:5:"title";s:18:"Dihydrotachysterol";s:3:"nid";s:5:"82411";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82412;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:137:"A non-NHP because listed in the Prescription Drug List as follows: Diiodohydroxyquin (except in preparations for topical use on the skin)";s:25:"field_non_nhp_rationale_f";s:163:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Diiodohydroxyquinoléine (sauf dans les préparations pour usage topique sur la peau)";s:16:"field_legacy_nid";s:5:"76844";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Diiodohydroxyquin";s:5:"title";s:17:"Diiodohydroxyquin";s:3:"nid";s:5:"82412";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82413;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Diltiazem or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Diltiazem ou ses sels";s:16:"field_legacy_nid";s:5:"76845";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Diltiazem";s:5:"title";s:9:"Diltiazem";s:3:"nid";s:5:"82413";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82414;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Dimercaprol";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dimercaprol";s:16:"field_legacy_nid";s:5:"76846";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Dimercaprol";s:5:"title";s:11:"Dimercaprol";s:3:"nid";s:5:"82414";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82415;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:117:"A non-NHP because listed in the Prescription Drug List as follows: 2,4-Dinitrophenol or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:126:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dinitro-2,4-phénol ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76847";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"2,4-Dinitrophenol";s:5:"title";s:17:"2,4-Dinitrophenol";s:3:"nid";s:5:"82415";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82416;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:112:"A non-NHP because listed in the Prescription Drug List as follows: Dinoprostone or its salts and its derivatives";s:25:"field_non_nhp_rationale_f";s:119:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dinoprostone ou ses sels et ses dérivés";s:16:"field_legacy_nid";s:5:"76848";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Dinoprostone";s:5:"title";s:12:"Dinoprostone";s:3:"nid";s:5:"82416";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82417;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Diphenidol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Diphénidol ou ses sels";s:16:"field_legacy_nid";s:5:"76849";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Diphenidol";s:5:"title";s:10:"Diphenidol";s:3:"nid";s:5:"82417";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82418;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:109:"A non-NHP because listed in the Prescription Drug List as follows: Diphenylhydantoin (phenytoin) or its salts";s:25:"field_non_nhp_rationale_f";s:124:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Diphénylhydantoine (phénytoïne) ou ses sels";s:16:"field_legacy_nid";s:5:"76850";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Diphenylhydantoin (phenytoin)";s:5:"title";s:29:"Diphenylhydantoin (phenytoin)";s:3:"nid";s:5:"82418";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82419;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Dipivefrin or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dipivefrine ou ses sels";s:16:"field_legacy_nid";s:5:"76851";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Dipivefrin";s:5:"title";s:10:"Dipivefrin";s:3:"nid";s:5:"82419";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82420;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:93:"A non-NHP because listed in the Prescription Drug List as follows: Diprophylline or its salts";s:25:"field_non_nhp_rationale_f";s:103:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Diprophylline ou ses sels";s:16:"field_legacy_nid";s:5:"76852";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Diprophylline";s:5:"title";s:13:"Diprophylline";s:3:"nid";s:5:"82420";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82421;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Dipyridamole";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dipyridamole";s:16:"field_legacy_nid";s:5:"76853";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Dipyridamole";s:5:"title";s:12:"Dipyridamole";s:3:"nid";s:5:"82421";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82422;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Dirithromycin";s:25:"field_non_nhp_rationale_f";s:91:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Dirithromycine";s:16:"field_legacy_nid";s:5:"77650";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Dirithromycin";s:5:"title";s:13:"Dirithromycin";s:3:"nid";s:5:"82422";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82423;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Disulfiram";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Disulfirame";s:16:"field_legacy_nid";s:5:"76854";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Disulfiram";s:5:"title";s:10:"Disulfiram";s:3:"nid";s:5:"82423";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82424;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Dobutamine or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dobutamine ou ses sels";s:16:"field_legacy_nid";s:5:"76855";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Dobutamine";s:5:"title";s:10:"Dobutamine";s:3:"nid";s:5:"82424";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82425;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:96:"A non-NHP because listed in the Prescription Drug List as follows: Docetaxel and its derivatives";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Docétaxel et ses dérivés";s:16:"field_legacy_nid";s:5:"76856";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Docetaxel";s:5:"title";s:9:"Docetaxel";s:3:"nid";s:5:"82425";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82426;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Dolasetron or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dolasétron ou ses sels";s:16:"field_legacy_nid";s:5:"76857";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Dolasetron";s:5:"title";s:10:"Dolasetron";s:3:"nid";s:5:"82426";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82427;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Domperidone";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dompéridone";s:16:"field_legacy_nid";s:5:"76858";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Domperidone";s:5:"title";s:11:"Domperidone";s:3:"nid";s:5:"82427";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82428;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Donepezil or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Donépézil ou ses sels";s:16:"field_legacy_nid";s:5:"76859";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Donepezil";s:5:"title";s:9:"Donepezil";s:3:"nid";s:5:"82428";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82429;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:17:"67;304;8245;17412";s:25:"field_non_nhp_rationale_e";s:128:"As per the Prescription Drug List, Dopamine or its salts, when sold for administration by injection, are classified as non-NHPs.";s:25:"field_non_nhp_rationale_f";s:159:"Selon la Liste des drogues sur ordonnance, la Dopamine ou ses sels, lorsqu’ils sont vendus pour administration par injection, sont classifiés comme non PSN.";s:19:"field_old_rationale";s:279:"Amendment: Dopamine and its salts in Part I of Schedule F to the Food and Drug Regulations is replaced by the following: Dopamine and its salts, when sold for administration by injection. Canada Gazette Part II: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/pdf/g2-14525.pdf.";s:16:"field_legacy_nid";s:5:"76860";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Dopamine";s:5:"title";s:8:"Dopamine";s:3:"nid";s:5:"82429";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82430;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:79:"A non-NHP because listed in the Prescription Drug List as follows: Dornase alfa";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dornase alfa";s:16:"field_legacy_nid";s:5:"76861";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Dornase alfa";s:5:"title";s:12:"Dornase alfa";s:3:"nid";s:5:"82430";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82431;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Dorzolamide or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dorzolamide ou ses sels";s:16:"field_legacy_nid";s:5:"76862";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Dorzolamide";s:5:"title";s:11:"Dorzolamide";s:3:"nid";s:5:"82431";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82432;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:86:"A non-NHP because listed in the Prescription Drug List as follows: Doxacurium chloride";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Doxacurium (cholure de)";s:16:"field_legacy_nid";s:5:"76863";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Doxacurium chloride";s:5:"title";s:19:"Doxacurium chloride";s:3:"nid";s:5:"82432";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82433;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:75:"A non-NHP because listed in the Prescription Drug List as follows: Doxapram";s:25:"field_non_nhp_rationale_f";s:86:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Doxapram";s:16:"field_legacy_nid";s:5:"76864";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Doxapram";s:5:"title";s:8:"Doxapram";s:3:"nid";s:5:"82433";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82434;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Doxazosin or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Doxazosine ou ses sels";s:16:"field_legacy_nid";s:5:"76865";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Doxazosin";s:5:"title";s:9:"Doxazosin";s:3:"nid";s:5:"82434";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82435;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:87:"A non-NHP because listed in the Prescription Drug List as follows: Doxepin or its salts";s:25:"field_non_nhp_rationale_f";s:99:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Doxépine ou ses sels";s:16:"field_legacy_nid";s:5:"76866";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Doxepin";s:5:"title";s:7:"Doxepin";s:3:"nid";s:5:"82435";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82436;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:102:"A non-NHP because listed in the Prescription Drug List as follows: Doxercalciferol and its derivatives";s:25:"field_non_nhp_rationale_f";s:111:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Doxercalciférol et ses dérivés";s:16:"field_legacy_nid";s:5:"76867";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Doxercalciferol";s:5:"title";s:15:"Doxercalciferol";s:3:"nid";s:5:"82436";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82437;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:91:"A non-NHP because listed in the Prescription Drug List as follows: Doxorubicin or its salts";s:25:"field_non_nhp_rationale_f";s:102:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Doxorubicine ou ses sels";s:16:"field_legacy_nid";s:5:"76868";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Doxorubicin";s:5:"title";s:11:"Doxorubicin";s:3:"nid";s:5:"82437";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82438;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:163:"A non-NHP because listed in the Prescription Drug List as follows: Doxylamine or its salts, when sold or recommended for use in the nausea or vomiting of pregnancy";s:25:"field_non_nhp_rationale_f";s:183:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Doxylamine ou ses sels lorsque vendus ou recommandés contre les nausées ou vomissements de la grossesse";s:16:"field_legacy_nid";s:5:"76869";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Doxylamine";s:5:"title";s:10:"Doxylamine";s:3:"nid";s:5:"82438";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82439;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:90:"A non-NHP because listed in the Prescription Drug List as follows: Droperidol or its salts";s:25:"field_non_nhp_rationale_f";s:101:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dropéridol ou ses sels";s:16:"field_legacy_nid";s:5:"76870";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Droperidol";s:5:"title";s:10:"Droperidol";s:3:"nid";s:5:"82439";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82440;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Dutasteride";s:25:"field_non_nhp_rationale_f";s:90:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Dutastéride";s:16:"field_legacy_nid";s:5:"76871";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Dutasteride";s:5:"title";s:11:"Dutasteride";s:3:"nid";s:5:"82440";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82441;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Econazole or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Éconazole ou ses sels";s:16:"field_legacy_nid";s:5:"76872";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Econazole";s:5:"title";s:9:"Econazole";s:3:"nid";s:5:"82441";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82442;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Ectylurea or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Ectylurée ou ses sels";s:16:"field_legacy_nid";s:5:"76873";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ectylurea";s:5:"title";s:9:"Ectylurea";s:3:"nid";s:5:"82442";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";}i:82443;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:263:"A non-NHP because it is a hormone obtained via recombinant DNA procedure, which falls under "Drugs Obtained By Recombinant DNA Procedures" listed in Schedule D of the Food and Drugs Act. Abatacept is also listed in the Prescription Drug List as follows: Abatacept";s:25:"field_non_nhp_rationale_f";s:309:"Un non PSN parce qu'une hormone obtenue par procédure de recombinaison de l' ADN, de qui correspond à "Drogues obtenues par des procédures de recombinaison de l’ADN" dans l'Annexe D de la Loi sur les aliments et les drogues. Abatacept est aussi présent sur la Liste des drogues sur ordonnance: Abatacept";s:19:"field_old_rationale";s:511:"Abatacept is a soluble recombinant fusion protein composed of the extracellular domain of the human CTLA-4 and a fragment of the Fc domain of the human immunoglobulin IgG1.  This immunosuppressive agent is currently approved for use in rheumatoid arthritis.  Since immunizing agents and drugs obtained by recombinant DNA procedures (fusion proteins are obtained by recombinant DNA procedures) are listed in Schedule D to the Food and Drugs Act, Abatacept will be considered as a non-NHP, a Schedule D substance.";s:16:"field_legacy_nid";s:5:"76540";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Abatacept";s:5:"title";s:9:"Abatacept";s:3:"nid";s:5:"82443";s:7:"changed";s:10:"2014-02-11";s:14:"workflow_state";s:9:"Published";}i:82444;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3213;17412";s:25:"field_non_nhp_rationale_e";s:281:"A non-NHP because it is an enzyme obtained via recombinant DNA procedure, which falls under "Drugs Obtained By Recombinant DNA Procedures" listed in Schedule D of the Food and Drugs Act. Alglucosidase alfa is also listed in the Prescription Drug List as follows: Alglucosidase alfa";s:25:"field_non_nhp_rationale_f";s:325:"Un non PSN parce qu'un enzyme obtenue par procédure de recombinaison de l' ADN, de qui correspond à "Drogues obtenues par des procédures de recombinaison de l’ADN" dans l'Annexe D de la Loi sur les aliments et les drogues. Alglucosidase alfa est aussi présent sur la Liste des drogues sur ordonnance: Alglucosidase alfa";s:19:"field_old_rationale";s:446:"Alglucosidase alfa consist of the human enzyme Acid alpha-glucosidase, produced by recombinant DNA technology; and available only as an intravenous infusion.  Since drugs obtained by recombinant DNA procedures are listed in Schedule D to the Food and Drugs Act; and that drugs administered by puncturing the dermis are excluded from NHP Regulations by being captured in Schedule 2, Alglucosidase alfa will be considered as a Schedule D substance.";s:16:"field_legacy_nid";s:5:"76541";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Alglucosidase alfa";s:5:"title";s:18:"Alglucosidase alfa";s:3:"nid";s:5:"82444";s:7:"changed";s:10:"2014-02-11";s:14:"workflow_state";s:9:"Published";}i:82445;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because listed in the Prescription Drug List as follows: Paclitaxel and its derivatives";s:25:"field_non_nhp_rationale_f";s:105:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Paclitaxel et ses dérivés";s:19:"field_old_rationale";s:1065:"Paclitaxel (more commonly known as Taxol) is a naturally occurring substance, which has been isolated from the stem bark of the Pacific yew tree, Taxus brevifolia, and in traces amounts in other plants and fungi.  Currently, most Paclitaxel production is accomplished by a plant cell fermentation technology or by a semi-synthetic route starting with 10-Deacetylbaccatin III, since this naturally occurring compound can be isolated in larger quantities than Paclitaxel.  Despite the fact that Paclitaxel is a naturally occurring compound, it is listed in Schedule F to the Food and Drug Regulations; therefore, it will be considered as a Schedule F drug, not a NHP.                                                                                                                 References: 
The Merck Index
Dictionary of Natural Products
http://en.wikipedia.org/wiki/Taxol
http://chem.sis.nlm.nih.gov/chemidplus/ProxyServlet?objectHandle=Search&actionHandle=getAll3DMViewFiles&nextPage=jsp%2Fcommon%2FChemFull.jsp%3FcalledFrom%3D&chemid=033069624&formatType=_3D";s:16:"field_legacy_nid";s:5:"76589";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Paclitaxel";s:5:"title";s:10:"Paclitaxel";s:3:"nid";s:5:"82445";s:7:"changed";s:10:"2014-02-11";s:14:"workflow_state";s:9:"Published";}i:82446;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:80:"A non-NHP because listed in the Prescription Drug List as follows: Acetohexamide";s:25:"field_non_nhp_rationale_f";s:92:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Acétohexamide";s:16:"field_legacy_nid";s:5:"76612";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Acetohexamide";s:5:"title";s:13:"Acetohexamide";s:3:"nid";s:5:"82446";s:7:"changed";s:10:"2014-02-11";s:14:"workflow_state";s:9:"Published";}i:82447;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:84:"A non-NHP because listed in the Prescription Drug List as follows: Aminoglutethimide";s:25:"field_non_nhp_rationale_f";s:95:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Aminoglutéhimide";s:16:"field_legacy_nid";s:5:"76639";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Aminoglutethimide";s:5:"title";s:17:"Aminoglutethimide";s:3:"nid";s:5:"82447";s:7:"changed";s:10:"2014-02-11";s:14:"workflow_state";s:9:"Published";}i:82448;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:77:"A non-NHP because listed in the Prescription Drug List as follows: Efalizumab";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Éfalizumab";s:16:"field_legacy_nid";s:5:"76875";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Efalizumab";s:5:"title";s:10:"Efalizumab";s:3:"nid";s:5:"82448";s:7:"changed";s:10:"2014-02-11";s:14:"workflow_state";s:9:"Published";}i:82449;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:89:"A non-NHP because listed in the Prescription Drug List as follows: Megestrol or its salts";s:25:"field_non_nhp_rationale_f";s:100:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Mégestrol ou ses sels";s:16:"field_legacy_nid";s:5:"77044";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Megestrol";s:5:"title";s:9:"Megestrol";s:3:"nid";s:5:"82449";s:7:"changed";s:10:"2014-02-11";s:14:"workflow_state";s:9:"Published";}i:82450;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"17412";s:25:"field_non_nhp_rationale_e";s:78:"A non-NHP because listed in the Prescription Drug List as follows: Tolbutamide";s:25:"field_non_nhp_rationale_f";s:89:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Tolbutamide";s:16:"field_legacy_nid";s:5:"77340";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Tolbutamide";s:5:"title";s:11:"Tolbutamide";s:3:"nid";s:5:"82450";s:7:"changed";s:10:"2014-02-11";s:14:"workflow_state";s:9:"Published";}i:82452;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"18151";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:129:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels";s:16:"field_legacy_nid";s:6:"106729";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Oxygenated glycerol triester";s:20:"field_limitation_ref";s:4:"NHPD";s:5:"title";s:28:"Oxygenated glycerol triester";s:3:"nid";s:5:"82452";s:7:"changed";s:10:"2014-05-01";s:14:"workflow_state";s:9:"Published";}i:82454;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"20497";s:25:"field_non_nhp_rationale_e";s:88:"A non-NHP because listed in the Prescription Drug List as follows: Lithium or its salts.";s:25:"field_non_nhp_rationale_f";s:98:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance : Lithium ou ses sels.";s:16:"field_legacy_nid";s:6:"107093";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Lithium orotate";s:20:"field_limitation_ref";s:4:"NHPD";s:5:"title";s:15:"Lithium orotate";s:3:"nid";s:5:"82454";s:7:"changed";s:10:"2014-06-26";s:14:"workflow_state";s:9:"Published";}i:82455;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"16533";s:25:"field_non_nhp_rationale_e";s:121:"A non-NHP because listed in Schedule D of the Food and Drugs Act as follows: Drugs obtained by recombinant DNA procedures";s:25:"field_non_nhp_rationale_f";s:159:"Un non PSN à cause de sa présence dans l'Annexe D de la Loi sur les aliments et les drogues: Drogues obtenues par des procédures de recombinaison de l’ADN";s:16:"field_legacy_nid";s:6:"107095";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Apoaequorin";s:20:"field_limitation_ref";s:4:"NHPD";s:5:"title";s:11:"Apoaequorin";s:3:"nid";s:5:"82455";s:7:"changed";s:10:"2014-06-26";s:14:"workflow_state";s:9:"Published";}i:82457;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:16:"87;67;3946;22702";s:25:"field_non_nhp_rationale_e";s:1349:"Petrolatum is a non-NHP because it is not falling under Schedule 1 to the NHP Regulations.  If petrolatum is declared as a medicinal ingredient in a product, the product is a drug, not an NHP. A Drug Identification Number Application should be submitted to Health Canada for this product.

If petrolatum is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is less than 30%, the product is an NHP.  A Natural Health Product Licence Application should be submitted to Health Canada for this product.

If petrolatum is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is greater than or equal to 30% and 3) it contributes to the claim (e.g. the Recommended Use or Purpose on the product is a statement to the effect of those permitted for petrolatum on the Diaper Rash Products or Medicated Skin Care Products monographs), then the product is considered a drug.  A Drug Identification Number Application should be submitted to Health Canada for this product.

If petrolatum is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is greater than or equal to 30% and 3) does not contribute to the claim (as defined above), the product is an NHP.  A Natural Health Product Licence Application should be submitted to Health Canada for this product.";s:25:"field_non_nhp_rationale_f";s:1667:"Le pétrolatum est un non-PSN puisqu'il n'est pas une substance décrite sous l'Annexe 1 du Règlement sur les produits de santé naturels.  Si le pétrolatum est déclaré comme ingrédient médicinal dans un produit, ce produit est une drogue, et non un PSN.  Une demande pour obtenir un numéro d'identification de médicament (DIN) doit être soumise à Santé Canada pour un tel produit.

Si le pétrolatum est 1) déclaré comme un ingrédient non médicinal et 2) est présent à une concentration qui est inférieure à 30%, le produit est un PSN.  Une demande de licence de mise en marché pour un produit de santé naturel doit être soumise à Santé Canada pour un tel produit.

Si le pétrolatum est 1) déclaré comme ingrédient non médicinal et 2) est présent à une concentration qui est supérieure ou égale à 30% et 3) qu'il contribue à l'allégation (p. ex. l'usage ou la fin recommandé pour le produit est un énoncé qui est comparable à ceux permis pour le pétrolatum  dans les monographies pour les produits de traitement de l'érythème fessier ou des produits médicamenteux pour le soin de la peau), ce produit est une drogue.  Une demande pour obtenir un numéro d'identification de médicament (DIN) doit être soumise à Santé Canada pour un tel produit.

Si le pétrolatum est 1) déclaré comme ingrédient non médicinal et 2) est présent à une concentration supérieure ou égale à 30% et 3) qu'il ne contribute pas à l'allégation (comme définie ci-haut), ce produit est un PSN.  Une demande de licence de mise en marché pour un produit de santé naturel doit être soumise à Santé Canada pour un tel produit.";s:19:"field_old_rationale";s:745:"At any concentration where Petrolatum is associated with a health claim (e.g. as a barrier in diaper rash products), petrolatum is classified as a drug medicinal ingredient subject to the Food and Drug Regulations, not an NHP, because petroleum products are not captured in Schedule 1 to the Natural Health Products Regulations.
Pour toutes les concentrations où le pétrolatum est associé à une allégation santé (e.g. comme barrière dans les produits de traitement de l'érythème fessier), le pétrolatum est classifié comme une drogue médicinale sujette au Règlement sur les aliments et les drogues, et non un PSN, parce que les produits de pétrolatum ne font pas partie de l'Annexe 1 du Règlement des produits de santé naturels.";s:16:"field_legacy_nid";s:5:"76353";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Petrolatum";s:5:"title";s:10:"Petrolatum";s:3:"nid";s:5:"82457";s:7:"changed";s:10:"2014-10-10";s:14:"workflow_state";s:9:"Published";}i:82458;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:10:"3946;22702";s:25:"field_non_nhp_rationale_e";s:1385:"White petrolatum is a non-NHP because it is not falling under Schedule 1 to the NHP Regulations.  If white petrolatum is declared as a medicinal ingredient in a product, the product is a drug, not an NHP. A Drug Identification Number Application should be submitted to Health Canada for this product.

If white petrolatum is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is less than 30%, the product is an NHP.  A Natural Health Product Licence Application should be submitted to Health Canada for this product.

If white petrolatum is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is greater than or equal to 30% and 3) it contributes to the claim (e.g. the Recommended Use or Purpose on the product is a statement to the effect of those permitted for white petrolatum on the Diaper Rash Products or Medicated Skin Care Products monographs), then the product is considered a drug.  A Drug Identification Number Application should be submitted to Health Canada for this product.

If white petrolatum is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is greater than or equal to 30% and 3) does not contribute to the claim (as defined above), the product is an NHP.  A Natural Health Product Licence Application should be submitted to Health Canada for this product.";s:25:"field_non_nhp_rationale_f";s:1702:"Le pétrolatum blanc est un non-PSN puisqu'il n'est pas une substance décrite sous l'Annexe 1 du Règlement sur les produits de santé naturels.  Si le pétrolatum blanc est déclaré comme ingrédient médicinal dans un produit, ce produit est une drogue, et non un PSN.  Une demande pour obtenir un numéro d'identification de médicament (DIN) doit être soumise à Santé Canada pour un tel produit.

Si le pétrolatum blanc est 1) déclaré comme un ingrédient non médicinal et 2) est présent à une concentration qui est inférieure à 30%, le produit est un PSN.  Une demande de licence de mise en marché pour un produit de santé naturel doit être soumise à Santé Canada pour un tel produit.

Si le pétrolatum blanc est 1) déclaré comme ingrédient non médicinal et 2) est présent à une concentration qui est supérieure ou égale à 30% et 3) qu'il contribue à l'allégation (p. ex. l'usage ou la fin recommandé pour le produit est un énoncé qui est comparable à ceux permis pour le pétrolatum blanc dans les monographies pour les produits de traitement de l'érythème fessier ou des produits médicamenteux pour le soin de la peau), ce produit est une drogue.  Une demande pour obtenir un numéro d'identification de médicament (DIN) doit être soumise à Santé Canada pour un tel produit.

Si le pétrolatum blanc est 1) déclaré comme ingrédient non médicinal et 2) est présent à une concentration supérieure ou égale à 30% et 3) qu'il ne contribute pas à l'allégation (comme définie ci-haut), ce produit est un PSN.  Une demande de licence de mise en marché pour un produit de santé naturel doit être soumise à Santé Canada pour un tel produit.";s:19:"field_old_rationale";s:757:"At any concentration where White Petrolatum is associated with a health claim (e.g. as a barrier in diaper rash products), petrolatum is classified as a drug medicinal ingredient subject to the Food and Drug Regulations, not an NHP, because petroleum products are not captured in Schedule 1 to the Natural Health Products Regulations.
Pour toutes les concentrations où le Pétrolatum blanc est associé à une allégation santé (e.g. comme barrière dans les produits de traitement de l'érythème fessier), le pétrolatum est classifié comme une drogue médicinale sujette au Règlement sur les aliments et les drogues, et non un PSN, parce que les produits de pétrolatum ne font pas partie de l'Annexe 1 du Règlement des produits de santé naturels.";s:16:"field_legacy_nid";s:5:"77639";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"White petrolatum";s:5:"title";s:16:"White petrolatum";s:3:"nid";s:5:"82458";s:7:"changed";s:10:"2014-10-10";s:14:"workflow_state";s:9:"Published";}i:82459;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:13:"67;5742;22704";s:25:"field_non_nhp_rationale_e";s:1352:"Dimethicone is a non-NHP because it is not falling under Schedule 1 to the NHP Regulations.  If dimethicone is declared as a medicinal ingredient in a product, the product is a drug, not an NHP. A Drug Identification Number Application should be submitted to Health Canada for this product.

If dimethicone is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is less than 1%, the product is an NHP.  A Natural Health Product Licence Application should be submitted to Health Canada for this product.

If dimethicone is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is greater than or equal to 1% and 3) it contributes to the claim (e.g. the Recommended Use or Purpose on the product is a statement to the effect of those permitted for dimethicone on the Diaper Rash Products or Medicated Skin Care Products monographs), then the product is considered a drug.  A Drug Identification Number Application should be submitted to Health Canada for this product.

If dimethicone is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is greater than or equal to 1% and 3) does not contribute to the claim (as defined above), the product is an NHP.  A Natural Health Product Licence Application should be submitted to Health Canada for this product.";s:25:"field_non_nhp_rationale_f";s:1669:"Le diméthicone est un non-PSN puisqu'il n'est pas une substance décrite sous l'Annexe 1 du Règlement sur les produits de santé naturels.  Si le diméthicone est déclaré comme ingrédient médicinal dans un produit, ce produit est une drogue, et non un PSN.  Une demande pour obtenir un numéro d'identification de médicament (DIN) doit être soumise à Santé Canada pour un tel produit.

Si le diméthicone est 1) déclaré comme un ingrédient non médicinal et 2) est présent à une concentration qui est inférieure à 1%, le produit est un PSN.  Une demande de licence de mise en marché pour un produit de santé naturel doit être soumise à Santé Canada pour un tel produit.

Si le diméthicone est 1) déclaré comme ingrédient non médicinal et 2) est présent à une concentration qui est supérieure ou égale à 1% et 3) qu'il contribue à l'allégation (p. ex. l'usage ou la fin recommandé pour le produit est un énoncé qui est comparable à ceux permis pour le diméthicone dans les monographies pour les produits de traitement de l'érythème fessier ou des produits médicamenteux pour le soin de la peau), ce produit est une drogue.  Une demande pour obtenir un numéro d'identification de médicament (DIN) doit être soumise à Santé Canada pour un tel produit.

Si le diméthicone est 1) déclaré comme ingrédient non médicinal et 2) est présent à une concentration supérieure ou égale à 1% et 3) qu'il ne contribute pas à l'allégation (comme définie ci-haut), ce produit est un PSN.  Une demande de licence de mise en marché pour un produit de santé naturel doit être soumise à Santé Canada pour un tel produit.";s:19:"field_old_rationale";s:596:"At any concentration where Dimethicone is associated with a health claim (e.g. as a barrier in diaper rash products), Dimethicone is classified as a drug medicinal ingredient subject to the Food and Drug Regulations, not an NHP.
À Toute concentration où Diméthicone est associé à une allégation de santé (p. ex. comme une barrière dans les produits de traitement de l'érythème fessier), Diméthicone est classifié comme ingrédient médicinal pour drogue assujetti au Règlement sur les aliments et drogues, et non pas comme PSN.
As per October 13, 2005 decision between TPD and NHPD";s:16:"field_legacy_nid";s:5:"76354";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Dimethicone";s:5:"title";s:11:"Dimethicone";s:3:"nid";s:5:"82459";s:7:"changed";s:10:"2014-10-14";s:14:"workflow_state";s:9:"Published";}i:82460;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:15:"5657;5657;22703";s:25:"field_non_nhp_rationale_e";s:1571:"Mineral oil is a non-NHP because it is not falling under Schedule 1 to the NHP Regulations.  If Mineral oil is declared as a medicinal ingredient in a product, the product is a drug, not an NHP. A Drug Identification Number Application should be submitted to Health Canada for this product.

If mineral oil is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is less than 50% (or less than 30% when in combination with colloidal oatmeal), the product is an NHP.  A Natural Health Product Licence Application should be submitted to Health Canada for this product.

If mineral oil is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is greater than or equal to 50% (or greater than or equal to 30% when in combination with colloidal oatmeal) and 3) it contributes to the claim (e.g. the Recommended Use or Purpose on the product is a statement to the effect of those permitted for mineral oil on the Diaper Rash Products or Medicated Skin Care Products monographs), then the product is considered a drug.  A Drug Identification Number Application should be submitted to Health Canada for this product.

If mineral oil is 1) declared as a non-medicinal ingredient and 2) is present at a concentration that is greater than or equal to 50% (or greater than or equal to 30% when in combination with colloidal oatmeal) and 3) does not contribute to the claim (as defined above), the product is an NHP.  A Natural Health Product Licence Application should be submitted to Health Canada for this product.";s:25:"field_non_nhp_rationale_f";s:1981:"L'huile minérale est un non-PSN puisqu'il n'est pas une substance décrite sous l'Annexe 1 du Règlement sur les produits de santé naturels.  Si l'huile minérale est déclaré comme ingrédient médicinal dans un produit, ce produit est une drogue, et non un PSN.  Une demande pour obtenir un numéro d'identification de médicament (DIN) doit être soumise à Santé Canada pour un tel produit.

Si l'huile minérale est 1) déclaré comme un ingrédient non médicinal et 2) est présent à une concentration qui est inférieure à 50% (ou supérieure ou égale à 30% lorsqu'il est en combinaison avec la farine d'avoine colloïdale), le produit est un PSN.  Une demande de licence de mise en marché pour un produit de santé naturel doit être soumise à Santé Canada pour un tel produit.

Si l'huile minérale est 1) déclaré comme ingrédient non médicinal et 2) est présent à une concentration qui est supérieure ou égale à 50% (ou supérieure ou égale à 30% lorsqu'il est en combinaison avec la farine d'avoine colloïdale) et 3) qu'il contribue à l'allégation (p. ex. l'usage ou la fin recommandé pour le produit est un énoncé qui est comparable à ceux permis pour l'huile minérale dans les monographies pour les produits de traitement de l'érythème fessier ou des produits médicamenteux pour le soin de la peau), ce produit est une drogue.  Une demande pour obtenir un numéro d'identification de médicament (DIN) doit être soumise à Santé Canada pour un tel produit.

Si l'huile minérale est 1) déclaré comme ingrédient non médicinal et 2) est présent à une concentration supérieure ou égale à 50% (ou supérieure ou égale à 30% lorsqu'il est en combinaison avec la farine d'avoine colloïdale) et 3) qu'il ne contribute pas à l'allégation (comme définie ci-haut), ce produit est un PSN.  Une demande de licence de mise en marché pour un produit de santé naturel doit être soumise à Santé Canada pour un tel produit.";s:19:"field_old_rationale";s:657:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.
Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels.
Mineral oil (liquid petrolatum) is a by-product obtained when petroleum (which exists in the upper strata of some areas of the Earth's crust) is distilled to produce gasoline. It is composed mainly of alkanes and cyclic paraffins. Since petroleum products contain some residual toxic ingredients and the petroleum are not captured in the Schedule 1 of the NHP Regulations, Mineral oil will be considered as drug, not a NHP.";s:16:"field_legacy_nid";s:5:"76344";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Mineral oil";s:5:"title";s:11:"Mineral oil";s:3:"nid";s:5:"82460";s:7:"changed";s:10:"2014-10-14";s:14:"workflow_state";s:9:"Published";}i:82461;a:12:{s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"22775";s:25:"field_non_nhp_rationale_e";s:97:"A non-NHP because falling under item 10 of Schedule I to the Controlled Drugs and Substances Act.";s:25:"field_non_nhp_rationale_f";s:139:"Un non PSN puisque considéré comme inclus sous l'article 10 de l'Annexe I de la Loi réglementant certaines drogues et autres substances.";s:16:"field_legacy_nid";s:6:"108073";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Sinomenine";s:20:"field_limitation_ref";s:4:"NHPD";s:5:"title";s:10:"Sinomenine";s:3:"nid";s:5:"82461";s:7:"changed";s:10:"2014-11-04";s:14:"workflow_state";s:9:"Published";}i:82462;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"23560";s:25:"field_non_nhp_rationale_e";s:122:"A non-NHP because not a naturally occurring substance falling under Schedule 1 to the Natural Health Products Regulations.";s:25:"field_non_nhp_rationale_f";s:146:"Un non PSN parce que cette substance n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:6:"108372";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Felbinac";s:20:"field_limitation_ref";s:4:"NHPD";s:5:"title";s:8:"Felbinac";s:3:"nid";s:5:"82462";s:7:"changed";s:10:"2014-12-02";s:14:"workflow_state";s:9:"Published";}i:82463;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:15:"304;17412;12530";s:25:"field_non_nhp_rationale_e";s:267:"This ingredient is assigned the role of non-NHP, as listed on the Prescription Drug List: Lovastatin except when sold in oral dosage form that provides 1 milligram (mg) or less per daily dose. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/pdl-ord/pdl_list_fin_ord-eng.php";s:25:"field_non_nhp_rationale_f";s:306:"Un rôle de non PSN a été affecté à cet ingrédient comme présenté à la Liste des drogues sur ordonnance: Lovastatin sauf quand vendu sous forme posologique orale à une concentration de 1.0 mg ou moins par dose quotidienne. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/pdl-ord/pdl_list_fin_ord-fra.php";s:16:"field_legacy_nid";s:5:"77032";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Lovastatin";s:20:"field_limitation_ref";s:3:"PDL";s:5:"title";s:10:"Lovastatin";s:3:"nid";s:5:"82463";s:7:"changed";s:10:"2014-12-11";s:14:"workflow_state";s:9:"Published";}i:82464;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"24172";s:25:"field_non_nhp_rationale_e";s:100:"A non-NHP because not a naturally occurring substance included in Schedule 1 of the NHP Regulations.";s:25:"field_non_nhp_rationale_f";s:130:"Un non PSN parce que n'est pas une substance naturelle comprise dans l'Annexe 1 du Règlement sur les produits de santé naturels.";s:16:"field_legacy_nid";s:6:"108563";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Iohexol";s:20:"field_limitation_ref";s:4:"NHPD";s:5:"title";s:7:"Iohexol";s:3:"nid";s:5:"82464";s:7:"changed";s:10:"2015-01-20";s:14:"workflow_state";s:9:"Published";}i:82465;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"24133";s:25:"field_non_nhp_rationale_e";s:243:"This ingredient is assigned the role of non-NHP, as listed on the Prescription Drug List:When sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.";s:25:"field_non_nhp_rationale_f";s:314:"Un rôle de non PSN a été affecté à cet ingrédient comme présenté à la Liste des drogues sur ordonnance: Lorsque vendu dans les préparations pour usage topique contenant les acides alpha hydroxylés seul ou en combinaison aux des concentrations supérieures de 30 % et/ou avec un pH acide de 3.0 ou moins.";s:16:"field_legacy_nid";s:6:"108605";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Citric acid";s:20:"field_limitation_ref";s:3:"PDL";s:5:"title";s:11:"Citric acid";s:3:"nid";s:5:"82465";s:7:"changed";s:10:"2015-01-23";s:14:"workflow_state";s:9:"Published";}i:82466;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"24133";s:25:"field_non_nhp_rationale_e";s:243:"This ingredient is assigned the role of non-NHP, as listed on the Prescription Drug List:When sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.";s:25:"field_non_nhp_rationale_f";s:314:"Un rôle de non PSN a été affecté à cet ingrédient comme présenté à la Liste des drogues sur ordonnance: Lorsque vendu dans les préparations pour usage topique contenant les acides alpha hydroxylés seul ou en combinaison aux des concentrations supérieures de 30 % et/ou avec un pH acide de 3.0 ou moins.";s:16:"field_legacy_nid";s:6:"108606";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Glycolic Acid";s:20:"field_limitation_ref";s:3:"PDL";s:5:"title";s:13:"Glycolic Acid";s:3:"nid";s:5:"82466";s:7:"changed";s:10:"2015-01-23";s:14:"workflow_state";s:9:"Published";}i:82467;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"24133";s:25:"field_non_nhp_rationale_e";s:243:"This ingredient is assigned the role of non-NHP, as listed on the Prescription Drug List:When sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.";s:25:"field_non_nhp_rationale_f";s:314:"Un rôle de non PSN a été affecté à cet ingrédient comme présenté à la Liste des drogues sur ordonnance: Lorsque vendu dans les préparations pour usage topique contenant les acides alpha hydroxylés seul ou en combinaison aux des concentrations supérieures de 30 % et/ou avec un pH acide de 3.0 ou moins.";s:16:"field_legacy_nid";s:6:"108607";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"D-Lactic acid";s:20:"field_limitation_ref";s:3:"PDL";s:5:"title";s:13:"D-Lactic acid";s:3:"nid";s:5:"82467";s:7:"changed";s:10:"2015-01-23";s:14:"workflow_state";s:9:"Published";}i:82468;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"24133";s:25:"field_non_nhp_rationale_e";s:243:"This ingredient is assigned the role of non-NHP, as listed on the Prescription Drug List:When sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.";s:25:"field_non_nhp_rationale_f";s:314:"Un rôle de non PSN a été affecté à cet ingrédient comme présenté à la Liste des drogues sur ordonnance: Lorsque vendu dans les préparations pour usage topique contenant les acides alpha hydroxylés seul ou en combinaison aux des concentrations supérieures de 30 % et/ou avec un pH acide de 3.0 ou moins.";s:16:"field_legacy_nid";s:6:"108608";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"DL-Lactic acid";s:20:"field_limitation_ref";s:3:"PDL";s:5:"title";s:14:"DL-Lactic acid";s:3:"nid";s:5:"82468";s:7:"changed";s:10:"2015-01-23";s:14:"workflow_state";s:9:"Published";}i:82469;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"24133";s:25:"field_non_nhp_rationale_e";s:243:"This ingredient is assigned the role of non-NHP, as listed on the Prescription Drug List:When sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.";s:25:"field_non_nhp_rationale_f";s:314:"Un rôle de non PSN a été affecté à cet ingrédient comme présenté à la Liste des drogues sur ordonnance: Lorsque vendu dans les préparations pour usage topique contenant les acides alpha hydroxylés seul ou en combinaison aux des concentrations supérieures de 30 % et/ou avec un pH acide de 3.0 ou moins.";s:16:"field_legacy_nid";s:6:"108609";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"L-Lactic acid";s:20:"field_limitation_ref";s:3:"PDL";s:5:"title";s:13:"L-Lactic acid";s:3:"nid";s:5:"82469";s:7:"changed";s:10:"2015-01-23";s:14:"workflow_state";s:9:"Published";}i:82470;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"24133";s:25:"field_non_nhp_rationale_e";s:243:"This ingredient is assigned the role of non-NHP, as listed on the Prescription Drug List:When sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.";s:25:"field_non_nhp_rationale_f";s:314:"Un rôle de non PSN a été affecté à cet ingrédient comme présenté à la Liste des drogues sur ordonnance: Lorsque vendu dans les préparations pour usage topique contenant les acides alpha hydroxylés seul ou en combinaison aux des concentrations supérieures de 30 % et/ou avec un pH acide de 3.0 ou moins.";s:16:"field_legacy_nid";s:6:"108611";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"dl-Mandelic acid";s:20:"field_limitation_ref";s:3:"PDL";s:5:"title";s:16:"dl-Mandelic acid";s:3:"nid";s:5:"82470";s:7:"changed";s:10:"2015-01-23";s:14:"workflow_state";s:9:"Published";}i:82471;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:20:"312;3213;17412;24503";s:25:"field_non_nhp_rationale_e";s:310:"A non-NHP because listed in the Prescription Drug List as follows: Adrenocortical hormones and their salts or derivatives, except hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 1% hydrocortisone in preparations for topical use on the skin.";s:25:"field_non_nhp_rationale_f";s:349:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Hormones corticosurrénales, leurs sels ou dérivés sauf l'hydrocortisone et l'acétate d'hydrocortisone vendus comme ingrédient médicinal unique dans les préparations pour usage topique sur la peau et présents dans celles-ci en concentration de 1 % d'hydrocortisone.";s:16:"field_legacy_nid";s:5:"77450";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Hydrocortisone";s:5:"title";s:14:"Hydrocortisone";s:3:"nid";s:5:"82471";s:7:"changed";s:10:"2015-02-06";s:14:"workflow_state";s:9:"Published";}i:82472;a:12:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:20:"312;3213;17412;24503";s:25:"field_non_nhp_rationale_e";s:310:"A non-NHP because listed in the Prescription Drug List as follows: Adrenocortical hormones and their salts or derivatives, except hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 1% hydrocortisone in preparations for topical use on the skin.";s:25:"field_non_nhp_rationale_f";s:349:"Un non PSN à cause de sa présence sur la Liste des drogues sur ordonnance: Hormones corticosurrénales, leurs sels ou dérivés sauf l'hydrocortisone et l'acétate d'hydrocortisone vendus comme ingrédient médicinal unique dans les préparations pour usage topique sur la peau et présents dans celles-ci en concentration de 1 % d'hydrocortisone.";s:16:"field_legacy_nid";s:5:"77451";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Hydrocortisone acetate";s:5:"title";s:22:"Hydrocortisone acetate";s:3:"nid";s:5:"82472";s:7:"changed";s:10:"2015-02-06";s:14:"workflow_state";s:9:"Published";}i:82473;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:11:"24133;24679";s:25:"field_non_nhp_rationale_e";s:243:"This ingredient is assigned the role of non-NHP, as listed on the Prescription Drug List:When sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.";s:25:"field_non_nhp_rationale_f";s:314:"Un rôle de non PSN a été affecté à cet ingrédient, tel que présenté sur la Liste des drogues sur ordonnance: Lorsque vendu dans les préparations pour usage topique contenant les acides alpha hydroxylés seuls ou en combinaison avec des concentrations supérieures à 30 % et/ou avec un pH de 3.0 ou moins.";s:16:"field_legacy_nid";s:6:"108610";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"L-Malic acid";s:20:"field_limitation_ref";s:3:"PDL";s:5:"title";s:12:"L-Malic acid";s:3:"nid";s:5:"82473";s:7:"changed";s:10:"2015-02-19";s:14:"workflow_state";s:9:"Published";}i:82474;a:13:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"NN";s:13:"field_its_ids";s:5:"24698";s:25:"field_non_nhp_rationale_e";s:276:"This ingredient is assigned the role of non-NHP, as listed on the Prescription Drug List: When sold in topical formulations containing salicylic acid at concentrations greater than 20% and/or with a pH less than 3.0, except when sold to be applied to warts, corns or calluses.";s:25:"field_non_nhp_rationale_f";s:357:"Un rôle de non PSN a été associé à cet ingrédient, comme présenté à la Liste des drogues sur ordonnance: Lorsque vendu dans les préparations pour usage topique contenant l'acide salicylique aux concentrations supérieures à 20 % et/ou avec un pH acide de 3.0 ou moins, sauf quand vendu pour le traitement des verrues, les cors ou les callosités.";s:16:"field_legacy_nid";s:6:"109076";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Salicylic acid";s:20:"field_limitation_ref";s:3:"PDL";s:5:"title";s:14:"Salicylic acid";s:3:"nid";s:5:"82474";s:7:"changed";s:10:"2015-02-26";s:14:"workflow_state";s:9:"Published";}}